ATLASCLEAR HOLDINGS, INC., S-1 filed on 12/31/2024
Securities Registration Statement
v3.24.4
Document And Entity Information
3 Months Ended
Sep. 30, 2024
Cover [Abstract]  
Document Type S-1
Entity Registrant Name AtlasClear Holdings, Inc.
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001963088
Amendment Flag false
v3.24.4
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Feb. 09, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
ASSETS                
Cash and cash equivalents $ 6,817,398 $ 6,558,176   $ 619,554   $ 1,132,900 $ 129,560  
Cash segregated - customers 19,980,711 20,548,972            
Cash segregated - PAB 768,767 200,738            
Receivables - broker-dealers and clearing organizations 1,917,175 1,333,306            
Receivables - customers, net 170,690 823,784            
Other receivables 230,037 64,842            
Prepaids 44,275 67,967   58,828     33,652  
Trading securities, market value, net 55 55   54,799,478     204,044,469  
Total Current Assets 29,929,108 29,597,840   55,477,860   1,212,164 204,207,681  
Operating lease right to use lease asset 288,191 326,336            
Property and equipment, net 11,511 16,080            
Customer list, net 13,843,665 14,150,856            
Goodwill 6,142,525 7,706,725            
Pacsquare asset purchase 1,928,800 1,726,500            
Bank acquisition deposit   91,200            
Cash deposits - broker-dealers and clearing organizations 3,515,000 3,515,000            
Other assets 336,017 336,017            
TOTAL ASSETS 55,994,817 57,466,554   55,477,860   58,621,911 204,207,681  
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Payables to customers 20,009,873 20,162,973            
Accounts and payables to officers/directors 728,936 686,579            
Accounts payable and accrued expenses 4,615,650 5,393,912   5,510,760   5,181,488 4,813,558  
Non-redemption agreement liability       1,441,653        
Payables - broker-dealers and clearing organizations 20,238 4,915            
Commissions, payroll and payroll taxes 221,769 273,386            
Current portion of lease liability 138,218 149,499            
Advances from related parties       3,104,097   1,968,116 319,166  
Convertible notes, net   3,783,437            
Secured convertible note, net   6,857,101            
Promissory notes 852,968 852,968            
Short-term merger financing, net   5,092,083            
Contingent guarantee   3,256,863 $ 3,256,863          
Subscription agreement 2,460,488 2,425,647            
Excise tax payable 2,067,572 2,067,572   1,528,101   1,485,236    
Total Current Liabilities 36,997,956 40,681,377   12,064,611   9,114,840 5,612,724  
Accrued contingent liability 100,000 100,000            
Long-term merger financing, net   7,606,561            
Derivative liability - convertible notes   16,462,690            
Derivative liability - warrants 61,531 307,656   307,656   307,656 184,594  
Earnout - liability 12,638,000 12,298,000            
Deferred income tax liability 3,702,645 5,245,886            
Subordinated borrowings 1,950,000 1,950,000            
Trading account deposit 100,000 100,000            
Long-term lease liability 155,616 182,729            
TOTAL LIABILITIES 79,156,852 95,575,437   12,372,267   9,422,496 5,797,318  
Commitments and Contingencies (Note 10)          
Common stock subject to possible redemption     54,618,469   57,113,761 203,420,202  
STOCKHOLDERS' DEFICIT                
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding      
Common stock, $0.0001 par value; 100,000,000 shares authorized; 22,245,698 and 12,455,157 shares issued and outstanding at September 30, 2024 and June 30, 2024, respectively (excluding 1,029,473 shares issued under the Tau Agreement included in liabilities as of September 30, 2024) 2,225 1,246   503   503 503  
Additional paid-in-capital 114,517,131 110,164,676            
Accumulated Deficit (137,526,772) (148,274,805)   (11,513,379)   (7,914,849) (5,010,342)  
TOTAL STOCKHOLDERS' DEFICIT (23,162,035) (38,108,883)   (11,512,876) $ (11,115,309) (7,914,346) (5,009,839) $ (13,885,204)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 55,994,817 57,466,554   55,477,860   $ 58,621,911 204,207,681  
Nonrelated Party                
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Stock payable 63,742 259,893            
Secured convertible note, net 7,066,449 6,857,101            
Promissory notes   852,968            
Related Party                
LIABILITIES AND STOCKHOLDERS' DEFICIT                
Stock payable $ 55,087 $ 55,087            
Promissory notes       $ 480,000     $ 480,000  
v3.24.4
CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
CONDENSED CONSOLIDATED BALANCE SHEETS        
Subject to possible redemption shares   0 5,050,384  
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000 1,000,000 1,000,000
Preferred stock, shares issued 0 0 0 0
Preferred stock, shares outstanding 0 0 0 0
Common Stock, par value (in Dollars per share) $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000 100,000,000 100,000,000
Common stock, shares issued 22,245,698 12,455,157 5,031,250 5,031,250
Common stock, shares outstanding 22,245,698 12,455,157 5,031,250 5,031,250
v3.24.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
REVENUES                
Commissions $ 1,383,828 $ 1,750,159     $ 2,679,673      
Vetting fees 365,383 340,050     499,125      
Clearing fees 1,047,712 624,550     756,393      
Net gain/(loss) on firm trading accounts 1,711 6,390     10,046      
Other revenue 5,448 9,650     56,246      
TOTAL REVENUES 2,804,082 2,730,799     4,001,483      
EXPENSES                
Compensation, payroll taxes and benefits 1,279,304 1,355,058     2,386,837      
Data processing and clearing costs 611,646 843,824     1,299,527      
Regulatory, professional fees and related expenses 1,095,819 112,216 $ 640,813   11,649,470      
Stock compensation - founder share transfer         1,462,650      
Communications 152,754 172,018     254,608      
Occupancy and equipment 54,004 54,765     76,324      
Transfer fees 51,590 54,807     75,425      
Bank charges 55,901 52,077     88,253      
Intangible assets amortization 307,191 337,911     791,375      
Operating and formation cost             $ 2,737,871 $ 3,024,231
Other 136,975     $ 577,313 185,840 $ 1,485,122    
TOTAL EXPENSES 3,745,184 3,129,718 640,813 577,313 18,270,309 1,485,122 2,737,871 3,024,231
LOSS FROM OPERATIONS (941,102) (398,919) (640,813) (577,313) (14,268,826) (1,485,122) (2,737,871) (3,024,231)
OTHER INCOME/(EXPENSE)                
Interest earned on marketable securities held in Trust Account 606,758   722,390   1,195,081   3,090,086 3,087,315
Net gain on settlement       829,853 146,706 829,853 829,853  
Loss on AtlasClear asset acquisition   (17,845,813)     (86,392,769)      
Change in fair value of warrant liability derivative 246,125 307,656 (184,594) (184,594)   (123,062) (123,062) 6,953,336
Change in fair value, convertible note derivative 3,167,309 (992,152)     (3,585,902)      
Change in fair value, long-term and short-term note derivative 11,152,870 (3,101,057)     (11,208,055)      
Change in fair value, contingent guarantee (839,775) (3,256,863)     (3,256,863)      
Change in fair value of non-redemption agreement     (11,759)   (164,626)   439,787  
Change in fair value of PIPE derivative liability               4,566,000
Change in fair value of earnout liability (340,000) (1,115,000)     (1,335,000)      
Change in fair value of subscription agreement (34,841) (4,413,946)     (38,796)      
Change in fair value of stock payable 196,151       985,072      
Extinguishment of accrued expenses   114,199     879,473      
Interest expense (1,456,996) (3,210,786)     (3,732,178)      
TOTAL OTHER INCOME/(EXPENSE) 11,710,887 (31,794,347) 526,037 1,381,185 (106,507,857) 2,744,170 4,258,859 14,606,651
NET INCOME/(LOSS) BEFORE INCOME TAXES 10,769,785 (32,193,266) (114,776) 803,872 (120,776,683) 1,259,048 1,520,988 11,582,420
Income tax (expense) benefit (21,752) 563,736 (141,202) (318,313) 569,736 (581,118) (726,038) (536,853)
NET INCOME/(LOSS) $ 10,748,033 $ (31,629,530) $ (255,978) $ 485,559 $ (120,206,947) $ 677,930 $ 794,950 $ 11,045,567
Redeemable Common Stock                
OTHER INCOME/(EXPENSE)                
Basic net income (loss) per share (in dollars per share)         $ (10.16)   $ 0.07 $ 0.44
Diluted net income (loss) per share (in dollars per share)     $ (0.03)   $ (10.16)   $ 0.07 $ 0.44
Basic weighted average shares outstanding (in shares)         1,109,975   6,898,644 20,125,000
Diluted weighted average shares outstanding (in shares)     5,205,217   1,109,975   6,898,644 20,125,000
Non-redeemable Common Stock                
OTHER INCOME/(EXPENSE)                
Basic net income (loss) per share (in dollars per share)         $ (11.6)   $ 0.07 $ 0.44
Diluted net income (loss) per share (in dollars per share)         $ (11.6)   $ 0.07 $ 0.44
Basic weighted average shares outstanding (in shares)         10,719,043   5,031,250 5,031,250
Diluted weighted average shares outstanding (in shares)         10,719,043   5,031,250 5,031,250
v3.24.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
ATLASCLEAR, INC
Common Stock
Pacsquare
Common Stock
Additional Paid-in Capital
ATLASCLEAR, INC
Additional Paid-in Capital
Pacsquare
Additional Paid-in Capital
Accumulated Deficit
ATLASCLEAR, INC
Pacsquare
Total
Beginning balance at Dec. 31, 2021     $ 503       $ (13,885,707)     $ (13,885,204)
Beginning balance (in shares) at Dec. 31, 2021     5,031,250              
Accretion of Common Stock subject to Possible Redemption             (2,170,202)     (2,170,202)
Net income (loss)             11,045,567     11,045,567
Ending balance at Dec. 31, 2022     $ 503       (5,010,342)     $ (5,009,839)
Ending balance (in shares) at Dec. 31, 2022     5,031,250             5,031,250
Net income (loss)                   $ 677,930
Ending balance at Jun. 30, 2023     $ 503       (7,914,849)     (7,914,346)
Ending balance (in shares) at Jun. 30, 2023     5,031,250              
Beginning balance at Dec. 31, 2022     $ 503       (5,010,342)     $ (5,009,839)
Beginning balance (in shares) at Dec. 31, 2022     5,031,250             5,031,250
Excise taxes related to redemptions             (1,528,101)     $ (1,528,101)
Cancellation of admin fees           $ 120,000       120,000
Fair value of non-redemption agreement liability at issuance             (1,881,440)     (1,881,440)
Accretion of Common Stock subject to Possible Redemption           (120,000) (3,888,446)     (4,008,446)
Net income (loss)             794,950     794,950
Ending balance at Dec. 31, 2023     $ 503       (11,513,379)     $ (11,512,876)
Ending balance (in shares) at Dec. 31, 2023     5,031,250             5,031,250
Beginning balance at Jun. 30, 2023     $ 503       (7,914,849)     $ (7,914,346)
Beginning balance (in shares) at Jun. 30, 2023     5,031,250              
Excise taxes related to redemptions             (42,865)     (42,865)
Fair value of non-redemption agreement liability at issuance             (1,881,440)     (1,881,440)
Accretion of Common Stock subject to Possible Redemption             (1,020,680)     (1,020,680)
Net income (loss)             (255,978)     (255,978)
Ending balance at Sep. 30, 2023     $ 503       (11,115,812)     (11,115,309)
Ending balance (in shares) at Sep. 30, 2023     5,031,250              
Beginning balance at Dec. 31, 2023     $ 503       (11,513,379)     $ (11,512,876)
Beginning balance (in shares) at Dec. 31, 2023     5,031,250             5,031,250
Common stock no longer subject to redemption     $ 11     1,195,555       $ 1,195,566
Common stock no longer subject to redemption (in shares)     109,499              
Common stock issued to settled vendor obligations     $ 35     1,459,941       1,459,976
Common stock issued to for consulting services (in shares)     353,198              
Stock Compensation Expense - Founder Shares transferred at closing           1,462,650       1,462,650
Founder Shares transferred at closing to non-redemption agreement holders           1,606,279       1,606,279
Founder Shares transferred at closing as consideration for Wilson Davis Acquisition           6,000,000       6,000,000
Founder Shares and warrants transferred to Secured convertible note holders           1,250,698       1,250,698
Shares issued to settle related party advances and promissory notes, net of deemed dividend     $ 200     19,999,800 (15,422,431)     $ 4,577,569
Shares issued to settle related party advances and promissory notes, net of deemed dividend (in shares)     2,000,000              
Shares issued as purchase consideration for the assets $ 445 $ 33   $ 44,399,555 $ 1,141,467     $ 44,400,000 $ 1,141,500  
Shares issued as purchase consideration for the assets (in shares) 4,440,000 336,000           4,440,000   4,400,000
Earnout shares granted as purchase consideration for the assets of AtlasClear, Inc.       $ 31,347,000       $ 31,347,000    
Shares issued as deposit for the Commercial Bank acquisition     $ 4     91,196       $ 91,200
Shares issued as deposit for the Commercial Bank acquisition (in shares)     40,000              
Shares issued as settlement of accrued interest     $ 15     210,535       210,550
Shares issued as settlement of accrued interest (in shares)     145,210              
Excise taxes related to redemptions             (539,471)     (539,471)
Accretion of Common Stock subject to Possible Redemption             (592,577)     (592,577)
Net income (loss)             (120,206,947)     (120,206,947)
Ending balance at Jun. 30, 2024     $ 1,246     110,164,676 (148,274,805)     $ (38,108,883)
Ending balance (in shares) at Jun. 30, 2024     12,455,157             12,455,157
Common stock issued to settled vendor obligations     $ 1     2,577       $ 2,578
Common stock issued to for consulting services (in shares)     12,000              
Shares issued as purchase consideration for the assets   $ 50     $ 122,250       $ 122,300  
Shares issued as purchase consideration for the assets (in shares)   500,000                
Shares issued as deposit for the Commercial Bank acquisition (in shares)                   1,234,990
Net income (loss)             10,748,033     $ 10,748,033
Ending balance at Sep. 30, 2024     $ 2,225     $ 114,517,131 $ (137,526,772)     $ (23,162,035)
Ending balance (in shares) at Sep. 30, 2024     22,245,698             22,245,698
v3.24.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities:              
Net income (loss) $ 10,748,033   $ (255,978) $ (120,206,947)   $ 794,950 $ 11,045,567
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:              
Change in fair value of warrant liability derivative (246,125) $ (307,656) 184,594   $ 123,062 123,062 (6,953,336)
Change in fair value of PIPE derivative liability             (4,566,000)
Change in fair value of contingent guarantee 839,775 3,256,863   3,256,863      
Change in fair value of non-redemption agreement     11,759 164,626   (439,787)  
Loss on AtlasClear asset acquisition       86,392,769      
Fee on Secured convertible note       1,500,000      
Change in fair value, convertible note derivative (3,167,309)     3,585,904      
Change in fair value, long-term and short-term note derivative (11,152,870) 3,101,057   11,208,055      
Interest expense on convertible notes       1,896,714      
Transaction costs paid with stock       1,401,937      
Stock based compensation 2,578     1,462,650      
Change in fair value, earnout liability 340,000 1,115,000   1,335,000      
Change in operating lease expense       68,727      
Interest earned on marketable securities held in Trust Account     (716,882) (251,569) (2,028,921) (3,090,086) (3,087,315)
Change in fair value, subscription agreement 34,841     38,796      
Depreciation expense 4,569     7,565      
Amortization of intangibles 307,191 337,911   791,375      
Bad debt expense 639     2,474      
Changes in operating assets and liabilities:              
Due from Atlas Clear 15,323     (12,903)   (58,828)  
Income taxes payable         44,118 189,038 536,853
Marketable securities       6,820      
Receivables from brokers & dealers (583,869)     2,203,271      
Receivables from customers 652,455     (303,486)      
Receivables from others (57,235)     (59,043)      
Advances and Prepaid expenses 23,692   (18,750) 133,158 4,194 33,652 305,798
Cash deposits with clearing organization & other B/Ds       21,664      
Other assets     (4,245) 49,041      
Payables to customers (153,100)     (5,124,740)      
Payables to officers & directors 42,357     98,048      
Payable to brokers & dealers 15,323     (12,903)   (58,828)  
Accounts payable and accrued expenses 223,401   161,531 (1,066,430) 443,812 628,164 1,634,174
Commissions and payroll taxes payable (51,617)     39,638      
Stock Loan       259,893      
Operating lease right-of-use asset       (11,713)      
Operating lease liability       (56,900)      
Deferred tax liability 20,959     (43,484)      
CASH PROVIDED BY (USED FOR) OPERATING ACTIVITIES 175,607   (637,971) (11,212,227) (785,611) (1,819,835) (1,084,259)
Cash Flows from Investing Activities:              
Cash withdrawn from Trust Account to pay franchise and income taxes     359,897 68,418   1,374,898 351,474
Investment of cash into Trust Account     (495,000) (160,000) (875,000) (1,850,000)  
Cash withdrawn from Trust Account in connection with redemption     4,286,537 53,947,064 1,015,001 152,810,179  
Cash paid for purchase of Pacsquare (65,000)     (500,000)      
Cash received from acquisition of Wilson-Davis       33,333,876      
Cash withdrawn from Trust Account for working capital purposes       1,195,565 148,523,642    
Cash paid to Wilson Davis shareholders       (8,092,568)      
CASH PROVIDED BY (USED FOR) INVESTING ACTIVITIES (65,000)   4,151,434 79,792,355 148,663,643 152,335,077 351,474
Cash Flows from Financing Activities:              
Proceeds from secured convertible note       6,000,000      
Transaction costs financed       5,002,968      
Proceeds from promissory note - related party             480,000
Repayment of advances from related party           (70,500)  
Advances from related party     352,981 1,052,300 1,948,950 2,855,431 319,166
Redemption of common stock     (4,286,537) (53,947,064) (148,523,642) (152,810,179)  
CASH PROVIDED BY (USED FOR) FINANCING ACTIVITIES 148,383   (3,933,556) (41,891,796) (146,874,692) (150,025,248) 799,166
NET INCREASE (DECREASE) IN CASH 258,990   (420,093) 26,688,332 1,003,340 489,994 66,381
CASH AT BEGINNING OF YEAR 27,307,886   1,132,900 619,554 129,560 129,560 63,179
CASH AT YEAR END 27,566,876 $ 27,307,886 712,807 27,307,886 1,132,900 619,554 129,560
Supplementary cash flow information:              
Cash paid for income taxes         537,000 537,000  
Supplemental disclosure of non-cash investing and financing activities:              
Shares issued to settled advances from related party and notes payable related party, net of deemed dividend       4,577,569      
Transaction cost settled with subscription payable       2,386,851      
Fair value of equity treated earnout in AtlasClear, Inc asset acquisition       31,347,000      
Fair value of shares issued in AtlasClear, Inc asset acquisition       44,400,000      
Fair value of liability treated earnout in AtlasClear, Inc asset acquisition       10,963,000      
Fair value of shares transferred to Wilson Davis shareholders       6,000,000      
Short term notes issued to Wilson Davis shareholders       5,000,000      
Long term notes issued to Wilson Davis shareholders       7,971,197      
Initial value of derivative liability on convertible notes       1,668,731      
Fair value of shares transferred to Secured convertible note holders       1,250,698      
Redeemable shares transferred to permanent equity       1,195,566      
Non-redemption agreement re-classed to permanent equity       1,606,279      
Shares issued to purchase Pacsquare and amounts included in accounts payable       1,226,500      
Shares issued as deposit for Commercial bank acquisition       91,200      
Initial Classification of non-redemption agreement liability     1,884,440 1,668,731      
Cancellation of admin fees         120,000 120,000  
Excise tax related to redemptions     42,865 539,471 1,485,236 1,528,101  
Accretion of common stock subject to possible redemption     $ 1,020,680 592,577 2,217,201 4,008,446 $ 2,170,202
Accounts payable settled with shares       64,376      
Interest settled with shares       210,550      
Interest settled with shares transferred by related party       48,750      
ATLASCLEAR, INC              
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:              
Amortization of intangibles       (317,231)      
Changes in operating assets and liabilities:              
Due from Atlas Clear         (49,806)    
Payable to brokers & dealers         $ (49,806)    
Supplemental disclosure of non-cash investing and financing activities:              
Fair value of equity treated earnout in AtlasClear, Inc asset acquisition       31,347,000      
Fair value of shares issued in AtlasClear, Inc asset acquisition       44,400,000      
Fair value of liability treated earnout in AtlasClear, Inc asset acquisition       10,963,000      
Pacsquare              
Supplemental disclosure of non-cash investing and financing activities:              
Shares issued to purchase Pacsquare and amounts included in accounts payable $ 137,300     $ 1,226,500      
Initial Classification of non-redemption agreement liability           $ 1,881,440  
v3.24.4
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS    
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

AtlasClear Holdings, Inc. (formerly known as Calculator New Pubco, Inc.) (the “Company” or “AtlasClear Holdings”) is a Delaware corporation and, prior to the Business Combination (defined below), was a direct, wholly-owned subsidiary of Quantum FinTech Acquisition Corporation (“Quantum”). Quantum was incorporated in Delaware on October 1, 2020. Quantum was a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

On February 9, 2024 (the “Closing Date”), the Company consummated the previously announced transactions pursuant to that certain Business Combination Agreement, dated November 16, 2022 (as amended, the “Business Combination Agreement”), by and among the Company, Quantum, Calculator Merger Sub 1, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 1”), Calculator Merger Sub 2, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 2”), AtlasClear, Inc., a Wyoming corporation (“AtlasClear”), Atlas FinTech Holdings Corp., a Delaware corporation (“Atlas FinTech”) and Robert McBey. The transactions consummated as a result of the Business Combination Agreement are hereinafter referred to as the “Business Combination.” In connection with the consummation of the Business Combination (the “Closing”), the Company changed its name from “Calculator New Pubco, Inc.” to “AtlasClear Holdings, Inc.” As a result, the operation history of Quantum survived the merger. Pursuant to the Business Combination Agreement, AtlasClear received certain assets from Atlas FinTech and Atlas Financial Technologies Corp., a Delaware corporation, and (ii) Broker-Dealer Acquisition Agreement (as defined in the Business Combination Agreement), AtlasClear completed the acquisition of broker-dealer, Wilson-Davis & Co., Inc. (“Wilson-Davis”).

On February 16, 2024, AtlasClear and Pacsquare Technologies, LLC (“Pacsquare”) entered into a Source Code Purchase and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear purchased a proprietary trading platform with clearing and settlement capabilities that will be developed by Pacsquare, including certain software and source code (the “AtlasClear Platform”).

AtlasClear Holdings’ goal is to build a cutting-edge technology enabled financial services firm that would create a more efficient platform for trading, clearing, settlement and banking, with evolving and innovative financial products that focus on financial services firms. AtlasClear Holdings is a fintech driven business-to-business platform that expects to power innovation in fintech, investing, and trading.

AtlasClear does not meet the definition of a business and therefore was treated as an asset acquisition by AtlasClear Holdings. As such the assets contributed from Atlas FinTech and the net assets of AtlasClear were recognized at historical cost. ASC 350 prohibits the recognition of goodwill in an asset purchase.

Quantum was deemed the accounting acquirer based on the following factors: i) Quantum issued cash and shares of its common stock; ii) Quantum controlled the voting rights under the no redemption and the maximum contractual redemption scenarios; iii) Quantum had the largest minority voting interest; iv) Quantum has control over the board of directors of the post-combination company and most of senior management of the post-combination company are former officers of Quantum.

Wilson-Davis is a securities broker and dealer, dealing in over-the-counter and listed securities. Wilson-Davis is registered with the Securities and Exchange Commission (the “SEC”) and is a member of the Financial Industry Regulatory Authority.

Revenue is derived principally from Wilson-Davis’ operations in three areas: commission revenue, fee revenue and interest revenue.

Wilson-Davis has operations in Utah, Arizona, California, Colorado, Florida, New York, Oklahoma and Texas. Transactions for customers are principally in the states where the Company operates, however, some customers are located in other states in which the Company is registered. Principal trading activities are conducted with other broker dealers throughout the United States.

Going Concern

As of September 30, 2024, the Company had $6,817,398 in its operating bank accounts and working capital deficit of $7,068,848.

The Company has raised and intends to raise additional capital through loans or additional investments from its stockholders, officers, directors, or third parties. The Company’s officers and directors may, but are not obligated to loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Codification Subtopic 205-40, “Presentation of Financial Statements – Going Concern,” the liquidity of the Company raises substantial doubt about the Company’s ability to continue as a going concern through the twelve months following the issuance of the financial statements. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. No adjustments have been made to the carrying amounts of assets or liabilities as a result of this uncertainty.

Inflation Reduction Act of 2022

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. As such the Company has accrued for the estimated excise tax as a result of the redemptions that occurred after December 31, 2022. As of September 30, 2024 and June 30, 2024 the excise tax payable is $2,067,572. As of the date of filing the Company has not paid the excise tax as such the Company may be subject to interest and penalties as a result.

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

AtlasClear Holdings, Inc. (formerly known as Calculator New Pubco, Inc.) (the “Company” or “AtlasClear Holdings”) is a Delaware corporation and a direct, wholly-owned subsidiary of Quantum FinTech Acquisition Corporation (“Quantum”) formed solely for the purpose of effectuating a business combination. Quantum was incorporated in Delaware on October 1, 2020. Quantum was a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

On February 9, 2024 (the “Closing Date”), the Company consummated the previously announced transactions pursuant to that certain Business Combination Agreement, dated November 16, 2022 (as amended, the “Business Combination Agreement”), by and among the Company, Quantum, Calculator Merger Sub 1, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 1”), Calculator Merger Sub 2, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 2”), AtlasClear, Inc., a Wyoming corporation (“AtlasClear”), Atlas FinTech Holdings Corp., a Delaware corporation (“Atlas FinTech”) and Robert McBey. The transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Business Combination.” In connection with the consummation of the Business Combination (the “Closing”), the Company changed its name from “Calculator New Pubco, Inc.” to “AtlasClear Holdings, Inc.” As a result, the operation history of Quantum survived the merger.

Pursuant to the Business Combination Agreement, among other things, (i) Merger Sub 1 merged with and into Quantum, with Quantum continuing as the surviving corporation and a wholly-owned subsidiary of AtlasClear Holdings and (ii) Merger Sub 2 merged with and into AtlasClear, with AtlasClear continuing as the surviving corporation and a wholly-owned subsidiary of AtlasClear Holdings. Prior to the Closing, pursuant to the (i) Contribution Agreement (as defined in the Business Combination Agreement), AtlasClear received certain assets from Atlas FinTech and Atlas Financial Technologies Corp., a Delaware corporation, and (ii) Broker-Dealer Acquisition Agreement (as defined in the Business Combination Agreement), AtlasClear completed the acquisition of broker-dealer, Wilson-Davis & Co., Inc. (“Wilson-Davis”). In addition, at Closing, the Bank Acquisition Agreement (as defined in the Business Combination Agreement), pursuant to which AtlasClear has agreed to acquire Commercial Bancorp, a Wyoming corporation and parent of Farmers State Bank (“Commercial Bancorp”), continued to be in full force and effect. Pursuant to the transactions contemplated by a letter of intent, on February 16, 2024, AtlasClear and Pacsquare Technologies, LLC (“Pacsquare”) entered into a Source Code Purchase and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear purchased a proprietary trading platform with clearing and settlement capabilities that will be developed by Pacsquare, including certain software and source code (the “AtlasClear Platform”).

The Business Combination has been accounted for in accordance with the acquisition method of accounting, with Quantum considered to be the accounting acquirer of Wilson-Davis. Under the acquisition method of accounting, the preliminary purchase price is allocated to the underlying tangible and intangible assets acquired and liabilities assumed based on their respective fair market values, with the excess purchase price, if any, allocated to goodwill. Costs related to the transaction were expensed as incurred. (See Note 8 – Acquisition of Wilson-Davis).

AtlasClear Holdings’ goal is to build a cutting-edge technology enabled financial services firm that would create a more efficient platform for trading, clearing, settlement and banking, with evolving and innovative financial products that focus on financial services firms. AtlasClear Holdings is a fintech driven business-to-business platform that expects to power innovation in fintech, investing, and trading.

AtlasClear does not meet the definition of a business and therefore was treated as an asset acquisition by AtlasClear Holdings. As such the assets contributed from Atlas Fintech and the net assets of AtlasClear were recognized at historical cost. ASC 350 prohibits the recognition of goodwill in an asset purchase. (See Note 9 – Acquisition of Assets of AtlasClear, Inc.)

Quantum was deemed the accounting acquirer based on the following factors: i) Quantum issued cash and shares of its common stock; ii) Quantum controlled the voting rights under the no redemption and the maximum contractual redemption scenarios; iii) Quantum had the largest minority voting interest; iv) Quantum has control over the board of directors of the post-combination company and most of senior management of the post-combination company are former officers of Quantum.

Wilson-Davis is a securities broker and dealer, dealing in over-the-counter and listed securities. Wilson-Davis is registered with the Securities and Exchange Commission (the “SEC”)) and is a member of the Financial Industry Regulatory Authority.

Revenue is derived principally Wilson-Davis’ operations in three areas: commission revenue, fee revenue and interest revenue.

Wilson-Davis has operations in Utah, Arizona, California, Colorado, Florida, New York, Oklahoma and Texas. Transactions for customers are principally in the states where the Company operates, however, some customers are located in other states in which the Company is registered. Principal trading activities are conducted with other broker dealers throughout the United States.

Going Concern

As of June 30, 2024, the Consolidated Company had $27,307,886 in its bank accounts and working capital deficit of $21,724,075.

The Company has raised and intends to raise additional capital through loans or additional investments from its stockholders, officers, directors, or third parties. The Company’s officers and directors may, but are not obligated to loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Codification Subtopic 205-40, “Presentation of Financial Statements – Going Concern,” the liquidity of the Company raises substantial doubt about the Company’s ability to continue as a going concern through the twelve months following the issuance of the financial statements. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. No adjustments have been made to the carrying amounts of assets or liabilities as a result of this uncertainty.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. As such the Company has accrued for the estimated excise tax as a result of the redemptions that occurred after December 31, 2022. As of June 30, 2024 - the excise tax payable is $2,067,572.

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Transition Report on Form 10-KT, as filed with the SEC on October 16, 2024. The accompanying condensed balance sheet as of June 30, 2024 has been derived from the audited financial statements included in the Form 10-KT. The interim results for the three months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending June 30, 2025 or for any future periods.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Goodwill

We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates, and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As a result of the Deferred tax the Goodwill

balance was reduced by the benefit received. As of September 30, 2024, the fair value of goodwill was $6,142,525, as described in Note 10.

Intangible Assets

Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of September 30, 2024, the carrying value of developed technology and customer list was $1,928,800 and $13,843,665, respectively, as described in Note 10 and Note 11.

Impairment of Long-lived and Intangible Assets

The Company had no impairment charges during the three-month periods ended September 30, 2024 and 2023.

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the condensed consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 14).

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) Income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the warrants issued and outstanding. For the three months ended September 30, 2024, the calculation excludes the dilutive impact of warrants because none would be issued under treasury method. The convertible financial instrument and other share obligations were included in the dilutive calculation under the as converted method, as such the number of shares were included as if the shares were issued on July 1, 2024 and the interest expense and the change in fair value associated with the financial instruments was adjusted from net income to determine the numerator and denominator.

For the three months ended September 30, 2023, the calculation excludes the dilutive impact of these instruments because the exercise of the warrants were contingent upon the occurrence of future events and inclusion would be antidilutive.

The following table reflects the calculation of basic net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30, 2024

September 30, 2023

    

Non-

    

    

Non-

 redeemable

Redeemable

 redeemable

Basic net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income, as adjusted

$

10,748,033

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Basic weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

Basic net income per common stock

$

0.70

$

(0.03)

$

(0.03)

The following table reflects the calculation of diluted net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30,2024

September 30,2023

Non-

Non-

    

redeemable

    

Redeemable

    

redeemable

Diluted net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income,

$

10,748,033

$

(130,164)

$

(125,814)

Change in fair value of financial instruments

 

(12,655,000)

 

 

Interest on dilutive instruments

 

1,419,843

 

 

Allocation of net income, as adjusted

$

(487,124)

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Dilutive weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

If converted shares

 

99,180,693

 

 

 

114,565,050

 

5,205,217

 

5,031,250

Diluted net income (loss) per common stock

$

(0.00)

$

(0.03)

$

(0.03)

Below is a summary of the dilutive instruments as of September 30, 2024 and 2023:

Description

    

September 30, 2024

    

September 30, 2023

Short Term Notes

 

49,050,804

 

Convertible notes

 

19,263,975

 

Secured convertible note

 

26,202,298

 

Subscription agreement

 

2,818,665

 

Tau agreement

 

1,253,514

 

Stock payable

250,000

Promissory note

341,437

Total Shares issuable under Convertible Note obligations – if converted total dilutive

99,180,693

Public Warrants

 

10,062,500

 

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

Secured convertible note warrants

 

600,000

 

Total excluded under treasury method – out of the money

 

16,215,625

 

16,215,625

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute

payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the private warrant liabilities, the fair value of the Subscription Agreement, the fair value of the conversion liabilities, realization of deferred tax assets, and the fair value of the customer list acquired on February 9, 2024. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all operating accounts that hold money market funds held and short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

Trading Securities

Securities held in the Company’s trading account and trading securities, consist primarily of over-the-counter securities and are valued based upon quoted market prices. The value of securities that are not readily marketable are estimated by management based upon quoted prices, the number of market makers, trading volume and number of shares held. Unrealized gains and losses are reflected in income in the financial statements.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation on property and equipment is provided using accelerated and straight-line methods over expected useful lives of three to seven years.

Leases

In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability on the statement of financial condition for all leases with terms longer than 12 months. Pursuant to this standard, the Company has recorded an operating lease right-of use (“ROU”) asset and operating lease liability in the accompanying balance sheet as of June 30, 2024.

The Company leases office space under the terms of several operating leases. The determination of whether an arrangement is a lease is made at the lease’s inception. Under ASC 842, a contract is (or contains) a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Control is defined under the standard as having both the right to obtain substantially all of the economic benefits from use of the asset and the right to direct the use of the asset. Management only reassesses its determination if the terms and conditions of the contract are changed.

ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses the implicit rate when it is readily determinable. Since the Company’s leases do not provide implicit rates, to determine the present value of lease payments, management uses the Company’s estimated incremental borrowing rate based on the information available at lease commencement.

Goodwill

Goodwill represents the excess of purchase price in a business combination over the fair value of the net identifiable assets acquired. We evaluate goodwill for impairment at the reporting unit level by assessing whether it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If this assessment concludes that it is more likely than not that the fair value of a reporting unit exceeds its carrying value, then goodwill is not considered impaired and no further impairment testing is required. Conversely, if the assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, a goodwill impairment test is performed to compare the fair value of the reporting unit to its carrying value. The Company determines fair value of the reporting unit using income models. Our models contain significant assumptions and accounting estimates about discount rates, future cash flows, that could materially affect our operating results or financial position if they were to change significantly in the future and could result in an impairment. We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As of June 30, 2024, the fair value of goodwill was $7,706,725, as described in Note 11.

Intangible Assets

Intangible assets are presented at fair value, net of amortization. The fair value is determined based on the appraised value of the asset. Intangible assets comprise of developed technology and customer list (See Note 11 and 13). Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of June 30, 2024, the fair value of developed technology and customer list was $1,726,500 and $14,625,000, respectively, as described in Note 11 and Note 13.

Impairment of Long-lived and Intangible Assets

In accordance with ASC 360-10 Property Plant and Equipment and ASC 350-10 Intangibles, the Company, on a regular basis, reviews the carrying amount of long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. The Company determines if the carrying amount of a long-lived asset is impaired based on anticipated undiscounted cash flows, before interest, from the use of the asset. In the event of impairment, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the asset. Fair value is determined based on the appraised value of the assets or the anticipated cash flows from the use of the asset, discounted at a rate commensurate with the risk involved. The Company recorded $17,845,813 of impairment charges included in loss on AtlasClear asset acquisition during the six months ended June 30.

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 9).

Income Taxes

The Company utilizes the asset and liability method to account for income taxes. The objective of this method is to establish deferred tax assets and liabilities for the temporary differences between net income for financial reporting basis and the tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized.

Income tax expense or benefit is provided based upon the financial statement earnings of the Company. The allowance for doubtful accounts is deductible for financial statement purposes, but not for tax purposes. Depreciation expense is recognized in different periods for tax and financial accounting purposes due to the use of accelerated depreciation methods for income tax purposes. The tax effects of such differences are reported as deferred income taxes in the financial statements.

Revenue Recognition

Wilson-Davis, a subsidiary of the Company, recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, using the modified retrospective method. This revenue recognition guidance requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance requires an entity to follow a five-step model to: (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when the entity satisfies a performance obligation.

Wilson-Davis acts as an agent by selling securities to customers and collecting commissions. Wilson-Davis recognizes commissions on a trade date basis, which is the day the transaction is executed. Wilson-Davis believes that the performance obligation is satisfied on the trade date because that is when the security is selected, the price is determined, the trade is executed, and the risks and rewards of ownership have been transferred to/from the customer.

Wilson-Davis also receives commissions on mutual funds purchased by customers. Wilson-Davis believes that the performance obligation is not satisfied until the mutual funds are purchased by customers and recognizes the commission at that time.

Wilson-Davis performs vetting services to customers that wish to convert restricted stock to eligible trading stock. In addition, Wilson-Davis charges clearing fees to another broker-dealer for which it clears trades. Wilson-Davis recognizes revenue as the related performance obligations are satisfied.

Common Stock Subject to Possible Redemption

The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Common Stock subject to mandatory redemption are classified as a liability instrument and is measured at fair value. Conditionally redeemable Common Stock (including Common Stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Common Stock is classified as stockholders’ equity. The Company’s Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all Common Stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. The accretion of redeemable Common Stock during the year ended December 31, 2023 was an increase of $4,008,446, which represents cumulative earnings and withdrawals on the Trust Account through December 31, 2023, net of reimbursable income and franchise tax obligations as of December 31, 2023. The dissolution expense of $100,000 is not included in the redemption value of the Common Stock subject to redemption since it is only taken into account in the event of the Company’s liquidation. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Common Stock resulted in charges against additional paid-in capital, to the extent available, and accumulated deficit. On February 9, 2024, the shareholders redeemed in connection with the business combination $53,947,064, the company withdrew $68,418 from trust to cover income tax payments and recognized reclassified the unredeemed shares to permanent equity of 1,195,566. As of June 30, 2024 the Company no longer has redeemable shares.

At June 30, 2024, December 31, 2023 and 2022, the Common Stock reflected in the balance sheets is reconciled in the following table:

Common Stock subject to possible redemption, December 31, 2021

    

$

201,250,000

Plus:

  

Accretion of carrying value to redemption value

2,170,202

Common Stock subject to possible redemption, December 31, 2022

 

203,420,202

Less:

 

  

Redemption

 

(152,810,179)

Plus:

 

  

Accretion of carrying value to redemption value

 

4,008,446

Common Stock subject to possible redemption, December 31, 2023

$

54,618,469

Less:

 

  

Redemption

 

(53,947,064)

Withdraw for taxes

 

(68,416)

Reclass to permanent equity

 

(1,195,566)

Plus:

 

  

Accretion of carrying value to redemption value

 

592,577

Common Stock subject to possible redemption, June 30, 2024

$

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the convertible derivative liability, subscription agreement, earnout shares nor the warrants issued and outstanding. The calculation excludes the dilutive impact of these instruments because the issuance of the securities underlying the exercise of the warrants are contingent upon the occurrence of future events and inclusion would be antidilutive. As a result, diluted net (loss) income per share of common stock is the same as basic net (loss) income per common stock for the periods presented.

The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):

    

FOR THE SIX MONTHS PERIOD ENDED

FOR THE YEAR ENDED

June 30, 2024

December 31, 2023

December 31, 2022

    

Non-

    

    

Non-

    

Non-

Redeemable

    

 redeemable

    

Redeemable

    

 redeemable

    

Redeemable

    

 Redeemable

Basic and diluted net income (loss) per share of Common Stock

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Net loss

$

(11,279,605)

$

(108,927,342)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Deemed dividend

(15,422,431)

Allocation of net income (loss)

$

(11,279,605)

$

(124,349,773)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Denominator:

 

 

 

 

Basic and diluted weighted average shares outstanding

 

10,719,043

 

1,109,975

6,898,644

5,031,250

 

20,125,000

 

5,031,250

Basic and diluted net income (loss) per share of Common Stock

$

(10.16)

$

(11.60)

$

0.07

$

0.07

$

0.44

$

0.44

Below is a summary of the dilutive instruments as of June 30, 2024, December 31, 2023 and, these were excluded as including them would be anti dilutive as of June 30, 2024 and were excluded in December 31, 2023 and June 30, 2023 as the exercise was contingent:

For the Six Months Ended

For the year ended

Description

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Shares issuable pursuant to Short Term and Long Term Notes

 

14,012,965

 

Shares issuable pursuant to Secured convertible note

 

9,801,273

 

Shares issuable pursuant to Convertible note

4,722,875

Shares issuable pursuant to Subscription agreement

938,967

Shares issuable pursuant to Promissory note

 

379,375

 

Total Shares issuable under Note obligations

 

29,855,455

 

Public Warrants

 

10,062,500

 

10,062,500

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

6,153,125

Secured convertible note warrants

 

600,000

 

Total dilutive

 

46,071,080

 

16,215,625

16,215,625

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for warrant liabilities, convertible derivatives and the earnout out liability (see Note 19).

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

v3.24.4
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS    
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS

NOTE 3. CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS

Wilson-Davis is required by Rule 15c3-3 of the SEC to maintain a cash reserve with respect to customers’ transactions and credit balances, on a settlement date basis. Such a reserve is computed weekly using a formula provided by the rule, and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of September 30, 2024, was calculated to be $18,830,537. Wilson-Davis had $19,667,586 cash which was $837,049 more than the amount required. On October 1, 2024, Wilson-Davis withdrew $337,049 from the reserve account in accordance with the rule, which resulted in an excess of $500,000.

Wilson-Davis is required by Rule 15c3-3 of the SEC to maintain a cash reserve with respect to broker-dealer transactions and credit balances. Such a reserve is computed weekly using a formula provided by the rule, and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of September 30, 2024, was calculated to be $100,000. Wilson-Davis had $200,000 cash on deposit in the reserve account, which was $100,000 more than the amount required.

NOTE 3. CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS

The Wilson-Davis is required by Rule 15c3-3 of the Securities and Exchange Commission to maintain a cash reserve with respect to customers’ transactions and credit balances, on a settlement date basis. Such a reserve is computed weekly using a formula provided by the rule and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of June 30, 2024, was calculated to be $19,326,300. Wilson-Davis had $19,677,378 cash on deposit in the reserve account, which was $351,078 more than the amount required. On July 1, 2024, Wilson-Davis deposited $150,000 to the reserve account in accordance with the rule which resulted in an excess of $501,078.

Wilson-Davis is required by Rule 15c3-3 of the Securities and Exchange Commission to maintain a cash reserve with respect to broker-dealer transactions and credit balances. Such a reserve is computed weekly using a formula provided by the rule and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of June 30, 2024, was calculated to be $100,000. Wilson-Davis had $200,738 cash on deposit in the reserve account, which was $100,738 more than the amount required.

v3.24.4
NET CAPITAL REQUIREMENTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
NET CAPITAL REQUIREMENTS    
NET CAPITAL REQUIREMENTS

NOTE 4. NET CAPITAL REQUIREMENTS

As a broker-dealer, Wilson-Davis is subject to the uniform net capital rule adopted and administered by the SEC. The rule requires maintenance of minimum net capital and prohibits a broker-dealer from engaging in securities transactions at a time when its net capital falls below minimum requirements, as those terms are defined by the rule. Under the alternative method permitted by this rule, net capital shall not be less than the greater of $250,000 or 2% of aggregate debit items arising from customer transactions, as defined. Also, Wilson-Davis has a minimum requirement based upon the number of securities markets that it maintains. On September 30, 2024, Wilson-Davis’s net capital was $10,449,178, which was $10,199,178 in excess of the minimum required.

NOTE 4. NET CAPITAL REQUIREMENTS

As a broker dealer, the Company is subject to the uniform net capital rule adopted and administered by the Securities and Exchange Commission. The rule requires maintenance of minimum net capital and prohibits a broker dealer from engaging in securities transactions at a time when its net capital falls below minimum requirements, as those terms are defined by the rule. Under the alternative method permitted by this rule, net capital shall not be less than the greater of $250,000 or 2% of aggregate debit items arising from customer transactions, as defined. Also, the Company has a minimum requirement based upon the number of securities’ markets that the Company maintains. At June 30, 2024, the Company’s net capital was $10,437,312 which was $10,187,312 in excess of the minimum required

v3.24.4
CASH AND RESTRICTED CASH
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CASH AND RESTRICTED CASH    
CASH AND RESTRICTED CASH

NOTE 5 – CASH AND RESTRICTED CASH

Reconciliation of cash and restricted cash as shown in the condensed statements of cash flows is presented in the table below:

    

For the Three Months

Ended 

September 30, 2024

Cash and cash equivalents

$

6,817,398

Cash segregated - customers

 

19,980,711

Cash segregated - PAB

 

768,767

Total cash and restricted cash shown in the statement of cash flows.

$

27,566,876

NOTE 5 – CASH AND RESTRICTED CASH

Reconciliation of cash and restricted cash as shown in the statements of cash flows is presented in the table below:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Cash and cash equivalents

$

6,558,176

$

619,554

$

129,560

Cash segregated - customers

 

20,548,972

 

 

Cash segregated - PAB

 

200,738

 

 

Total cash and restricted cash shown in the statement of cash flows.

$

27,307,886

$

619,554

$

129,560

v3.24.4
RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION
6 Months Ended
Jun. 30, 2024
RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION  
RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION

NOTE 6 – RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION

Amounts receivable and payable with broker dealers and the clearing organization include:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Due from clearing organizations, net

$

1,094,453

$

$

Fails to deliver and receive

 

238,853

 

 

Total receivables

$

1,333,306

$

$

Due from clearing organizations, net

$

3,003

$

$

Fails to deliver and receive

 

1,912

 

 

Total payables

$

4,915

$

$

No losses were recognized on the receivables from broker dealers or clearing organizations during the six-month period ended June 30, 2024.

v3.24.4
CUSTOMER RECEIVABLE AND PAYABLES
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CUSTOMER RECEIVABLE AND PAYABLES    
CUSTOMER RECEIVABLE AND PAYABLES

NOTE 6 – CUSTOMER RECEIVABLE AND PAYABLES

Accounts receivable from and payable to customers at September 30, 2024, include cash and margin accounts. Securities owned by customers are held as collateral for any unpaid amounts. Such collateral is not reflected in the financial statements. The Company provides an allowance for doubtful accounts, as needed, for accounts in which collection is uncertain. Management periodically evaluates each account on a case-by-case basis to determine impairment. Accounts that are deemed uncollectible are written off to bad debt expense. Bad debt expense net of bad debt recoveries and trading error adjustments for the three-month period ended September 30, 2024 was $639 and $15,000 for the transition period ended June 30, 2024.

NOTE 7 – CUSTOMER RECEIVABLE AND PAYABLES

Accounts receivable from and payable to customers at June 30, 2024, include cash and margin accounts. Securities owned by customers are held as collateral for any unpaid amounts. Such collateral is not reflected in the financial statements. The Company provides an allowance for doubtful accounts, as needed, for accounts in which collection is uncertain. Management periodically evaluates each account on a case-by-case basis to determine impairment. Accounts that are deemed uncollectible are written off to bad debt expense. Bad debt expense net of bad debt recoveries and trading error adjustments for the six months period ended June 30, 2024 was $15,000 and zero for the year ended December 31, 2023 and December 31, 2022.

v3.24.4
PROPERTY AND EQUIPMENT
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
PROPERTY AND EQUIPMENT    
PROPERTY AND EQUIPMENT

NOTE 7 – PROPERTY AND EQUIPMENT

Depreciation expense for the three-month period ended September 30, 2024, was $4,569. The Company acquired the below on February 9, 2024, in connection with the acquisition of Wilson-Davis, see Note 10 for further detail. Property and equipment are summarized by major classifications as follows:

    

September 30, 2024

Equipment

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(364,537)

$

11,511

NOTE 8 – PROPERTY AND EQUIPMENT

Depreciation expense for the six-month period ended June 30, 2024, was $7,565. The Company acquired the below on February 9, 2024, in connection with the closing of the business combination with Wilson-Davis, see Note 11 for further detail. Property and equipment are summarized by major classifications as follows:

June 30, 2024

Equipment

      

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(359,968)

$

16,080

v3.24.4
RELATED PARTY TRANSACTIONS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
RELATED PARTY TRANSACTIONS    
RELATED PARTY TRANSACTIONS

NOTE 8. RELATED PARTY TRANSACTIONS

Related Party Share Issuance/Transfers

Quantum Ventures LLC (“Quantum Ventures” or the “Sponsor”) and AtlasFinTech transferred 1,558,923 and 991,665 shares, respectively for total contributed shares of 2,550,588 shares recorded as contributed capital for $2,412,930. The Company recorded contributed capital for the value of the liabilities settled with their personal shareholding. The contributed capital recognized was $21,299 in interest paid in shares for Promissory Notes, $217,397 in interest paid in shares for Secured Convertible Note, $400,000 of Principal converted under the Chardan convertible note along with $212,803 in interest paid in shares for the Chardan convertible note, $351,141 in interest paid in shares for Short and long term Notes and $1,210,290 for payment in shares under the contingent obligation to sellers.

On August 9, 2024, the Company entered into a Satisfaction of Discharge of indebtedness agreement with Atlas FinTech. Pursuant to the agreement the Company issued 2,788,276 shares in satisfaction of $803,860 included in accounts payable. In addition, the Company issued 1,337,500 shares as reimbursement for 991,665 shares that were transferred by AtlasFinTech, as stated above, to satisfy the Company requirements to pay interest on various loans with unrestricted shares. As such a total of 4,125,776 shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”) were transferred to Atlas FinTech in satisfaction.

Advances from Related Parties

Atlas FinTech, a related party and shareholder, incurred expenditures of $803,860 in connection with the business combination. The amount is included in account payable and accrued liabilities as of June 30, 2024. On August 9, 2024 the Company issued 2,788,276 shares to Atlas FinTech as full settlement of this payable as described above.

On May 9, 2024, Quantum Ventures, a related party transferred 56,073 shares to pay for the $47,750 of interest in connection with the short term sellers notes. The shares are to be reissued at a 13% interest rate, as such a payable of $55,087 was accrued.

NOTE 9. RELATED PARTY TRANSACTIONS

Founder Shares

On October 23, 2020, Quantum Ventures LLC (“Quantum Ventures”), an affiliate of the Company, purchased 4,312,500 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. In January 2021, Quantum Ventures sold 813,500 Founder Shares to Chardan Quantum LLC (“Chardan Quantum” and together with Quantum Ventures, the “Co-Sponsors”) and 35,000 Founder Shares to each of the Company’s directors and director nominees, for a total of 245,000 Founder Shares, in each case at the original price per share, resulting in Quantum Ventures holding a balance of 3,254,000 Founder Shares. On February 4, 2021, the Company effected a stock dividend of 718,750 shares with respect to its common stock, resulting in the initial stockholders holding an aggregate of 5,031,250 Founder Shares. The Founder Shares included an aggregate of up to 656,250 shares that were subject to forfeiture. As a result of the underwriters’ election to fully exercise their over-allotment option on February 12, 2021, no Founder Shares are currently subject to forfeiture.

At the time of the Initial Public Offering, the initial stockholders placed the Founder Shares into an escrow account maintained by Continental Stock Transfer & Trust Company until (1) with respect to 50% of the Founder Shares, the earlier of six months after the completion of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after a Business Combination and (2) with respect to the remaining 50% of the Founder Shares, six months after the completion of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. If the Company seeks stockholder approval in connection with a Business Combination, the Co-Sponsors have (a) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination.

The sale of the Founders Shares to the Company’s directors and director nominees is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 245,000 shares granted to the Company’s directors and director nominees was $1,462,650 or $5.97 per share. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of December 31, 2023, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense had been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. Since the transaction closed on February 9, 2024 the transaction was recognized as of February 9, 2024.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, Quantum Ventures or an affiliate of Quantum Ventures, or certain of the Company’s officers and directors loaned the Company funds as required (“Working Capital Loans”). Such Working Capital Loans were to be evidenced by promissory notes. The notes were to be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may have been converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Warrants.

On March 14, 2022, the Company issued an unsecured promissory note, effective as of January 3, 2022, in the amount of up to $480,000 to Quantum Ventures to evidence the Working Capital Loans. The note bore no interest and was payable in full upon the earlier (i) February 9, 2023 and (ii) the effective date of the consummation of an initial business combination. The note was required to be repaid in cash at the Closing and was not convertible into Private Warrants. As of December 31, 2023 and 2022, a principal balance of $480,000 had been advanced. The promissory note was past due as of December 31, 2023 and on February 9, 2024, upon the Closing of the Business Combination, the unsecured promissory note was settled with the issuance of 2,000,000 shares (see below.)

Advances from Related Parties

As of December 31, 2023 and 2022, the Co-Sponsors had advanced $3,104,097 and $319,166, respectively, to the Company. Through February 9, 2024, the Co-Sponsors advanced an additional $1,052,300 for an aggregate of $4,156,397 advanced to the Company and offset the balance by $58,828 in receivable from Co-Sponsor. On February 9, 2024, upon the Closing of the Business Combination, the advances from related party, the related party loan of $480,000 as described above and the $58,828 receivable from related party was settled with the issuance of 2,000,000 shares settling a total of $4,636,397 in liabilities and $58,828 in receivables . The value of the shares granted was based on $10 per share resulting in a deemed dividend to the related party of $15,422,431.

As of February 9, 2024 and as of June 30, 2024, AtlasFintech Holdings Corp (“AFHC”), a related party and shareholder, incurred expenditures of $803,860 in connection with the business combination. The amount is included in account payable and accrued liabilities. On August 9, 2024 the Company issued 2,788,276 shares to AFHC as full settlement of this payable.

On May 9, 2024 Quantum Ventures, a shareholder and related party transferred 56,073 shares to pay for the $47,750 of interest in connection with the short term sellers notes. The shares are to be reissued at a 13% interest rate, as such a payable of $55,087 was accrued.

v3.24.4
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2024
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES

NOTE 10. COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on February 4, 2021, the holders of the Founder Shares, as well as the holders of the Private Warrants (and underlying securities) and any warrants issued in payment of Working Capital Loans made to the Company (and underlying securities) will have registration and stockholder rights pursuant to an agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the insider shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Warrants (and underlying securities) can elect to exercise these registration rights at any time after the consummation of a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The registration and stockholder rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. On May 14, 2024, the Company filed a registration statement on Form S-1 to register the resale of up to 37,885,852 shares of Common Stock by the selling stockholders named in the registration statement. The Company will not receive any of the proceeds from these sales.

Business Combination Marketing Agreement

On February 9, 2021 at closing of the initial public offering, the Company engaged the underwriters as advisors in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’s attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with the potential Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay the underwriters the marketing fee for such services upon the consummation of our initial business combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the Initial Public offering or $7,043,750.

In connection with the Closing on February 9, 2024, the Company and Chardan Capital Markets LLC (“Chardan”) agreed that the fee, in the amount of $7,043,750, payable by the Company to Chardan upon the Closing pursuant to the terms of the business combination marketing agreement entered into in connection with Quantum’s initial public offering, would be waived in exchange for the issuance by the Company to Chardan of a convertible promissory note in the aggregate principal amount of $4,150,000. Such note (the “Chardan Note”) was issued by the Company at the Closing. Under ASC 815 the conversion feature was bifurcated resulting in a conversion liability of  $404,483 at issuance. As of June 30, 2024, the company recognized $212,803 in interest expense on the principal and $37,920 of interest related to the amortization of the debt discount created with the derivative liability. See Note 19 for additional information on the fair value of the derivative.

The Chardan Note has a stated maturity date of February 9, 2028. Interest accrues at a rate per annum equal to 13%, and is payable quarterly on the first day of each calendar quarter. On each interest payment date, the accrued and unpaid interest shall, at the election of the Company, be either paid in cash or, subject to the satisfaction of certain conditions, in shares of Common Stock, at a rate equal to 85% of the VWAP for the trading day immediately prior to the applicable interest payment date. The Chardan Note is convertible, in whole or in part, into shares of Common Stock at the election of the holder at any time at a conversion price equal to 85% of the VWAP of the Common Stock for the trading day immediately preceding the applicable conversion date. In addition, on each conversion date the Company is required to pay to Chardan in cash (or, at the Company’s option and subject to certain conditions, a combination of cash and Common Stock) all accrued interest on the Chardan Note and all interest that would otherwise accrue on the amount of the Note being converted if such converted amount would be held to three years after the applicable conversion date. Conversion of the Chardan Note, including the issuance of shares to pay interest thereon, is limited to the extent that such conversion would result in Chardan (together with its affiliates and any other persons acting as a group together with Chardan or its affiliates) beneficially owning in excess of 9.99% of the outstanding shares of Common Stock outstanding immediately prior to such conversion. The conversion price applicable to the Chardan Note is subject to adjustment is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and is subject to price-based adjustment, on a “full ratchet” basis, in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for, Common Stock at a price below the then-applicable conversion price (subject to certain exceptions). The Chardan Note is subject to a demand for immediate repayment in cash upon the occurrence of certain events of default specified therein.

Also on February 9, 2024, the Company entered into a registration rights agreement with Chardan (the “Chardan Registration Rights Agreement”), pursuant to which the Company agreed, among other things, to file with the U.S. Securities and Exchange Commission within 45 days after the Closing Date a registration statement registering the resale of the shares of Common Stock issuable upon exercise of the Chardan Note and to use its reasonable best efforts to have such registration statement declared effective as soon as possible after filing. If the registration statement is not filed within 45 days after the Closing or is not effective within a specified period after the Closing (or if effectiveness is subsequently suspended or terminated for at least 15 days, subject to certain exceptions), then the interest rate of the Chardan Note will increase by 2% for each week that such event continues. The Chardan Registration Rights Agreement also provides that the Company is obligated to file additional registration statements under certain circumstances, and provides Chardan with customary “piggyback” registration rights.

On May 7, 2024, Chardan Capital Markets LLC (“Chardan”) filed a complaint in the Court of Chancery of the State of Delaware in an action entitled Chardan Capital Markets LLC v. AtlasClear Holdings, Inc., C.A. No. 2024-0480-LWW, for alleged breach of contract, breach of the implied covenant of good faith and fair dealing, and specific performance, alleging that the Company breached a Registration Rights Agreement entered into by and between the Company and Chardan, dated February 9, 2024, by failing to file a registration statement with the SEC to permit the public resale of certain Registerable Securities in an amount sufficient to cover a Convertible Promissory Note (“Convertible Note”) in the principal amount of $4,150,000. Chardan has alleged that the Company’s failure to file the registration statement left Chardan without the ability to convert and sell shares of the Company’s common stock as allowed for under the Convertible Note. Chardan seeks specific performance, an award of compensatory damages in an amount to be approved at trial, attorney’s fees and other legal and equitable relief as the Court deems just and proper. The Company disputes all allegations and has completed the registration statement required. No trial on the merits has been scheduled, and the parties, as of the date of this filing, are engaged in settlement discussions.

Non-Redemption Agreement

On August 1, 2023, the Company and Quantum Ventures entered into a non-redemption agreement (the “Non-Redemption Agreement”) with Funicular Funds, LP (the “Holder”) in exchange for the Holder agreeing either not to request redemption in connection with the Extension (as defined below) or to reverse any previously submitted redemption demand in connection with the Extension with respect to an aggregate of 2,351,800 shares of common stock at the special meeting of stockholders called by the Company to, among other things, approve an amendment to the Company’s amended and restated certificate of incorporation to extend the date by which the Company must consummate an initial business combination to up to February 9, 2024 or such earlier date as is determined by the board of directors of the Company to be in the best interests of the Company (the “Extension”). In consideration of the foregoing agreement, immediately prior to, and substantially concurrently with, the closing of an initial business combination, (i) Quantum Ventures (or its designees or transferees) will surrender and forfeit to the Company for no consideration an aggregate of 235,180 shares of common stock held by Quantum Ventures (the “Forfeited Shares”) and an aggregate of 235,180 warrants held by Quantum Ventures to purchase 235,180 shares of common stock (the “Forfeited Warrants”) and (ii) the Company shall issue to the Holder a number shares of common stock equal to the number of Forfeited Shares and a number of warrants to purchase shares of common stock equal to the number of Forfeited Warrants. As a result of the closing of the Business Combination, there is no further obligation regarding the Non-Redemption Agreement, as such the liability was trued up as of February 9, 2024 and transferred to permanent equity as the shares have been transferred.

Expense Settlements

In connection with the Closing, AtlasClear Holdings agreed to settle certain accrued expenses and other obligations to certain parties through the issuance of shares of Common Stock. Additionally, on the Closing Date, AtlasClear Holdings issued notes to settle other expenses of Quantum in the aggregate principal amount of approximately $3.3 million, some of which are convertible into shares of Common Stock.

Additional Settlements

Grant Thornton LLP – 46,010 shares of Common Stock that were issued to Grant Thornton LLP (“Grant Thornton”), pursuant to a Satisfaction and Discharge Agreement, dated as of February 9, 2024, between Grant Thornton and the Company (the “Grant Thornton Agreement”), in lieu of payment for services in the amount of $460,100, at a price per share of $10.00.
IB Capital LLC – 155,000 shares of Common Stock that were issued to IB Capital LLC (“IB”), pursuant to a Satisfaction and Discharge Agreement, dated as of February 9, 2024, between IB and the Company (the “IB Agreement”), in lieu of
payment for services in the amount of $294,500, at a price per share of $1.90. The shares were valued based on agreed upon value included in the executed subscription agreement.
Outside The Box Capital Inc. – 20,000 shares of Common Stock that were issued to Outside The Box Capital Inc. (“OTB”), pursuant to a Marketing Services Agreement, dated as of September 13, 2023, between OTB and Quantum (the “OTB Agreement”), as payment in shares for services rendered to Quantum valued at $10 per share for total consideration paid of $200,000.
Carriage House Capital, Inc. – up to 350,000 shares of Common Stock that were issued, or may become issuable, to Carriage House Capital, Inc. (“Carriage”), pursuant to the Consulting Agreement, dated as of February 19, 2024, between Carriage and the Company (the “Carriage Agreement”), as partial consideration for consulting services rendered to the Company, at the price per share of $4.41 on the day of issuance. The total consideration due under the Consulting Agreement is 350,000 shares of Common Stock, 100,007 shares of which were due upon signing of the contract and 27,777 shares of which are due in months four through twelve from the date of signing. As of June 30, 2024, 100,000 shares were issued, and were valued at $4.41 per share as agreed upon consideration. The Stock payable for the remaining 250,000 shares was valued at $1,244,965 and recorded as a stock payable. As of June 30, 2024 the value of the stock payable of 250,000 shares was $259,893 based on stock price at June 30, 2024.
Interest Solutions, LLC – up to 298,017 shares of Common Stock that may become issuable to Interest Solutions, LLC (“Interest Solutions”), pursuant to a convertible promissory note, dated as of February 9, 2024, in the aggregate principal amount of $275,000 (the “Interest Solutions Note”) at a price per share of $2.00. Accrued interest on the Interest Solutions Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum. Until all payments have been made to the Wilson-Davis Sellers, interest on the Interest Solutions Note may be paid in cash or shares of Common Stock valued at the then-current conversion price. Thereafter, all accrued interest must be paid in cash. As of June 30, 2024, the amount is included in Promissory note payable.
JonesTrading Institutional Services LLC – up to 375,000 shares of Common Stock that may become issuable to JonesTrading Institutional Services LLC (“JonesTrading”), pursuant to a convertible promissory note, dated as of February 9, 2024, in the aggregate principal amount of $375,000 (the “JonesTrading Note”) at a price per share of $2.00. Accrued interest on the JonesTrading Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum. Until all payments have been made to the Wilson-Davis Sellers, interest on the Interest Solutions Note may be paid in cash or shares of Common Stock valued at the then-current conversion price. Thereafter, all accrued interest must be paid in cash. As of June 30, 2024, the amount is included in Promissory note payable.
Winston & Strawn LLP – up to $2,500,000 in shares of Common Stock that may become issuable to Winston & Strawn LLP (“Winston & Strawn”), pursuant to a subscription agreement, dated as of February 9, 2024, between Winston & Strawn and the Company (the “Winston & Strawn Agreement”). Pursuant to the Winston Agreement, the Company may issue $2,500,000 worth of shares of Common Stock as payment for legal services, in three equal installments of $833,333 beginning on August 9, 2024. As of June 30, 2024, the amount is included in Subscription agreement as an liability of $2,425,647. Due to the nature of the settlement terms, the subreption agreement was deemed to be a derivative liability to the Company as of June 30, 2024 under ASC 480. Change in fair value of the subscription agreement are measured at each reporting period with change reported in earnings. See valuation approach and further disclosure on Note 19.
Toppan Merrill LLC – the Company issued to Toppan Merrill LLC (“Toppan”) a promissory note, dated as of February 9, 2024, in the aggregate principal amount of $160,025 (the “Toppan Note”). The maturity date of the Toppan Note is February 8, 2026 and the note accrues interest at a rate of 13% per annum. The principal and interest payments due under the note is not payable in shares of Common Stock. As of June 30, 2024, the amount is included in Promissory note payable.
Lead Nectar – up to 12,000 shares of Common Stock that may become issuable to Lead Nectar in lieu of payment for internet marketing services in the amount of $20,000. Shares were issued after June 30, 2024.

Excise Taxes Payable

On February 6, 2023, the Company’s stockholders redeemed 14,667,626 shares of common stock for a total of $148,523,642. On August 4, 2023, the Company’s stockholders redeemed 406,990 shares of common stock for a total of $4,286,537. On February 9, 2024, the Company’s stockholders redeemed 4,940,885 shares of common stock for a total of $53,947,064. The Company evaluated the classification and accounting of the excise tax related to these stock redemptions under ASC 450, “Contingencies”. ASC 450 states that when a loss contingency exists the likelihood that the future event(s) will confirm the loss or impairment of an asset, or the incurrence of a liability can range from probable to remote. A contingent liability must be reviewed at each reporting period to determine appropriate treatment. The Company evaluated the current status and probability of completing a Business Combination as of September 30, 2023 and determined that a contingent liability should be calculated and recorded. As of June 30, 2024, December 31, 2023, the Company recorded $2,067,572 and $1,528,101, respectively, of excise tax liability calculated as 1% of shares redeemed.

Secured Convertible Note Financing

On February 9, 2024, Wilson-Davis and Quantum entered into a securities purchase agreement (the “Purchase Agreement”) with Funicular Funds, LP, a Delaware limited partnership (“Funicular”), pursuant to which the Company sold and issued to Funicular, on that date, a secured convertible promissory note in the principal amount of $6,000,000 (the “Funicular Note”) for a purchase price of $6,000,000, in a private placement (the “Secured Note Financing”). The proceeds raised in the Note Financing were used to pay a portion of the purchase price paid at Closing to the Wilson-Davis Sellers.

The Funicular Note has a stated maturity date of November 9, 2025. Interest accrues at a rate per annum equal to 12.5%, and is payable semi-annually on each June 30 and December 31. On each interest payment date, the accrued and unpaid interest shall, at the election of the Company in its sole discretion, be either paid in cash or paid in-kind by increasing the principal amount of the Funicular Note. In the event of an Event of Default (as defined in the Funicular Note), in addition to Funicular’s other rights and remedies, the interest rate would increase to 20% per annum. The Funicular Note is convertible, in whole or in part, into shares of Common Stock at the election of the holder at any time at an initial conversion price of $10.00 per share (the “Conversion Price”). The Conversion Price is subject to adjustment monthly to a price equal to the trailing five-day VWAP, subject to a floor of $2.00 per share (provided that if the Company sells stock at an effective price below $2.00 per share, such floor would be reduced to such effective price), and is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like. The Company has the right to redeem the Funicular Note upon 30 days’ notice after the earlier of August 7, 2024 and the effectiveness of the Registration Statement (as defined in the Funicular Note), and Funicular would have the right to require the Company to redeem the Note in connection with a Change of Control (as defined in the Note), in each case for a price equal to 101% of the outstanding principal amount of the Note plus accrued and unpaid interest. The Funicular Note contains covenants which, among other things, limit the ability of the Company and its subsidiaries to incur additional indebtedness, incur additional liens and sell its assets or properties.

The Funicular Note is secured by a perfected security interest in substantially all of the existing and future assets of the Company and each Grantor (as defined in the Security Agreement, as defined below), including a pledge of all of the capital stock of each of the Grantors, subject to certain exceptions, as evidenced by (i) a security agreement, dated as of February 9, 2024 (the “Security Agreement”), entered into among the Company, each of the Company’s subsidiaries and Funicular, and (ii) a guaranty, dated as of February 9, 2024 (the “Guaranty”), executed by each of the Company’s subsidiaries pursuant to which each of them has agreed to guaranty the obligations of the Company under the Funicular Note and the other Loan Documents (as defined in the Funicular Note).

Pursuant to the Purchase Agreement, the Company agreed, among other things, that if the Funicular Note becomes convertible into a number of shares of Common Stock in excess of 19.9% of the Company’s total number of shares of Common Stock outstanding, to seek the approval of its stockholders for the issuance of all shares of Common Stock issuable upon conversion of the Funicular Note in excess of that amount, in accordance with the rules of the NYSE American. Also pursuant to the Purchase Agreement, at the Closing the Sponsor transferred 600,000 Founder Shares and 600,000 Private Warrants to Funicular, which transfers terminated Quantum’s obligation to issue shares to Funicular pursuant to the terms of the non-redemption agreement, dated August 1, 2023, between Quantum and Funicular. The purchase price was allocated on a relative fair value basis resulting in the allocated value of the warrants transferred at $28,496 and the value of the shares transferred at $1,222,202 for a total discount to the note value of $1,250,698 recorded as additional paid in capital for the equity components granted.

In connection with the Note Financing, on February 9, 2024, the Company entered into a registration rights agreement with Funicular (the “Funicular Registration Rights Agreement”), pursuant to which the Company agreed, among other things, to file with the U.S. Securities and Exchange Commission within 15 days after the Closing Date a registration statement registering the resale of the shares of Common Stock issuable upon exercise of the Funicular Note (the “Funicular Registration Statement”), and the Company agreed to

use its best efforts to have the Funicular Registration Statement declared effective as promptly as reasonably possible after the filing thereof, but in any event within 60 days of the Closing Date. If the registration statement is not filed within 30 days after the Closing or is not declared effective by the applicable deadline set forth in the Registration Rights Agreement, or under certain other circumstances described in the Registration Rights Agreement, then the Company shall be obligated to pay to the Buyer an amount in cash equal to 5% of the original principal amount of the Note on a monthly basis until the applicable event giving rise to such payments is cured. The Funicular Registration Rights Agreement also provides that the Company is obligated to file additional registration statements under certain circumstances, and provides Funicular with customary “piggyback” registration rights.

As a result of the delay in filing the registration statement the Company incurred $1,500,000 in fees through June 30, 2024 which has been added to the principal of the note. As of June 30, 2024, the company recognized $328,767 in interest expense on the principal and $279,032 of interest related to the amortization of the debt discount described above. As of June 30, 2024 the carrying value of the notes is $6,857,101 net of discount of $971,666.

Sellers Note

As described in note 11 below, (i) $5,000,000 in aggregate principal amount of notes due 90 days after the Closing Date (the “Short-Term Notes”) and (ii) $7,971,000 in aggregate principal amount of notes due 24 months after the Closing Date (the “Long-Term Notes” and, together with the Short-Term Notes, the “Seller Notes”). The Short-Term Notes accrue interest at a rate of 9% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, cash), and are convertible at the option of the holder at any time during the continuance of an event of default, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion. The Long-Term Notes accrue interest at a rate of 13% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, in cash), and are convertible at the option of the holder at any time commencing six months after the Closing Date, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion (or 85% if an event of default occurs and is continuing).

Under ASC 815 the conversion feature was bifurcated resulting in a conversion liability of $487,329 for the short term loan and $776,919 for the long-term loan at issuance. As of June 30, 2024, the company recognized $610,440 in interest expense on the principal and $640,555 of interest related to the amortization of the debt discount created with the derivative liability. See Note 19 for additional information on the fair value of the derivative.

Subscription Agreement and Satisfaction and Discharge Agreement

On February 9, 2024, the Registrant entered into a Subscription Agreement (the “Subscription Agreement”) and Satisfaction and Discharge Agreement (“Discharge Agreement”) with Winston & Strawn LLP (“Winston”), Calculator New Pubco, Inc. and Quantum. The Registrant accepted the offer of Winston to subscribe for an aggregate of $2.5 million worth of shares of its common stock in lieu of fees accrued prior to the Business Combination. In accordance with the Discharge Agreement, Winston, the service provider, has irrevocably waived their rights to receive the professional fees for the Prior Services in cash and has agreed to the Company tendering the full amount of the Fees in cash at Closing, Winston accept common stock of the Post-Closing Company as satisfaction of the Fees. As a result of the Discharge Agreement, Winston has legally released the Company from being the primary obligor under the liability. As a result, the Company has concluded that such liabilities are no longer an obligation of the Company and therefore qualify for extinguishment. The Subscription Agreement is considered a variable-share obligation under ASC Topic 480 (“Distinguishing Liabilities from Equity”). The Subscription Agreement meets the requirements for classification under ASC 480 and as a result is required to be accounted for as a liability under ASC 480 and is presented as such on the Consolidated Balance Sheets. The Company will record a change in fair value on each reporting period until settlement in its Consolidated Statement of Operations. See foot note 19 for additional disclosures.

Indemnification Agreements

On the Closing Date, in connection with the Closing, the Company entered into indemnification agreements with each of its directors and executive officers, which provide for indemnification and advancements by the Company of certain expenses and costs under certain circumstances. The indemnification agreements provide that AtlasClear Holdings will indemnify each of its directors and executive officers against any and all expenses incurred by that director or executive officer because of his or her status as a director or officer of AtlasClear Holdings, to the fullest extent permitted by Delaware law, the Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws.

Wilson-Davis

On February 27, 2018, an extended hearing panel of the Department of Enforcement of the Financial Industry Regulatory Authority, Inc. (“FINRA”), Office of Hearing Officers, issued its decision ordering fines aggregating $1.47 million for violations of the applicable short sales and anti-money laundering rules. Wilson-Davis appealed the decision to the National Adjudicatory Council (“NAC”). On December 19, 2019, NAC issued its decision ordering that the fines be reduced by $205,000 to an aggregate $1.265 million. Wilson-Davis made a timely appeal to the SEC to hear the case. Pursuant to FINRA rules, Wilson-Davis’s timely appeal of the decision to the SEC deferred the effectiveness of the findings and sanctions. Due to the disparity in the range of fines of similar cases, Wilson-Davis believes that the final amount is not reasonably estimable. Wilson-Davis has booked a contingent liability totaling $100,000, which represents the estimated low end of the possible range of fines. On December 28, 2023, the SEC issued an Opinion sustaining FINRA’s findings of violations against Wilson-Davis. The Opinion set aside the fines FINRA imposed on Wilson-Davis for the Reg SHO violations and the supervisory and AML violations. The SEC remanded the case to FINRA to reconsider the appropriate sanctions.

On October 16, 2023, Wilson-Davis entered into a Fifth Addendum to Lease for the Salt Lake City office. The lease is for three years.

On December 21, 2023, Wilson-Davis entered into a Second Amendment to Office Lease for the Denver office. The lease is for one year.

v3.24.4
ACQUISITION OF WILSON-DAVIS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
ACQUISITION OF WILSON-DAVIS    
ACQUISITION OF WILSON-DAVIS

NOTE 10. ACQUISITION OF WILSON-DAVIS

Prior to the Closing, AtlasClear and the Company entered into two amendments to the Broker-Dealer Acquisition Agreement with Wilson-Davis and the then-owners of Wilson-Davis.

As a result of the closing of the business combination the Company allocated the purchase price with the acquisition of Wilson-Davis under the acquisition method of accounting. The final allocation of the purchase consideration for the Mergers will be determined after the completion of a thorough analysis to determine the fair value of all assets acquired and liabilities assumed, but in no event later than one year following the completion of the Mergers. During the quarter ended the Company revised the deferred tax liabilities that resulted from the business combination, thus reducing the goodwill value.

As such the allocation of the purchase price is revised as follows:

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(3,724,270)

Trading Account deposit

 

(100,000)

Net assets acquired

 

6,296,241

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

20,767,525

The fair value of property and equipment was determined using the indirect cost approach which utilizes fixed asset record information including historical costs, acquisition dates, and asset descriptions and applying asset category specific nationally recognized indices to the historical cost of each asset to derive replacement cost new less depreciation. Management has also made the initial determination that all other assets and liabilities to be acquired are primarily estimated to be stated at their fair values, which approximates their recorded cost. While a final determination of the value of the identifiable intangibles has not been completed, management has made an initial determination that approximately $20.77 million of the excess of the purchase price over the net assets acquired should be allocated to identifiable intangible assets.

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

20,767,525

 

Goodwill

$

6,142,525

 

(a)The Wilson-Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

Pro Forma Financial Information

The unaudited pro forma financial information in the table below summarizes the combined results of Wilson-Davis operations and AtlasClear Holdings’ operations, as though the acquisition of Wilson-Davis had been completed as of the beginning of fiscal 2023. The

pro forma financial information for the three months ended September 30, 2023 combines our results for these periods with that of AtlasClear Holdings’ results for the three months ended September 30, 2023.

The following table summarizes the unaudited pro forma financial information:

    

September 30, 2023

Total revenue

$

1,834,164

Net loss

$

(1,575,799)

Weighted average shares

 

  

Basic

 

11,801,759

Net loss per shares:

 

  

Basic

$

(0.13)

Weighted average shares

 

  

Diluted

 

11,801,759

Net loss per shares:

 

  

Diluted

$

(0.13)

The unaudited pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition and the cost of financing the acquisition had taken place at the beginning of fiscal 2023. The financial information for the periods presented above includes pro forma adjustments as follows:

    

September 30, 2023

Transaction cost

$

Amortization of intangibles

$

(307,192)

Interest earned on investments held in trust

$

(722,390)

NOTE 11. ACQUISITION OF WILSON-DAVIS

Prior to the Closing, AtlasClear and the Company entered into two amendments to the Broker-Dealer Acquisition Agreement with Wilson-Davis and the then-owners of Wilson-Davis (the “Wilson-Davis Sellers”), Amendment No. 8 dated January 9, 2024 (“Amendment No. 8”) and Amendment No. 9 dated February 7, 2024 (“Amendment No. 9” and, together with Amendment No. 8, the “Amendments”). Among other things, the Amendments reduced the total purchase price payable under the Broker- Dealer Acquisition Agreement by $5 million and reduced the cash payable at the Wilson-Davis Closing as part of the purchase price to $8 million, with the balance of the purchase price paid in the form of convertible promissory notes issued by AtlasClear to the Wilson-Davis Sellers, as follows: (i) $5,000,000 in aggregate principal amount of notes due 90 days after the Closing Date (the “Short-Term Notes”) and (ii) $7,971,000 in aggregate principal amount of notes due 24 months after the Closing Date (the “Long-Term Notes” and, together with the Short-Term Notes, the “Seller Notes”). The Short-Term Notes accrue interest at a rate of 9% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, cash), and are convertible at the option of the holder at any time during the continuance of an event of default, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion. The Long-Term Notes accrue interest at a rate of 13% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, in cash), and are convertible at the option of the holder at any time commencing six months after the Closing Date, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion (or 85% if an event of default occurs and is continuing). As of May 9, 2024 the short-term notes became due, as such the interest rate increase to 13% per annum, payable quarterly in arrears.

Pursuant to the terms of the Amendments, at the closing of the transactions contemplated by the Broker-Dealer Acquisition Agreement (the “Wilson-Davis Closing”) the Company entered into a parent guaranty and registration rights agreement with the Wilson-Davis Sellers (the “Wilson-Davis Guaranty and RRA”), pursuant to which the Company guaranteed the obligations of AtlasClear under the Notes.

The Sponsor also entered into Amendment No. 9, for the limited purpose of agreeing to transfer certain Founder Shares owned by the Sponsor to the Wilson-Davis Sellers. The Sponsor agreed to transfer to the Wilson-Davis Sellers, at the Wilson-Davis Closing, Founder Shares having an aggregate value of $6 million, based on the VWAP of Quantum Common Stock for the five trading days immediately prior to the Wilson-Davis Closing, which resulted in the transfer of an aggregate of 885,010 Founder Shares at the Closing to cover the cash deficit of $4,000,000 and $2,000,000 bonus paid as consideration. The share transfer from Founder was accounted for as contributed capital and recorded in additional paid in capital. From time to time prior to the six month anniversary of the Closing, the Sponsor may be required to transfer additional Founder Shares to the Wilson-Davis Sellers, as set forth in Amendment No. 9, provided that in no event will the Sponsor be required to transfer more than an aggregate of 2,500,000 Founder Shares (including the Founder Shares transferred at the Closing).

As a result of the closing of the business combination the Company allocated the purchase price with the acquisition of Wilson-Davis under the acquisition method of accounting. The final allocation of the purchase consideration for the Mergers will be determined after

the completion of a thorough analysis to determine the fair value of all assets acquired and liabilities assumed, but in no event later than one year following the completion of the Mergers.

Accordingly, the final acquisition accounting adjustments could differ. The preliminary allocation of the purchase price is as follows:

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(5,288,470)

Trading Account deposit

 

(100,000)

Net assets acquired

 

4,732,041

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

22,331,725

The fair value of property and equipment was determined using the indirect cost approach which utilizes fixed asset record information including historical costs, acquisition dates, and asset descriptions and applying asset category specific nationally recognized indices to the historical cost of each asset to derive replacement cost new less depreciation. Management has also made the initial determination that all other assets and liabilities to be acquired are primarily estimated to be stated at their fair values, which approximates their recorded cost. While a final determination of the value of the identifiable intangibles has not been completed, management has made an initial determination that approximately $20.77 million of the excess of the purchase price over the net assets acquired should be allocated to identifiable intangible assets.

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

22,331,725

 

Goodwill

$

7,706,725

 

(a)

The Wilson Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

Pro Forma Financial Information

The unaudited pro forma financial information in the table below summarizes the combined results of Wilson-Davis operations and AtlasClear Holdings’s operations, as though the acquisition of Wilson Davis had been completed as of the beginning of fiscal 2022. The pro forma financial information for the six months ended June 30, 2024, and for the years ended December 31, 2023, and 202 combines our results for these periods with that of AtlasClear Holdings’s results for the six months ended June 30, 2024 and for the years ended December 31, 2023 and 2022.

The following table summarizes the unaudited pro forma financial information:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Total revenue

$

5,247,150

$

8,258,254

$

9,527,324

Net loss

 

(23,878,060)

$

(4,695,016)

$

(90,186,458)

Weighted average shares

 

  

 

  

 

  

Basic and diluted

 

11,801,759

 

11,801,759

 

11,906,245

Net loss per shares:

 

  

 

  

 

  

Basic and diluted

$

(2.02)

$

(0.40)

$

(8.87)

The unaudited pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition and the cost of financing the acquisition had taken place at the beginning of fiscal 2022. The financial information for the periods presented above includes pro forma adjustments as follows:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Transaction cost

$

(9,008,053)

$

$

9,008,053

Amortization of intangibles

$

$

2,437,500

$

2,437,500

Loss on AtlasClear acquisition

$

86,392,769

$

$

(86,392,769)

Interest earned on investments held in trust

$

(256,279)

$

(3,090,086)

$

(3,087,315)

v3.24.4
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC
6 Months Ended
Jun. 30, 2024
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC

NOTE 12. ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC

In connection with the Closing, and pursuant to the terms of the Business Combination Agreement, stockholders of AtlasClear (the “AtlasClear Stockholders”) received merger consideration (the “Merger Consideration Shares”) consisting of 4,440,000 shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”). In addition, the AtlasClear Stockholders will receive up to 5,944,444 shares of Common Stock (the “Earn Out Shares”) upon certain milestones (based on the achievement of certain price targets of Common Stock following the Closing). In the event such milestones are not met within the first 18 months following the Closing, the Earn Out Shares will not be issued. Atlas FinTech will also receive up to $20 million of shares of Common Stock (“Software Products Earn Out Shares”), which will be issued to Atlas FinTech upon certain milestones based on the achievement of certain revenue targets of software products contributed to AtlasClear by Atlas FinTech and Atlas Financial Technologies Corp. following the Closing. The revenue targets will be measured yearly for five years following Closing, with no catch-up between the years.

To reflect the purchase of Developed Technology identified under the Assignment and Assumption Agreement and Bill of Sale (the “Contribution Agreement”) between AtlasClear, Atlas FinTech and Atlas Financial Technologies Corp., pursuant to which Atlas FinTech and Atlas Financial Technologies Corp. contributed to AtlasClear all rights, title and interest in certain intellectual property, among other things. There are no historical revenues for the Developed Technology and AtlasClear’s management determined the fair value based on their experience and expectations from running similar models in previous companies. The value was derived based on the purchase price allocation as follows: (the table below is expressed in thousands)

Total Purchase Price(a)

    

$

44,400,000

Fair value of Software Product Earn Out Shares(b)

 

10,963,000

Fair value of Earn Out Shares(c)

 

31,347,000

Purchase price allocated to Contribution Agreement

$

86,710,000

SURFACExchange

$

381,461

Bond Quantum

 

32,284

Atlas

 

7,749,299

Rubicon

 

10,000,000

Total Developed Technology acquired(d)

$

18,163,044

Transaction cost(e)

$

68,546,956

Technology acquired

$

18,163,044

Amortization recognized

(317,231)

Carrying balance of Technology acquired written off

17,845,813

Total loss on AtlasClear technology acquired

$

86,392,769

(a)

The closing consideration of $44.40 million is to be delivered in common stock. As such 4,400,000 were delivered based on $10 per share presumed value of common stock.

(b)

Atlas FinTech will receive up to $20.00 million of Common Stock (“Software Products Earn Out Shares”), which will be issued to Atlas FinTech upon certain milestones (based on the achievement of certain revenue targets of software products contributed to AtlasClear by Atlas FinTech and Atlas Financial Technologies Corp. following the Closing). The revenue targets will be measured yearly for the five years following Closing, with no catch-up between the years. The value was determined based on projected revenue based on a discount factor. The Earn Out provision was analyzed under ASC 480 and ASC 815. the Software Products Earn Out Shares Payments in this transaction are within the scope of ASC 480 and therefore will be accounted for as a liability and included in the purchase price consideration. The revenue earnout was estimated using a Monte Carlo simulation to determine if and when the revenue hurdles would be achieved. The revenue volatility and revenue to equity correlation was based upon the same guideline public companies. The Monte Carlo simulation was performed simultaneously on both the share price and revenue to account for the correlation between revenue and equity.

(c)

Atlas FinTech will receive up to 5,944,444 shares of Common Stock (the “Earn Out Shares”). The Earn Out Shares will be issued to AtlasClear Stockholders upon certain milestones (based on the achievement of certain price targets of Common Stock following the Closing). In the event such milestones are not met within the first 18 months following the Closing, the Earn Out Shares will be cancelled. The Earn Out provision was analyzed under ASC 480 and ASC 815. The earnout provision was deemed to be indexed to the Company’s own stock and therefore equity classified. The share based earnout was estimated using a Monte Carlo simulation to determine if and when the stock price hurdles would be achieved. The expected stock price volatility was based upon guideline public companies.

(d)

Under SAB topic 5G transfers of nonmonetary assets for stock prior to an initial offering should be recorded at predecessor cost in accordance with GAAP. As such the value of the Developed Technology was based on the carrying value of Atlas FinTech of $18.16 million. The estimated useful life was determined to be eight years. There are no historical revenues for the Developed Technology and AtlasClear’s management determined the fair value based on their experience and expectations from running similar models in previous companies.

(e)

ASC 350 prohibits the recognition of goodwill in an asset purchase. As such the difference between the purchase price of $86.98 million was charged as transactions and recorded under accumulated deficit of $68.55 million.

Pursuant to the Contribution Agreement, Atlas FinTech and Atlas Financial Technologies Corp. contributed to AtlasClear all their rights, title and interest to the above stated software products and intellectual property assets upon the closing of the Business Combination (the “FinTech Assets”). At present, none of the FinTech assets are in production. Further, due to limited capital contributions from the Quantum’s trust account, management views timelines for revenue recognition from the FinTech Assets to be unknowable and therefore has decided to write down the assets.

v3.24.4
INTANGIBLE ASSETS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
INTANGIBLE ASSETS    
INTANGIBLE ASSETS

NOTE 11. INTANGIBLE ASSETS

Pacsquare Purchase Agreement

Pursuant to the transactions contemplated by a letter of intent, on February 16, 2024, AtlasClear and Pacsquare entered into a Source Code Purchase Agreement and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear acquired the AtlasClear Platform. Pursuant to the Pacsquare Purchase Agreement, Pacsquare will develop, implement and launch the AtlasClear Platform and provide maintenance and support services as described in the agreement. The Pacsquare Purchase Agreement provides that Pacsquare will develop and deliver to AtlasClear the Level 1 equities trading platform and that it will develop and deliver all modules of the clearing platform within 12 months of signing the Pacsquare Purchase Agreement. AtlasClear owns all the intellectual property relating to the AtlasClear Platform, including the software and source code. The Pacsquare Purchase Agreement also granted AtlasClear a right of first refusal to any products or services that relate to trading, settlement, clearance or any other business of AtlasClear that Pacsquare proposes to offer to other persons. The purchase price for the assets was $4.8 million as follows: (i) $1.9 million, consisting of (A) $100,000 payable in a cash upon delivery of the source code and execution of the Pacsquare Purchase Agreement; (B) $850,000 payable in shares of Common Stock at a price of $6.00 per share; and (C) $950,000 to be paid in four monthly installments of $237,500, payable in shares of Common Stock at the price per share on the day of issuance and (ii) $2.7 million to be paid ratably on a module-by-module basis upon delivery and acceptance of each of the AtlasClear Platform modules. AtlasClear has sole discretion to determine whether any of the foregoing payments will be made in cash or shares of Common Stock. As of June 30, 2024, the Company has issued 336,000 shares of Common Stock 141,667 of which were valued at $6 per share as per agreed upon terms and 194,333 valued at $1.50 per share based on the fair value of common stock on March 12, 2024 the date the share were issued to Pacsquare pursuant to the terms of the Pacsquare Purchase Agreement and paid $500,000 in cash and accrued $85,000 in accounts payable for total carrying value of $1,726,500. During the three months ended September 30, 2024 the Company issued 500,000 shares valued at $122,300 on issuance date to Pacsquare as additional consideration towards the AtlasClear platform and accrued and additional $15,000 in accrued invoices received bringing the balance to $1,928,800 as of September 30, 2024. The AtlasClear platform is not yet in use as such amortization has not yet commenced. The Company anticipates commencing amortization during the quarter ended December 31, 2024.

Intangible Assets of the company at September 30, 2024, are summarized as follows:

September 30, 2024

    

    

Accumulated

    

Impairment

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,928,800

 

 

 

1,928,800

Customer Lists

12 years

 

14,625,000

 

(781,335)

 

 

13,843,665

Intangible Assets

$

22,696,325

$

(781,335)

$

(17,845,813)

$

21,914,990

Below is a summary of the amortization of intangible assets for the next five years:

Fiscal Year

    

Amount

June 30, 2025

$

911,558

June 30, 2026

 

1,411,630

June 30, 2027

 

1,411,630

June 30, 2028

 

1,414,970

June 30, 2029

 

1,411,630

Thereafter

 

9,211,047

NOTE 13. INTANGIBLE ASSETS

Pacsquare Purchase Agreement

Pursuant to the transactions contemplated by a letter of intent, on February 16, 2024, AtlasClear and Pacsquare entered into a Source Code Purchase Agreement and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear acquired the AtlasClear Platform. Pursuant to the Pacsquare Purchase Agreement, Pacsquare will develop, implement and launch the AtlasClear Platform and provide maintenance and support services as described in the agreement. The Pacsquare Purchase Agreement provides that Pacsquare will develop and deliver to AtlasClear the Level 1 equities trading platform and that it will develop and deliver all modules of the clearing platform within 12 months of signing the Pacsquare Purchase Agreement. AtlasClear owns all the intellectual property relating to the AtlasClear Platform, including the software and source code. The Pacsquare Purchase Agreement also granted AtlasClear a right of first refusal to any products or services that relate to trading, settlement, clearance or any other business of AtlasClear that Pacsquare proposes to offer to other persons. The purchase price for the assets was $4.8 million as follows: (i) $1.9 million, consisting of (A) $100,000 payable in a cash upon delivery of the source code and execution of the Pacsquare Purchase Agreement; (B) $850,000 payable in shares of Common Stock at a price of $6.00 per share; and (C) $950,000 to be paid in four monthly installments of $237,500, payable in shares of Common Stock at the price per share on the day of issuance and (ii) $2.7 million to be paid ratably on a module-by-module basis upon delivery and acceptance of each of the AtlasClear Platform modules. AtlasClear has sole discretion to determine whether any of the foregoing payments will be made in cash or shares of Common Stock. As of June 30, 2024, the Company has issued 336,000 shares of Common Stock 141,667 valued at $6 per share as per agreed upon terms and 194,333 valued at $1.50 per share based on the fair value of common stock on March 12, 2024 date share were issued to Pacsquare pursuant to the terms of the Pacsquare Purchase Agreement and paid $500,000 in cash and accrued $85,000 in accounts payable for total carrying value of $1,726,500. The AtlasClear platform is not yet in use as such amortization has not yet commenced.

Intangible Assets of the company at June 30, 2024 are summarized as follows:

June 30, 2024

    

    

Accumulated

    

Impairment

    

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,726,500

 

 

 

1,726,500

Technology acquired

zero years

 

18,163,044

 

(317,231)

 

(17,845,813)

 

Customer Lists

12 years

 

14,625,000

 

(474,144)

 

 

14,150,856

Intangible Assets

$

40,657,069

$

(791,375)

$

(17,845,813)

$

22,019,881

Below is a summary of the amortization of intangible assets for the next five years:

Year

    

Amount

June 30, 2025

$

1,218,750

June 30, 2026

 

1,391,400

June 30, 2027

 

1,391,400

June 30, 2028

 

1,394,739

June 30, 2029

 

1,391,400

Thereafter

 

9,089,667

v3.24.4
DEPOSIT ON ACQUISITION OF COMMERCIAL BANCORP
6 Months Ended
Jun. 30, 2024
DEPOSIT ON ACQUISITION OF COMMERCIAL BANCORP  
DEPOSIT ON ACQUISITION OF COMMERCIAL BANCORP

NOTE 14. DEPOSIT ON ACQUISITION OF COMMERCIAL BANCORP

Amendment to Bank Acquisition Agreement

On February 26, 2024, AtlasClear and Commercial Bancorp entered into an amendment (the “Amendment”) to the Amended and Restated Agreement and Plan of Merger, dated as of November 16, 2022, by and between AtlasClear and Commercial Bancorp (the “Bank Acquisition Agreement”), pursuant to which, among other things, Commercial Bancorp is expected to merge with and into a subsidiary of AtlasClear. Pursuant to the Amendment Commercial Bancorp received 40,000 shares of Common Stock in lieu of a nonrefundable escrow deposit valued at $2.28 based on the fair value of common stock on February 26, 2024 date of the amended agreement.

v3.24.4
LEASES
6 Months Ended
Jun. 30, 2024
LEASES  
LEASES

NOTE 15. LEASES

The Company has operating lease obligations for office space at its headquarters location and two branch offices.

The various leases have the following characteristics:

The Company renewed a three-year operating lease for office space in February 2024, which will expire January 31, 2027. The terms of the agreement call for an annual 3% escalation in rents and one three-year renewal option at market rates.

In December 2023, the Company renewed a 12-month operating lease for office space. The lease commenced January 1, 2024. The terms of the agreement call for a fixed rent payment of $1,100 per month.

The Company entered into a 63-month operating lease for office space in April 2020, which will expire May 31, 2025. The terms of the agreement call for specific annual escalation in rents and two five-year renewal options at market rates. Rent expense under the three operating agreements totaling $203,227 was charged to operations during the fiscal year ended June 30, 2024. The future minimum payments required by the office lease agreements in effect at June 30, 2024:

2025

$

164,271

2026

118,597

2027

70,377

Total minimum lease payments

353,245

Less interest factor

(21,017)

Total operating lease liability

332,228

Less operating lease liability - current portion

(149,499)

Operating lease liability - long term portion

$

182,729

As disclosed in Note 1, the Company adopted ASU No. 2016-02, Leases (Topic 842), which requires leases with durations greater than 12 months to be recognized on the statement of financial condition. The Company uses its estimated cost-of-capital at lease commencement as its interest rate, as the operating leases do not provide readily determinable implicit interest rates.

The following table presents the Company’s lease-related assets and liabilities as of June 30, 2024:

June 30,

    

2024

Operating lease ROU Asset - February 9, 2024

$

395,063

Increase

Decrease

(68,727)

Operating lease ROU Asset - Ending Balance

$

326,336

Operating lease liability - Short Term

$

149,499

Operating lease liability - Long Term

182,729

Operating lease liability - Total

$

332,228

The following table presents the weighted-average remaining lease term and weighted-average discount rates related to the Company’s operating leases as of June 30, 2024:

    

June 30, 

 

2024

 

Weighted average remaining lease term

 

2.35

years

Weighted average discount rate

 

4.97

%

The future minimum payments required by the lease agreements in effect at June 30, 2024 are as follows:

v3.24.4
STOCKHOLDERS' EQUITY (DEFICIT)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
STOCKHOLDERS' DEFICIT    
STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 12. STOCKHOLDERS’ DEFICIT

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2024 and June 30, 2024, there were no shares of preferred stock issued or outstanding.

Common stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At September 30, 2024 and June 30, 2024, there were 22,245,698 and 12,277,759, respectively. As of September 30, 2024 1,029,473 shares of common stock, which are considered liability under ASC 815, were issued under the Tau agreement as such they are issued but not outstanding. Refer to Note 9 Tau Agreement for further information. In additional the Company does not currently have sufficient shares authorized to issue shares under various convertible note agreements, see Note 2 Net (loss) income for common stock disclosure for additional detail.

The Common Stock commenced trading on the NYSE American LLC (“NYSE”) under the symbol “ATCH” on February 12, 2024. AtlasClear Holdings’ warrants commenced trading on the over-the-counter market (the “OTC”) under the symbol “ATCH WS” on February 12, 2024.

NOTE 16. STOCKHOLDERS’ EQUITY (DEFICIT)

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2024, December 31, 2023 and 2022, there were no shares of preferred stock issued or outstanding.

Common stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At June 30, 2024 and December 31, 2023 and 2022, there were 12,277,759 and 5,031,250, respectively.

In connection with the Closing, each share of Quantum’s common stock (“Quantum Common Stock” or “Public Shares”) that was outstanding and had not been redeemed was converted into one share of Common Stock. Each outstanding public warrant to purchase Quantum Common Stock became a warrant to purchase one-half of a share of Common Stock. Each outstanding warrant to purchase Quantum Common Stock initially issued in a private placement in connection with Quantum’s initial public offering became a warrant to purchase one share of Common Stock.

In connection with the stockholder vote to approve the Business Combination Agreement and the Business Combination, holders of an aggregate of 4,940,885 shares of Quantum Common Stock properly exercised their right to have their shares redeemed for a full pro rata portion of the Trust Account holding the proceeds from the IPO, which was approximately $10.92 per share, or $53,947,064 in the aggregate. The remaining balance of the Trust Account immediately prior to the Closing of approximately $1.2 million was used to partially fund the Business Combination. As a result of such redemptions, a total of 109,499 Public Shares remained outstanding at the Closing. After giving effect to the Business Combination, the redemption of the Public Shares described above, the separation of the Quantum Units and the issuance of Merger Consideration Shares and the issuance of shares of Common Stock pursuant to Expense Settlements (described below), as of the Closing Date, there were 12,277,759 shares of Common Stock issued and outstanding.

In connection with the Closing, the Company instructed Continental Stock Transfer & Trust Company (“CST”), as escrow agent under the Stock Escrow Agreement, dated as of February 4, 2021 (the “Stock Escrow Agreement”), between the Company and CST, to release from escrow 4,000,000 of the Founder Shares that were held in escrow pursuant to the terms of the Stock Escrow Agreement (consisting of 949,084 shares owned by Chardan Quantum, LLC and 3,050,916 shares owned by the Sponsor; as contemplated by the previously-disclosed amendment to the Stock Escrow Agreement entered into on October 31, 2023.)

The Common Stock commenced trading on the NYSE American LLC (“NYSE”) under the symbol “ATCH” on February 12, 2024. AtlasClear Holdings’ warrants commenced trading on the over-the-counter market (the “OTC”) under the symbol “ATCH WS” on February 12, 2024.

v3.24.4
WARRANTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
WARRANTS    
WARRANTS

NOTE 13. WARRANTS

As of September 30, 2024 and June 30, 2024, there are 20,125,000 Public Warrants outstanding, each Public Warrant entitles the holder to purchase one-half of one share of common stock at an exercise price of $11.50 per whole share, that are classified and accounted for as equity instruments. The Public Warrants are now exercisable.

As of September 30, 2024 and June 30, 2024, there are 6,153,125 Private Warrants to purchase an equal number of common shares that are outstanding that are classified and accounted for as derivative liabilities. Under this accounting treatment, the Company is required to measure the fair value of the Private Warrants at the end of each reporting period as well as re-evaluate the treatment of the Private Warrants and recognize changes in the fair value from the prior period in the Company’s operating results for the current period.

NOTE 17. WARRANTS

As of June 30, 2024 and December 31, 2023, there are 20,125,000 Public Warrants outstanding, each Public Warrant entitles the holder to purchase one-half of one share of common stock at an exercise price of $11.50 per whole share, that are classified and accounted for as equity instruments. The Public Warrants are now exercisable. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within 120 days from the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

Once the warrants become exercisable, the Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.01 per warrant;
at any time after the warrants become exercisable;
upon not less than 30 days’ prior written notice of redemption;
if, and only if, the reported last sale price of the shares of common stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third business day prior to the notice of redemption to warrant holders; and
if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants.

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares or Private Warrants held by the initial stockholders or their affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and income thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.

As of June 30, 2024 and December 31, 2023, there are 6,153,125 Private Warrants to purchase an equal number of common shares that are outstanding that are classified and accounted for as derivative liabilities. Under this accounting treatment, the Company is required to measure the fair value of the Private Warrants at the end of each reporting period as well as re-evaluate the treatment of the Private Warrants and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (i) each private warrant is exercisable for one share of common stock at an exercise price of $11.50 per share, and (ii) the Private Warrants will be non-redeemable and may be exercised on a cashless basis, in each case so long as they continue to be held by the initial purchasers or their permitted transferees. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

On the Closing Date, the Company, AtlasClear Holdings and CST entered into that certain Assignment, Assumption and Amendment Agreement (the “New Warrant Agreement”). The New Warrant Agreement amends that certain Warrant Agreement, dated as of February 4, 2021, by and between the Company and CST (the “Existing Warrant Agreement”), to provide for the assignment by the Company of all its rights, title and interest in the warrants of the Company to AtlasClear Holdings. Pursuant to the New Warrant Agreement, all Company warrants under the Existing Warrant Agreement will no longer be exercisable for shares of Quantum Common Stock, but instead will be exercisable for shares of Common Stock.

v3.24.4
INCOME TAX
6 Months Ended
Jun. 30, 2024
INCOME TAX  
INCOME TAX

NOTE 18. INCOME TAX

The Company accounts for income taxes using an asset and liability approach. Under this method, the tax provision includes taxes currently due plus the net change in deferred tax assets and liabilities. Deferred tax assets and liabilities arise from temporary differences between the tax basis of an asset or liability and its reported amount in the consolidated financial statements, as well as from net operating loss and tax credit carryforwards. Deferred tax amounts are determined by using the tax rates expected to be in effect when the taxes will actually be paid or refund received, as provided for under currently enacted tax law. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, is not expected to be realized.

The benefit (provision) for income taxes consisted of the following for the periods indicated:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Current Tax:

  

  

  

Federal

$

$

726,038

$

536,853

State

 

3,170

 

 

Total current

 

3,170

 

726,038

 

536,853

Deferred Tax:

 

 

 

Federal

 

(546,276)

 

 

State

 

(26,630)

 

 

Total deferred

 

(572,906)

 

 

Total provision for income taxes

$

(569,736)

$

726,038

$

536,853

The benefit from or provision for income taxes differs from the amount computed by applying the federal statutory income tax rate to the Company’s loss or income before income taxes as follows for the periods indicated:

    

June 30, 2024

    

Rate

 

Tax at Statutory rate (21%)

$

(25,376,496)

21.00

%

Permanent Differences:

 

Change in fair value of NRA liability

$

34,571

(0.03)

%

Meals

 

1,769

0.00

%

Entertainment

 

161

0.00

%

Nondeductible transaction Costs

 

1,891,691

(1.57)

%

Change in fair value of Long-Term and Short-Term Investor Notes

 

2,353,692

(1.95)

%

Change in fair value of Secured Convertible Note

 

753,039

(0.62)

%

Change in fair value of Earnout Liability

 

280,350

(0.23)

%

Change in fair value of Subscription Agreement

 

8,147

(0.01)

%

Change in fair value of Stock Payable

 

(206,865)

0.17

%

Loss on AtlasClear acquisition

 

18,142,481

(15.01)

%

Stock Compensation Expense

 

307,157

(0.25)

%

Extinguishment of Accrued Liabilities

 

(184,689)

0.15

%

Change in fair value of WDCO Share payable

 

683,941

(0.57)

%

Return To Provision

 

(477,461)

0.40

%

State Tax – Net of Federal Benefit

 

(220,234)

0.18

%

State Minimum Tax – Net of Federal Benefit

 

2,504

0.00

%

Chang in Valuation Allowance – State

 

499,331

(0.41)

%

Chang in Valuation Allowance - Federal

 

937,175

(0.78)

%

Total

$

(569,736)

0.47

%

A reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2023 and 2022 is as follows, as restated:

    

December 31,

    

December 31,

 

2023

2022

 

Statutory federal income tax rate

 

21.0

%  

21.0

%

Business combination expenses

 

15.27

%  

(0.51)

%

Change in fair value of warrant liability

 

1.70

%  

(12.61)

%

Change in fair value of PIPE derivative liability

 

(6.07)

%  

(8.28)

%

Transaction costs - warrants

 

0.0

%  

0.0

%

Penalties & Interest

 

0.08

%  

0.07

%

Valuation allowance

 

15.73

%  

4.97

%

Income tax provision

 

47.71

%  

4.64

%

The change in the Company’s effective tax rate in the current year, as compared to the prior year, was primarily due to the addition of the state tax provision.

Deferred income taxes reflect the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities were as follows for the periods indicated:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Deferred Tax Assets:

 

  

 

  

 

  

Fixed Assets

$

261

$

$

Business Combination Expenses

 

530,560

 

437,530

 

427,319

IRC Sec. 195 Start-Up Costs

 

956,768

 

974,835

 

745,713

Allowance for Bad Debt

 

3,820

 

 

Accrued Contingent Liability

 

25,465

 

 

Lease Liability (ASC 842)

 

84,602

 

 

IRC Sec. 1231 Losses

 

1,774

 

 

Net Operating Loss

 

1,361,541

 

 

Total Deferred Tax Asset

 

2,964,791

 

1,412,365

 

1,173,032

Deferred Tax Liabilities:

 

 

 

Intangible Assets

 

5,167,729

 

 

ROU Lease Asset (ASC 842)

 

83,102

 

 

State Tax - Current

 

526

 

 

State Tax - Deferred

 

110,452

 

 

Total Deferred Tax Liability

 

5,361,809

 

 

Net Deferred Tax Asset/(Liability) before Valuation allowance

 

(2,397,018)

 

1,412,365

 

1,173,032

Valuation Allowance

 

(2,848,868)

 

(1,412,365)

 

(1,173,032)

Net Deferred Tax Asset/(Liability)

$

(5,245,886)

$

$

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets (“DTA”). Under ASC 740, the guidance requires an analysis of deferred tax assets to determine the realizability of deferred tax assets. Deferred tax assets require a valuation allowance if its more-likely-than-not, greater than 50% likelihood that some portion, or all, of the deferred tax assets will not be realized in the near future. The analysis is based on the weight of all available evidence, both positive and negative evidence. Management has considered all available positive and negative evidence in performing an assessment as to the need for a deferred tax asset valuation allowance.

The negative evidence considered included:

Tax net operating loss carryforwards generated in the current year.
The Company has deemed to begin business operations in the current year and is no longer considered a startup company pursuant to IRC Sec. 195. As a result, the company is eligible to start amortizing previously capitalized startup costs for income tax purposes, which will generate current and future tax deductions.

The positive evidence considered included:

The company has had taxable income in the most recent previous tax years.

On the basis of this evaluation, as of June 30, 2024, a valuation allowance of $1.36 million has been recorded because management has concluded that it is more likely than not that such DTA will ultimately not be realized in the near future. The amount of the DTA considered realizable, however, could be adjusted in future years if estimates of future taxable income during the carryforward period are reduced or increased, or if objective negative evidence in the form of cumulative losses is no longer present and additional weight is given to subjective evidence such as projections for growth.

The Company’s policy is to record interest and penalties related to unrecognized tax benefits in general and administrative expenses. The Company has not recorded any unrecognized tax benefits, or related interest and penalties, as of the period ended June 30, 2024. Per discussions with the management, there are no significant fines/penalties for the period ended June 30, 2024 and there are no new audits or any open audits as of June, 30 2024.

For financial statement disclosure of tax positions taken or expected to be taken on a tax return, the impact of an uncertain income tax position on the income tax return is recognized at the largest amount that is more-likely than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. There was no recognition of uncertain tax positions required for the period ended June 30, 2024. Based upon review of the federal and state return for the open years and review of the draft financial statements for the period ended June 30, 2024, there are no material uncertain tax positions that require financial statement disclosure. The Company has federal income tax net operating loss (“NOL”) carryforwards of $5.38 million as of June 30, 2024. The net operating losses can be carried forward indefinitely. The Company also has various state NOL carryforwards of $5.37 million as of June 30, 2024 which are expected to expire beginning in 2044. The Company’s NOLs may be limited under Section 382 of the Internal Revenue Code (“IRC”). NOLs are limited when there is a significant ownership change as defined by the IRC Section 382. The Company has not yet determined whether an ownership change has occurred that could limit the availability of its net operating loss carryforwards into 2025.

v3.24.4
FAIR VALUE MEASUREMENTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
FAIR VALUE MEASUREMENTS    
FAIR VALUE MEASUREMENTS

NOTE 14. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2024 and June 30, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

    

    

September 30,

    

June 30,

Description

Level

2024

2024

 

 

  

 

  

Liabilities:

 

Subscription agreement

3

$

2,460,488

$

2,425,647

Contingent Guarantee

3

$

$

3,256,863

Warrant liability – Private Warrants

3

$

61,531

$

307,656

Earnout liability

 

3

$

12,638,000

$

12,298,000

Convertible notes derivative

 

3

$

2,142,511

$

16,462,690

Merger financing derivative

3

$

176,239

Secured convertible derivative

3

$

89,535

Tau agreement

 

3

$

972,508

$

Subscription Agreement

On February 9, 2024, the Registrant entered into a Subscription Agreement and Discharge Agreement with Winston & Strawn LLP (“Winston”) Calculator New Pubco, Inc. and Quantum, as described in Note 9.

The Subscription Agreement is considered a variable-share obligation under ASC Topic 480 (“Distinguishing Liabilities from Equity”). The Subscription Agreement meets the requirements for classification under ASC 480 and as a result is required to be accounted for as a liability under ASC 480 and is presented as such on the Condensed Consolidated Balance Sheets. The Company will record a change in fair value on each reporting period until settlement in its Condensed Consolidated Statement of Operations. See Note 9 for further discussion.

The key inputs into the Monte Carlo model for the Subscription Agreement were as follows:

    

June 30,

    

June 30,

 

Input

 

2024

 

2024

Market price of public shares

$

0.21

$

1.04

Equity volatility

 

34.4

%  

 

26.2

%

Risk-free rate

 

4.01

%  

 

5.05

%

Contingent Guarantee

In connection with the acquisition of Wilson-Davis, Founder shares were transferred to cover a cash deficit of $6,000,000. The share have a make-whole provision that require to be accounted for under ASC 480. The Company has valued the obligation as of June 30, 2024 of $3,256,863 based on the cash value that would need to be renumerated by the Company. The value of the cash that would be paid was deemed to be the fair value of the contingent guarantee. The Company issued shares valued at $1,210,290 during the three months ended September 30, 2024 and based on the value of shares sold as of August 8, 2024 the Company was obligated to repay $2,886,347 under the contingent guarantee, resulting in a change in fair value of $839,775. On August 9, 2024 the Company issued convertible note to modify the repayment conditions, resulting in the extinguishment of the contingent liability and recognizing the fair value of the convertible note agreement referred to as Merger financing, see Note 9 for further discussion and below.

Warrant Liability

The Private Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability in the consolidated statements of operations. See Note 13 for further discussion.

The Private Placement Warrants were, initially and as of the end of each subsequent reporting period, valued using a lattice model, specifically a Black-Scholes model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the Company’s common stock. The expected volatility of the Company’s common stock was determined based on the implied volatility of the publicly traded Public Warrants.

The key inputs into the Black-Scholes model for the Private Warrants were as follows:

    

June 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Risk-free rate

 

3.52

%  

 

4.27

%

Dividend yield

 

0.00

%  

 

0.00

%

Volatility

 

87.4

%  

 

58.7

%

Exercise price

$

11.50

$

11.50

Effective expiration date

 

February 2029

 

February 2029

Earnout Liability

The Earnout liability was, initially as of February 9, 2024, valued using a Monte Carlo simulation to determine if and when the revenue hurdles would be achieved. The revenue volatility and revenue to equity correlation was based upon the same guideline public companies. The Monte Carlo simulation was performed simultaneously on both the share price and revenue to account for the correlation between revenue and equity.

The key inputs into the Monte Carlo model for the Earnout liability were as follows:

    

September 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

9.61

%  

 

9.69

%

Convertible Note Derivatives

The Conversion derivative, associated with Short-term notes, Long-Term notes, and the Original Chardan Note was accounted for as a liability in accordance with ASC 815-40. The Conversion derivative liability was measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of Conversion derivative liability in the consolidated statements of operations. The Convertible note derivative is made up of the fair value of the embedded conversion option included in the Short-term notes, Long-Term notes, and the Original Chardan Note with a fair value as of September 30, 2024 of $335,906, $983,529 and $823,076, respectively totaling, $2,142,511 and as of June 30, 2024 of $4,807,692, $7,664,613 and $3,990,385, respectively totaling, $16,462,690.

Short-Term Note

On February 9, 2024, the Company issued short-term notes to the former officers and directors of Wilson-Davis. The short-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The conversion feature is deemed to include an embedded derivative that requires bifurcation and separate account. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the note. The discount will be amortized as interest expense over the term of the short-term note(s). The derivative liability will be revalued at each reporting period with the change being charged to the income statement. The original derivative liability – for the short term note notes was valued at $487,329. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $4,320,363 to $4,807,692. The original $487,929 discount was amortized over the 90-day maturity. As of June 30, 2024, the Company did not repay the short-term notes as such has incurred penalty interest from 9% to 13% until the note is repaid. The note is due on demand but will default on the long term note date of February 2026. No notice of default has been received.

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024 valuation of the convertible note conversion feature under Black-Scholes was no longer appropriate as it does not take into account the probability of multiple components. As such as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the short term loan at $335,906. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

 

Input

 

2024

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

 

28.9

%

Volatility

 

36.7

%

Effective expiration date

 

February 2026

The key inputs into the Black-Scholes model for the Conversion derivative as of June 30, 2024 were as follows:

    

June 30,

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

5.49

%

Dividend yield

 

0.00

%

Volatility

 

14,643.0

%

Exercise price

$

0.99

Effective expiration date

May 2024

Long-Term Note

On February 9, 2024, the Company issued long-term notes to the former officers and directors of Wilson-Davis. The long-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024 and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement.

The conversion feature is deemed to include an embedded derivative that required bifurcation and separate accounting. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the notes. The discount will be amortized as interest expense over the term of the notes. The derivative liability will be revalued at each reporting period with the change being charged to Derivative liability – convertible notes. The original derivative liability – for the long term note notes was valued at $776,919. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $6,887,694 to $7,664,613. The original $776,919 discount will be amortized over the maturity.

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024 valuation of the convertible note conversion feature under Black-Scholes was no longer appropriate as it does not take into account the probability of multiple components. As such as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the long term loan at $983,529. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

28.9

%

Volatility

36.7

%

Effective expiration date

February 2026

The key inputs into the Black-Scholes model for the Conversion derivative were as follows:

    

June 30,

 

Input

 

2024

Market price of public shares

$

1.04

Risk-free rate

 

4.90

%

Dividend yield

 

0.00

%

Volatility

 

14,461

%

Exercise price

$

0.99

Effective expiration date

 

February 2026

Chardan Note

In connection with the Closing, AtlasClear Holdings and Chardan agreed that the fee, in the amount of $7,043,750, payable by Quantum to Chardan upon the Closing pursuant to the terms of the business combination marketing agreement entered into in connection with Quantum’s initial public offering, would be waived in exchange for the issuance by AtlasClear Holdings to Chardan of the Original Chardan Note in the aggregate principal amount of $4,150,000. The Original Chardan Note was issued by AtlasClear Holdings at the Closing. The Original Chardan Note had a stated maturity date of February 9, 2028. Interest accrued at a rate per annum equal to 13%, and was payable quarterly on the first day of each calendar quarter. On each interest payment date, the accrued and unpaid interest would have been, at the election of AtlasClear Holdings, either paid in cash or, subject to the satisfaction of certain conditions, in shares of Common Stock, at a rate equal to 85% of the VWAP for the trading day immediately prior to the applicable interest payment date. On October 23, 2024, the Company, Quantum Ventures, Chardan and Chardan Quantum LLC entered into the Settlement Agreement. In connection with the Settlement Agreement, Chardan exchanged the Chardan Note for an amended non-interest bearing, convertible note in the aggregate principal amount of $5,209,764 (as amended, the “Chardan Note”). While the Chardan Note does not bear interest, it can be converted from time to time by Chardan into shares of Common Stock, on terms substantially similar to the conversion provisions in the Original Chardan Note, and any remaining outstanding principal is to be repaid in full on the same maturity date as the Original Chardan Note.

The Chardan Note qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The original derivative liability – for the Chardan Note was valued at $404,483. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $3,585,901 to $3,990,385. The original $404,483 discount will be amortized over the maturity. See Note 9 for additional information.

In addition, on each conversion date AtlasClear Holdings was required to pay to Chardan in cash (or, at AtlasClear Holding’s option and subject to certain conditions, a combination of cash and Common Stock) all accrued interest on the Chardan Note and all interest that would otherwise accrue on the amount of the Note being converted if such converted amount would be held to three years after the applicable conversion date. The first quarterly interest payment due on the Chardan Note has not been paid as of the date of this filing.

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024, valuation of the convertible note conversion feature under Black-Scholes was no longer appropriate as it does not take into account the probability of multiple components. As such, as of September 30, 2024, the conversion feature was valued using Monte Carlo model resulting in the fair value of the conversion option included in the Chardan Note at $823,076. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.36

%

Discount rate

 

7.72

%

Probability of default

 

41.2

%

Recovery rate

 

47.6

%

Volatility

 

43.9

%

Effective expiration date

 

February 2028

The key inputs into the Black-Scholes model for the conversion derivative are as follows:

    

June 30,

 

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

4.52

%

Dividend yield

 

0.00

%

Volatility

 

166,681.0

%

Exercise price

$

0.84

Effective expiration date

 

February 2028

Secured Convertible Note

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024 valuation of the secured convertible note conversion feature now was required to be bifurcated under ASC 815 as such the Company fair valued the embedded derivative. As such as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the Secured Convertible Note at $89,535. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

3.87

%

Discount rate

 

7.84

%

Probability of default

 

19.8

%

Recovery rate

 

47.6

%

Volatility

 

36.8

%

Effective expiration date

 

November 2025

Merger Financing

As discussed above under Contingent Guarantee, on August 9, 2024 the Company issued convertible note to modify the repayment conditions, resulting in the extinguishment of the contingent liability and recognizing the fair value of the convertible note agreement. As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that the merger financing notes conversion feature was required to be bifurcated under ASC 815 as such the Company fair valued the embedded derivative. As such as of August 9, 2024 the issuance date and as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the Merger financing notes at $113,044 and $176,239, respectively. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

    

August 9,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

4.84

%

 

4.78

%

Discount rate

 

11.72

%

 

16.98

%

Probability of default

 

23.5

%

 

25.4

%

Recovery rate

 

28.9

%

 

28.9

%

Volatility

 

36.7

%

 

37.2

%

Effective expiration date

 

February 2026

 

February 2026

Tau Agreement

As discussed in Note 9 the Tau Agreement has both a Commitment Amount and a Commitment fee that requires to be fair valued under ASC 815 and ASC 480, respectively. As such as of July 31, 2024 the issuance date and as of September 30, 2024 both the Commitment Amount and the Commitment Fee were valued using Mote Carlo model resulting in the fair value of the Commitment Amount at $966,153 and $892,558, respectively and the Commitment Fee at $124,796 and $79,948, respectively.

The key inputs into the Monte-Carlo model for the Commitment Amount as of issuance date of July 31, 2024, and September 30, 2024 were as follows:

    

September 30,

    

July 31

 

Input

2024

2024

 

Anticipated Monthly Advance Amounts

$

40,000

$

40,000

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

The key inputs into the Monte-Carlo model for the Commitment Fee as of issuance date of July 31, 2024, and September 30, 2024 were as follows:

    

September 30,

    

July 31,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

The following table presents the changes in the fair value of the following:

    

Private

    

Tau

Placement

 Agreement

Warrants

Liability

Fair value as of June 30, 2024

$

307,656

$

Initial measurement

1,090,949

Transferred to equity

(303,000)

Change in valuation inputs or other assumptions

(246,125)

184,559

Fair value as of September 30, 2024

$

61,531

$

972,508

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

Change in valuation inputs or other assumptions

 

(14,320,179)

 

 

340,000

Fair value as of September 30, 2024

$

2,142,511

 

$

12,638,000

    

Subscription

    

Contingent

Agreement

Guarantee

Fair value as of June 30, 2024

$

2,425,647

$

3,256,863

Shares issued as partial payment

 

 

(1,210,290)

Change in valuation inputs or other assumptions

 

34,841

 

839,774

Exchanged to Merger financing note

 

 

(2,886,347)

Fair value liability as of September 30, 2024

$

2,460,488

$

    

Merger

    

Secured

Financing

Convertible

Derivative

Derivative

Fair value as of June 30, 2024

$

$

Initial measurement

 

113,044

 

Change in valuation inputs or other assumptions

 

63,195

 

89,535

Fair value as of September 30, 2024

$

176,239

$

89,535

There were no transfers between levels during the three months ended September 30, 2024 and 2023.

NOTE 19. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2024, December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

    

    

June 30,

    

December 31,

    

December 31,

Description

Level

2024

2023

2022

Assets:

 

 

  

 

  

 

  

Marketable securities held in Trust Account

 

1

$

$

54,799,478

$

204,044,469

Liabilities:

 

 

  

 

  

 

  

Subscription agreement

3

$

2,084,691

$

$

Contingent Guarantee

3

$

3,256,863

$

$

Warrant liability – Private Warrants

 

3

$

307,656

$

307,656

$

184,594

Non-redemption agreement liability

3

$

$

1,441,653

$

Convertible notes derivative

3

$

16,462,690

$

$

Earnout liability

 

3

$

12,298,000

$

$

Subscription Agreement

On February 9, 2024, the Registrant entered into a Subscription Agreement and Discharge Agreement with Winston & Strawn LLP (“Winston”) Calculator New Pubco, Inc. and Quantum, as described in Note 1. The Company has concluded that such liabilities are no longer an obligation of the Company and therefore qualify for extinguishment.

The Subscription Agreement is considered a variable-share obligation under ASC Topic 480 (“Distinguishing Liabilities from Equity”). The Subscription Agreement meets the requirements for classification under ASC 480 and as a result is required to be accounted for as a liability under ASC 480 and is presented as such on the Consolidated Balance Sheets. The Company will record a change in fair value on each reporting period until settlement in its Consolidated Statement of Operations. See note 10 for further discussion.

The key inputs into the Monte Carlo model for the Subscription Agreement were as follows:

February 9,

 

June 30,

2024

 

Input

    

2024

    

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Equity volatility

 

26.2

%  

 

29.8

%

Risk-free rate

 

5.05

%  

 

4.67

%

Contingent Guarantee

In connection with the acquisition of Wilson-Davis, Founder shares were transferred to cover a cash deficit of $6,000,000. The share have a make-whole provision that require to be accounted for under ASC 480. The Company has valued the obligation as of June 30, 2024 of $3,256,863 based on the cash value that would need to be renumerated by the Company. The value of the cash that would be paid was deemed to be the fair value of the contingent guarantee. The company analyzed the public sales of the shares transferred to determine the amount of cash recovered less the $4,000,000 contingent guarantee resulting in a liability due of $3,256,863. As of February 9, 2024 the 885,010 shares transferred by the Founder were valued at $8,850,100 which was greater than the $4,000,000 guaranted value as such the value of the guarantee was deemed to be zero on February 9, 2024. As a result of the decrease in stock prices through June 30, 2024 the Sellers have recovered $743,137 in cash through sales of the shares transferred resulting in the value of the liability as of June 30, 2024 to be $3,256,863.

Warrant liability

The Private Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability in the consolidated statements of operations. See note 17 for further discussion.

The Private Placement Warrants were, initially and as of the end of each subsequent reporting period, valued using a lattice model, specifically a Black-Scholes model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the Company’s common stock. The expected volatility of the Company’s common stock was determined based on the implied volatility of the publicly traded Public Warrants.

The key inputs into the Black-Scholes model for the Private Warrants were as follows:

    

June 30,

    

December 31,

December 31,

 

Input

2024

2023

2022

 

Market price of public shares

$

1.04

$

6.20

$

10.05

Risk-free rate

 

4.27

%  

 

3.77

%  

 

3.91

%

Dividend yield

 

0.00

%  

 

0.00

%  

 

0.00

%

Volatility

 

58.7

%  

 

12.0

%  

 

2.6

%

Probability of a business combination

 

100

%  

 

100

%  

 

4.5

%

Exercise price

$

11.50

$

11.50

$

11.50

Effective expiration date

 

February 29

 

February 29

 

February 29

Non-Redemption Agreement

The non-redemption agreement liability was measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of non-redemption agreement liability in the consolidated statements of operations.

The non-redemption agreement liability is comprised of 235,180 shares of non-redeemable common stock and 235,180 Private Placement Warrants. The non-redeemable common stock was valued using a Monte Carlo model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the non-redeemable common stock is equity volatility, probability of acquisition, the discount for marketability and discount for expected forfeiture. As of February 9, 2024, the shares and warrants were transferred and valued based on the trading prices of the stock and warrants and reclassified as permanent equity at total value of $1,606,279.

The key inputs into the Monte Carlo model for the non-redeemable common stock were as follows:

    

December 31,

August 1,

 

Input

2023

2023

 

Market price of public shares

$

6.20

$

10.57

Probability of acquisition

 

100.0

%

 

82.0

%

Equity volatility

 

12.0

%

 

19.9

%

Discount for lack of marketability

 

8.0

%

 

3.0

%

Discount for expected forfeiture

 

5.10

%

 

5.10

%

Earnout Liability

The Earnout liability was, initially and as of February 9, 2024, valued using a Monte Carlo simulation to determine if and when the revenue hurdles would be achieved. The revenue volatility and revenue to equity correlation was based upon the same guideline public companies. The Monte Carlo simulation was performed simultaneously on both the share price and revenue to account for the correlation between revenue and equity.

The key inputs into the Monte Carlo model for the Earnout liability were as follows:

    

    

February 9,

 

June 30,

2024

 

Input

2024

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

96.9

%  

 

99.5

%

Convertible Note Derivatives

The Conversion derivative, associated with Short-term notes, Long-Term notes, and the Chardan Note was accounted for as a liability in accordance with ASC 815-40. The Conversion derivative liability was measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of Conversion derivative liability in the consolidated statements of operations. The Convertible note derivative is made up of the fair value of the embedded conversion option included in the Short-term

notes, Long-Term notes, and the Chardan Note with a fair value as of June 30, 2024 of $4,807,692, $7,664,613 and $3,990,385, respectively.

On February 9, 2024, the Company issued short-term notes to the former officers and directors of Wilson-Davis. The short-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The conversion feature is deemed to include an embedded derivative that requires bifurcation and separate account. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the note. The discount will be amortized as interest expense over the term of the short-term note(s). The derivative liability will be revalued at each reporting period with the change being charged to the income statement. The original derivative liability – for the short term note notes was valued at $487,329. On June 30, 2024, a Black-Scholes calculation was performed (see above chart) and the value of the fair value of the derivative liability – convertible notes increased $4,320,3630 to $4,807,692. The original $487,929 discount was amortized over the 90-day maturity. As of June 30, 2024, the company did not repay the short-term notes as such has incurred penalty interest from 9% to 13% until the note is repaid. No notice of default has been received. See note 10 for additional information.

The key inputs into the Black-Scholes model for the Conversion derivative were as follows:

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

5.49

 

5.44

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,643.0

 

4,120.0

%

Exercise price

$

0.99

$

7.27

Effective expiration date

May 2024

May 2024

On February 9, 2024, the Company issued long-term notes to the former officers and directors of Wilson-Davis. The long-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024 and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement.

The conversion feature is deemed to include an embedded derivative that required bifurcation and separate accounting. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the notes. The discount will be amortized as interest expense over the term of the notes. The derivative liability will be revalued at each reporting period with the change being charged to Derivative liability – convertible notes. The original derivative liability – for the long term note notes was valued at $776,919. On June 30, 2024, a Black-Scholes calculation was performed (see above chart) and the value of the fair value of the derivative liability – convertible notes increased $6,887,694 to $7,664,613. The original $776,919 discount will be amortized over the maturity. See note 10 for additional information.

The key inputs into the Black-Scholes model for the Conversion derivative were as follows:

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.90

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,461

 

41,200

%

Exercise price

$

0.99

$

7.27

Effective expiration date

February 2026

February 2026

In connection with the Closing, AtlasClear Holdings and Chardan agreed that the fee, in the amount of $7,043,750, payable by Quantum to Chardan upon the Closing pursuant to the terms of the business combination marketing agreement entered into in connection with Quantum’s IPO, would be waived in exchange for the issuance by AtlasClear Holdings to Chardan of a convertible promissory note in the aggregate principal amount of $4,150,000. The Chardan Note was issued by AtlasClear Holdings at the Closing. The Chardan Note

has a stated maturity date of February 9, 2028. Interest accrues at a rate per annum equal to 13%, and is payable quarterly on the first day of each calendar quarter. On each interest payment date, the accrued and unpaid interest shall, at the election of AtlasClear Holdings, be either paid in cash or, subject to the satisfaction of certain conditions, in shares of Common Stock, at a rate equal to 85% of the VWAP for the trading day immediately prior to the applicable interest payment date.

The Chardan Note qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The original derivative liability – for the Chardan convertible note was valued at $404,483. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $3,585,901 to $3,990,385. The original $404,483 discount will be amortized over the maturity. See note 10 for additional information.

In addition, on each conversion date AtlasClear Holdings is required to pay to Chardan in cash (or, at AtlasClear Holding’s option and subject to certain conditions, a combination of cash and Common Stock) all accrued interest on the Chardan Note and all interest that would otherwise accrue on the amount of the Note being converted if such converted amount would be held to three years after the applicable conversion date. The first quarterly interest payment due on the Chardan Note has not been paid as of the date of this filing.

The key inputs into the Black-Scholes model for the conversion derivative are as follows:

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.52

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

166,681.0

 

4,120.0

%

Exercise price

$

0.84

$

10.26

Effective expiration date

February 2028

February 2028

On February 9, 2024, the Company issued a long-term note to Interest Solutions in the amount of $275,000. The Company also issued a long-term note to JonesTrading Institutional Services for $375,000. Both of the notes accrue interest at 13% per annum. The outstanding principal, together with any then unpaid and accrued interest and other amounts payable, shall be due and payable at the earlier of (i) when requested by the note holder on or after February 9, 2026, or (ii) when, upon the occurrence and during the continuance of an event of default. The conversion feature in the notes do not qualify for derivative treatment.

The following table presents the changes in the fair value of the following:

    

Private

    

Non-Redemption

Placement

 Agreement

Warrants

Liability

Fair value as of December 31, 2021

$

7,137,930

$

Change in valuation inputs or other assumptions

(6,953,336)

1,881,440

Fair value as of December 31, 2022

$

184,594

$

Initial measurement as of August 1, 2023

1,881,440

Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability

123,062

(439,787)

Fair value as of December 31, 2023

$

307,656

$

1,441,653

Change in valuation inputs or other assumptions

164,626

Transferred to equity

(1,606,279)

Fair value as of June 30, 2024

$

307,656

$

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of December 31, 2023

$

 

$

Initial measurement as of February 9, 2024

1,668,731

10,963,000

Change in valuation inputs or other assumptions

 

14,793,959

 

 

1,335,000

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

    

Subscription

    

Merger Financing

Agreement

Liability

Fair value as of December 31, 2023

$

$

Initial measurement as of February 9, 2024

 

2,386,851

 

Change in valuation inputs or other assumptions

 

38,796

 

3,256,863

Fair value (asset) liability as of June 30, 2024

$

2,425,647

$

3,256,863

There were no transfers between levels during the year ended and period ended June 30, 2024 and December 31, 2023 and 2022.

v3.24.4
TRANSITION PERIOD COMPARATIVE DATA
6 Months Ended
Jun. 30, 2024
TRANSITION PERIOD COMPARATIVE DATA  
TRANSITION PERIOD COMPARATIVE DATA

NOTE 20. TRANSITION PERIOD COMPARATIVE DATA

On August 9, 2024, the board of directors of AtlasClear Holdings, Inc. (the “Company”) determined to change the Company’s fiscal year end from December 31 to June 30. Below is a summary of financial statements for the six-month transition period from January 1, 2024 to June 30, 2024 compared to the six month period ended June 30, 2023.

1.Consolidated Balance Sheets

    

June 30,

    

June 30,

2024

2023

ASSETS

 

 

(Unaudited)

Current assets

Cash and cash equivalents

$

6,558,176

$

1,132,900

Cash segregated - customers

 

20,548,972

 

Cash segregated - PAB

 

200,738

 

Receivables - broker-dealers and clearing organizations

 

1,333,306

 

Receivables - customers, net

 

823,784

 

Other receivables

 

64,842

 

Prepaid expenses

 

67,967

 

29,458

Trading securities, market value, net

 

55

 

Due from Atlas Clear

 

 

49,806

Total Current Assets

 

29,597,840

 

1,212,164

Operating lease right to use lease asset

 

326,336

 

Property and equipment, net

 

16,080

 

Customer list, net

 

14,150,856

 

Goodwill

 

7,706,725

 

Pacsquare asset purchase

 

1,726,500

 

Bank acquisition deposit

 

91,200

 

Cash deposits - broker-dealers and clearing organizations

 

3,515,000

 

Other assets

 

336,017

 

Marketable securities held in Trust Account

 

 

57,409,747

TOTAL ASSETS

$

57,466,554

$

58,621,911

LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT

 

  

 

  

Current liabilities

 

  

 

  

Payables to customers

$

20,162,973

$

Accounts and payables to officers/directors

 

686,579

 

Accounts payable and accrued expenses

 

5,393,912

 

5,181,488

Payables - broker-dealers and clearing organizations

 

4,915

 

Commissions, payroll and payroll taxes

 

273,386

 

Current portion of lease liability

 

149,499

 

Stock payable

 

259,893

 

Convertible notes, net

 

3,783,437

 

Secured convertible note, net

 

6,857,101

 

Promissory notes

 

852,968

 

Short-term merger financing, net

 

5,092,083

 

Contingent gurantee

3,256,863

Subscription agreement

 

2,425,647

 

Excise tax payable

 

2,067,572

 

Excise taxes payable

 

 

1,485,236

Stock payable - related party

55,087

Advance from related parties

 

 

1,968,116

Promissory note – related party

 

 

480,000

Total Current Liabilities

 

51,321,915

 

9,114,840

Accrued contingent liability

 

100,000

 

Long-term merger financing, net

 

7,606,561

 

Derivative liability - convertible notes

 

16,462,690

 

Derivative liability - warrants

 

307,656

 

307,656

Earnout - liability

 

12,298,000

 

Deferred income tax liability

5,245,886

Subordinated borrowings

 

1,950,000

 

Trading account deposit

 

100,000

 

Long-term lease liability

 

182,729

 

Total Liabilities

 

95,575,437

 

9,422,496

Commitments and Contingencies (Note 10)

Common stock subject to possible redemption

 

 

57,113,761

Stockholders’ Deficit

Preferred stock, $0.0001 par value;

 

 

Common stock, $0.0001 par value;

 

1,246

 

503

Additional paid-in capital

 

110,164,676

 

Accumulated deficit

 

(148,274,805)

 

(7,914,849)

Total Stockholders’ Deficit

 

(38,108,883)

 

(7,914,346)

TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT

$

57,466,554

$

58,621,911

2.Statements of consolidated Net Income (loss)

     

Three Months Ended

    

Six Months Ended

June 30,

June 30,

2024

     

2023

2024

    

2023

REVENUES

Commissions

$

1,750,159

$

$

2,679,673

$

Vetting fees

 

340,050

 

499,125

 

Clearing fees

 

624,550

 

 

756,393

 

Net gain/(loss) on firm trading accounts

 

6,390

 

 

10,046

 

Other revenue

 

9,650

 

56,246

TOTAL REVENUES

 

2,730,799

 

 

4,001,483

 

EXPENSES

 

  

 

  

 

  

 

  

Compensation, payroll taxes and benefits

 

1,355,058

 

 

2,386,837

 

Data processing and clearing costs

 

843,824

 

 

1,299,527

 

Regulatory, professional fees and related expenses

 

112,216

 

11,649,470

 

Stock compensation - founder share transfer

 

 

 

1,462,650

 

Communications

 

172,018

 

 

254,608

 

Occupancy and equipment

 

54,765

 

 

76,324

 

Transfer fees

 

54,807

 

 

75,425

 

Bank charges

 

52,077

 

 

88,253

 

Intangible assets amortization

 

337,911

 

 

791,375

 

Other

 

147,042

 

 

185,840

 

Operating and formation costs

 

 

577,313

 

 

1,485,122

TOTAL EXPENSES

 

3,129,718

 

577,313

 

18,270,309

 

1,485,122

LOSS FROM OPERATIONS

 

(398,919)

 

(577,313)

 

(14,268,826)

 

(1,485,122)

OTHER INCOME/(EXPENSE)

Interest income

 

587,637

 

8,458

 

938,802

 

8,458

Interest earned on marketable securities held in Trust Account

 

727,468

 

256,279

 

2,028,921

Gain on sale of assets

 

146,706

 

 

146,706

 

Net gain on settlement

 

 

829,853

 

 

829,853

Loss on AtlasClear asset acquisition

 

(17,845,813)

 

 

(86,392,769)

 

Change in fair value of warrant liability derivative

 

307,656

 

(184,594)

 

 

(123,062)

Change in fair value, convertible note derivative

 

(992,152)

 

 

(3,585,902)

 

Change in fair value, long-term and short-term note derivative

 

(3,101,057)

 

 

(11,208,055)

 

Change in fair value of non-redemption agreement

 

 

 

(164,626)

 

Change in fair value of Contingent guarantee

(3,256,863)

(3,256,863)

Change in fair value of earnout liability

 

(1,115,000)

 

 

(1,335,000)

 

Change in fair value of subscription agreement

 

(4,413,946)

 

 

(38,796)

 

Extinguishment of stock payable

 

985,072

 

 

985,072

 

Extinguishment of accrued expenses

 

114,199

 

 

879,473

 

Interest expense

 

(3,210,786)

 

 

(3,732,178)

 

TOTAL OTHER INCOME/(EXPENSE)

 

(31,794,347)

 

1,381,185

 

(106,507,857)

 

2,744,170

Income before provision for income taxes

 

(32,193,266)

 

803,872

 

(120,776,683)

 

1,259,048

Provision for income taxes

 

563,736

 

(318,313)

 

569,736

 

(581,118)

Net income

$

(31,629,530)

$

485,559

$

(120,206,947)

$

677,930

3.Statements of consolidated cash flow

      

Six Months Ended June 30,

2024

      

2023

Cash Flows from Operating Activities:

Net income (loss)

$

(120,206,947)

$

677,930

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Change in fair value of warrant liability derivative

123,062

Change in fair value of non-redemption agreement

164,626

Loss on AtlsClear asset acquisition

86,392,769

Change in fair value, convertible note derivative

3,585,904

Change in fair value, long-term and short-term note derivative

11,208,055

Interest expense on convertible notes

1,896,714

Transaction costs paid with stock

1,401,937

Stock based compensation

1,462,650

Change in fair value, earnout liability

1,335,000

Fee on Secured convertible note

1,500,000

Change in operating lease expense

68,727

Change in fair value, contingent guarantee

3,256,863

Interest earned on marketable securities held in Trust Account

(251,569)

(2,028,921)

Change in fair value, subscription agreement

38,796

Depreciation expense

7,565

Amortization of intangibles

791,375

Bad debt expense

2,474

Changes in operating assets and liabilities:

Due from Atlas Clear

(49,806)

Income taxes payable

44,118

Marketable securities

6,820

Receivables from brokers & dealers

2,203,271

Receivables from customers

(303,486)

Receivables from others

(59,043)

Advances and Prepaid expenses

133,158

4,194

Cash deposits with clearing organization & other B/Ds

21,664

Change in operating lease right-of-use assets

(11,713)

Other assets

49,041

Payables to customers

(5,124,740)

Payables to officers & directors

98,048

Payable to brokers & dealers

(12,903)

Deferred tax liability

(43,484)

Accounts payable and accrued expenses

(1,066,430)

443,812

Commissions and payroll taxes payable

39,638

Stock Loan

259,893

Change in operatin lease right-of-use asset

(56,900)

Receivables from brokers & dealers

Receivables from customers

Net cash provided by (used in) operating activities

(11,212,227)

(785,611)

Cash Flows from Investing Activities:

Cash withdrawn from Trust Account to pay franchise and income taxes

68,418

Investment of cash into Trust Account

(160,000)

(875,000)

Cash withdrawn from Trust Account in connection with redemption

53,947,064

1,015,001

Cash paid for purchase of Pacsquare

(500,000)

Cash received from acquisition of Wilson-Davis

33,333,876

Cash withdrawn from Trust Account for working capital purposes

1,195,565

148,523,642

Cash paid to Wilson Davis shareholders

(8,092,568)

Net cash provided by (used in) investing activities

79,792,355

148,663,643

Cash Flows from Financing Activities:

Proceeds from secured convertible note

6,000,000

Transaction costs financed

5,002,968

Repayment of advances from related party

(300,000)

Advances from related party

1,052,300

1,948,950

Redemption of common stock

(53,947,064)

(148,523,642)

Net cash provided by (used in) financing activities

(41,891,796)

(146,874,692)

Net Change in Cash

26,688,332

1,003,340

Cash – Beginning

619,554

129,560

Cash – Ending

$

27,307,886

$

1,132,900

Supplementary cash flow information:

Cash paid for income taxes

$

$

537,000

Supplemental disclosure of non-cash investing and financing activities:

Shares issued to settled advances from related party and notes payable related party

 

$

4,577,569

$

Transaction cost settled with subscription payable

 

$

2,386,851

$

Fair value of equity treated earnout in AtlasClear, Inc asset acquisition

 

$

31,347,000

$

Fair value of shares issued in AtlasClear, Inc asset acquisition

 

$

44,400,000

$

Fair value of liability treated earnout in AtlasClear, Inc asset acquisition

 

$

10,963,000

$

Fair value of shares transferred to Wilson Davis shareholders

 

$

6,000,000

$

Short term notes issued to Wilson Davis shareholders

 

$

5,000,000

$

Long term notes issued to Wilson Davis shareholders

 

$

7,971,197

$

Common stock issued to settled vendor obligations

 

$

64,376

$

Fair value of shares transferred to Secured convertible note holders

 

$

1,250,698

$

Redeemable shares transferred to permanent equity

 

$

1,195,566

$

Non-redemption agreement re-classed to permanent equity

 

$

1,606,279

$

Shares issued to purchase Pacsquare

 

$

1,226,500

$

Shares issued as deposit for Commercial bank acquisition

 

$

91,200

$

Initial Classification of derivative liability – convertible notes

 

$

1,668,731

$

Interes settled with shares

$

210,550

$

Interest settled with shares transferred by related party

$

48,750

$

Cancellation of admin fees

 

$

$

120,000

Excise tax related to redemptions

 

$

539,471

$

1,485,236

Accretion of common stock subject to possible redemption

 

$

592,577

$

2,217,201

v3.24.4
SUBSEQUENT EVENTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUBSEQUENT EVENTS    
SUBSEQUENT EVENTS

NOTE 15. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, other than as described below.

Prior to the maturity date of October 13, 2024, FINRA approved a one-year extension for $1,280,000 in Subordinated notes. The interest rate on the subordinated notes increased from 5% to 8% and the notes mature on October 13, 2025. One of the notes, $20,000, was not renewed and will not be included in the Net Capital calculations. The note will be treated as debt.

On October 21, 2024, the Company held a special meeting of stockholders (the “Special Meeting”) in connection with the 1-for-30 Reverse Stock Split Proposal, 1-for-40 Reverse Stock Split Proposal, 1-for-50 Reverse Stock Split Proposal, 1-for-60 Reverse Stock Split Proposal, and Authorized Share Increase Proposal as defined and described in the definitive proxy statement filed by the Company with the SEC on October 8, 2024 (the “Proxy Statement”). The Company’s board of directors subsequently approved the 1-for-60 Reverse Stock Split ratio.

The proposal to amend the Company’s amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock from 100,000,000 shares to 500,000,000 shares and the number of authorized shares of preferred stock, par value $0.0001 per share, from 1,000,000 shares to 25,000,000 shares. On December 30, 2024, the Company filed a certificate of amendment to the amended and restated certificate of incorporation to increase the number of authorized shares of common stock and preferred stock.

On October 23, 2024, AtlasClear Holdings, Quantum Ventures, Chardan and Chardan Quantum LLC entered into the Settlement Agreement discussed above. In connection with the Settlement Agreement, Chardan exchanged the convertible, interest-bearing Original Chardan Note originally issued by the Company on February 9, 2024, in the aggregate principal amount of $4,150,000 for an amended non-interest bearing, convertible note in the aggregate principal amount of $5,209,764. While the amended Chardan Note does not bear interest, it can be converted from time to time by Chardan into shares of Common Stock on terms substantially similar to the conversion provisions in the Original Chardan Note, and any remaining outstanding principal is to be repaid in full on the same maturity date as the Original Note.

In connection with the Settlement Agreement, on October 23, 2024, the Company and Chardan entered into an amendment (the “Chardan Amended RRA”) to the registration rights agreement, dated February 9, 2024, pursuant to which the Company agreed, among other things, to file, by December 31, 2024, a registration statement with the SEC, registering the resale of shares of Common Stock issuable upon conversion of the Amended Chardan Note. If the resale registration statement (i) is not filed by December 31, 2024, then the interest rate of the Amended Chardan Note will increase by 2% per annum until the date of the filing, and shall be prorated for such period until the date of such filing and (ii) is not effective by March 31, 2025, then the interest rate on the Amended Chardan Note will increase to 19.99% per annum from March 31, 2025 until the date of effectiveness.

On November 14, 2024, the Company and Commercial Bancorp agreed to amend the agreement and plan of merger, dated November 16, 2022 (as amended, the “Bank Acquisition Agreement”), to extend the termination date of the Bank Acquisition Agreement from November 16, 2024, to May 14, 2025. Pursuant to the amendment, the parties expect to enter into a new and mutually agreed agreement for the Company to acquire the shares held by such shareholders of Commercial Bancorp. No Commercial Bancorp shareholder is required to agree to such amended or new agreement. Failure to enter into a new agreement or amendment to the Bank Acquisition Agreement shall constitute termination of the Bank Acquisition Agreement without liability. The Company shall issue to the shareholders of Commercial Bancorp, without additional compensation, 500,000 shares of common stock and the previously issued 40,000 shares to the Commercial Bancorp shareholders shall be cancelled. The shares have not yet been issued as of the date of filing.

NOTE 21. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements, other than as described below.

On July 5, 2024 pursuant to the transactions contemplated by a letter of intent, between AtlasClear and Pacsquare for the Source Code Purchase Agreement and Master Services Agreement, the Company issued and additional 500,000 shares to Pacsquare.

In accordance with the Chardan Convertible Note agreement, the note holder converted $725,000 in principle and received 2,263,031 shares on various dates subsequent to June 30, 2024, 493,909 of the shares were transferred by Atlas Fintech, Co-Sponsor. In addition, interest for the quarter ended March 31, 2024 and June 30, 2024 was paid with shares transferred by a Atlas Fintech on behalf of the Company for a total of 198,196 shares.

Subsequent to June 30, 2024, Quantum Venture, Co-Sponsor and Atlas Fintech, Co-Sponsor transferred 1,558,923 and 1,183,629 shares respectively as payment of interest under various Note obligations such as the Promissory notes, Secured Convertible notes and the Short and long term notes due to sellers.

On July 31, 2024, the Company and Tau entered into the ELOC Agreement. Pursuant to the ELOC Agreement, upon the terms thereof and subject to the satisfaction of certain conditions, the Company has the right from time to time at the Company’s option to direct Tau to purchase up to a specified maximum amount of shares of our Common Stock, up to a maximum aggregate purchase price of $10 million (the “Aggregate Limit”), over the 24-month term of the ELOC Agreement. The Company may request, individual advances up to the greater of 100,000 shares or such amount as is equal to 50% of the average daily volume traded of the Common Stock during the 30 trading days immediately prior to the date the request of each advance, subject to the Aggregate Limit. Any such advance will reduce amounts that the Company can request for future advances and draw downs. The purchase price payable for the shares sold pursuant to any advance will be equal to 97% of the lowest VWAP of the Common Stock during a pricing period of three consecutive trading days following Tau’s receipt of the applicable advance notice. Tau’s obligation to purchase the shares the Company request to sell pursuant to any advance is conditioned upon, in addition to certain other customary closing conditions, the continued effectiveness of a registration statement pursuant to which Tau may freely sell the shares to be received. 10,000,000 of the shares of Common Stock that may be issuable to Tau pursuant to the ELOC Agreement are being registered hereby. Tau is an underwriter within the meaning of Section 2(a)(11) of the Securities Act. The registration of the shares hereunder does not mean that Tau will actually purchase or that the Company will actually issue and sell all or any of the 10,000,000 shares of our Common Stock being registered for potential issuance to Tau pursuant to this registration statement. The Company has issued 2,475,000 shares under the ELOC.

On August 9, 2024, the Company entered into a Satisfaction of Discharge of indebtedness agreement with Atlas Fintech Holdings Corporation. In the agreement the Company agreed to issue 2,788,276 shares in satisfaction of $803,860 included in accounts payable. In addition the Company issued 1,337,500 shares as reimbursement for 1,183,629 shares that were transferred by Atlas Fintech Holdings Corporation to satisfy the Company requirements to pay interest on various loans with unrestricted shares. The company agreed to compensate the Atlas Fintech Holding Corporation 13% fee. As such a total of 4,125,776 Common Stock shares were transferred.

On August 28, 2024, the Company issued an additional 1,055,448 shares to the Wilson-Davis selling shareholders as payment of interest under the short term and long term note and as consideration for the Merger Consideration paid in stock.

On August 29, 2024, the Company issued 12,000 shares of Common Stock to Lead Nectar in lieu of payment for internet marketing services in the amount of $20,000, at a price per share of $1.66.

On July 10, 2024 and August 29, 2024, the Company issued 1,602,994 and 882,668 shares, respectively as partial conversion and payments of interest on the Short- and Long term Sellers Notes, the July distribution included share transfer from counders to cover the contingent guarantee made to the sellets.

Prior to the maturity date of October 13, 2024, FINRA approved a one-year extension for $1,280,000 in Subordinated notes. The interest rate on the subordinated notes increased from 5% to 8% and the notes mature on October 13, 2025. One of the notes, $20,000, was not renewed and will not be included in the Net Capital calculations. The note will be treated as debt.

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Transition Report on Form 10-KT, as filed with the SEC on October 16, 2024. The accompanying condensed balance sheet as of June 30, 2024 has been derived from the audited financial statements included in the Form 10-KT. The interim results for the three months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending June 30, 2025 or for any future periods.

Basis of Presentation

The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

Principles of Consolidation

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company  

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute

payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates  

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the private warrant liabilities, the fair value of the Subscription Agreement, the fair value of the conversion liabilities, realization of deferred tax assets, and the fair value of the customer list acquired on February 9, 2024. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents  

Cash and Cash Equivalents

The Company considers all operating accounts that hold money market funds held and short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

Trading Securities  

Trading Securities

Securities held in the Company’s trading account and trading securities, consist primarily of over-the-counter securities and are valued based upon quoted market prices. The value of securities that are not readily marketable are estimated by management based upon quoted prices, the number of market makers, trading volume and number of shares held. Unrealized gains and losses are reflected in income in the financial statements.

Property and Equipment  

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation on property and equipment is provided using accelerated and straight-line methods over expected useful lives of three to seven years.

Leases  

Leases

In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability on the statement of financial condition for all leases with terms longer than 12 months. Pursuant to this standard, the Company has recorded an operating lease right-of use (“ROU”) asset and operating lease liability in the accompanying balance sheet as of June 30, 2024.

The Company leases office space under the terms of several operating leases. The determination of whether an arrangement is a lease is made at the lease’s inception. Under ASC 842, a contract is (or contains) a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Control is defined under the standard as having both the right to obtain substantially all of the economic benefits from use of the asset and the right to direct the use of the asset. Management only reassesses its determination if the terms and conditions of the contract are changed.

ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses the implicit rate when it is readily determinable. Since the Company’s leases do not provide implicit rates, to determine the present value of lease payments, management uses the Company’s estimated incremental borrowing rate based on the information available at lease commencement.

Goodwill

Goodwill

We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates, and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As a result of the Deferred tax the Goodwill

balance was reduced by the benefit received. As of September 30, 2024, the fair value of goodwill was $6,142,525, as described in Note 10.

Goodwill

Goodwill represents the excess of purchase price in a business combination over the fair value of the net identifiable assets acquired. We evaluate goodwill for impairment at the reporting unit level by assessing whether it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If this assessment concludes that it is more likely than not that the fair value of a reporting unit exceeds its carrying value, then goodwill is not considered impaired and no further impairment testing is required. Conversely, if the assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, a goodwill impairment test is performed to compare the fair value of the reporting unit to its carrying value. The Company determines fair value of the reporting unit using income models. Our models contain significant assumptions and accounting estimates about discount rates, future cash flows, that could materially affect our operating results or financial position if they were to change significantly in the future and could result in an impairment. We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As of June 30, 2024, the fair value of goodwill was $7,706,725, as described in Note 11.

Intangible Assets

Intangible Assets

Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of September 30, 2024, the carrying value of developed technology and customer list was $1,928,800 and $13,843,665, respectively, as described in Note 10 and Note 11.

Intangible Assets

Intangible assets are presented at fair value, net of amortization. The fair value is determined based on the appraised value of the asset. Intangible assets comprise of developed technology and customer list (See Note 11 and 13). Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of June 30, 2024, the fair value of developed technology and customer list was $1,726,500 and $14,625,000, respectively, as described in Note 11 and Note 13.

Impairment of Long-lived and Intangible Assets

Impairment of Long-lived and Intangible Assets

The Company had no impairment charges during the three-month periods ended September 30, 2024 and 2023.

Impairment of Long-lived and Intangible Assets

In accordance with ASC 360-10 Property Plant and Equipment and ASC 350-10 Intangibles, the Company, on a regular basis, reviews the carrying amount of long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. The Company determines if the carrying amount of a long-lived asset is impaired based on anticipated undiscounted cash flows, before interest, from the use of the asset. In the event of impairment, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the asset. Fair value is determined based on the appraised value of the assets or the anticipated cash flows from the use of the asset, discounted at a rate commensurate with the risk involved. The Company recorded $17,845,813 of impairment charges included in loss on AtlasClear asset acquisition during the six months ended June 30.

Warrant Liabilities

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the condensed consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 14).

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 9).

Income Taxes  

Income Taxes

The Company utilizes the asset and liability method to account for income taxes. The objective of this method is to establish deferred tax assets and liabilities for the temporary differences between net income for financial reporting basis and the tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized.

Income tax expense or benefit is provided based upon the financial statement earnings of the Company. The allowance for doubtful accounts is deductible for financial statement purposes, but not for tax purposes. Depreciation expense is recognized in different periods for tax and financial accounting purposes due to the use of accelerated depreciation methods for income tax purposes. The tax effects of such differences are reported as deferred income taxes in the financial statements.

Revenue Recognition  

Revenue Recognition

Wilson-Davis, a subsidiary of the Company, recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, using the modified retrospective method. This revenue recognition guidance requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance requires an entity to follow a five-step model to: (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when the entity satisfies a performance obligation.

Wilson-Davis acts as an agent by selling securities to customers and collecting commissions. Wilson-Davis recognizes commissions on a trade date basis, which is the day the transaction is executed. Wilson-Davis believes that the performance obligation is satisfied on the trade date because that is when the security is selected, the price is determined, the trade is executed, and the risks and rewards of ownership have been transferred to/from the customer.

Wilson-Davis also receives commissions on mutual funds purchased by customers. Wilson-Davis believes that the performance obligation is not satisfied until the mutual funds are purchased by customers and recognizes the commission at that time.

Wilson-Davis performs vetting services to customers that wish to convert restricted stock to eligible trading stock. In addition, Wilson-Davis charges clearing fees to another broker-dealer for which it clears trades. Wilson-Davis recognizes revenue as the related performance obligations are satisfied.

Common Stock Subject to Possible Redemption  

Common Stock Subject to Possible Redemption

The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Common Stock subject to mandatory redemption are classified as a liability instrument and is measured at fair value. Conditionally redeemable Common Stock (including Common Stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Common Stock is classified as stockholders’ equity. The Company’s Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all Common Stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. The accretion of redeemable Common Stock during the year ended December 31, 2023 was an increase of $4,008,446, which represents cumulative earnings and withdrawals on the Trust Account through December 31, 2023, net of reimbursable income and franchise tax obligations as of December 31, 2023. The dissolution expense of $100,000 is not included in the redemption value of the Common Stock subject to redemption since it is only taken into account in the event of the Company’s liquidation. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Common Stock resulted in charges against additional paid-in capital, to the extent available, and accumulated deficit. On February 9, 2024, the shareholders redeemed in connection with the business combination $53,947,064, the company withdrew $68,418 from trust to cover income tax payments and recognized reclassified the unredeemed shares to permanent equity of 1,195,566. As of June 30, 2024 the Company no longer has redeemable shares.

At June 30, 2024, December 31, 2023 and 2022, the Common Stock reflected in the balance sheets is reconciled in the following table:

Common Stock subject to possible redemption, December 31, 2021

    

$

201,250,000

Plus:

  

Accretion of carrying value to redemption value

2,170,202

Common Stock subject to possible redemption, December 31, 2022

 

203,420,202

Less:

 

  

Redemption

 

(152,810,179)

Plus:

 

  

Accretion of carrying value to redemption value

 

4,008,446

Common Stock subject to possible redemption, December 31, 2023

$

54,618,469

Less:

 

  

Redemption

 

(53,947,064)

Withdraw for taxes

 

(68,416)

Reclass to permanent equity

 

(1,195,566)

Plus:

 

  

Accretion of carrying value to redemption value

 

592,577

Common Stock subject to possible redemption, June 30, 2024

$

Net (Loss) Income per Common Stock

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) Income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the warrants issued and outstanding. For the three months ended September 30, 2024, the calculation excludes the dilutive impact of warrants because none would be issued under treasury method. The convertible financial instrument and other share obligations were included in the dilutive calculation under the as converted method, as such the number of shares were included as if the shares were issued on July 1, 2024 and the interest expense and the change in fair value associated with the financial instruments was adjusted from net income to determine the numerator and denominator.

For the three months ended September 30, 2023, the calculation excludes the dilutive impact of these instruments because the exercise of the warrants were contingent upon the occurrence of future events and inclusion would be antidilutive.

The following table reflects the calculation of basic net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30, 2024

September 30, 2023

    

Non-

    

    

Non-

 redeemable

Redeemable

 redeemable

Basic net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income, as adjusted

$

10,748,033

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Basic weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

Basic net income per common stock

$

0.70

$

(0.03)

$

(0.03)

The following table reflects the calculation of diluted net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30,2024

September 30,2023

Non-

Non-

    

redeemable

    

Redeemable

    

redeemable

Diluted net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income,

$

10,748,033

$

(130,164)

$

(125,814)

Change in fair value of financial instruments

 

(12,655,000)

 

 

Interest on dilutive instruments

 

1,419,843

 

 

Allocation of net income, as adjusted

$

(487,124)

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Dilutive weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

If converted shares

 

99,180,693

 

 

 

114,565,050

 

5,205,217

 

5,031,250

Diluted net income (loss) per common stock

$

(0.00)

$

(0.03)

$

(0.03)

Below is a summary of the dilutive instruments as of September 30, 2024 and 2023:

Description

    

September 30, 2024

    

September 30, 2023

Short Term Notes

 

49,050,804

 

Convertible notes

 

19,263,975

 

Secured convertible note

 

26,202,298

 

Subscription agreement

 

2,818,665

 

Tau agreement

 

1,253,514

 

Stock payable

250,000

Promissory note

341,437

Total Shares issuable under Convertible Note obligations – if converted total dilutive

99,180,693

Public Warrants

 

10,062,500

 

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

Secured convertible note warrants

 

600,000

 

Total excluded under treasury method – out of the money

 

16,215,625

 

16,215,625

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the convertible derivative liability, subscription agreement, earnout shares nor the warrants issued and outstanding. The calculation excludes the dilutive impact of these instruments because the issuance of the securities underlying the exercise of the warrants are contingent upon the occurrence of future events and inclusion would be antidilutive. As a result, diluted net (loss) income per share of common stock is the same as basic net (loss) income per common stock for the periods presented.

The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):

    

FOR THE SIX MONTHS PERIOD ENDED

FOR THE YEAR ENDED

June 30, 2024

December 31, 2023

December 31, 2022

    

Non-

    

    

Non-

    

Non-

Redeemable

    

 redeemable

    

Redeemable

    

 redeemable

    

Redeemable

    

 Redeemable

Basic and diluted net income (loss) per share of Common Stock

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Net loss

$

(11,279,605)

$

(108,927,342)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Deemed dividend

(15,422,431)

Allocation of net income (loss)

$

(11,279,605)

$

(124,349,773)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Denominator:

 

 

 

 

Basic and diluted weighted average shares outstanding

 

10,719,043

 

1,109,975

6,898,644

5,031,250

 

20,125,000

 

5,031,250

Basic and diluted net income (loss) per share of Common Stock

$

(10.16)

$

(11.60)

$

0.07

$

0.07

$

0.44

$

0.44

Below is a summary of the dilutive instruments as of June 30, 2024, December 31, 2023 and, these were excluded as including them would be anti dilutive as of June 30, 2024 and were excluded in December 31, 2023 and June 30, 2023 as the exercise was contingent:

For the Six Months Ended

For the year ended

Description

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Shares issuable pursuant to Short Term and Long Term Notes

 

14,012,965

 

Shares issuable pursuant to Secured convertible note

 

9,801,273

 

Shares issuable pursuant to Convertible note

4,722,875

Shares issuable pursuant to Subscription agreement

938,967

Shares issuable pursuant to Promissory note

 

379,375

 

Total Shares issuable under Note obligations

 

29,855,455

 

Public Warrants

 

10,062,500

 

10,062,500

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

6,153,125

Secured convertible note warrants

 

600,000

 

Total dilutive

 

46,071,080

 

16,215,625

16,215,625

Concentration of Credit Risk  

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments  

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for warrant liabilities, convertible derivatives and the earnout out liability (see Note 19).

Derivative Financial Instruments  

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Recent Accounting Standards

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Schedule of common stock reflected in the balance sheets  

Common Stock subject to possible redemption, December 31, 2021

    

$

201,250,000

Plus:

  

Accretion of carrying value to redemption value

2,170,202

Common Stock subject to possible redemption, December 31, 2022

 

203,420,202

Less:

 

  

Redemption

 

(152,810,179)

Plus:

 

  

Accretion of carrying value to redemption value

 

4,008,446

Common Stock subject to possible redemption, December 31, 2023

$

54,618,469

Less:

 

  

Redemption

 

(53,947,064)

Withdraw for taxes

 

(68,416)

Reclass to permanent equity

 

(1,195,566)

Plus:

 

  

Accretion of carrying value to redemption value

 

592,577

Common Stock subject to possible redemption, June 30, 2024

$

Schedule of basic and diluted net income per share of Common Stock

The following table reflects the calculation of basic net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30, 2024

September 30, 2023

    

Non-

    

    

Non-

 redeemable

Redeemable

 redeemable

Basic net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income, as adjusted

$

10,748,033

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Basic weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

Basic net income per common stock

$

0.70

$

(0.03)

$

(0.03)

The following table reflects the calculation of diluted net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30,2024

September 30,2023

Non-

Non-

    

redeemable

    

Redeemable

    

redeemable

Diluted net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income,

$

10,748,033

$

(130,164)

$

(125,814)

Change in fair value of financial instruments

 

(12,655,000)

 

 

Interest on dilutive instruments

 

1,419,843

 

 

Allocation of net income, as adjusted

$

(487,124)

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Dilutive weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

If converted shares

 

99,180,693

 

 

 

114,565,050

 

5,205,217

 

5,031,250

Diluted net income (loss) per common stock

$

(0.00)

$

(0.03)

$

(0.03)

The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):

    

FOR THE SIX MONTHS PERIOD ENDED

FOR THE YEAR ENDED

June 30, 2024

December 31, 2023

December 31, 2022

    

Non-

    

    

Non-

    

Non-

Redeemable

    

 redeemable

    

Redeemable

    

 redeemable

    

Redeemable

    

 Redeemable

Basic and diluted net income (loss) per share of Common Stock

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Net loss

$

(11,279,605)

$

(108,927,342)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Deemed dividend

(15,422,431)

Allocation of net income (loss)

$

(11,279,605)

$

(124,349,773)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Denominator:

 

 

 

 

Basic and diluted weighted average shares outstanding

 

10,719,043

 

1,109,975

6,898,644

5,031,250

 

20,125,000

 

5,031,250

Basic and diluted net income (loss) per share of Common Stock

$

(10.16)

$

(11.60)

$

0.07

$

0.07

$

0.44

$

0.44

Schedule of dilutive instruments

Description

    

September 30, 2024

    

September 30, 2023

Short Term Notes

 

49,050,804

 

Convertible notes

 

19,263,975

 

Secured convertible note

 

26,202,298

 

Subscription agreement

 

2,818,665

 

Tau agreement

 

1,253,514

 

Stock payable

250,000

Promissory note

341,437

Total Shares issuable under Convertible Note obligations – if converted total dilutive

99,180,693

Public Warrants

 

10,062,500

 

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

Secured convertible note warrants

 

600,000

 

Total excluded under treasury method – out of the money

 

16,215,625

 

16,215,625

For the Six Months Ended

For the year ended

Description

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Shares issuable pursuant to Short Term and Long Term Notes

 

14,012,965

 

Shares issuable pursuant to Secured convertible note

 

9,801,273

 

Shares issuable pursuant to Convertible note

4,722,875

Shares issuable pursuant to Subscription agreement

938,967

Shares issuable pursuant to Promissory note

 

379,375

 

Total Shares issuable under Note obligations

 

29,855,455

 

Public Warrants

 

10,062,500

 

10,062,500

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

6,153,125

Secured convertible note warrants

 

600,000

 

Total dilutive

 

46,071,080

 

16,215,625

16,215,625

v3.24.4
CASH AND RESTRICTED CASH (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CASH AND RESTRICTED CASH    
Schedule of reconciliation of cash and restricted cash as shown in the statements of cash flows

    

For the Three Months

Ended 

September 30, 2024

Cash and cash equivalents

$

6,817,398

Cash segregated - customers

 

19,980,711

Cash segregated - PAB

 

768,767

Total cash and restricted cash shown in the statement of cash flows.

$

27,566,876

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Cash and cash equivalents

$

6,558,176

$

619,554

$

129,560

Cash segregated - customers

 

20,548,972

 

 

Cash segregated - PAB

 

200,738

 

 

Total cash and restricted cash shown in the statement of cash flows.

$

27,307,886

$

619,554

$

129,560

v3.24.4
RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION (Tables)
6 Months Ended
Jun. 30, 2024
RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION  
Schedule of amounts receivable and payable with broker dealers and the clearing organization

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Due from clearing organizations, net

$

1,094,453

$

$

Fails to deliver and receive

 

238,853

 

 

Total receivables

$

1,333,306

$

$

Due from clearing organizations, net

$

3,003

$

$

Fails to deliver and receive

 

1,912

 

 

Total payables

$

4,915

$

$

v3.24.4
PROPERTY AND EQUIPMENT (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
PROPERTY AND EQUIPMENT    
Summary of major classifications of property and equipment

    

September 30, 2024

Equipment

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(364,537)

$

11,511

June 30, 2024

Equipment

      

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(359,968)

$

16,080

v3.24.4
ACQUISITION OF WILSON-DAVIS (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
ACQUISITION OF WILSON-DAVIS    
Summary of preliminary allocation of the purchase price

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(3,724,270)

Trading Account deposit

 

(100,000)

Net assets acquired

 

6,296,241

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

20,767,525

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(5,288,470)

Trading Account deposit

 

(100,000)

Net assets acquired

 

4,732,041

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

22,331,725

Summary of identifiable intangible assets acquired

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

20,767,525

 

Goodwill

$

6,142,525

 

(a)The Wilson-Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

22,331,725

 

Goodwill

$

7,706,725

 

(a)

The Wilson Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

Summary the pro forma financial information

    

September 30, 2023

Total revenue

$

1,834,164

Net loss

$

(1,575,799)

Weighted average shares

 

  

Basic

 

11,801,759

Net loss per shares:

 

  

Basic

$

(0.13)

Weighted average shares

 

  

Diluted

 

11,801,759

Net loss per shares:

 

  

Diluted

$

(0.13)

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Total revenue

$

5,247,150

$

8,258,254

$

9,527,324

Net loss

 

(23,878,060)

$

(4,695,016)

$

(90,186,458)

Weighted average shares

 

  

 

  

 

  

Basic and diluted

 

11,801,759

 

11,801,759

 

11,906,245

Net loss per shares:

 

  

 

  

 

  

Basic and diluted

$

(2.02)

$

(0.40)

$

(8.87)

Summary of pro forma adjustments

    

September 30, 2023

Transaction cost

$

Amortization of intangibles

$

(307,192)

Interest earned on investments held in trust

$

(722,390)

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Transaction cost

$

(9,008,053)

$

$

9,008,053

Amortization of intangibles

$

$

2,437,500

$

2,437,500

Loss on AtlasClear acquisition

$

86,392,769

$

$

(86,392,769)

Interest earned on investments held in trust

$

(256,279)

$

(3,090,086)

$

(3,087,315)

v3.24.4
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC (Tables)
6 Months Ended
Jun. 30, 2024
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
Schedule of asset purchase price allocation The value was derived based on the purchase price allocation as follows: (the table below is expressed in thousands)

Total Purchase Price(a)

    

$

44,400,000

Fair value of Software Product Earn Out Shares(b)

 

10,963,000

Fair value of Earn Out Shares(c)

 

31,347,000

Purchase price allocated to Contribution Agreement

$

86,710,000

SURFACExchange

$

381,461

Bond Quantum

 

32,284

Atlas

 

7,749,299

Rubicon

 

10,000,000

Total Developed Technology acquired(d)

$

18,163,044

Transaction cost(e)

$

68,546,956

Technology acquired

$

18,163,044

Amortization recognized

(317,231)

Carrying balance of Technology acquired written off

17,845,813

Total loss on AtlasClear technology acquired

$

86,392,769

(a)

The closing consideration of $44.40 million is to be delivered in common stock. As such 4,400,000 were delivered based on $10 per share presumed value of common stock.

(b)

Atlas FinTech will receive up to $20.00 million of Common Stock (“Software Products Earn Out Shares”), which will be issued to Atlas FinTech upon certain milestones (based on the achievement of certain revenue targets of software products contributed to AtlasClear by Atlas FinTech and Atlas Financial Technologies Corp. following the Closing). The revenue targets will be measured yearly for the five years following Closing, with no catch-up between the years. The value was determined based on projected revenue based on a discount factor. The Earn Out provision was analyzed under ASC 480 and ASC 815. the Software Products Earn Out Shares Payments in this transaction are within the scope of ASC 480 and therefore will be accounted for as a liability and included in the purchase price consideration. The revenue earnout was estimated using a Monte Carlo simulation to determine if and when the revenue hurdles would be achieved. The revenue volatility and revenue to equity correlation was based upon the same guideline public companies. The Monte Carlo simulation was performed simultaneously on both the share price and revenue to account for the correlation between revenue and equity.

(c)

Atlas FinTech will receive up to 5,944,444 shares of Common Stock (the “Earn Out Shares”). The Earn Out Shares will be issued to AtlasClear Stockholders upon certain milestones (based on the achievement of certain price targets of Common Stock following the Closing). In the event such milestones are not met within the first 18 months following the Closing, the Earn Out Shares will be cancelled. The Earn Out provision was analyzed under ASC 480 and ASC 815. The earnout provision was deemed to be indexed to the Company’s own stock and therefore equity classified. The share based earnout was estimated using a Monte Carlo simulation to determine if and when the stock price hurdles would be achieved. The expected stock price volatility was based upon guideline public companies.

(d)

Under SAB topic 5G transfers of nonmonetary assets for stock prior to an initial offering should be recorded at predecessor cost in accordance with GAAP. As such the value of the Developed Technology was based on the carrying value of Atlas FinTech of $18.16 million. The estimated useful life was determined to be eight years. There are no historical revenues for the Developed Technology and AtlasClear’s management determined the fair value based on their experience and expectations from running similar models in previous companies.

(e)

ASC 350 prohibits the recognition of goodwill in an asset purchase. As such the difference between the purchase price of $86.98 million was charged as transactions and recorded under accumulated deficit of $68.55 million.

v3.24.4
INTANGIBLE ASSETS (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
INTANGIBLE ASSETS    
Summary of intangible assets

September 30, 2024

    

    

Accumulated

    

Impairment

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,928,800

 

 

 

1,928,800

Customer Lists

12 years

 

14,625,000

 

(781,335)

 

 

13,843,665

Intangible Assets

$

22,696,325

$

(781,335)

$

(17,845,813)

$

21,914,990

June 30, 2024

    

    

Accumulated

    

Impairment

    

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,726,500

 

 

 

1,726,500

Technology acquired

zero years

 

18,163,044

 

(317,231)

 

(17,845,813)

 

Customer Lists

12 years

 

14,625,000

 

(474,144)

 

 

14,150,856

Intangible Assets

$

40,657,069

$

(791,375)

$

(17,845,813)

$

22,019,881

Summary of amortization intangible assets

Fiscal Year

    

Amount

June 30, 2025

$

911,558

June 30, 2026

 

1,411,630

June 30, 2027

 

1,411,630

June 30, 2028

 

1,414,970

June 30, 2029

 

1,411,630

Thereafter

 

9,211,047

Year

    

Amount

June 30, 2025

$

1,218,750

June 30, 2026

 

1,391,400

June 30, 2027

 

1,391,400

June 30, 2028

 

1,394,739

June 30, 2029

 

1,391,400

Thereafter

 

9,089,667

v3.24.4
LEASES (Tables)
6 Months Ended
Jun. 30, 2024
LEASES  
Schedule of other information related to the Company's operating leases

June 30,

    

2024

Operating lease ROU Asset - February 9, 2024

$

395,063

Increase

Decrease

(68,727)

Operating lease ROU Asset - Ending Balance

$

326,336

Operating lease liability - Short Term

$

149,499

Operating lease liability - Long Term

182,729

Operating lease liability - Total

$

332,228

Schedule of weighted-average remaining lease term and weighted-average discount rates related to the Company's operating leases

    

June 30, 

 

2024

 

Weighted average remaining lease term

 

2.35

years

Weighted average discount rate

 

4.97

%

Tabular disclosure of future minimum payments required by the lease agreements

2025

$

164,271

2026

118,597

2027

70,377

Total minimum lease payments

353,245

Less interest factor

(21,017)

Total operating lease liability

332,228

Less operating lease liability - current portion

(149,499)

Operating lease liability - long term portion

$

182,729

v3.24.4
INCOME TAX (Tables)
6 Months Ended
Jun. 30, 2024
INCOME TAX  
Schedule of income tax (benefit) provision

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Current Tax:

  

  

  

Federal

$

$

726,038

$

536,853

State

 

3,170

 

 

Total current

 

3,170

 

726,038

 

536,853

Deferred Tax:

 

 

 

Federal

 

(546,276)

 

 

State

 

(26,630)

 

 

Total deferred

 

(572,906)

 

 

Total provision for income taxes

$

(569,736)

$

726,038

$

536,853

Schedule of federal income tax rate to the company's effective tax rate

    

June 30, 2024

    

Rate

 

Tax at Statutory rate (21%)

$

(25,376,496)

21.00

%

Permanent Differences:

 

Change in fair value of NRA liability

$

34,571

(0.03)

%

Meals

 

1,769

0.00

%

Entertainment

 

161

0.00

%

Nondeductible transaction Costs

 

1,891,691

(1.57)

%

Change in fair value of Long-Term and Short-Term Investor Notes

 

2,353,692

(1.95)

%

Change in fair value of Secured Convertible Note

 

753,039

(0.62)

%

Change in fair value of Earnout Liability

 

280,350

(0.23)

%

Change in fair value of Subscription Agreement

 

8,147

(0.01)

%

Change in fair value of Stock Payable

 

(206,865)

0.17

%

Loss on AtlasClear acquisition

 

18,142,481

(15.01)

%

Stock Compensation Expense

 

307,157

(0.25)

%

Extinguishment of Accrued Liabilities

 

(184,689)

0.15

%

Change in fair value of WDCO Share payable

 

683,941

(0.57)

%

Return To Provision

 

(477,461)

0.40

%

State Tax – Net of Federal Benefit

 

(220,234)

0.18

%

State Minimum Tax – Net of Federal Benefit

 

2,504

0.00

%

Chang in Valuation Allowance – State

 

499,331

(0.41)

%

Chang in Valuation Allowance - Federal

 

937,175

(0.78)

%

Total

$

(569,736)

0.47

%

    

December 31,

    

December 31,

 

2023

2022

 

Statutory federal income tax rate

 

21.0

%  

21.0

%

Business combination expenses

 

15.27

%  

(0.51)

%

Change in fair value of warrant liability

 

1.70

%  

(12.61)

%

Change in fair value of PIPE derivative liability

 

(6.07)

%  

(8.28)

%

Transaction costs - warrants

 

0.0

%  

0.0

%

Penalties & Interest

 

0.08

%  

0.07

%

Valuation allowance

 

15.73

%  

4.97

%

Income tax provision

 

47.71

%  

4.64

%

Schedule of net deferred tax assets (liability)

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Deferred Tax Assets:

 

  

 

  

 

  

Fixed Assets

$

261

$

$

Business Combination Expenses

 

530,560

 

437,530

 

427,319

IRC Sec. 195 Start-Up Costs

 

956,768

 

974,835

 

745,713

Allowance for Bad Debt

 

3,820

 

 

Accrued Contingent Liability

 

25,465

 

 

Lease Liability (ASC 842)

 

84,602

 

 

IRC Sec. 1231 Losses

 

1,774

 

 

Net Operating Loss

 

1,361,541

 

 

Total Deferred Tax Asset

 

2,964,791

 

1,412,365

 

1,173,032

Deferred Tax Liabilities:

 

 

 

Intangible Assets

 

5,167,729

 

 

ROU Lease Asset (ASC 842)

 

83,102

 

 

State Tax - Current

 

526

 

 

State Tax - Deferred

 

110,452

 

 

Total Deferred Tax Liability

 

5,361,809

 

 

Net Deferred Tax Asset/(Liability) before Valuation allowance

 

(2,397,018)

 

1,412,365

 

1,173,032

Valuation Allowance

 

(2,848,868)

 

(1,412,365)

 

(1,173,032)

Net Deferred Tax Asset/(Liability)

$

(5,245,886)

$

$

v3.24.4
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
FAIR VALUE MEASUREMENTS    
Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis

    

    

September 30,

    

June 30,

Description

Level

2024

2024

 

 

  

 

  

Liabilities:

 

Subscription agreement

3

$

2,460,488

$

2,425,647

Contingent Guarantee

3

$

$

3,256,863

Warrant liability – Private Warrants

3

$

61,531

$

307,656

Earnout liability

 

3

$

12,638,000

$

12,298,000

Convertible notes derivative

 

3

$

2,142,511

$

16,462,690

Merger financing derivative

3

$

176,239

Secured convertible derivative

3

$

89,535

Tau agreement

 

3

$

972,508

$

    

    

June 30,

    

December 31,

    

December 31,

Description

Level

2024

2023

2022

Assets:

 

 

  

 

  

 

  

Marketable securities held in Trust Account

 

1

$

$

54,799,478

$

204,044,469

Liabilities:

 

 

  

 

  

 

  

Subscription agreement

3

$

2,084,691

$

$

Contingent Guarantee

3

$

3,256,863

$

$

Warrant liability – Private Warrants

 

3

$

307,656

$

307,656

$

184,594

Non-redemption agreement liability

3

$

$

1,441,653

$

Convertible notes derivative

3

$

16,462,690

$

$

Earnout liability

 

3

$

12,298,000

$

$

Schedule of Key Inputs into the models

    

June 30,

    

June 30,

 

Input

 

2024

 

2024

Market price of public shares

$

0.21

$

1.04

Equity volatility

 

34.4

%  

 

26.2

%

Risk-free rate

 

4.01

%  

 

5.05

%

    

June 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Risk-free rate

 

3.52

%  

 

4.27

%

Dividend yield

 

0.00

%  

 

0.00

%

Volatility

 

87.4

%  

 

58.7

%

Exercise price

$

11.50

$

11.50

Effective expiration date

 

February 2029

 

February 2029

    

September 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

9.61

%  

 

9.69

%

    

September 30,

 

Input

 

2024

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

 

28.9

%

Volatility

 

36.7

%

Effective expiration date

 

February 2026

    

June 30,

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

5.49

%

Dividend yield

 

0.00

%

Volatility

 

14,643.0

%

Exercise price

$

0.99

Effective expiration date

May 2024

    

September 30,

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

28.9

%

Volatility

36.7

%

Effective expiration date

February 2026

    

June 30,

 

Input

 

2024

Market price of public shares

$

1.04

Risk-free rate

 

4.90

%

Dividend yield

 

0.00

%

Volatility

 

14,461

%

Exercise price

$

0.99

Effective expiration date

 

February 2026

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.36

%

Discount rate

 

7.72

%

Probability of default

 

41.2

%

Recovery rate

 

47.6

%

Volatility

 

43.9

%

Effective expiration date

 

February 2028

    

June 30,

 

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

4.52

%

Dividend yield

 

0.00

%

Volatility

 

166,681.0

%

Exercise price

$

0.84

Effective expiration date

 

February 2028

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

3.87

%

Discount rate

 

7.84

%

Probability of default

 

19.8

%

Recovery rate

 

47.6

%

Volatility

 

36.8

%

Effective expiration date

 

November 2025

    

September 30,

    

August 9,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

4.84

%

 

4.78

%

Discount rate

 

11.72

%

 

16.98

%

Probability of default

 

23.5

%

 

25.4

%

Recovery rate

 

28.9

%

 

28.9

%

Volatility

 

36.7

%

 

37.2

%

Effective expiration date

 

February 2026

 

February 2026

    

September 30,

    

July 31

 

Input

2024

2024

 

Anticipated Monthly Advance Amounts

$

40,000

$

40,000

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

    

September 30,

    

July 31,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

The key inputs into the Monte Carlo model for the Subscription Agreement were as follows:

February 9,

 

June 30,

2024

 

Input

    

2024

    

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Equity volatility

 

26.2

%  

 

29.8

%

Risk-free rate

 

5.05

%  

 

4.67

%

The key inputs into the Black-Scholes model for the Private Warrants were as follows:

    

June 30,

    

December 31,

December 31,

 

Input

2024

2023

2022

 

Market price of public shares

$

1.04

$

6.20

$

10.05

Risk-free rate

 

4.27

%  

 

3.77

%  

 

3.91

%

Dividend yield

 

0.00

%  

 

0.00

%  

 

0.00

%

Volatility

 

58.7

%  

 

12.0

%  

 

2.6

%

Probability of a business combination

 

100

%  

 

100

%  

 

4.5

%

Exercise price

$

11.50

$

11.50

$

11.50

Effective expiration date

 

February 29

 

February 29

 

February 29

The key inputs into the Monte Carlo model for the non-redeemable common stock were as follows:

    

December 31,

August 1,

 

Input

2023

2023

 

Market price of public shares

$

6.20

$

10.57

Probability of acquisition

 

100.0

%

 

82.0

%

Equity volatility

 

12.0

%

 

19.9

%

Discount for lack of marketability

 

8.0

%

 

3.0

%

Discount for expected forfeiture

 

5.10

%

 

5.10

%

The key inputs into the Monte Carlo model for the Earnout liability were as follows:

    

    

February 9,

 

June 30,

2024

 

Input

2024

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

96.9

%  

 

99.5

%

maturity. As of June 30, 2024, the company did not repay the short-term notes as such has incurred penalty interest from 9% to 13% until the note is repaid. No notice of default has been received. See note 10 for additional information.

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

5.49

 

5.44

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,643.0

 

4,120.0

%

Exercise price

$

0.99

$

7.27

Effective expiration date

May 2024

May 2024

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.90

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,461

 

41,200

%

Exercise price

$

0.99

$

7.27

Effective expiration date

February 2026

February 2026

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.52

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

166,681.0

 

4,120.0

%

Exercise price

$

0.84

$

10.26

Effective expiration date

February 2028

February 2028

Schedule of changes in the fair value

    

Private

    

Tau

Placement

 Agreement

Warrants

Liability

Fair value as of June 30, 2024

$

307,656

$

Initial measurement

1,090,949

Transferred to equity

(303,000)

Change in valuation inputs or other assumptions

(246,125)

184,559

Fair value as of September 30, 2024

$

61,531

$

972,508

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

Change in valuation inputs or other assumptions

 

(14,320,179)

 

 

340,000

Fair value as of September 30, 2024

$

2,142,511

 

$

12,638,000

    

Subscription

    

Contingent

Agreement

Guarantee

Fair value as of June 30, 2024

$

2,425,647

$

3,256,863

Shares issued as partial payment

 

 

(1,210,290)

Change in valuation inputs or other assumptions

 

34,841

 

839,774

Exchanged to Merger financing note

 

 

(2,886,347)

Fair value liability as of September 30, 2024

$

2,460,488

$

    

Merger

    

Secured

Financing

Convertible

Derivative

Derivative

Fair value as of June 30, 2024

$

$

Initial measurement

 

113,044

 

Change in valuation inputs or other assumptions

 

63,195

 

89,535

Fair value as of September 30, 2024

$

176,239

$

89,535

    

Private

    

Non-Redemption

Placement

 Agreement

Warrants

Liability

Fair value as of December 31, 2021

$

7,137,930

$

Change in valuation inputs or other assumptions

(6,953,336)

1,881,440

Fair value as of December 31, 2022

$

184,594

$

Initial measurement as of August 1, 2023

1,881,440

Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability

123,062

(439,787)

Fair value as of December 31, 2023

$

307,656

$

1,441,653

Change in valuation inputs or other assumptions

164,626

Transferred to equity

(1,606,279)

Fair value as of June 30, 2024

$

307,656

$

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of December 31, 2023

$

 

$

Initial measurement as of February 9, 2024

1,668,731

10,963,000

Change in valuation inputs or other assumptions

 

14,793,959

 

 

1,335,000

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

    

Subscription

    

Merger Financing

Agreement

Liability

Fair value as of December 31, 2023

$

$

Initial measurement as of February 9, 2024

 

2,386,851

 

Change in valuation inputs or other assumptions

 

38,796

 

3,256,863

Fair value (asset) liability as of June 30, 2024

$

2,425,647

$

3,256,863

v3.24.4
TRANSITION PERIOD COMPARATIVE DATA (Tables)
6 Months Ended
Jun. 30, 2024
TRANSITION PERIOD COMPARATIVE DATA  
Schedule of transition period comparative data

    

June 30,

    

June 30,

2024

2023

ASSETS

 

 

(Unaudited)

Current assets

Cash and cash equivalents

$

6,558,176

$

1,132,900

Cash segregated - customers

 

20,548,972

 

Cash segregated - PAB

 

200,738

 

Receivables - broker-dealers and clearing organizations

 

1,333,306

 

Receivables - customers, net

 

823,784

 

Other receivables

 

64,842

 

Prepaid expenses

 

67,967

 

29,458

Trading securities, market value, net

 

55

 

Due from Atlas Clear

 

 

49,806

Total Current Assets

 

29,597,840

 

1,212,164

Operating lease right to use lease asset

 

326,336

 

Property and equipment, net

 

16,080

 

Customer list, net

 

14,150,856

 

Goodwill

 

7,706,725

 

Pacsquare asset purchase

 

1,726,500

 

Bank acquisition deposit

 

91,200

 

Cash deposits - broker-dealers and clearing organizations

 

3,515,000

 

Other assets

 

336,017

 

Marketable securities held in Trust Account

 

 

57,409,747

TOTAL ASSETS

$

57,466,554

$

58,621,911

LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT

 

  

 

  

Current liabilities

 

  

 

  

Payables to customers

$

20,162,973

$

Accounts and payables to officers/directors

 

686,579

 

Accounts payable and accrued expenses

 

5,393,912

 

5,181,488

Payables - broker-dealers and clearing organizations

 

4,915

 

Commissions, payroll and payroll taxes

 

273,386

 

Current portion of lease liability

 

149,499

 

Stock payable

 

259,893

 

Convertible notes, net

 

3,783,437

 

Secured convertible note, net

 

6,857,101

 

Promissory notes

 

852,968

 

Short-term merger financing, net

 

5,092,083

 

Contingent gurantee

3,256,863

Subscription agreement

 

2,425,647

 

Excise tax payable

 

2,067,572

 

Excise taxes payable

 

 

1,485,236

Stock payable - related party

55,087

Advance from related parties

 

 

1,968,116

Promissory note – related party

 

 

480,000

Total Current Liabilities

 

51,321,915

 

9,114,840

Accrued contingent liability

 

100,000

 

Long-term merger financing, net

 

7,606,561

 

Derivative liability - convertible notes

 

16,462,690

 

Derivative liability - warrants

 

307,656

 

307,656

Earnout - liability

 

12,298,000

 

Deferred income tax liability

5,245,886

Subordinated borrowings

 

1,950,000

 

Trading account deposit

 

100,000

 

Long-term lease liability

 

182,729

 

Total Liabilities

 

95,575,437

 

9,422,496

Commitments and Contingencies (Note 10)

Common stock subject to possible redemption

 

 

57,113,761

Stockholders’ Deficit

Preferred stock, $0.0001 par value;

 

 

Common stock, $0.0001 par value;

 

1,246

 

503

Additional paid-in capital

 

110,164,676

 

Accumulated deficit

 

(148,274,805)

 

(7,914,849)

Total Stockholders’ Deficit

 

(38,108,883)

 

(7,914,346)

TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT

$

57,466,554

$

58,621,911

     

Three Months Ended

    

Six Months Ended

June 30,

June 30,

2024

     

2023

2024

    

2023

REVENUES

Commissions

$

1,750,159

$

$

2,679,673

$

Vetting fees

 

340,050

 

499,125

 

Clearing fees

 

624,550

 

 

756,393

 

Net gain/(loss) on firm trading accounts

 

6,390

 

 

10,046

 

Other revenue

 

9,650

 

56,246

TOTAL REVENUES

 

2,730,799

 

 

4,001,483

 

EXPENSES

 

  

 

  

 

  

 

  

Compensation, payroll taxes and benefits

 

1,355,058

 

 

2,386,837

 

Data processing and clearing costs

 

843,824

 

 

1,299,527

 

Regulatory, professional fees and related expenses

 

112,216

 

11,649,470

 

Stock compensation - founder share transfer

 

 

 

1,462,650

 

Communications

 

172,018

 

 

254,608

 

Occupancy and equipment

 

54,765

 

 

76,324

 

Transfer fees

 

54,807

 

 

75,425

 

Bank charges

 

52,077

 

 

88,253

 

Intangible assets amortization

 

337,911

 

 

791,375

 

Other

 

147,042

 

 

185,840

 

Operating and formation costs

 

 

577,313

 

 

1,485,122

TOTAL EXPENSES

 

3,129,718

 

577,313

 

18,270,309

 

1,485,122

LOSS FROM OPERATIONS

 

(398,919)

 

(577,313)

 

(14,268,826)

 

(1,485,122)

OTHER INCOME/(EXPENSE)

Interest income

 

587,637

 

8,458

 

938,802

 

8,458

Interest earned on marketable securities held in Trust Account

 

727,468

 

256,279

 

2,028,921

Gain on sale of assets

 

146,706

 

 

146,706

 

Net gain on settlement

 

 

829,853

 

 

829,853

Loss on AtlasClear asset acquisition

 

(17,845,813)

 

 

(86,392,769)

 

Change in fair value of warrant liability derivative

 

307,656

 

(184,594)

 

 

(123,062)

Change in fair value, convertible note derivative

 

(992,152)

 

 

(3,585,902)

 

Change in fair value, long-term and short-term note derivative

 

(3,101,057)

 

 

(11,208,055)

 

Change in fair value of non-redemption agreement

 

 

 

(164,626)

 

Change in fair value of Contingent guarantee

(3,256,863)

(3,256,863)

Change in fair value of earnout liability

 

(1,115,000)

 

 

(1,335,000)

 

Change in fair value of subscription agreement

 

(4,413,946)

 

 

(38,796)

 

Extinguishment of stock payable

 

985,072

 

 

985,072

 

Extinguishment of accrued expenses

 

114,199

 

 

879,473

 

Interest expense

 

(3,210,786)

 

 

(3,732,178)

 

TOTAL OTHER INCOME/(EXPENSE)

 

(31,794,347)

 

1,381,185

 

(106,507,857)

 

2,744,170

Income before provision for income taxes

 

(32,193,266)

 

803,872

 

(120,776,683)

 

1,259,048

Provision for income taxes

 

563,736

 

(318,313)

 

569,736

 

(581,118)

Net income

$

(31,629,530)

$

485,559

$

(120,206,947)

$

677,930

      

Six Months Ended June 30,

2024

      

2023

Cash Flows from Operating Activities:

Net income (loss)

$

(120,206,947)

$

677,930

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Change in fair value of warrant liability derivative

123,062

Change in fair value of non-redemption agreement

164,626

Loss on AtlsClear asset acquisition

86,392,769

Change in fair value, convertible note derivative

3,585,904

Change in fair value, long-term and short-term note derivative

11,208,055

Interest expense on convertible notes

1,896,714

Transaction costs paid with stock

1,401,937

Stock based compensation

1,462,650

Change in fair value, earnout liability

1,335,000

Fee on Secured convertible note

1,500,000

Change in operating lease expense

68,727

Change in fair value, contingent guarantee

3,256,863

Interest earned on marketable securities held in Trust Account

(251,569)

(2,028,921)

Change in fair value, subscription agreement

38,796

Depreciation expense

7,565

Amortization of intangibles

791,375

Bad debt expense

2,474

Changes in operating assets and liabilities:

Due from Atlas Clear

(49,806)

Income taxes payable

44,118

Marketable securities

6,820

Receivables from brokers & dealers

2,203,271

Receivables from customers

(303,486)

Receivables from others

(59,043)

Advances and Prepaid expenses

133,158

4,194

Cash deposits with clearing organization & other B/Ds

21,664

Change in operating lease right-of-use assets

(11,713)

Other assets

49,041

Payables to customers

(5,124,740)

Payables to officers & directors

98,048

Payable to brokers & dealers

(12,903)

Deferred tax liability

(43,484)

Accounts payable and accrued expenses

(1,066,430)

443,812

Commissions and payroll taxes payable

39,638

Stock Loan

259,893

Change in operatin lease right-of-use asset

(56,900)

Receivables from brokers & dealers

Receivables from customers

Net cash provided by (used in) operating activities

(11,212,227)

(785,611)

Cash Flows from Investing Activities:

Cash withdrawn from Trust Account to pay franchise and income taxes

68,418

Investment of cash into Trust Account

(160,000)

(875,000)

Cash withdrawn from Trust Account in connection with redemption

53,947,064

1,015,001

Cash paid for purchase of Pacsquare

(500,000)

Cash received from acquisition of Wilson-Davis

33,333,876

Cash withdrawn from Trust Account for working capital purposes

1,195,565

148,523,642

Cash paid to Wilson Davis shareholders

(8,092,568)

Net cash provided by (used in) investing activities

79,792,355

148,663,643

Cash Flows from Financing Activities:

Proceeds from secured convertible note

6,000,000

Transaction costs financed

5,002,968

Repayment of advances from related party

(300,000)

Advances from related party

1,052,300

1,948,950

Redemption of common stock

(53,947,064)

(148,523,642)

Net cash provided by (used in) financing activities

(41,891,796)

(146,874,692)

Net Change in Cash

26,688,332

1,003,340

Cash – Beginning

619,554

129,560

Cash – Ending

$

27,307,886

$

1,132,900

Supplementary cash flow information:

Cash paid for income taxes

$

$

537,000

Supplemental disclosure of non-cash investing and financing activities:

Shares issued to settled advances from related party and notes payable related party

 

$

4,577,569

$

Transaction cost settled with subscription payable

 

$

2,386,851

$

Fair value of equity treated earnout in AtlasClear, Inc asset acquisition

 

$

31,347,000

$

Fair value of shares issued in AtlasClear, Inc asset acquisition

 

$

44,400,000

$

Fair value of liability treated earnout in AtlasClear, Inc asset acquisition

 

$

10,963,000

$

Fair value of shares transferred to Wilson Davis shareholders

 

$

6,000,000

$

Short term notes issued to Wilson Davis shareholders

 

$

5,000,000

$

Long term notes issued to Wilson Davis shareholders

 

$

7,971,197

$

Common stock issued to settled vendor obligations

 

$

64,376

$

Fair value of shares transferred to Secured convertible note holders

 

$

1,250,698

$

Redeemable shares transferred to permanent equity

 

$

1,195,566

$

Non-redemption agreement re-classed to permanent equity

 

$

1,606,279

$

Shares issued to purchase Pacsquare

 

$

1,226,500

$

Shares issued as deposit for Commercial bank acquisition

 

$

91,200

$

Initial Classification of derivative liability – convertible notes

 

$

1,668,731

$

Interes settled with shares

$

210,550

$

Interest settled with shares transferred by related party

$

48,750

$

Cancellation of admin fees

 

$

$

120,000

Excise tax related to redemptions

 

$

539,471

$

1,485,236

Accretion of common stock subject to possible redemption

 

$

592,577

$

2,217,201

v3.24.4
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS        
Cash in bank account $ 6,817,398 $ 27,307,886    
Working capital deficit 7,068,848 21,724,075    
Excise tax payable $ 2,067,572 $ 2,067,572 $ 1,528,101 $ 1,485,236
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Accretion of redeemable common stock increase       $ 4,008,446  
Dissolution expense       $ 100,000  
Effective tax rate     0.47% 47.71% 4.64%
Statutory tax rate     21.00% 21.00% 21.00%
Fair value of goodwill $ 6,142,525   $ 7,706,725    
Impairment charges $ 0 $ 0 $ 17,845,813 $ 17,845,813 $ 17,845,813
Minimum          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives     3 years    
Maximum          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives     7 years    
Developed technology          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives 10 years   10 years    
Intangible assets fair value $ 1,928,800   $ 1,726,500    
Customer Lists          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives 12 years   12 years    
Intangible assets fair value $ 13,843,665   $ 14,625,000    
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Schedule of common stock reflected in the balance sheets - USD ($)
6 Months Ended 12 Months Ended
Feb. 09, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES        
Common stock subject to possible redemption, beginning   $ 54,618,469 $ 203,420,202 $ 201,250,000
Less:        
Redemption $ (53,947,064) (53,947,064) (152,810,179)  
Withdraw for taxes (1,195,566) (1,195,566)    
Reclass to permanent equity $ (68,418) (68,416)    
Plus:        
Accretion of carrying value to redemption value   $ 592,577 4,008,446 2,170,202
Common Stock subject to possible redemption, ending     $ 54,618,469 $ 203,420,202
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of basic and diluted net (loss) income per share of common stock (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Numerator:                
Net loss $ 10,748,033 $ (31,629,530) $ (255,978) $ 485,559 $ (120,206,947) $ 677,930 $ 794,950 $ 11,045,567
Redeemable                
Numerator:                
Net loss         (11,279,605)   460,174 8,836,454
Allocation of net income, as adjusted         $ (11,279,605)   $ 460,174 $ 8,836,454
Denominator:                
Basic weighted average shares outstanding (in shares)         10,719,043   6,898,644 20,125,000
Diluted weighted average shares outstanding (in shares)         10,719,043   6,898,644 20,125,000
Basic net income per common stock (in dollars per share)         $ (10.16)   $ 0.07 $ 0.44
Diluted net income (loss) per common stock (in dollars per share)         $ (10.16)   $ 0.07 $ 0.44
Non-redeemable                
Numerator:                
Net loss         $ (108,927,342)   $ 335,609 $ 2,209,113
Deemed dividend         (15,422,431)      
Allocation of net income, as adjusted         $ (124,349,773)   $ 335,609 $ 2,209,113
Denominator:                
Basic weighted average shares outstanding (in shares)         1,109,975   5,031,250 5,031,250
Diluted weighted average shares outstanding (in shares)         1,109,975   5,031,250 5,031,250
Basic net income per common stock (in dollars per share)         $ (11.6)   $ 0.07 $ 0.44
Diluted net income (loss) per common stock (in dollars per share)         $ (11.6)   $ 0.07 $ 0.44
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of dilutive instruments (Details) - shares
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share 16,215,625 16,215,625 46,071,080 16,215,625 16,215,625
Total Shares issuable under Convertible Note obligations          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share     29,855,455    
Shares issuable pursuant to Short Term and Long Term Notes          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share     14,012,965    
Shares issuable pursuant to Secured convertible note          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share     9,801,273    
Shares issuable pursuant to Convertible note          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share     4,722,875    
Subscription agreement          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share     938,967    
Shares issuable pursuant to Promissory note          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share     379,375    
Public Warrants          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share 10,062,500 10,062,500 10,062,500 10,062,500 10,062,500
Private Placement Warrants          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share 5,553,125 6,153,125 5,553,125 6,153,125 6,153,125
Secured convertible note warrants          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Antidilutive securities excluded from computation of earnings per share 600,000   600,000    
v3.24.4
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS (Details) - USD ($)
Oct. 01, 2024
Sep. 30, 2024
Jul. 01, 2024
Jun. 30, 2024
Customers transactions and credit balances        
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS        
Calculated required reserve   $ 18,830,537   $ 19,326,300
Cash on deposit in the reserve account   19,667,586   19,677,378
Cash reserve deposit more than amount required   837,049   351,078
Amount deposited to reserve account in accordance with the rule     $ 150,000  
Cash on deposit in the reserve account in excess of the amount required $ 500,000   $ 501,078  
Broker-dealer transactions and credit balances        
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS        
Calculated required reserve   100,000   100,000
Cash on deposit in the reserve account   200,000   200,738
Cash reserve deposit more than amount required   $ 100,000   $ 100,738
v3.24.4
NET CAPITAL REQUIREMENTS (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
NET CAPITAL REQUIREMENTS    
Net capital $ 10,449,178 $ 10,437,312
Net capital in excess of the minimum required $ 10,199,178 $ 10,187,312
v3.24.4
CASH AND RESTRICTED CASH (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH AND RESTRICTED CASH              
Cash and cash equivalents $ 6,817,398 $ 6,558,176 $ 619,554   $ 1,132,900 $ 129,560  
Cash segregated - customers 19,980,711 20,548,972          
Cash segregated - PAB 768,767 200,738          
Total cash and restricted cash shown in the statement of cash flows. $ 27,566,876 $ 27,307,886 $ 619,554 $ 712,807 $ 1,132,900 $ 129,560 $ 63,179
v3.24.4
RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION (Details) - USD ($)
6 Months Ended
Jun. 30, 2024
Sep. 30, 2024
Receivable from Broker-Dealer and Clearing Organization    
Due from clearing organizations, net $ 1,094,453  
Fails to deliver and receive 238,853  
Total receivables 1,333,306 $ 1,917,175
Broker-Dealer, Payable to Other Broker-Dealer and Clearing Organization    
Due from clearing organizations, net 3,003  
Fails to deliver and receive 1,912  
Total payables 4,915 $ 20,238
Losses on receivables from broker dealers or clearing organizations $ 0  
v3.24.4
CUSTOMER RECEIVABLE AND PAYABLES (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
CUSTOMER RECEIVABLE AND PAYABLES          
Bad Debt Expense $ 639 $ 15,000 $ 15,000 $ 0 $ 0
v3.24.4
PROPERTY AND EQUIPMENT (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
PROPERTY AND EQUIPMENT    
Depreciation expense $ 4,569 $ 7,565
v3.24.4
PROPERTY AND EQUIPMENT - Summary of major classifications of property and equipment (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Property, Plant and Equipment    
Property and equipment, gross $ 376,048 $ 376,048
Less: Accumulated depreciation and Amortization (364,537) (359,968)
Property and equipment, net 11,511 16,080
Equipment    
Property, Plant and Equipment    
Property and equipment, gross 150,202 150,202
Leasehold improvements    
Property, Plant and Equipment    
Property and equipment, gross 89,087 89,087
Software    
Property, Plant and Equipment    
Property and equipment, gross 85,042 85,042
Furniture and fixtures    
Property, Plant and Equipment    
Property and equipment, gross $ 51,717 $ 51,717
v3.24.4
RELATED PARTY TRANSACTIONS - Founder Shares (Details)
1 Months Ended 6 Months Ended
Feb. 12, 2021
shares
Feb. 04, 2021
shares
Oct. 23, 2020
USD ($)
shares
Jan. 31, 2021
shares
Jun. 30, 2024
USD ($)
D
$ / shares
shares
Feb. 09, 2024
$ / shares
RELATED PARTY TRANSACTIONS            
Common stock dividend (in Shares)   718,750        
Sale price per share (in Dollars per share) | $ / shares         $ 10 $ 10
Over-Allotment Option            
RELATED PARTY TRANSACTIONS            
Stock issued subject to forfeiture (in Shares)   656,250        
Initial Stockholders            
RELATED PARTY TRANSACTIONS            
Stock issued during period shares (in Shares)   5,031,250        
Founder Shares            
RELATED PARTY TRANSACTIONS            
Number of shares outstanding (in Shares)       3,254,000    
Stock issued subject to forfeiture (in Shares) 0          
Founder Shares | First 50% of founder shares            
RELATED PARTY TRANSACTIONS            
Percentage of shares         50.00%  
Commencement period for placing shares in Escrow account         6 months  
Market price of public shares (in Dollars per share) | $ / shares         $ 12.5  
Threshold trading days | D         20  
Threshold consecutive trading days | D         30  
Founder Shares | Second 50% of Founder Shares            
RELATED PARTY TRANSACTIONS            
Percentage of shares         50.00%  
Commencement period for placing shares in Escrow account         6 months  
Director            
RELATED PARTY TRANSACTIONS            
Stock issued during period shares (in Shares)         245,000  
Shares issued under Tau agreement settled through September 30, 2024 | $         $ 1,462,650  
Sponsor purchased shares (in Shares)       35,000    
Sale price per share (in Dollars per share) | $ / shares         $ 5.97  
Sponsor            
RELATED PARTY TRANSACTIONS            
Stock issued during period shares (in Shares)     4,312,500      
Shares issued under Tau agreement settled through September 30, 2024 | $     $ 25,000      
Sponsor purchased shares (in Shares)       813,500    
Sponsor | Director            
RELATED PARTY TRANSACTIONS            
Number of Founder Shares transferred (in shares)       245,000    
v3.24.4
RELATED PARTY TRANSACTIONS - Related Party Loans (Details) - USD ($)
6 Months Ended
Feb. 09, 2024
Jun. 30, 2024
Dec. 31, 2023
Mar. 14, 2022
RELATED PARTY TRANSACTIONS        
Price per warrant (in Dollars per share)   $ 1    
Working capital loans       $ 480,000
Principal balance amount     $ 480,000  
Qvent, LLC | Affiliate of sponsor        
RELATED PARTY TRANSACTIONS        
Shares issued in settlement of obligations (in shares) 2,000,000      
Promissory Notes        
RELATED PARTY TRANSACTIONS        
Conversion amount   $ 1,500,000    
v3.24.4
RELATED PARTY TRANSACTIONS - Advances from Related Parties (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 09, 2024
Jun. 30, 2024
May 09, 2024
Feb. 09, 2024
Feb. 09, 2023
Sep. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
RELATED PARTY TRANSACTIONS                    
Advances from related parties               $ 1,968,116 $ 3,104,097 $ 319,166
Proceeds from related party                   480,000
Related party loan           $ 352,981 $ 1,052,300 $ 1,948,950 2,855,431 319,166
Number of shares issued for settlement       2,000,000            
Liabilities settled       $ 4,636,397            
Receivables settled       $ 58,828            
Sale price per share (in Dollars per share)   $ 10   $ 10     $ 10      
Deemed dividend to the related party       $ 15,422,431            
AtlasFintech Holdings Corp                    
RELATED PARTY TRANSACTIONS                    
Settlement payable 2,788,276                  
AtlasFintech Holdings Corp                    
RELATED PARTY TRANSACTIONS                    
Business combination expense   $ 803,860   803,860            
Quantum Ventures LLC                    
RELATED PARTY TRANSACTIONS                    
Shares transferred     56,073              
Pay of interest on debt     $ 47,750              
Interest rate (in percent)     13.00%              
Accrued amount     $ 55,087              
Related Party Loan                    
RELATED PARTY TRANSACTIONS                    
Related party loan       480,000            
Co-Sponsors                    
RELATED PARTY TRANSACTIONS                    
Advances from related parties         $ 4,156,397       $ 3,104,097 $ 319,166
Proceeds from related party         $ 1,052,300          
Co-sponsors have advanced       $ 58,828            
v3.24.4
RELATED PARTY TRANSACTIONS - Settlement of related party debt (Details) - USD ($)
6 Months Ended
Jun. 30, 2024
Feb. 09, 2024
RELATED PARTY TRANSACTIONS    
Shares issued to settled advances from related party and notes payable related party, net of deemed dividend $ 4,577,569  
Sale price per share (in Dollars per share) $ 10 $ 10
v3.24.4
COMMITMENTS AND CONTINGENCIES - Registration Rights (Details)
May 14, 2024
shares
COMMITMENTS AND CONTINGENCIES  
Number of to be resale 77,577,099
v3.24.4
COMMITMENTS AND CONTINGENCIES - Business Combination Marketing Agreement (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Feb. 09, 2024
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
COMMITMENTS AND CONTINGENCIES            
Percentage of aggregate gross proceeds   3.50%        
Marketing Fees Payable To Underwriters, Waived In Exchange For Notes Payable   $ 7,043,750        
Period to file registration statement with SEC   30 days        
Non-Redemption Agreement Liability            
COMMITMENTS AND CONTINGENCIES            
Derivative liability           $ 1,881,440
Conversion derivative            
COMMITMENTS AND CONTINGENCIES            
Derivative liability       $ 1,668,731    
Earnout Liability            
COMMITMENTS AND CONTINGENCIES            
Derivative liability       10,963,000    
Chardan Note            
COMMITMENTS AND CONTINGENCIES            
Aggregate principal amount   $ 4,150,000        
Accrued interest expense $ 212,803     212,803 $ 212,803  
Interest expense related to the amortization of the debt discount $ 37,920     37,920 37,920  
Interest rate (in percent)   13.00%        
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)   85.00%        
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent)   85.00%        
Number of years up to which the converted amount is to be held for payment of interest 3 years 3 years 3 years      
Beneficial ownership (in percent)   9.99%        
Period to file registration statement with SEC   45 days        
Minimum period for which the registration statement with SEC is suspended, considered for increase in interest rate   15 days        
Incremental weekly interest rate, if the registration statement is not filed or is not effective or terminated or suspended (in percent)   2.00%        
Chardan Note | Chardan Capital Market LLC            
COMMITMENTS AND CONTINGENCIES            
Marketing Fees Payable To Underwriters, Waived In Exchange For Notes Payable     $ 7,043,750      
Aggregate principal amount $ 3,990,385   $ 4,150,000 $ 3,990,385 $ 3,990,385  
Interest rate (in percent) 13.00%   13.00% 13.00% 13.00%  
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)     85.00%   85.00%  
Debt principal amount   $ 4,150,000        
Chardan Note | JonesTrading Institutional Services            
COMMITMENTS AND CONTINGENCIES            
Aggregate principal amount   375,000        
Chardan Note | Conversion derivative            
COMMITMENTS AND CONTINGENCIES            
Derivative liability   404,483        
Initial Public Offering            
COMMITMENTS AND CONTINGENCIES            
Marketing fees payable to underwriters   $ 7,043,750        
v3.24.4
COMMITMENTS AND CONTINGENCIES - Non-Redemption Agreement (Details)
Aug. 01, 2023
shares
COMMITMENTS AND CONTINGENCIES  
Aggregate shares of common stock 2,351,800
Quantum Ventures LLC  
COMMITMENTS AND CONTINGENCIES  
Aggregate shares of common stock 235,180
Aggregate of warrants shares 235,180
Purchase shares of common stock 235,180
v3.24.4
COMMITMENTS AND CONTINGENCIES - Expense Settlements (Details)
Feb. 09, 2024
USD ($)
Quantum Ventures LLC  
COMMITMENTS AND CONTINGENCIES  
Aggregate principal amount $ 3,300,000
Chardan Note  
COMMITMENTS AND CONTINGENCIES  
Aggregate principal amount $ 4,150,000
v3.24.4
COMMITMENTS AND CONTINGENCIES - Additional Settlements (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 29, 2024
shares
Jul. 10, 2024
shares
Feb. 19, 2024
$ / shares
shares
Feb. 09, 2024
USD ($)
installment
$ / shares
shares
Sep. 13, 2023
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares 882,668 1,602,994            
Common stock issued to settled vendor obligations           $ 2,578 $ 1,459,976  
Sale price per share (in Dollars per share) | $ / shares       $ 10     $ 10 $ 10
Stock payable for remaining shares | shares           250,000   250,000
Nonrelated Party                
COMMITMENTS AND CONTINGENCIES                
Stock payable           $ 63,742 $ 259,893 $ 259,893
Related Party                
COMMITMENTS AND CONTINGENCIES                
Stock payable           $ 55,087 $ 55,087 $ 55,087
Interest solutions note                
COMMITMENTS AND CONTINGENCIES                
Sale price per share (in Dollars per share) | $ / shares       $ 2        
Interest rate (in percent)       13.00%        
Convertible amount       $ 275,000        
Jones Trading Note                
COMMITMENTS AND CONTINGENCIES                
Sale price per share (in Dollars per share) | $ / shares       $ 2        
Interest rate (in percent)       13.00%        
Convertible amount       $ 375,000        
Toppan Note                
COMMITMENTS AND CONTINGENCIES                
Interest rate (in percent)       13.00%        
Aggregate principal amount       $ 160,025        
Maximum | Interest solutions note                
COMMITMENTS AND CONTINGENCIES                
Number of shares issuable upon debt conversion | shares       144,454        
Maximum | Jones Trading Note                
COMMITMENTS AND CONTINGENCIES                
Number of shares issuable upon debt conversion | shares       196,983        
Grant Thornton LLP                
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares       46,010        
Common stock issued to settled vendor obligations       $ 460,100        
Sale price per share (in Dollars per share) | $ / shares       $ 10        
IB Capital LLC                
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares       155,000        
Common stock issued to settled vendor obligations       $ 294,500        
Sale price per share (in Dollars per share) | $ / shares       $ 1.9        
Outside The Box Capital Inc                
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares         20,000      
Common stock issued to settled vendor obligations         $ 200,000      
Sale price per share (in Dollars per share) | $ / shares         $ 10      
Carriage House Capital, Inc                
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares       100,000     100,000  
Sale price per share (in Dollars per share) | $ / shares     $ 4.98 $ 4.98     $ 4.41 $ 4.41
Stock payable for remaining shares | shares           250,000 250,000  
Stock payable           $ 1,244,965 $ 1,244,965 $ 1,244,965
Shares issuable for consulting services | shares             250,000  
Carriage House Capital, Inc | Nonrelated Party                
COMMITMENTS AND CONTINGENCIES                
Stock payable             $ 259,893 259,893
Carriage House Capital, Inc | Due upon signing of the contract                
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares     100,007          
Carriage House Capital, Inc | Due in months four through twelve from the date of signing                
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares     27,777          
Carriage House Capital, Inc | Maximum                
COMMITMENTS AND CONTINGENCIES                
Stock issued for services | shares     350,000          
Winston & Strawn LLP                
COMMITMENTS AND CONTINGENCIES                
Value of shares issuable for services       $ 2,500,000        
Number of installments | installment       3        
Value of shares issuable for services in each installment       $ 833,333        
Subscription payable, liability           $ 2,460,488 $ 2,425,647 $ 2,425,647
Aggregate principal amount       $ 2,500,000        
Winston & Strawn LLP | Maximum                
COMMITMENTS AND CONTINGENCIES                
Number of shares issuable for services | shares       2,500,000        
Lead Nectar                
COMMITMENTS AND CONTINGENCIES                
Number of shares issuable for services | shares       12,000        
Value of shares payable for internet marketing services       $ 20,000        
v3.24.4
COMMITMENTS AND CONTINGENCIES - Excise Taxes Payable (Details) - USD ($)
6 Months Ended 12 Months Ended
Feb. 09, 2024
Aug. 04, 2023
Feb. 06, 2023
Jun. 30, 2024
Dec. 31, 2023
Sep. 30, 2024
Jun. 30, 2023
COMMITMENTS AND CONTINGENCIES              
Excise tax liability (in Dollars)       $ 2,067,572 $ 1,528,101 $ 2,067,572 $ 1,485,236
Excise Taxes Payable              
COMMITMENTS AND CONTINGENCIES              
Excise tax liability shares redeemed, percentage       1.00% 1.00%    
Common Stock              
COMMITMENTS AND CONTINGENCIES              
Number of shares redeemed (in shares) 4,940,885 406,990 14,667,626        
Value of shares redeemed     $ 148,523,642        
Stockholders redeemed value (in Dollars) $ 53,947,064 $ 4,286,537          
v3.24.4
COMMITMENTS AND CONTINGENCIES - Secured Convertible Note Financing (Details)
6 Months Ended
Feb. 09, 2024
USD ($)
D
$ / shares
shares
Oct. 23, 2020
USD ($)
Jun. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
COMMITMENTS AND CONTINGENCIES            
Period To File Registration Statement With SEC 30 days          
Fee on Secured Convertible Note     $ 1,500,000      
Promissory notes     852,968 $ 852,968    
Secured convertible note, net     6,857,101      
Unamortized discount (Premium), Net     971,666 791,581    
Related Party            
COMMITMENTS AND CONTINGENCIES            
Promissory notes         $ 480,000 $ 480,000
Sponsor            
COMMITMENTS AND CONTINGENCIES            
Value of shares issued   $ 25,000        
Nonrelated Party            
COMMITMENTS AND CONTINGENCIES            
Promissory notes     852,968      
Secured convertible note, net     6,857,101 7,066,449    
Funicular Note            
COMMITMENTS AND CONTINGENCIES            
Aggregate principal amount $ 6,000,000          
Purchase price of notes $ 6,000,000          
Interest rate (in percent) 12.50%          
Interest rate in the event of default (in percent) 20.00%          
Conversion Price (in dollars per share) | $ / shares $ 10          
Threshold trading days over which VWAP is considered to make monthly adjustments to the Conversion price | D 5          
Floor on Conversion price (in dollars per share) | $ / shares $ 2          
Market price of public shares (in Dollars per share) | $ / shares $ 2          
Number of days notice required for redemption of notes 30 days          
Redemption price as a percentage of the outstanding principal amount (in percent) 101.00%          
Threshold maximum percentage of outstanding common stock, above which stockholder's approval is required for conversion (in percent) 19.90%          
Period To File Registration Statement With SEC 15 days          
Number Of Days Within Which The Registration Statement Should Be Declared Effective 60 days          
Stock issued for purchase price adjusted to additional paid in capital 5.00%          
Fee on Secured Convertible Note     1,500,000      
Accrued interest expense     328,767 246,660    
Interest expense related to the amortization of the debt discount     $ 279,032 $ 180,085    
Funicular Note | Sponsor            
COMMITMENTS AND CONTINGENCIES            
Value of warrants issued $ 28,496          
Value of shares issued 1,222,202          
Stock issued for purchase price adjusted to additional paid in capital $ 1,250,698          
Funicular Note | Sponsor | Private Placement            
COMMITMENTS AND CONTINGENCIES            
Number of private warrants transferred (in shares) | shares 600,000          
Funicular Note | Sponsor | Founder Shares            
COMMITMENTS AND CONTINGENCIES            
Number of private warrants transferred (in shares) | shares 600,000          
v3.24.4
COMMITMENTS AND CONTINGENCIES - Sellers Note (Details) - USD ($)
6 Months Ended 12 Months Ended
Feb. 09, 2024
Feb. 07, 2024
Jun. 30, 2024
Dec. 31, 2023
Non-Redemption Agreement Liability        
COMMITMENTS AND CONTINGENCIES        
Derivative liability       $ 1,881,440
Conversion derivative        
COMMITMENTS AND CONTINGENCIES        
Derivative liability     $ 1,668,731  
Earnout Liability        
COMMITMENTS AND CONTINGENCIES        
Derivative liability     10,963,000  
Short Term Notes        
COMMITMENTS AND CONTINGENCIES        
Aggregate principal amount   $ 5,000,000    
Maturity (in days)   90 days    
Interest rate (in percent)   9.00%    
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)   90.00%    
Conversion rate, as a percentage of trailing seven-trading day VWAP, if an event of default occurs and is continuing (in percent)   90.00%    
Accrued interest expense     610,440  
Short Term Notes | Conversion derivative        
COMMITMENTS AND CONTINGENCIES        
Derivative liability   $ 487,329    
Long-Term Notes        
COMMITMENTS AND CONTINGENCIES        
Aggregate principal amount   $ 7,971,000    
Maturity (in days)   24 months    
Interest rate (in percent)   13.00%    
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)   90.00%    
Conversion rate, as a percentage of trailing seven-trading day VWAP, if an event of default occurs and is continuing (in percent)   85.00%    
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent)   90.00%    
Interest expense related to the amortization of the debt discount     640,555  
Long-Term Notes | Conversion derivative        
COMMITMENTS AND CONTINGENCIES        
Derivative liability   $ 776,919 776,919  
Chardan Note        
COMMITMENTS AND CONTINGENCIES        
Aggregate principal amount $ 4,150,000      
Interest rate (in percent) 13.00%      
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent) 85.00%      
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent) 85.00%      
Accrued interest expense     212,803  
Interest expense related to the amortization of the debt discount     $ 37,920  
Chardan Note | Conversion derivative        
COMMITMENTS AND CONTINGENCIES        
Derivative liability $ 404,483      
v3.24.4
COMMITMENTS AND CONTINGENCIES - Subscription Agreement and Satisfaction and Discharge Agreement (Details)
$ in Millions
Feb. 09, 2024
USD ($)
Winston & Strawn LLP  
COMMITMENTS AND CONTINGENCIES  
Aggregate principal amount $ 2.5
v3.24.4
COMMITMENTS AND CONTINGENCIES - Wilson-Davis (Details) - USD ($)
Dec. 19, 2019
Feb. 27, 2018
Feb. 29, 2024
Dec. 31, 2023
Dec. 21, 2023
Oct. 16, 2023
Apr. 30, 2020
COMMITMENTS AND CONTINGENCIES              
Term of lease     3 years 12 months     63 months
Wilson Davis Co Inc              
COMMITMENTS AND CONTINGENCIES              
Amount of damages awarded to the plaintiff in the legal matter. $ 1,265,000 $ 1,470,000          
Damage reduced 205,000            
Accrued contingent liability $ 100,000            
Wilson Davis Co Inc | Lease For Salt Lake City Office              
COMMITMENTS AND CONTINGENCIES              
Term of lease           3 years  
Wilson Davis Co Inc | Office Lease For Denver Office              
COMMITMENTS AND CONTINGENCIES              
Term of lease         1 year    
v3.24.4
ACQUISITION OF WILSON-DAVIS - Broker-Dealer Acquisition Agreement (Details)
6 Months Ended
Feb. 07, 2024
USD ($)
item
D
Jun. 30, 2024
USD ($)
May 09, 2024
ACQUISITION OF WILSON-DAVIS      
Number of amendments to the Broker-Dealer Acquisition Agreement | item 2    
Reduction in total purchase price payable $ 5,000,000    
Cash payable $ 8,000,000 $ 8,092,568  
Conversion term at the option of holder after the closing date 6 months    
WILSON-DAVIS      
ACQUISITION OF WILSON-DAVIS      
Cash payable $ 8,092,569    
WILSON-DAVIS | Short term      
ACQUISITION OF WILSON-DAVIS      
Short-term and long-term notes $ 5,000,000    
Maturity (in days) 90 days    
Interest rate (in percent) 9.00%    
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent) 90.00%    
Conversion rate, Number of trading days over which the VWAP is considered | D 7    
WILSON-DAVIS | Long term      
ACQUISITION OF WILSON-DAVIS      
Short-term and long-term notes $ 7,971,197    
Maturity (in days) 24 months    
Interest rate (in percent) 13.00%   13.00%
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent) 90.00%    
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent) 90.00%    
Conversion rate, Number of trading days over which the VWAP is considered | D 7    
Conversion rate, as a percentage of trailing seven-trading day VWAP, if an event of default occurs and is continuing (in percent) 85.00%    
v3.24.4
ACQUISITION OF WILSON-DAVIS - Sponsors (Details)
Feb. 07, 2024
USD ($)
D
shares
ACQUISITION OF WILSON-DAVIS  
Value of founder shares transferred to cover cash deficit $ 6,000,000
WILSON-DAVIS  
ACQUISITION OF WILSON-DAVIS  
Aggregate value of Founder Shares agreed to transfer to the Wilson-Davis Sellers $ 6,000,000
Number of trading days over which VWAP of Quantum Common Stock is considered for determination of Founder Shares agreed to transfer | D 5
Number of Founder Shares transferred (in shares) | shares 885,010
Value of founder shares transferred to cover cash deficit $ 4,000,000
Value of founder shares transferred to cover bonus paid as consideration $ 2,000,000
Term within which additional founder shares can be transferred 6 months
Maximum number of Founder Shares that can be transferred (in shares) | shares 2,500,000
v3.24.4
ACQUISITION OF WILSON-DAVIS - Preliminary allocation of the purchase price (Details) - USD ($)
6 Months Ended
Feb. 07, 2024
Jun. 30, 2024
Sep. 30, 2024
ACQUISITION OF WILSON-DAVIS      
Cash payable $ 8,000,000 $ 8,092,568  
Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill   22,019,881 $ 21,914,990
WILSON-DAVIS      
ACQUISITION OF WILSON-DAVIS      
Cash payable 8,092,569    
Value of shares transferred from sponsor 6,000,000    
Total consideration paid 27,063,766    
Cash 11,333,271    
Cash segregated 22,000,605    
Receivables 4,065,148    
Trading Securities, market value 6,875    
Prepaid Income Tax 201,125    
Accounts payable, accrued expenses and other current liabilities (28,045,034)    
Current portion of lease liability (161,212)    
Property and equipment 23,645    
Cash deposit BDs and Clearing Organizations 3,536,664    
Operating Lease Right-to-Use Lease Assets 395,063    
Other Assets 385,058    
Stock loan (1,431,068)    
Long-term Lease liability (239,629)    
Subordinated Borrowing (1,950,000)    
Deferred tax liability (3,724,270)    
Trading Account deposit (100,000)    
Net assets acquired 6,296,241    
Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill 20,767,525 $ 22,331,725  
WILSON-DAVIS | Short term      
ACQUISITION OF WILSON-DAVIS      
Short-term and long-term notes 5,000,000    
WILSON-DAVIS | Long term      
ACQUISITION OF WILSON-DAVIS      
Short-term and long-term notes $ 7,971,197    
v3.24.4
ACQUISITION OF WILSON-DAVIS - Unidentified excess of the purchase price over the fair value of the net assets acquired recorded as goodwill (Details) - USD ($)
6 Months Ended
Feb. 07, 2024
Jun. 30, 2024
Sep. 30, 2024
ACQUISITION OF WILSON-DAVIS      
Excess of purchase price   $ 22,019,881 $ 21,914,990
Goodwill   7,706,725 $ 6,142,525
WILSON-DAVIS      
ACQUISITION OF WILSON-DAVIS      
Customer Lists $ 14,625,000 14,625,000  
Excess of purchase price 20,767,525 22,331,725  
Goodwill $ 6,142,525 $ 7,706,725  
Estimated Useful Life (Years) 12 years 12 years  
v3.24.4
ACQUISITION OF WILSON-DAVIS - Pro forma financial information (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
ACQUISITION OF WILSON-DAVIS        
Total revenue $ 1,834,164 $ 5,247,150 $ 8,258,254 $ 9,527,324
Net loss $ (1,575,799) $ (23,878,060) $ (4,695,016) $ (90,186,458)
Weighted average shares, Basic 11,801,759 11,801,759 11,801,759 11,906,245
Weighted average shares, Diluted 11,801,759 11,801,759 11,801,759 11,906,245
Net loss per shares: Basic $ (0.13) $ (2.02) $ (0.4) $ (8.87)
Net loss per shares: Diluted $ (0.13) $ (2.02) $ (0.4) $ (8.87)
v3.24.4
ACQUISITION OF WILSON-DAVIS - Pro forma adjustments (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
ACQUISITION OF WILSON-DAVIS        
Transaction cost   $ (9,008,053)   $ 9,008,053
Amortization of intangibles $ (307,192)   $ 2,437,500 2,437,500
Loss on AtlasClear acquisition   86,392,769   (86,392,769)
Interest earned on investments held in trust $ (722,390) $ (256,279) $ (3,090,086) $ (3,087,315)
v3.24.4
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2024
Sep. 30, 2024
Aug. 09, 2024
Dec. 31, 2023
Dec. 31, 2022
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC          
Shares issued as purchase consideration for the assets (in shares) 4,400,000        
Common Stock, par value (in Dollars per share) $ 0.0001 $ 0.0001   $ 0.0001 $ 0.0001
Threshold period from Closing to achieve milestones considered for issuance of Earn Out Shares 18 months        
Period for measurement of revenue targets 5 years        
Atlas FinTech          
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC          
Common Stock, par value (in Dollars per share)     $ 0.0001    
Earn Out Shares, maximum shares issuable to stockholders (in shares) 5,944,444        
Threshold period from Closing to achieve milestones considered for issuance of Earn Out Shares 18 months        
Software Products Earn Out Shares, maximum amount of shares issuable to stockholders $ 20,000        
Period for measurement of revenue targets 5 years        
ATLASCLEAR, INC          
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC          
Shares issued as purchase consideration for the assets (in shares) 4,440,000        
Common Stock, par value (in Dollars per share) $ 0.0001        
Earn Out Shares, maximum shares issuable to stockholders (in shares) 5,944,444        
Software Products Earn Out Shares, maximum amount of shares issuable to stockholders $ 20,000        
v3.24.4
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC - Purchase price allocation (Details)
6 Months Ended
Jun. 30, 2024
USD ($)
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
Fair value of Software Product Earn Out Shares $ 10,963,000
Fair value of Earn Out Shares 31,347,000
ATLASCLEAR, INC  
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
Total Purchase Price 44,400,000
Fair value of Software Product Earn Out Shares 10,963,000
Fair value of Earn Out Shares 31,347,000
Purchase price allocated to Contribution Agreement 86,710,000
Total Developed Technology acquired 18,163,044
Transaction cost 68,546,956
ATLASCLEAR, INC | SURFACExchange  
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
Total Developed Technology acquired 381,461
ATLASCLEAR, INC | Bond Quantum  
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
Total Developed Technology acquired 32,284
ATLASCLEAR, INC | Atlas  
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
Total Developed Technology acquired 7,749,299
ATLASCLEAR, INC | Rubicon  
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC  
Total Developed Technology acquired $ 10,000,000
v3.24.4
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC - Additional information (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Feb. 09, 2024
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC        
Shares issued as purchase consideration for the assets (in shares)     4,400,000  
Price per public share (in Dollars per share)   $ 10 $ 10 $ 10
Period for measurement of revenue targets     5 years  
Threshold period from Closing to achieve milestones considered for issuance of Earn Out Shares     18 months  
Amortization of intangibles $ 307,191 $ 337,911 $ 791,375  
Atlas FinTech        
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC        
Software Products Earn Out Shares, maximum amount of shares issuable to stockholders   $ 20,000,000 $ 20,000,000  
Period for measurement of revenue targets     5 years  
Earn Out Shares, maximum shares issuable to stockholders (in shares)   5,944,444 5,944,444  
Threshold period from Closing to achieve milestones considered for issuance of Earn Out Shares     18 months  
Total Developed Technology acquired     $ 18,160,000  
Estimated Useful Life (Years)     8 years  
Purchase price     $ 86,980,000  
Transaction cost     68,550,000  
ATLASCLEAR, INC        
ACQUISITION OF THE ASSETS OF ATLASCLEAR, INC        
Total Purchase Price     $ 44,400,000  
Shares issued as purchase consideration for the assets (in shares)     4,440,000  
Software Products Earn Out Shares, maximum amount of shares issuable to stockholders   $ 20,000,000 $ 20,000,000  
Earn Out Shares, maximum shares issuable to stockholders (in shares)   5,944,444 5,944,444  
Total Developed Technology acquired     $ 18,163,044  
Transaction cost     68,546,956  
Amortization of intangibles     (317,231)  
Carrying balance of Technology acquired written off     17,845,813  
Total loss on AtlasClear technology acquired     $ 86,392,769  
v3.24.4
INTANGIBLE ASSETS - Pacsquare Purchase Agreement (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
installment
$ / shares
shares
Jun. 30, 2024
USD ($)
installment
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
INTANGIBLE ASSES          
Common stock, shares issued | shares 22,245,698 12,455,157 12,455,157 5,031,250 5,031,250
Common Stock, par value (in Dollars per share) | $ / shares $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Accrued in accounts payable   $ 85,000 $ 85,000    
AtlasClear Platform | Pacsquare          
INTANGIBLE ASSES          
Threshold period to receive level 1 equities trading platform from signing of agreement 12 months 12 months      
Purchase price $ 4,800,000 $ 4,800,000      
Payable in cash and in shares of common stock 1,900,000 1,900,000 1,900,000    
Payable in cash upon delivery of source code and execution of purchase agreement 100,000 100,000 $ 100,000    
Total Purchase Price $ 850,000 $ 850,000      
Market price of public shares (in Dollars per share) | $ / shares $ 6 $ 6 $ 6    
Four monthly installments payable $ 950,000 $ 950,000 $ 950,000    
Number of monthly installments 237,500 4 4    
Monthly installments payable $ 4 $ 237,500 $ 237,500    
Payable ratably on module-by-module basis upon delivery and acceptance of each of platform modules $ 2,700,000 $ 2,700,000 $ 2,700,000    
Common stock, shares issued | shares   336,000 336,000    
Cash consideration   $ 500,000 $ 500,000    
Purchase price allocated to Contribution Agreement   $ 1,726,500 $ 1,726,500    
AtlasClear Platform | Pacsquare | Price per share at $6.00          
INTANGIBLE ASSES          
Common stock, shares issued | shares   141,667 141,667    
Common Stock, par value (in Dollars per share) | $ / shares   $ 6 $ 6    
AtlasClear Platform | Pacsquare | Price per share at $1.50          
INTANGIBLE ASSES          
Common stock, shares issued | shares   194,333 194,333    
Common Stock, par value (in Dollars per share) | $ / shares   $ 1.5 $ 1.5    
v3.24.4
INTANGIBLE ASSETS (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Cost    
Indefinite lived $ 6,142,525 $ 6,142,525
Intangible assets, gross including goodwill 22,696,325 40,657,069
Accumulated Amortization (781,335) (791,375)
Impairment of Asset    
Intangible assets excluding goodwill accumulated impairment loss (17,845,813) (17,845,813)
Net    
Intangible assets excluding goodwill 6,142,525 6,142,525
Excess of purchase price $ 21,914,990 $ 22,019,881
Technology acquired    
INTANGIBLE ASSES    
Est useful life   0 days
Cost    
Finite lived intangible assets, gross   $ 18,163,044
Accumulated Amortization   (317,231)
Impairment of Asset    
Intangible assets excluding goodwill accumulated impairment loss   $ (17,845,813)
Customer Lists    
INTANGIBLE ASSES    
Est useful life 12 years 12 years
Cost    
Finite lived intangible assets, gross $ 14,625,000 $ 14,625,000
Accumulated Amortization (781,335) (474,144)
Net    
Intangible assets, net $ 13,843,665 $ 14,150,856
Pacsquare assets - Proprietary Software    
INTANGIBLE ASSES    
Est useful life 10 years 10 years
Cost    
Indefinite lived $ 1,928,800 $ 1,726,500
Net    
Intangible assets excluding goodwill $ 1,928,800 $ 1,726,500
v3.24.4
INTANGIBLE ASSETS - Amortization of intangible assets (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
June 30, 2025 $ 911,558 $ 1,218,750
June 30, 2026 1,411,630 1,391,400
June 30, 2027 1,411,630 1,391,400
June 30, 2028 1,414,970 1,394,739
June 30, 2029 1,411,630 1,391,400
thereafter $ 9,211,047 $ 9,089,667
v3.24.4
DEPOSIT ON ACQUISITION OF COMMERCIAL BANCORP - Amendment to Bank Acquisition Agreement (Details)
Feb. 26, 2024
USD ($)
shares
DEPOSIT ON ACQUISITION OF COMMERCIAL BANCORP  
Shares issued in lieu of nonrefundable escrow deposit | shares 40,000
Nonrefundable escrow deposit | $ $ 2.28
v3.24.4
LEASES - Narrative (Details) - USD ($)
1 Months Ended 6 Months Ended
Jan. 01, 2024
Feb. 29, 2024
Jun. 30, 2024
Dec. 31, 2023
Apr. 30, 2020
LEASES          
Term of lease   3 years   12 months 63 months
Annual rent escalation (in percent)   3.00%      
Lease renewal term   3 years     5 years
Fixed rent payment $ 1,100        
Operating segments     $ 203,227    
v3.24.4
LEASES - Tabular disclosure of future minimum payments required by the lease agreements (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
LEASES    
2025   $ 164,271
2026   118,597
2027   70,377
Total minimum lease payments   353,245
Less interest factor   (21,017)
Total operating lease liability   332,228
Current portion of lease liability $ (138,218) (149,499)
Long-term lease liability $ 155,616 $ 182,729
v3.24.4
LEASES - Schedule of other information related to the Company's operating leases (Details) - USD ($)
5 Months Ended
Jun. 30, 2024
Sep. 30, 2024
LEASES    
Operating lease ROU Asset - February 9, 2024 $ 395,063  
Increase 0  
Decrease (68,727)  
Operating lease ROU Asset - Ending Balance 326,336  
Operating lease liability - Short Term 149,499 $ 138,218
Operating lease liability - Long Term 182,729 $ 155,616
Total operating lease liability $ 332,228  
v3.24.4
LEASES - Schedule of weighted-average remaining lease term and weighted-average discount rates related to the Company's operating leases (Details)
Jun. 30, 2024
LEASES  
Weighted average remaining lease term 2 years 4 months 6 days
Weighted average discount rate 4.97%
v3.24.4
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
3 Months Ended 6 Months Ended
Feb. 09, 2024
shares
Feb. 04, 2021
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
STOCKHOLDERS' DEFICIT            
Preferred stock, shares authorized     1,000,000 1,000,000 1,000,000 1,000,000
Preferred stock, par value (in Dollars per share) | $ / shares     $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, shares issued     0 0 0 0
Preferred stock, shares outstanding     0 0 0 0
Common stock, shares authorized     100,000,000 100,000,000 100,000,000 100,000,000
Common Stock, par value (in Dollars per share) | $ / shares     $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Common Stock, voting rights     one one    
Common stock, shares issued     22,245,698 12,455,157 5,031,250 5,031,250
Common stock, shares outstanding     22,245,698 12,455,157 5,031,250 5,031,250
Shares redeemed | $     $ 148,383      
Quantum Fintech Acquisition Corp            
STOCKHOLDERS' DEFICIT            
Share exchange ratio 1          
Quantum Fintech Acquisition Corp | Warrants issued in exchange for public warrants to purchase Quantum Common Stock            
STOCKHOLDERS' DEFICIT            
Number of shares called by each warrant 0.5          
Quantum Fintech Acquisition Corp | Warrants issued in exchange for private warrants to purchase Quantum Common Stock            
STOCKHOLDERS' DEFICIT            
Number of shares called by each warrant 1          
Founder Shares            
STOCKHOLDERS' DEFICIT            
Shares owned   4,000,000        
Chardan Quantum LLC            
STOCKHOLDERS' DEFICIT            
Shares owned   949,084        
Sponsor            
STOCKHOLDERS' DEFICIT            
Shares owned   3,050,916        
Quantum Common Stock            
STOCKHOLDERS' DEFICIT            
Common stock, shares issued 12,277,759          
Common stock, shares outstanding 12,277,759          
Aggregate shares       4,940,885    
Market price of public shares (in Dollars per share) | $ / shares       $ 10.92    
Shares redeemed | $       $ 53,947,064    
Remaining balance of trust account | $       $ 1,200,000    
Common Stock subject to possible redemption       109,499    
v3.24.4
WARRANTS (Details)
6 Months Ended
Jun. 30, 2024
D
$ / shares
shares
Sep. 30, 2024
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
WARRANTS      
Issue price per share (in Dollars per share) $ 9.2    
Equity proceeds 60.00%    
Exercise price per share (in Dollars per share) $ 9.5    
Warrant Percentage 115.00%    
Issue price 16.5    
Market value percentage 165.00%    
Public Warrants [Member]      
WARRANTS      
Public warrants outstanding (in shares) | shares 20,125,000 20,125,000 20,125,000
Number of shares called by each warrant | shares 0.5 0.5 0.5
Warrant exercise price (in Dollars per share) $ 11.5 $ 11.5 $ 11.5
Number of days within which the registration statement should be declared effective 120 days    
Expire term 5 years    
Redemption price per warrant (in Dollars per share) $ 0.01    
Notice period redemption 30 days    
Price of the entity's common stock (in Dollars per share) $ 16.5    
Threshold number of specified trading days | D 20    
Threshold consecutive number of specified trading days | D 30    
Private Warrants [Member]      
WARRANTS      
Public warrants outstanding (in shares) | shares 6,153,125 6,153,125 6,153,125
Number of shares called by each warrant | shares 1    
Warrant exercise price (in Dollars per share) $ 11.5    
v3.24.4
INCOME TAX - Benefit (provision) for income taxes (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Current Tax:                
Federal             $ 726,038 $ 536,853
State         $ 3,170      
Total current         3,170   726,038 536,853
Deferred Tax:                
Deferred         (546,276)      
State         (26,630)      
Total deferred         (572,906)      
Income tax provision $ 21,752 $ (563,736) $ 141,202 $ 318,313 $ (569,736) $ 581,118 $ 726,038 $ 536,853
v3.24.4
INCOME TAX - Reconciliation (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Effective Income Tax Reconciliation, Amount                
Tax at Statutory rate (21%)         $ (25,376,496)      
Change in fair value of NRA liability         34,571      
Meals         1,769      
Entertainment         161      
Nondeductible transaction Costs         1,891,691      
Change in fair value of Long-Term and Short-Term Investor Notes         2,353,692      
Change in fair value of Secured Convertible Note         753,039      
Change in fair value of Earnout Liability         280,350      
Change in fair value of Subscription Agreement         8,147      
Change in fair value of Stock Payable         (206,865)      
Loss on AtlasClear acquisition         18,142,481      
Stock Compensation Expense         307,157      
Extinguishment of Accrued Liabilities         (184,689)      
Change in fair value of WDCO Share payable         683,941      
Return To Provision         (477,461)      
State Tax - Net of Federal Benefit         (220,234)      
State Minimum Tax - Net of Federal Benefit         2,504      
Change in Valuation Allowance - State         499,331      
Change in Valuation Allowance - Federal         937,175      
Income tax provision $ 21,752 $ (563,736) $ 141,202 $ 318,313 $ (569,736) $ 581,118 $ 726,038 $ 536,853
Effective Income Tax Reconciliation, Rate                
Statutory tax rate         21.00%   21.00% 21.00%
Change in fair value of NRA liability         (0.03%)      
Meals         0.00%      
Entertainment         0.00%      
Nondeductible transaction Costs         (1.57%)      
Change in fair value of Long-Term and Short-Term Investor Notes         (1.95%)      
Change in fair value of Secured Convertible Note         (0.62%)      
Change in fair value of Earnout Liability         (0.23%)      
Change in fair value of Subscription Agreement         (0.01%)      
Change in fair value of Stock Payable         0.17%      
Loss on AtlasClear acquisition         (15.01%)      
Business combination expenses         (0.25%)   15.27% (0.51%)
Extinguishment of Accrued Liabilities         0.15%      
Change in fair value of WDCO Share payable         (0.57%)      
Return To Provision         0.40%      
State Tax - Net of Federal Benefit         0.18%      
State Minimum Tax - Net of Federal Benefit         0.00%      
Change in Valuation Allowance - State         (0.41%)      
Change in Valuation Allowance - Federal         (0.78%)      
Income tax provision         0.47%   47.71% 4.64%
v3.24.4
INCOME TAX - Reconciliation of the federal income tax rate to the Company's effective tax rate (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
INCOME TAX      
Statutory federal income tax rate 21.00% 21.00% 21.00%
Business combination expenses (0.25%) 15.27% (0.51%)
Change in fair value of warrant liability   1.70% (12.61%)
Change in fair value of PIPE derivative liability   (6.07%) (8.28%)
Transaction costs - warrants   0.00% 0.00%
Penalties & Interest   0.08% 0.07%
Valuation allowance   15.73% 4.97%
Income tax provision 0.47% 47.71% 4.64%
v3.24.4
INCOME TAX - Deferred tax assets and liabilities (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Deferred Tax Assets:      
Fixed Assets $ 261    
Business Combination Expenses 530,560 $ 437,530 $ 427,319
IRC Sec. 195 Start-Up Costs 956,768 974,835 745,713
Allowance for Bad Debt 3,820    
Accrued Contingent Liability 25,465    
Lease Liability (ASC 842) 84,602    
IRC Sec. 1231 Losses 1,774    
Net operating loss carryforward 1,361,541    
Total deferred tax assets (liability) 2,964,791 1,412,365 1,173,032
Deferred Tax Liabilities:      
Intangible Assets 5,167,729    
ROU Lease Asset (ASC 842) 83,102    
State Tax - Current 526    
State Tax - Deferred 110,452    
Total Deferred Tax Liability 5,361,809    
Net Deferred Tax Asset/(Liability) before Valuation allowance (2,397,018) 1,412,365 1,173,032
Valuation Allowance (2,848,868) $ (1,412,365) $ (1,173,032)
Net Deferred Tax Asset/(Liability) $ (5,245,886)    
v3.24.4
INCOME TAX - Additional information (Details) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
INCOME TAX      
Valuation Allowance $ 2,848,868 $ 1,412,365 $ 1,173,032
Federal      
INCOME TAX      
Net operating loss carryovers 5,380,000    
State      
INCOME TAX      
Net operating loss carryovers $ 5,370,000    
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
FAIR VALUE MEASUREMENTS        
Marketable securities held in Trust Account $ 55 $ 55 $ 54,799,478 $ 204,044,469
Convertible notes derivative   16,462,690    
Level 1        
FAIR VALUE MEASUREMENTS        
Marketable securities held in Trust Account     54,799,478 204,044,469
Level 3        
FAIR VALUE MEASUREMENTS        
Subscription agreement 2,460,488 2,425,647    
Contingent Guarantee   3,256,863    
Warrant liability - Private Warrants 61,531 307,656 307,656 $ 184,594
Non-redemption agreement liability     $ 1,441,653  
Convertible notes derivative 2,142,511 16,462,690    
Earnout liability $ 12,638,000 $ 12,298,000    
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of key inputs into the Monte Carlo model for the Subscription Agreement (Details)
Sep. 30, 2024
$ / shares
Jun. 30, 2024
$ / shares
Feb. 09, 2024
$ / shares
Market price of public shares      
FAIR VALUE MEASUREMENTS      
Subscription agreement 0.21 1.04 10.26
Equity volatility      
FAIR VALUE MEASUREMENTS      
Subscription agreement 0.344 0.262 0.298
Risk-free rate      
FAIR VALUE MEASUREMENTS      
Subscription agreement 0.0401 0.0505 0.0467
v3.24.4
FAIR VALUE MEASUREMENTS - Contingent Guarantee (Details) - USD ($)
5 Months Ended
Feb. 09, 2024
Feb. 07, 2024
Jun. 30, 2024
Jun. 30, 2024
Sep. 30, 2024
Jun. 29, 2024
FAIR VALUE MEASUREMENTS            
Value of founder shares transferred to cover cash deficit   $ 6,000,000        
Shares of Founder Shares Transferred 885,010          
Contingent guarantee $ 3,256,863   $ 3,256,863 $ 3,256,863    
Contingent Guarantee Deemed Value 0          
Debt Instrument, Penalty Interest     13.00% 13.00%   9.00%
Value of founder shares transferred 4,000,000          
Amount of cash recovered through transfer of shares     $ 743,137 $ 743,137    
Short term            
FAIR VALUE MEASUREMENTS            
Embedded Derivative, Fair Value of Embedded Derivative, Net     4,807,692 4,807,692    
Value of founder shares transferred $ 8,850,100          
Long term            
FAIR VALUE MEASUREMENTS            
Embedded Derivative, Fair Value of Embedded Derivative, Net     7,664,613 7,664,613    
Chardan Note            
FAIR VALUE MEASUREMENTS            
Embedded Derivative, Fair Value of Embedded Derivative, Net     $ 3,990,385 $ 3,990,385 $ 823,076  
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of Key Inputs into the Black-Scholes model for the Private Warrants (Details)
6 Months Ended 12 Months Ended
Feb. 09, 2024
USD ($)
Jun. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
$ / shares
Dec. 31, 2022
$ / shares
Sep. 30, 2024
$ / shares
FAIR VALUE MEASUREMENTS          
Effective expiration date   Feb. 09, 2029 Feb. 09, 2029 Feb. 09, 2029  
Non-redemption agreement liability shares (in Shares) | shares   235,180      
Non-redemption of common stock shares (in Shares) | shares   235,180      
Warrants reclassified as permanent equity at total value | $ $ 1,606,279 $ 1,606,279      
Market price of public shares          
FAIR VALUE MEASUREMENTS          
Private warrants | $ / shares   1.04 6.2 10.05 0.21
Risk-free rate          
FAIR VALUE MEASUREMENTS          
Private warrants   0.0427 0.0377 0.0391 0.0352
Dividend yield          
FAIR VALUE MEASUREMENTS          
Private warrants   0 0 0 0
Volatility          
FAIR VALUE MEASUREMENTS          
Private warrants   0.587 0.12 0.026 0.874
Probability of a business combination          
FAIR VALUE MEASUREMENTS          
Private warrants   1 1 0.045  
Exercise price          
FAIR VALUE MEASUREMENTS          
Private warrants | $ / shares   11.5 11.5 11.5 11.5
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of key inputs into the Monte Carlo model for the non-redeemable Common Stock (Details)
Dec. 31, 2023
$ / shares
Aug. 01, 2023
$ / shares
Market price of public shares    
FAIR VALUE MEASUREMENTS    
Non-redeemable common stock 6.2 10.57
Probability of acquisition    
FAIR VALUE MEASUREMENTS    
Non-redeemable common stock 1 0.82
Equity volatility    
FAIR VALUE MEASUREMENTS    
Non-redeemable common stock 0.12 0.199
Discount for lack of marketability    
FAIR VALUE MEASUREMENTS    
Non-redeemable common stock 0.08 0.03
Discount factor for revenue    
FAIR VALUE MEASUREMENTS    
Non-redeemable common stock 0.051 0.051
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of key inputs into the Monte Carlo model for the Earnout liability (Details)
Sep. 30, 2024
$ / shares
Jun. 30, 2024
$ / shares
Feb. 09, 2024
$ / shares
Market price of public shares      
FAIR VALUE MEASUREMENTS      
Earnout liability 0.21 1.04 10.26
Revenue volatility      
FAIR VALUE MEASUREMENTS      
Earnout liability 0.15 0.15 0.15
Discount rate      
FAIR VALUE MEASUREMENTS      
Earnout liability 0.0961 0.0969 0.995
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of key inputs into the Black-Scholes model for the Conversion derivative (Details)
6 Months Ended 12 Months Ended
Feb. 09, 2024
$ / shares
Jun. 30, 2024
$ / shares
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2024
$ / shares
FAIR VALUE MEASUREMENTS          
Effective Expiration Date   Feb. 09, 2029 Feb. 09, 2029 Feb. 09, 2029  
Short Term Notes          
FAIR VALUE MEASUREMENTS          
Effective Expiration Date May 01, 2024 May 01, 2024      
Market price of public shares          
FAIR VALUE MEASUREMENTS          
Convertible derivative   1.04      
Market price of public shares | Short Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 10.26 1.04     0.21
Market price of public shares | Long-Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 10.26 1.04     0.21
Market price of public shares | Chardan Note          
FAIR VALUE MEASUREMENTS          
Convertible derivative 10.26 1.04     0.21
Risk-free rate          
FAIR VALUE MEASUREMENTS          
Convertible derivative   0.0452      
Risk-free rate | Short Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 0.0544 0.0549     0.0484
Risk-free rate | Long-Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 0.0448 0.049     0.0484
Risk-free rate | Chardan Note          
FAIR VALUE MEASUREMENTS          
Convertible derivative 0.0448 0.0452     0.0436
Dividend yield          
FAIR VALUE MEASUREMENTS          
Convertible derivative   0      
Dividend yield | Short Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 0 0      
Dividend yield | Long-Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 0 0     0.1172
Dividend yield | Chardan Note          
FAIR VALUE MEASUREMENTS          
Convertible derivative 0 0      
Volatility          
FAIR VALUE MEASUREMENTS          
Convertible derivative   1,666.81      
Volatility | Short Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 41.20 146.43     0.367
Volatility | Long-Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 412 144.61     0.229
Volatility | Chardan Note          
FAIR VALUE MEASUREMENTS          
Convertible derivative 41.20 1,666.81     0.439
Exercise price          
FAIR VALUE MEASUREMENTS          
Convertible derivative   0.84      
Exercise price | Short Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 7.27 0.99      
Exercise price | Long-Term Notes          
FAIR VALUE MEASUREMENTS          
Convertible derivative 7.27 0.99     0.367
Exercise price | Chardan Note          
FAIR VALUE MEASUREMENTS          
Convertible derivative 10.26 0.84      
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of changes in the fair value (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Subscription Agreement          
Fair value asset          
Fair value $ 2,425,647 $ 0      
Initial measurement as of February 9, 2024   2,386,851      
Change in valuation inputs or other assumptions 34,841 38,796      
Fair value 2,460,488 2,425,647 $ 0    
Private Placement Warrants          
Fair value liability          
Fair value 307,656 307,656 184,594 $ 7,137,930  
Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability     123,062    
Change in valuation inputs or other assumptions (246,125)       $ (6,953,336)
Fair value 61,531 307,656 307,656 184,594 $ 7,137,930
Non-Redemption Agreement Liability          
Fair value liability          
Fair value   1,441,653      
Initial measurement     1,881,440    
Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability     (439,787)    
Change in valuation inputs or other assumptions   164,626   $ 1,881,440  
Transferred to equity   (1,606,279)      
Fair value     1,441,653    
Conversion Derivative          
Fair value liability          
Fair value 16,462,690 0      
Initial measurement   1,668,731      
Change in valuation inputs or other assumptions (14,320,179) 14,793,959      
Fair value 2,142,511 16,462,690 0    
Earnout Liability          
Fair value liability          
Fair value 12,298,000 0      
Initial measurement   10,963,000      
Change in valuation inputs or other assumptions 340,000 1,335,000      
Fair value 12,638,000 12,298,000 0    
Merger Financing Liability          
Fair value liability          
Fair value 3,256,863 0      
Change in valuation inputs or other assumptions $ 839,774 3,256,863      
Fair value   $ 3,256,863 $ 0    
v3.24.4
FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 29, 2024
Feb. 09, 2024
Feb. 07, 2024
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Short-Term Debt [Line Items]              
Marketing fees payable to underwriters     $ 7,043,750        
Conversion derivative              
Short-Term Debt [Line Items]              
Initial measurement           $ 1,668,731  
Increase in fair value of derivative liability         $ (14,320,179) 14,793,959  
Short Term Notes              
Short-Term Debt [Line Items]              
Aggregate principal amount       $ 5,000,000      
Maturity (in days)       90 days      
Interest rate (in percent)       9.00%      
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)       90.00%      
Short Term Notes | Conversion derivative              
Short-Term Debt [Line Items]              
Initial measurement       $ 487,329      
Unamortized discount $ 487,929         487,929 $ 487,929
Increase in fair value of derivative liability 4,807,692 $ 4,320,363          
Short Term Notes | Wilson-Davis Sellers              
Short-Term Debt [Line Items]              
Aggregate principal amount     $ 487,329        
Maturity (in days)     90 days        
Long-Term Notes              
Short-Term Debt [Line Items]              
Aggregate principal amount       $ 7,971,000      
Maturity (in days)       24 months      
Interest rate (in percent)       13.00%      
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)       90.00%      
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent)       90.00%      
Long-Term Notes | Conversion derivative              
Short-Term Debt [Line Items]              
Initial measurement       $ 776,919   776,919  
Increased fair value 7,664,613         7,664,613 7,664,613
Unamortized discount $ 776,919         776,919 776,919
Increase in fair value of derivative liability           6,887,694  
Long-Term Notes | Conversion derivative | Minimum              
Short-Term Debt [Line Items]              
Increase in fair value of derivative liability           4,150,000  
Long-Term Notes | Interest Solutions              
Short-Term Debt [Line Items]              
Aggregate principal amount     $ 275,000        
Interest rate (in percent)     13.00%        
Long-Term Notes | JonesTrading Institutional Services              
Short-Term Debt [Line Items]              
Interest rate (in percent)     13.00%        
Chardan Note              
Short-Term Debt [Line Items]              
Aggregate principal amount     $ 4,150,000        
Interest rate (in percent)     13.00%        
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)     85.00%        
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent)     85.00%        
Unamortized discount         $ 280,355    
Number of years up to which the converted amount is to be held for payment of interest 3 years   3 years   3 years    
Chardan Note | Conversion derivative              
Short-Term Debt [Line Items]              
Initial measurement     $ 404,483        
Increased fair value   $ 3,585,901          
Unamortized discount $ 404,483         404,483 404,483
Chardan Note | Conversion derivative | Maximum              
Short-Term Debt [Line Items]              
Increase in fair value of derivative liability           404,483  
Chardan Note | Chardan Capital Market LLC              
Short-Term Debt [Line Items]              
Aggregate principal amount $ 3,990,385       $ 4,150,000 $ 3,990,385 $ 3,990,385
Interest rate (in percent) 13.00%       13.00% 13.00% 13.00%
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)         85.00%   85.00%
Marketing fees payable to underwriters         $ 7,043,750    
Chardan Note | JonesTrading Institutional Services              
Short-Term Debt [Line Items]              
Aggregate principal amount     $ 375,000        
v3.24.4
TRANSITION PERIOD COMPARATIVE DATA - Consolidated Balance Sheets (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Feb. 09, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Current assets                
Cash and cash equivalents $ 6,817,398 $ 6,558,176   $ 619,554   $ 1,132,900 $ 129,560  
Cash segregated - customers 19,980,711 20,548,972            
Cash segregated - PAB 768,767 200,738            
Receivables - broker-dealers and clearing organizations 1,917,175 1,333,306            
Receivables - customers, net 170,690 823,784            
Other receivables 230,037 64,842            
Prepaid expenses   67,967       29,458    
Trading securities, market value, net 55 55   54,799,478     204,044,469  
Due from Atlas Clear           49,806    
Total Current Assets 29,929,108 29,597,840   55,477,860   1,212,164 204,207,681  
Operating lease right to use lease asset 288,191 326,336            
Property and equipment, net 11,511 16,080            
Customer list, net 13,843,665 14,150,856            
Goodwill 6,142,525 7,706,725            
Pacsquare asset purchase 1,928,800 1,726,500            
Bank acquisition deposit   91,200            
Cash deposits - broker-dealers and clearing organizations   3,515,000            
Other assets 336,017 336,017            
Marketable securities held in Trust Account           57,409,747    
TOTAL ASSETS 55,994,817 57,466,554   55,477,860   58,621,911 204,207,681  
Current liabilities                
Payables to customers 20,009,873 20,162,973            
Accounts and payables to officers/directors 728,936 686,579            
Accounts payable and accrued expenses 4,615,650 5,393,912   5,510,760   5,181,488 4,813,558  
Payables - broker-dealers and clearing organizations 20,238 4,915            
Commissions, payroll and payroll taxes 221,769 273,386            
Current portion of lease liability (138,218) (149,499)            
Convertible notes, net   3,783,437            
Secured convertible note, net   6,857,101            
Promissory notes 852,968 852,968            
Short-term merger financing, net   5,092,083            
Contingent guarantee   3,256,863 $ 3,256,863          
Subscription agreement 2,460,488 2,425,647            
Excise tax payable 2,067,572 2,067,572   1,528,101   1,485,236    
Advances from related parties       3,104,097   1,968,116 319,166  
Total Current Liabilities 36,997,956 40,681,377   12,064,611   9,114,840 5,612,724  
Accrued contingent liability 100,000 100,000            
Long-term merger financing, net   7,606,561            
Derivative liability - convertible notes   16,462,690            
Derivative liability - warrants 61,531 307,656   307,656   307,656 184,594  
Earnout - liability 12,638,000 12,298,000            
Deferred income tax liability   5,245,886            
Subordinated borrowings 1,950,000 1,950,000            
Trading account deposit 100,000 100,000            
Long-term lease liability 155,616 182,729            
TOTAL LIABILITIES 79,156,852 95,575,437   12,372,267   9,422,496 5,797,318  
Commitments and Contingencies (Note 10)          
Common stock subject to possible redemption     54,618,469   57,113,761 203,420,202  
STOCKHOLDERS' DEFICIT                
Preferred stock, $0.0001 par value;      
Common stock, $0.0001 par value; 2,225 1,246   503   503 503  
Additional paid-in-capital 114,517,131 110,164,676            
Accumulated Deficit (137,526,772) (148,274,805)   (11,513,379)   (7,914,849) (5,010,342)  
TOTAL STOCKHOLDERS' DEFICIT (23,162,035) (38,108,883)   (11,512,876) $ (11,115,309) (7,914,346) (5,009,839) $ (13,885,204)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 55,994,817 57,466,554   $ 55,477,860   58,621,911 $ 204,207,681  
Nonrelated Party                
Current liabilities                
Stock payable   259,893            
Related Party                
Current liabilities                
Stock payable   $ 55,087            
Promissory notes           $ 480,000    
v3.24.4
TRANSITION PERIOD COMPARATIVE DATA - Consolidated Balance Sheets Parentheticals (Details) - $ / shares
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
TRANSITION PERIOD COMPARATIVE DATA        
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Common Stock, par value (in Dollars per share) $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
v3.24.4
TRANSITION PERIOD COMPARATIVE DATA - Statements of consolidated Net Income (loss) (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
REVENUES                
Commissions $ 1,383,828 $ 1,750,159     $ 2,679,673      
Vetting fees 365,383 340,050     499,125      
Clearing fees 1,047,712 624,550     756,393      
Net gain/(loss) on firm trading accounts 1,711 6,390     10,046      
Other revenue 5,448 9,650     56,246      
TOTAL REVENUES 2,804,082 2,730,799     4,001,483      
EXPENSES                
Compensation, payroll taxes and benefits 1,279,304 1,355,058     2,386,837      
Data processing and clearing costs 611,646 843,824     1,299,527      
Regulatory, professional fees and related expenses 1,095,819 112,216 $ 640,813   11,649,470      
Stock compensation - founder share transfer         1,462,650      
Communications 152,754 172,018     254,608      
Occupancy and equipment 54,004 54,765     76,324      
Transfer fees 51,590 54,807     75,425      
Bank charges 55,901 52,077     88,253      
Intangible assets amortization 307,191 337,911     791,375      
Other   147,042     185,840      
Other operating and formation cost 136,975     $ 577,313 185,840 $ 1,485,122    
TOTAL EXPENSES 3,745,184 3,129,718 640,813 577,313 18,270,309 1,485,122 $ 2,737,871 $ 3,024,231
LOSS FROM OPERATIONS (941,102) (398,919) (640,813) (577,313) (14,268,826) (1,485,122) (2,737,871) (3,024,231)
OTHER INCOME/(EXPENSE)                
Interest income   587,637   8,458 938,802 8,458 22,195  
Interest earned on marketable securities held in Trust Account       727,468 256,279 2,028,921    
Gain/Loss on Fixed assets   146,706     146,706      
Net gain on settlement       829,853 146,706 829,853 829,853  
Loss on AtlasClear asset acquisition   (17,845,813)     (86,392,769)      
Change in fair value of warrant liability derivative 246,125 307,656 (184,594) (184,594)   (123,062) (123,062) 6,953,336
Change in fair value, convertible note derivative 3,167,309 (992,152)     (3,585,902)      
Change in fair value, long-term and short-term note derivative 11,152,870 (3,101,057)     (11,208,055)      
Change in fair value of non-redemption agreement     (11,759)   (164,626)   439,787  
Change in fair value, contingent guarantee (839,775) (3,256,863)     (3,256,863)      
Change in fair value of earnout liability (340,000) (1,115,000)     (1,335,000)      
Change in fair value of subscription agreement (34,841) (4,413,946)     (38,796)      
Extinguishment of stock payable   985,072     985,072      
Extinguishment of accrued expenses   114,199     879,473      
Interest expense (1,456,996) (3,210,786)     (3,732,178)      
TOTAL OTHER INCOME/(EXPENSE) 11,710,887 (31,794,347) 526,037 1,381,185 (106,507,857) 2,744,170 4,258,859 14,606,651
Income before provision for income taxes 10,769,785 (32,193,266) (114,776) 803,872 (120,776,683) 1,259,048 1,520,988 11,582,420
Income tax (expense) benefit (21,752) 563,736 (141,202) (318,313) 569,736 (581,118) (726,038) (536,853)
NET INCOME/(LOSS) $ 10,748,033 $ (31,629,530) $ (255,978) $ 485,559 $ (120,206,947) $ 677,930 $ 794,950 $ 11,045,567
v3.24.4
TRANSITION PERIOD COMPARATIVE DATA - Statements of consolidated cash flow (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 09, 2024
Feb. 07, 2024
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities:                    
Net income (loss)     $ 10,748,033 $ (31,629,530) $ (255,978) $ 485,559 $ (120,206,947) $ 677,930 $ 794,950 $ 11,045,567
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                    
Change in fair value of warrant liability     (246,125) (307,656) 184,594 184,594   123,062 123,062 (6,953,336)
Change in fair value of non-redemption agreement liability             164,626      
Loss on AtlasClear asset acquisition             86,392,769      
Change in fair value, convertible note derivative     (3,167,309)       3,585,904      
Change in fair value, long-term and short-term note derivative     (11,152,870) 3,101,057     11,208,055      
Interest expense on convertible notes             1,896,714      
Transaction costs paid with stock             1,401,937      
Stock based compensation     2,578       1,462,650      
Change in fair value, earnout liability     340,000 1,115,000     1,335,000      
Fee on Secured convertible note             1,500,000      
Change in operating lease expense             68,727      
Change in fair value of contingent guarantee     839,775 3,256,863     3,256,863      
Interest earned on marketable securities held in Trust Account         (716,882)   (251,569) (2,028,921) (3,090,086) (3,087,315)
Change in fair value, subscription agreement     34,841 4,413,946     38,796      
Depreciation expense     4,569       7,565      
Amortization of intangibles     307,191 337,911     791,375      
Bad debt expense     639       2,474      
Changes in operating assets and liabilities:                    
Due from Atlas Clear     15,323       (12,903)   (58,828)  
Income taxes payable               44,118 189,038 536,853
Marketable securities             6,820      
Receivables from brokers & dealers     (583,869)       2,203,271      
Receivables from customers     652,455       (303,486)      
Receivables from others     (57,235)       (59,043)      
Advances and Prepaid expenses     23,692   (18,750)   133,158 4,194 33,652 305,798
Cash deposits with clearing organization & other B/Ds             21,664      
Change in operating lease right-of-use asset             (11,713)      
Other assets         (4,245)   49,041      
Payables to customers     (153,100)       (5,124,740)      
Payables to officers & directors     42,357       98,048      
Deferred tax liability             (43,484)      
Accounts payable and accrued expenses     223,401   161,531   (1,066,430) 443,812 628,164 1,634,174
Commissions and payroll taxes payable     (51,617)       39,638      
Stock Loan             259,893      
Operating lease liability             (56,900)      
CASH PROVIDED BY (USED FOR) OPERATING ACTIVITIES     175,607   (637,971)   (11,212,227) (785,611) (1,819,835) (1,084,259)
Cash Flows from Investing Activities:                    
Cash withdrawn from Trust Account to pay franchise and income taxes         359,897   68,418   1,374,898 351,474
Investment of cash into Trust Account         (495,000)   (160,000) (875,000) (1,850,000)  
Cash withdrawn from Trust Account in connection with redemption         4,286,537   53,947,064 1,015,001 152,810,179  
Cash paid for purchase of Pacsquare     (65,000)       (500,000)      
Cash received from acquisition of Wilson-Davis             33,333,876      
Cash withdrawn from Trust Account for working capital purposes             1,195,565 148,523,642    
Cash paid to Wilson Davis shareholders   $ (8,000,000)         (8,092,568)      
CASH PROVIDED BY (USED FOR) INVESTING ACTIVITIES     (65,000)   4,151,434   79,792,355 148,663,643 152,335,077 351,474
Cash Flows from Financing Activities:                    
Proceeds from promissory note - related party                   480,000
Proceeds from secured convertible note             6,000,000      
Transaction costs financed             5,002,968      
Repayment of advances from related party               (300,000)    
Advances from related party         352,981   1,052,300 1,948,950 2,855,431 319,166
Redemption of common stock         (4,286,537)   (53,947,064) (148,523,642) (152,810,179)  
Dividends             (11,713)      
CASH PROVIDED BY (USED FOR) FINANCING ACTIVITIES     148,383   (3,933,556)   (41,891,796) (146,874,692) (150,025,248) 799,166
NET INCREASE (DECREASE) IN CASH     258,990   (420,093)   26,688,332 1,003,340 489,994 66,381
CASH AT BEGINNING OF YEAR     27,307,886   1,132,900   619,554 129,560 129,560 63,179
CASH AT YEAR END     $ 27,566,876 $ 27,307,886 712,807 $ 1,132,900 27,307,886 1,132,900 619,554 129,560
Supplementary cash flow information:                    
Cash paid for income taxes               537,000 537,000  
Supplemental disclosure of non-cash investing and financing activities:                    
Shares issued to settled advances from related party and notes payable related party             4,577,569      
Transaction cost settled with subscription payable             2,386,851      
Fair value of equity treated earnout in AtlasClear, Inc asset acquisition             31,347,000      
Fair value of shares issued in AtlasClear, Inc asset acquisition             44,400,000      
Fair value of liability treated earnout in AtlasClear, Inc asset acquisition             10,963,000      
Fair value of shares transferred to Wilson Davis shareholders             6,000,000      
Short term notes issued to Wilson Davis shareholders             5,000,000      
Long term notes issued to Wilson Davis shareholders             7,971,197      
Common stock issued to settled vendor obligations             64,376      
Fair value of shares transferred to Secured convertible note holders             1,250,698      
Redeemable shares transferred to permanent equity             1,195,566      
Non-redemption agreement re-classed to permanent equity $ 1,606,279           1,606,279      
Shares issued to purchase Pacsquare and amounts included in accounts payable             1,226,500      
Shares issued as deposit for Commercial bank acquisition             91,200      
Initial value of derivative liability on convertible notes             1,668,731      
Interest settled with shares             210,550      
Interest settled with shares transferred by related party             48,750      
Cancellation of admin fees               120,000 120,000  
Excise tax related to redemptions         42,865   539,471 1,485,236 1,528,101  
Accretion of common stock subject to possible redemption         $ 1,020,680   592,577 2,217,201 $ 4,008,446 $ 2,170,202
ATLASCLEAR, INC                    
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                    
Amortization of intangibles             (317,231)      
Changes in operating assets and liabilities:                    
Due from Atlas Clear               $ (49,806)    
Supplemental disclosure of non-cash investing and financing activities:                    
Fair value of equity treated earnout in AtlasClear, Inc asset acquisition             31,347,000      
Fair value of shares issued in AtlasClear, Inc asset acquisition             44,400,000      
Fair value of liability treated earnout in AtlasClear, Inc asset acquisition             $ 10,963,000      
v3.24.4
SUBSEQUENT EVENTS (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Nov. 14, 2024
shares
Oct. 23, 2024
USD ($)
Oct. 13, 2024
USD ($)
Oct. 12, 2024
Aug. 29, 2024
USD ($)
$ / shares
shares
Aug. 28, 2024
shares
Aug. 09, 2024
USD ($)
shares
Jul. 31, 2024
USD ($)
D
shares
Jul. 10, 2024
shares
Jul. 05, 2024
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Feb. 09, 2024
USD ($)
$ / shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
shares
Sep. 30, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
shares
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
shares
SUBSEQUENT EVENTS                                      
Shares issued as deposit for the Commercial Bank acquisition (in shares)                             1,234,990        
Conversion, shares transferred                             2,550,588        
Common Stock that may be issuable                             10,000,000        
Common stock, shares issued                     12,455,157   12,455,157   22,245,698 12,455,157 5,031,250   5,031,250
Common stock, $0.0001 par value; | $                     $ 1,246   $ 1,246   $ 2,225 $ 1,246 $ 503 $ 503 $ 503
Proceeds from Tau agreement | $                             148,383        
Common stock issued to for consulting services (in shares)         882,668       1,602,994                    
Common stock issued to settled vendor obligations | $                             2,578 $ 1,459,976      
Sale price per share (in Dollars per share) | $ / shares                     $ 10 $ 10 $ 10     $ 10      
Chardan Note                                      
SUBSEQUENT EVENTS                                      
Conversion amount | $                       $ 4,150,000 $ 725,000 $ 725,000 $ 725,000        
Conversion, shares issued                         2,263,031 2,263,031 2,263,031        
Conversion, shares transferred                             145,606 198,196      
Quantum Ventures LLC                                      
SUBSEQUENT EVENTS                                      
Conversion, shares transferred                             366,750        
Quantum Ventures LLC | Shares issuable pursuant to Short Term and Long Term Notes                                      
SUBSEQUENT EVENTS                                      
Conversion, shares transferred                     1,558,923                
Atlas FinTech                                      
SUBSEQUENT EVENTS                                      
Conversion, shares issued             2,788,276                        
Conversion, shares transferred                             127,159        
Common stock, $0.0001 par value; | $             $ 803,860                        
Number of additional shares issued             991,665                        
Reimbursement shares transferred             1,337,500                        
Common stock issued to for consulting services (in shares)             4,125,776                        
Atlas FinTech | Chardan Note                                      
SUBSEQUENT EVENTS                                      
Conversion, shares transferred                             52,590        
Atlas FinTech | Shares issuable pursuant to Short Term and Long Term Notes                                      
SUBSEQUENT EVENTS                                      
Conversion, shares transferred                     1,183,629                
AtlasClear Platform                                      
SUBSEQUENT EVENTS                                      
Stock issued during period shares (in Shares)                               493,909      
AtlasClear Platform | Pacsquare                                      
SUBSEQUENT EVENTS                                      
Common stock, shares issued                     336,000   336,000     336,000      
ELOC Agreement                                      
SUBSEQUENT EVENTS                                      
Maximum aggregate purchase price | $               $ 10,000,000                      
Agreement term               24 months                      
Number of shares of individual advances requested               100,000                      
Advances requested, percentage of average daily volume of common stock traded               50.00%                      
Threshold trading days | D               30                      
Shares price payable as percentage of VWAP of the Common Stock               97.00%             97.00%        
Threshold consecutive trading days | D               3                      
Common Stock that may be issuable                             2,310,000        
Stock issued during period shares (in Shares)                             1,445,527        
Proceeds from Tau agreement | $                             $ 148,382        
Subsequent Event                                      
SUBSEQUENT EVENTS                                      
Stock issued during period shares (in Shares) 500,000                                    
Value of subordinated notes | $     $ 1,280,000                                
Value of subordinated notes not renewed | $     $ 20,000                                
Extension term of subordinated notes     1 year                                
Interest rate of subordinated debt     8.00% 5.00%                              
Subsequent Event | WILSON-DAVIS                                      
SUBSEQUENT EVENTS                                      
Shares issued as deposit for the Commercial Bank acquisition (in shares)           1,055,448                          
Subsequent Event | Chardan Note                                      
SUBSEQUENT EVENTS                                      
Conversion amount | $   $ 5,209,764                                  
Subsequent Event | Atlas FinTech                                      
SUBSEQUENT EVENTS                                      
Common stock, $0.0001 par value; | $             $ 803,860                        
Number of additional shares issued             1,183,629                        
Reimbursement shares transferred             1,337,500                        
Percentage of compensation fees agreed             13                        
Common stock issued to for consulting services (in shares)             2,788,276                        
Subsequent Event | Lead Nectar                                      
SUBSEQUENT EVENTS                                      
Common stock issued to for consulting services (in shares)         12,000                            
Common stock issued to settled vendor obligations | $         $ 20,000                            
Sale price per share (in Dollars per share) | $ / shares         $ 1.66                            
Subsequent Event | AtlasClear Platform | Pacsquare                                      
SUBSEQUENT EVENTS                                      
Shares issued as deposit for the Commercial Bank acquisition (in shares)                   500,000                  
Subsequent Event | ELOC Agreement                                      
SUBSEQUENT EVENTS                                      
Maximum aggregate purchase price | $               $ 10,000,000                      
Agreement term               24 months                      
Number of shares of individual advances requested               100,000                      
Advances requested, percentage of average daily volume of common stock traded               50.00%                      
Threshold trading days | D               30                      
Shares price payable as percentage of VWAP of the Common Stock               97.00%                      
Threshold consecutive trading days | D               3                      
Common Stock that may be issuable               10,000,000                      
Stock issued during period shares (in Shares)               2,475,000                      
v3.24.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Jun. 30, 2024
ASSETS    
Cash and cash equivalents $ 6,817,398 $ 6,558,176
Cash segregated - customers 19,980,711 20,548,972
Cash segregated - PAB 768,767 200,738
Receivables - broker-dealers and clearing organizations 1,917,175 1,333,306
Receivables - customers, net 170,690 823,784
Other receivables 230,037 64,842
Prepaids 44,275 67,967
Trading securities, market value, net 55 55
Total Current Assets 29,929,108 29,597,840
Operating lease right to use lease asset 288,191 326,336
Property and equipment, net 11,511 16,080
Customer list, net 13,843,665 14,150,856
Goodwill 6,142,525 7,706,725
Pacsquare asset purchase 1,928,800 1,726,500
Cash deposits - broker-dealers and clearing organizations 3,515,000 3,515,000
Bank acquisition deposit   91,200
Other assets 336,017 336,017
TOTAL ASSETS 55,994,817 57,466,554
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Payables to customers 20,009,873 20,162,973
Accounts and payables to officers/directors 728,936 686,579
Accounts payable and accrued expenses 4,615,650 5,393,912
Payables - broker-dealers and clearing organizations 20,238 4,915
Commissions, payroll and payroll taxes 221,769 273,386
Current portion of lease liability 138,218 149,499
Promissory notes 852,968 852,968
Short-term merger financing, net 4,790,907 5,092,083
Contingent guarantee   3,256,863
Tau agreement liability 972,508  
Subscription agreement 2,460,488 2,425,647
Excise tax payable 2,067,572 2,067,572
Total Current Liabilities 36,997,956 40,681,377
Accrued contingent liability 100,000 100,000
Convertible notes, net 3,282,518 3,783,437
Secured convertible note, net 7,066,449 6,857,101
Long-term merger financing, net 7,708,615 7,606,561
Merger financing - convertible notes 2,985,237  
Derivative liability - Warrants 61,531 307,656
Earnout - liability 12,638,000 12,298,000
Deferred income tax liability 3,702,645 5,245,886
Subordinated borrowings 1,950,000 1,950,000
Trading account deposit 100,000 100,000
Long-term lease liability 155,616 182,729
TOTAL LIABILITIES 79,156,852 95,575,437
Commitments and Contingencies (Note 9)
Common stock subject to possible redemption  
STOCKHOLDERS' DEFICIT    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 22,245,698 and 12,455,157 shares issued and outstanding at September 30, 2024 and June 30, 2024, respectively (excluding 1,029,473 shares issued under the Tau Agreement included in liabilities as of September 30, 2024) 2,225 1,246
Additional paid-in-capital 114,517,131 110,164,676
Stock subscription receivable (154,619)  
Accumulated Deficit (137,526,772) (148,274,805)
TOTAL STOCKHOLDERS' DEFICIT (23,162,035) (38,108,883)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT 55,994,817 57,466,554
Secured convertible notes    
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Derivative liability 89,535  
Merger financing    
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Derivative liability 176,239  
Convertible notes    
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Derivative liability 2,142,511 16,462,690
Nonrelated Party    
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Stock payable 63,742 259,893
Promissory notes   852,968
Related Party    
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Stock payable $ 55,087 $ 55,087
v3.24.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
CONDENSED CONSOLIDATED BALANCE SHEETS        
Subject to possible redemption shares   0 5,050,384  
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000 1,000,000 1,000,000
Preferred stock, shares issued 0 0 0 0
Preferred stock, shares outstanding 0 0 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000 100,000,000 100,000,000
Common stock, shares issued 22,245,698 12,455,157 5,031,250 5,031,250
Common stock, shares outstanding 22,245,698 12,455,157 5,031,250 5,031,250
Shares of common stock issued under Tau Agreement 1,029,473      
v3.24.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
REVENUES                
Commissions $ 1,383,828 $ 1,750,159     $ 2,679,673      
Vetting fees 365,383 340,050     499,125      
Clearing fees 1,047,712 624,550     756,393      
Net gain/(loss) on firm trading accounts 1,711 6,390     10,046      
Other revenue 5,448 9,650     56,246      
TOTAL REVENUES 2,804,082 2,730,799     4,001,483      
EXPENSES                
Compensation, payroll taxes and benefits 1,279,304 1,355,058     2,386,837      
Data processing and clearing costs 611,646 843,824     1,299,527      
Regulatory, professional fees and related expenses 1,095,819 112,216 $ 640,813   11,649,470      
Communications 152,754 172,018     254,608      
Occupancy and equipment 54,004 54,765     76,324      
Transfer fees 51,590 54,807     75,425      
Bank charges 55,901 52,077     88,253      
Intangible assets amortization 307,191 337,911     791,375      
Operating and formation cost             $ 2,737,871 $ 3,024,231
Other 136,975     $ 577,313 185,840 $ 1,485,122    
TOTAL EXPENSES 3,745,184 3,129,718 640,813 577,313 18,270,309 1,485,122 2,737,871 3,024,231
LOSS FROM OPERATIONS (941,102) (398,919) (640,813) (577,313) (14,268,826) (1,485,122) (2,737,871) (3,024,231)
OTHER INCOME/(EXPENSE)                
Interest income 606,758   722,390   1,195,081   3,090,086 3,087,315
Net gain on settlement       829,853 146,706 829,853 829,853  
Loss on AtlasClear asset acquisition   (17,845,813)     (86,392,769)      
Change in fair value of warrant liability derivative 246,125 307,656 (184,594) (184,594)   (123,062) (123,062) 6,953,336
Change in fair value of convertible note derivative 3,167,309 (992,152)     (3,585,902)      
Change in fair value of long-term and short-term note derivative 11,152,870 (3,101,057)     (11,208,055)      
Change in fair value of contingent guarantee (839,775) (3,256,863)     (3,256,863)      
Change in fair value of non-redemption agreement     (11,759)   (164,626)   439,787  
Change in fair value of secured convertible note (89,535)              
Change in fair value of merger financing (63,195)              
Change in fair value of PIPE derivative liability               4,566,000
Change in fair value of earnout liability (340,000) (1,115,000)     (1,335,000)      
Change in fair value of subscription agreement (34,841) (4,413,946)     (38,796)      
Change in fair value of stock payable 196,151       985,072      
Change in fair value of Tau agreement (833,984)              
Extinguishment of accrued expenses   114,199     879,473      
Interest expense (1,456,996) (3,210,786)     (3,732,178)      
TOTAL OTHER INCOME/(EXPENSE) 11,710,887 (31,794,347) 526,037 1,381,185 (106,507,857) 2,744,170 4,258,859 14,606,651
NET INCOME/(LOSS) BEFORE INCOME TAXES 10,769,785 (32,193,266) (114,776) 803,872 (120,776,683) 1,259,048 1,520,988 11,582,420
Income tax (expense) benefit (21,752) 563,736 (141,202) (318,313) 569,736 (581,118) (726,038) (536,853)
NET INCOME/(LOSS) $ 10,748,033 $ (31,629,530) $ (255,978) $ 485,559 $ (120,206,947) $ 677,930 $ 794,950 $ 11,045,567
Redeemable Common Stock                
OTHER INCOME/(EXPENSE)                
Basic weighted average common stock outstanding (in shares)     5,205,217          
Diluted weighted average shares outstanding (in shares)     5,205,217          
Basic net income (loss) per share (in dollars per share)     $ (0.03)          
Diluted net income (loss) per share (in dollars per share)     $ (0.03)          
Non-redeemable Common Stock                
OTHER INCOME/(EXPENSE)                
Basic weighted average common stock outstanding (in shares) 15,384,357   5,031,250          
Diluted weighted average shares outstanding (in shares) 114,565,050   5,031,250          
Basic net income (loss) per share (in dollars per share) $ 0.7   $ (0.03)          
Diluted net income (loss) per share (in dollars per share) $ 0   $ (0.03)          
Redeemable Common Stock                
OTHER INCOME/(EXPENSE)                
Basic weighted average common stock outstanding (in shares)         1,109,975   6,898,644 20,125,000
Diluted weighted average shares outstanding (in shares)     5,205,217   1,109,975   6,898,644 20,125,000
Basic net income (loss) per share (in dollars per share)         $ (10.16)   $ 0.07 $ 0.44
Diluted net income (loss) per share (in dollars per share)     $ (0.03)   $ (10.16)   $ 0.07 $ 0.44
Non-redeemable Common Stock                
OTHER INCOME/(EXPENSE)                
Basic weighted average common stock outstanding (in shares)         10,719,043   5,031,250 5,031,250
Diluted weighted average shares outstanding (in shares)         10,719,043   5,031,250 5,031,250
Basic net income (loss) per share (in dollars per share)         $ (11.6)   $ 0.07 $ 0.44
Diluted net income (loss) per share (in dollars per share)         $ (11.6)   $ 0.07 $ 0.44
v3.24.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Pacsquare
Common Stock
Convertible notes
Common Stock
Short-term Merger Financing
Common Stock
Tau Agreement
Common Stock
Additional Paid-in Capital
Pacsquare
Additional Paid-in Capital
Convertible notes
Additional Paid-in Capital
Short-term Merger Financing
Additional Paid-in Capital
Tau Agreement
Additional Paid-in Capital
Accumulated Deficit
Subscription Receivable
Tau Agreement
Subscription Receivable
Pacsquare
Convertible notes
Short-term Merger Financing
Tau Agreement
Total
Beginning balance at Dec. 31, 2021         $ 503           $ (13,885,707)             $ (13,885,204)
Beginning balance (in shares) at Dec. 31, 2021         5,031,250                          
Accretion of Common Stock subject to Possible Redemption                     (2,170,202)             (2,170,202)
Net loss                     11,045,567             11,045,567
Ending balance at Dec. 31, 2022         $ 503           (5,010,342)             $ (5,009,839)
Ending balance (in shares) at Dec. 31, 2022         5,031,250                         5,031,250
Net loss                                   $ 677,930
Ending balance at Jun. 30, 2023         $ 503           (7,914,849)             (7,914,346)
Ending balance (in shares) at Jun. 30, 2023         5,031,250                          
Beginning balance at Dec. 31, 2022         $ 503           (5,010,342)             $ (5,009,839)
Beginning balance (in shares) at Dec. 31, 2022         5,031,250                         5,031,250
Cancellation of admin fees                   $ 120,000               $ 120,000
Accretion of Common Stock subject to Possible Redemption                   (120,000) (3,888,446)             (4,008,446)
Fair value of non-redemption agreement liability at issuance                     (1,881,440)             (1,881,440)
Excise taxes related to redemptions                     (1,528,101)             (1,528,101)
Net loss                     794,950             794,950
Ending balance at Dec. 31, 2023         $ 503           (11,513,379)             $ (11,512,876)
Ending balance (in shares) at Dec. 31, 2023         5,031,250                         5,031,250
Beginning balance at Jun. 30, 2023         $ 503           (7,914,849)             $ (7,914,346)
Beginning balance (in shares) at Jun. 30, 2023         5,031,250                          
Accretion of Common Stock subject to Possible Redemption                     (1,020,680)             (1,020,680)
Fair value of non-redemption agreement liability at issuance                     (1,881,440)             (1,881,440)
Excise taxes related to redemptions                     (42,865)             (42,865)
Net loss                     (255,978)             (255,978)
Ending balance at Sep. 30, 2023         $ 503           (11,115,812)             (11,115,309)
Ending balance (in shares) at Sep. 30, 2023         5,031,250                          
Beginning balance at Dec. 31, 2023         $ 503           (11,513,379)             $ (11,512,876)
Beginning balance (in shares) at Dec. 31, 2023         5,031,250                         5,031,250
Common stock no longer subject to redemption         $ 11         1,195,555               $ 1,195,566
Common stock no longer subject to redemption (in shares)         109,499                          
Common stock issued to for consulting services         $ 35         1,459,941               $ 1,459,976
Common stock issued to for consulting services (in shares)         353,198                          
Shares issued as purchase consideration for the assets $ 33         $ 1,141,467               $ 1,141,500        
Shares issued as purchase consideration for the assets (in shares) 336,000                                 4,400,000
Shares issued to additional consideration for delayed payment         $ 4         91,196               $ 91,200
Shares issued to additional consideration for delayed payments (in shares)         40,000                          
Stock Compensation Expense - Founder Shares transferred at closing                   1,462,650               1,462,650
Founder Shares transferred at closing to non-redemption agreement holders                   1,606,279               1,606,279
Founder Shares transferred at closing as consideration for Wilson Davis Acquisition                   6,000,000               6,000,000
Founder Shares and warrants transferred to Secured convertible note holders                   1,250,698               1,250,698
Shares issued to settle related party advances and promissory notes, net of deemed dividend         $ 200         19,999,800 (15,422,431)             4,577,569
Shares issued to settle related party advances and promissory notes, net of deemed dividend (in shares)         2,000,000                          
Shares issued as settlement of accrued interest         $ 15         210,535               210,550
Shares issued as settlement of accrued interest (in shares)         145,210                          
Accretion of Common Stock subject to Possible Redemption                     (592,577)             (592,577)
Excise taxes related to redemptions                     (539,471)             (539,471)
Net loss                     (120,206,947)             (120,206,947)
Ending balance at Jun. 30, 2024         $ 1,246         110,164,676 (148,274,805)             $ (38,108,883)
Ending balance (in shares) at Jun. 30, 2024         12,455,157                         12,455,157
Common stock issued to for consulting services         $ 1         2,577               $ 2,578
Common stock issued to for consulting services (in shares)         12,000                          
Shares issued as purchase consideration for the assets $ 50         $ 122,250               $ 122,300        
Shares issued as purchase consideration for the assets (in shares) 500,000                                  
Shares issued as conversion in principle and interest on convertible notes   $ 177 $ 186       $ 324,823 $ 367,240             $ 325,000 $ 367,426    
Shares issued as conversion in principle and interest on convertible notes (in shares)   1,769,122 1,862,116                              
Shares transferred by related parties as settlement for Company obligations under various financial instruments             $ 2,412,930               $ 2,412,930      
Shares issued to additional consideration for delayed payment     $ 8         $ 16,332               $ 16,340    
Shares issued to additional consideration for delayed payments (in shares)     76,000                             1,234,990
Shares issued to related party as settlement in related party payable         $ 279         803,581               $ 803,860
Shares issued to related party as settlement in related party payable. (in shares)         2,788,276                          
Shares issued under Tau agreement settled through September 30, 2024       $ 144         $ 302,856     $ (154,619)         $ 148,381  
Shares issued under Tau agreement settled through September 30, 2024 (in shares)       1,445,527                         1,445,527  
Shares transferred by related party as repayment of shares transferred to cover Company obligations as noted above net of contributed capital for debt assumed         $ (134)         134                
Shares transferred by related party as repayment of shares transferred to cover Company obligations as noted above net of contributed capital for debt assumed         1,337,500                          
Net loss                     10,748,033             10,748,033
Ending balance at Sep. 30, 2024         $ 2,225         $ 114,517,131 $ (137,526,772)   $ (154,619)         $ (23,162,035)
Ending balance (in shares) at Sep. 30, 2024         22,245,698                         22,245,698
v3.24.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parentheticals)
3 Months Ended
Sep. 30, 2024
USD ($)
Principal amount $ 359,896
Accounts Payable, Current 803,860
Convertible notes  
Conversion amount 325,000
Short-term Merger Financing  
Principal amount 359,896
Interest amount $ 7,530
v3.24.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
3 Months Ended
Sep. 30, 2024
USD ($)
Cash Flows from Operating Activities:  
Net income (loss) $ 10,748,033
Adjustments to reconcile net income to net cash provided by operating activities:  
Change in fair value of warrant liability derivative (246,125)
Change in fair value of convertible note derivative (3,167,309)
Change in fair value of long-term and short-term note derivative (11,152,870)
Change in fair value of contingent guarantee 839,775
Change in fair value of secured convertible note 89,535
Change in fair value of merger financing 63,195
Change in fair value of earnout liability 340,000
Change in fair value of subscription agreement 34,841
Change in fair value of stock payable (196,151)
Change in fair value of Tau agreement 833,984
Late fee paid in shares to sellers 16,340
Non-cash interest in expense on financial instruments 1,403,503
Realized gain on Tau agreement 30,562
Stock based compensation 2,578
Bank acquisition deposit write off 91,200
Depreciation expense 4,569
Amortization of intangibles 307,191
Allowance for bad debt 639
Net lease payments (249)
Changes in operating assets and liabilities:  
Receivables from brokers & dealers (583,869)
Receivables from customers 652,455
Receivables from others (57,235)
Advances & prepaid expenses 23,692
Payables to customers (153,100)
Payables to officers & directors 42,357
Payable to brokers & dealers 15,323
Accounts payable and accrued expenses 223,401
Commissions and payroll taxes payable (51,617)
Deferred tax liability 20,959
CASH PROVIDED BY (USED FOR) OPERATING ACTIVITIES 175,607
CASH FLOWS FROM INVESTING ACTIVITIES  
Cash paid for purchase of Pacsquare (65,000)
CASH PROVIDED BY (USED FOR) INVESTING ACTIVITIES (65,000)
CASH FLOWS FROM FINANCING ACTIVITIES  
Proceeds from Tau agreement 148,383
CASH PROVIDED BY (USED FOR) FINANCING ACTIVITIES 148,383
NET INCREASE (DECREASE) IN CASH 258,990
CASH AT BEGINNING OF YEAR 27,307,886
CASH AT YEAR END 27,566,876
Non-cash investing and financing activities:  
Decrease in goodwill due to change in deferred tax liability 1,562,200
Initial shares issued under Tau agreement 441,524
Value of shares transferred by related parties to settle obligations 2,412,930
Shares issued as payment towards contingent guarantee 1,210,290
Shares issued to related party for settlement of accounts payable 803,860
Receivable from shares advanced under Tau agreement 154,619
Initial value of derivative included in merger financing 113,044
Convertible notes  
Non-cash investing and financing activities:  
Share issued for conversion 325,000
Short-term Merger Financing  
Non-cash investing and financing activities:  
Share issued for conversion 367,426
Merger financing  
Non-cash investing and financing activities:  
Initial value of derivative included in merger financing 113,044
Pacsquare  
Non-cash investing and financing activities:  
Shares issued to purchase Pacsquare and amounts included in accounts payable $ 137,300
v3.24.4
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS    
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

AtlasClear Holdings, Inc. (formerly known as Calculator New Pubco, Inc.) (the “Company” or “AtlasClear Holdings”) is a Delaware corporation and, prior to the Business Combination (defined below), was a direct, wholly-owned subsidiary of Quantum FinTech Acquisition Corporation (“Quantum”). Quantum was incorporated in Delaware on October 1, 2020. Quantum was a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

On February 9, 2024 (the “Closing Date”), the Company consummated the previously announced transactions pursuant to that certain Business Combination Agreement, dated November 16, 2022 (as amended, the “Business Combination Agreement”), by and among the Company, Quantum, Calculator Merger Sub 1, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 1”), Calculator Merger Sub 2, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 2”), AtlasClear, Inc., a Wyoming corporation (“AtlasClear”), Atlas FinTech Holdings Corp., a Delaware corporation (“Atlas FinTech”) and Robert McBey. The transactions consummated as a result of the Business Combination Agreement are hereinafter referred to as the “Business Combination.” In connection with the consummation of the Business Combination (the “Closing”), the Company changed its name from “Calculator New Pubco, Inc.” to “AtlasClear Holdings, Inc.” As a result, the operation history of Quantum survived the merger. Pursuant to the Business Combination Agreement, AtlasClear received certain assets from Atlas FinTech and Atlas Financial Technologies Corp., a Delaware corporation, and (ii) Broker-Dealer Acquisition Agreement (as defined in the Business Combination Agreement), AtlasClear completed the acquisition of broker-dealer, Wilson-Davis & Co., Inc. (“Wilson-Davis”).

On February 16, 2024, AtlasClear and Pacsquare Technologies, LLC (“Pacsquare”) entered into a Source Code Purchase and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear purchased a proprietary trading platform with clearing and settlement capabilities that will be developed by Pacsquare, including certain software and source code (the “AtlasClear Platform”).

AtlasClear Holdings’ goal is to build a cutting-edge technology enabled financial services firm that would create a more efficient platform for trading, clearing, settlement and banking, with evolving and innovative financial products that focus on financial services firms. AtlasClear Holdings is a fintech driven business-to-business platform that expects to power innovation in fintech, investing, and trading.

AtlasClear does not meet the definition of a business and therefore was treated as an asset acquisition by AtlasClear Holdings. As such the assets contributed from Atlas FinTech and the net assets of AtlasClear were recognized at historical cost. ASC 350 prohibits the recognition of goodwill in an asset purchase.

Quantum was deemed the accounting acquirer based on the following factors: i) Quantum issued cash and shares of its common stock; ii) Quantum controlled the voting rights under the no redemption and the maximum contractual redemption scenarios; iii) Quantum had the largest minority voting interest; iv) Quantum has control over the board of directors of the post-combination company and most of senior management of the post-combination company are former officers of Quantum.

Wilson-Davis is a securities broker and dealer, dealing in over-the-counter and listed securities. Wilson-Davis is registered with the Securities and Exchange Commission (the “SEC”) and is a member of the Financial Industry Regulatory Authority.

Revenue is derived principally from Wilson-Davis’ operations in three areas: commission revenue, fee revenue and interest revenue.

Wilson-Davis has operations in Utah, Arizona, California, Colorado, Florida, New York, Oklahoma and Texas. Transactions for customers are principally in the states where the Company operates, however, some customers are located in other states in which the Company is registered. Principal trading activities are conducted with other broker dealers throughout the United States.

Going Concern

As of September 30, 2024, the Company had $6,817,398 in its operating bank accounts and working capital deficit of $7,068,848.

The Company has raised and intends to raise additional capital through loans or additional investments from its stockholders, officers, directors, or third parties. The Company’s officers and directors may, but are not obligated to loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Codification Subtopic 205-40, “Presentation of Financial Statements – Going Concern,” the liquidity of the Company raises substantial doubt about the Company’s ability to continue as a going concern through the twelve months following the issuance of the financial statements. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. No adjustments have been made to the carrying amounts of assets or liabilities as a result of this uncertainty.

Inflation Reduction Act of 2022

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. As such the Company has accrued for the estimated excise tax as a result of the redemptions that occurred after December 31, 2022. As of September 30, 2024 and June 30, 2024 the excise tax payable is $2,067,572. As of the date of filing the Company has not paid the excise tax as such the Company may be subject to interest and penalties as a result.

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

AtlasClear Holdings, Inc. (formerly known as Calculator New Pubco, Inc.) (the “Company” or “AtlasClear Holdings”) is a Delaware corporation and a direct, wholly-owned subsidiary of Quantum FinTech Acquisition Corporation (“Quantum”) formed solely for the purpose of effectuating a business combination. Quantum was incorporated in Delaware on October 1, 2020. Quantum was a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

On February 9, 2024 (the “Closing Date”), the Company consummated the previously announced transactions pursuant to that certain Business Combination Agreement, dated November 16, 2022 (as amended, the “Business Combination Agreement”), by and among the Company, Quantum, Calculator Merger Sub 1, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 1”), Calculator Merger Sub 2, Inc., a Delaware corporation and a wholly-owned subsidiary of the registrant (“Merger Sub 2”), AtlasClear, Inc., a Wyoming corporation (“AtlasClear”), Atlas FinTech Holdings Corp., a Delaware corporation (“Atlas FinTech”) and Robert McBey. The transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Business Combination.” In connection with the consummation of the Business Combination (the “Closing”), the Company changed its name from “Calculator New Pubco, Inc.” to “AtlasClear Holdings, Inc.” As a result, the operation history of Quantum survived the merger.

Pursuant to the Business Combination Agreement, among other things, (i) Merger Sub 1 merged with and into Quantum, with Quantum continuing as the surviving corporation and a wholly-owned subsidiary of AtlasClear Holdings and (ii) Merger Sub 2 merged with and into AtlasClear, with AtlasClear continuing as the surviving corporation and a wholly-owned subsidiary of AtlasClear Holdings. Prior to the Closing, pursuant to the (i) Contribution Agreement (as defined in the Business Combination Agreement), AtlasClear received certain assets from Atlas FinTech and Atlas Financial Technologies Corp., a Delaware corporation, and (ii) Broker-Dealer Acquisition Agreement (as defined in the Business Combination Agreement), AtlasClear completed the acquisition of broker-dealer, Wilson-Davis & Co., Inc. (“Wilson-Davis”). In addition, at Closing, the Bank Acquisition Agreement (as defined in the Business Combination Agreement), pursuant to which AtlasClear has agreed to acquire Commercial Bancorp, a Wyoming corporation and parent of Farmers State Bank (“Commercial Bancorp”), continued to be in full force and effect. Pursuant to the transactions contemplated by a letter of intent, on February 16, 2024, AtlasClear and Pacsquare Technologies, LLC (“Pacsquare”) entered into a Source Code Purchase and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear purchased a proprietary trading platform with clearing and settlement capabilities that will be developed by Pacsquare, including certain software and source code (the “AtlasClear Platform”).

The Business Combination has been accounted for in accordance with the acquisition method of accounting, with Quantum considered to be the accounting acquirer of Wilson-Davis. Under the acquisition method of accounting, the preliminary purchase price is allocated to the underlying tangible and intangible assets acquired and liabilities assumed based on their respective fair market values, with the excess purchase price, if any, allocated to goodwill. Costs related to the transaction were expensed as incurred. (See Note 8 – Acquisition of Wilson-Davis).

AtlasClear Holdings’ goal is to build a cutting-edge technology enabled financial services firm that would create a more efficient platform for trading, clearing, settlement and banking, with evolving and innovative financial products that focus on financial services firms. AtlasClear Holdings is a fintech driven business-to-business platform that expects to power innovation in fintech, investing, and trading.

AtlasClear does not meet the definition of a business and therefore was treated as an asset acquisition by AtlasClear Holdings. As such the assets contributed from Atlas Fintech and the net assets of AtlasClear were recognized at historical cost. ASC 350 prohibits the recognition of goodwill in an asset purchase. (See Note 9 – Acquisition of Assets of AtlasClear, Inc.)

Quantum was deemed the accounting acquirer based on the following factors: i) Quantum issued cash and shares of its common stock; ii) Quantum controlled the voting rights under the no redemption and the maximum contractual redemption scenarios; iii) Quantum had the largest minority voting interest; iv) Quantum has control over the board of directors of the post-combination company and most of senior management of the post-combination company are former officers of Quantum.

Wilson-Davis is a securities broker and dealer, dealing in over-the-counter and listed securities. Wilson-Davis is registered with the Securities and Exchange Commission (the “SEC”)) and is a member of the Financial Industry Regulatory Authority.

Revenue is derived principally Wilson-Davis’ operations in three areas: commission revenue, fee revenue and interest revenue.

Wilson-Davis has operations in Utah, Arizona, California, Colorado, Florida, New York, Oklahoma and Texas. Transactions for customers are principally in the states where the Company operates, however, some customers are located in other states in which the Company is registered. Principal trading activities are conducted with other broker dealers throughout the United States.

Going Concern

As of June 30, 2024, the Consolidated Company had $27,307,886 in its bank accounts and working capital deficit of $21,724,075.

The Company has raised and intends to raise additional capital through loans or additional investments from its stockholders, officers, directors, or third parties. The Company’s officers and directors may, but are not obligated to loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Codification Subtopic 205-40, “Presentation of Financial Statements – Going Concern,” the liquidity of the Company raises substantial doubt about the Company’s ability to continue as a going concern through the twelve months following the issuance of the financial statements. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. No adjustments have been made to the carrying amounts of assets or liabilities as a result of this uncertainty.

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. As such the Company has accrued for the estimated excise tax as a result of the redemptions that occurred after December 31, 2022. As of June 30, 2024 - the excise tax payable is $2,067,572.

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Transition Report on Form 10-KT, as filed with the SEC on October 16, 2024. The accompanying condensed balance sheet as of June 30, 2024 has been derived from the audited financial statements included in the Form 10-KT. The interim results for the three months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending June 30, 2025 or for any future periods.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Goodwill

We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates, and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As a result of the Deferred tax the Goodwill

balance was reduced by the benefit received. As of September 30, 2024, the fair value of goodwill was $6,142,525, as described in Note 10.

Intangible Assets

Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of September 30, 2024, the carrying value of developed technology and customer list was $1,928,800 and $13,843,665, respectively, as described in Note 10 and Note 11.

Impairment of Long-lived and Intangible Assets

The Company had no impairment charges during the three-month periods ended September 30, 2024 and 2023.

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the condensed consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 14).

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) Income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the warrants issued and outstanding. For the three months ended September 30, 2024, the calculation excludes the dilutive impact of warrants because none would be issued under treasury method. The convertible financial instrument and other share obligations were included in the dilutive calculation under the as converted method, as such the number of shares were included as if the shares were issued on July 1, 2024 and the interest expense and the change in fair value associated with the financial instruments was adjusted from net income to determine the numerator and denominator.

For the three months ended September 30, 2023, the calculation excludes the dilutive impact of these instruments because the exercise of the warrants were contingent upon the occurrence of future events and inclusion would be antidilutive.

The following table reflects the calculation of basic net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30, 2024

September 30, 2023

    

Non-

    

    

Non-

 redeemable

Redeemable

 redeemable

Basic net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income, as adjusted

$

10,748,033

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Basic weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

Basic net income per common stock

$

0.70

$

(0.03)

$

(0.03)

The following table reflects the calculation of diluted net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30,2024

September 30,2023

Non-

Non-

    

redeemable

    

Redeemable

    

redeemable

Diluted net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income,

$

10,748,033

$

(130,164)

$

(125,814)

Change in fair value of financial instruments

 

(12,655,000)

 

 

Interest on dilutive instruments

 

1,419,843

 

 

Allocation of net income, as adjusted

$

(487,124)

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Dilutive weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

If converted shares

 

99,180,693

 

 

 

114,565,050

 

5,205,217

 

5,031,250

Diluted net income (loss) per common stock

$

(0.00)

$

(0.03)

$

(0.03)

Below is a summary of the dilutive instruments as of September 30, 2024 and 2023:

Description

    

September 30, 2024

    

September 30, 2023

Short Term Notes

 

49,050,804

 

Convertible notes

 

19,263,975

 

Secured convertible note

 

26,202,298

 

Subscription agreement

 

2,818,665

 

Tau agreement

 

1,253,514

 

Stock payable

250,000

Promissory note

341,437

Total Shares issuable under Convertible Note obligations – if converted total dilutive

99,180,693

Public Warrants

 

10,062,500

 

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

Secured convertible note warrants

 

600,000

 

Total excluded under treasury method – out of the money

 

16,215,625

 

16,215,625

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute

payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the private warrant liabilities, the fair value of the Subscription Agreement, the fair value of the conversion liabilities, realization of deferred tax assets, and the fair value of the customer list acquired on February 9, 2024. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all operating accounts that hold money market funds held and short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

Trading Securities

Securities held in the Company’s trading account and trading securities, consist primarily of over-the-counter securities and are valued based upon quoted market prices. The value of securities that are not readily marketable are estimated by management based upon quoted prices, the number of market makers, trading volume and number of shares held. Unrealized gains and losses are reflected in income in the financial statements.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation on property and equipment is provided using accelerated and straight-line methods over expected useful lives of three to seven years.

Leases

In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability on the statement of financial condition for all leases with terms longer than 12 months. Pursuant to this standard, the Company has recorded an operating lease right-of use (“ROU”) asset and operating lease liability in the accompanying balance sheet as of June 30, 2024.

The Company leases office space under the terms of several operating leases. The determination of whether an arrangement is a lease is made at the lease’s inception. Under ASC 842, a contract is (or contains) a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Control is defined under the standard as having both the right to obtain substantially all of the economic benefits from use of the asset and the right to direct the use of the asset. Management only reassesses its determination if the terms and conditions of the contract are changed.

ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses the implicit rate when it is readily determinable. Since the Company’s leases do not provide implicit rates, to determine the present value of lease payments, management uses the Company’s estimated incremental borrowing rate based on the information available at lease commencement.

Goodwill

Goodwill represents the excess of purchase price in a business combination over the fair value of the net identifiable assets acquired. We evaluate goodwill for impairment at the reporting unit level by assessing whether it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If this assessment concludes that it is more likely than not that the fair value of a reporting unit exceeds its carrying value, then goodwill is not considered impaired and no further impairment testing is required. Conversely, if the assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, a goodwill impairment test is performed to compare the fair value of the reporting unit to its carrying value. The Company determines fair value of the reporting unit using income models. Our models contain significant assumptions and accounting estimates about discount rates, future cash flows, that could materially affect our operating results or financial position if they were to change significantly in the future and could result in an impairment. We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As of June 30, 2024, the fair value of goodwill was $7,706,725, as described in Note 11.

Intangible Assets

Intangible assets are presented at fair value, net of amortization. The fair value is determined based on the appraised value of the asset. Intangible assets comprise of developed technology and customer list (See Note 11 and 13). Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of June 30, 2024, the fair value of developed technology and customer list was $1,726,500 and $14,625,000, respectively, as described in Note 11 and Note 13.

Impairment of Long-lived and Intangible Assets

In accordance with ASC 360-10 Property Plant and Equipment and ASC 350-10 Intangibles, the Company, on a regular basis, reviews the carrying amount of long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. The Company determines if the carrying amount of a long-lived asset is impaired based on anticipated undiscounted cash flows, before interest, from the use of the asset. In the event of impairment, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the asset. Fair value is determined based on the appraised value of the assets or the anticipated cash flows from the use of the asset, discounted at a rate commensurate with the risk involved. The Company recorded $17,845,813 of impairment charges included in loss on AtlasClear asset acquisition during the six months ended June 30.

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 9).

Income Taxes

The Company utilizes the asset and liability method to account for income taxes. The objective of this method is to establish deferred tax assets and liabilities for the temporary differences between net income for financial reporting basis and the tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized.

Income tax expense or benefit is provided based upon the financial statement earnings of the Company. The allowance for doubtful accounts is deductible for financial statement purposes, but not for tax purposes. Depreciation expense is recognized in different periods for tax and financial accounting purposes due to the use of accelerated depreciation methods for income tax purposes. The tax effects of such differences are reported as deferred income taxes in the financial statements.

Revenue Recognition

Wilson-Davis, a subsidiary of the Company, recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, using the modified retrospective method. This revenue recognition guidance requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance requires an entity to follow a five-step model to: (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when the entity satisfies a performance obligation.

Wilson-Davis acts as an agent by selling securities to customers and collecting commissions. Wilson-Davis recognizes commissions on a trade date basis, which is the day the transaction is executed. Wilson-Davis believes that the performance obligation is satisfied on the trade date because that is when the security is selected, the price is determined, the trade is executed, and the risks and rewards of ownership have been transferred to/from the customer.

Wilson-Davis also receives commissions on mutual funds purchased by customers. Wilson-Davis believes that the performance obligation is not satisfied until the mutual funds are purchased by customers and recognizes the commission at that time.

Wilson-Davis performs vetting services to customers that wish to convert restricted stock to eligible trading stock. In addition, Wilson-Davis charges clearing fees to another broker-dealer for which it clears trades. Wilson-Davis recognizes revenue as the related performance obligations are satisfied.

Common Stock Subject to Possible Redemption

The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Common Stock subject to mandatory redemption are classified as a liability instrument and is measured at fair value. Conditionally redeemable Common Stock (including Common Stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Common Stock is classified as stockholders’ equity. The Company’s Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all Common Stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. The accretion of redeemable Common Stock during the year ended December 31, 2023 was an increase of $4,008,446, which represents cumulative earnings and withdrawals on the Trust Account through December 31, 2023, net of reimbursable income and franchise tax obligations as of December 31, 2023. The dissolution expense of $100,000 is not included in the redemption value of the Common Stock subject to redemption since it is only taken into account in the event of the Company’s liquidation. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Common Stock resulted in charges against additional paid-in capital, to the extent available, and accumulated deficit. On February 9, 2024, the shareholders redeemed in connection with the business combination $53,947,064, the company withdrew $68,418 from trust to cover income tax payments and recognized reclassified the unredeemed shares to permanent equity of 1,195,566. As of June 30, 2024 the Company no longer has redeemable shares.

At June 30, 2024, December 31, 2023 and 2022, the Common Stock reflected in the balance sheets is reconciled in the following table:

Common Stock subject to possible redemption, December 31, 2021

    

$

201,250,000

Plus:

  

Accretion of carrying value to redemption value

2,170,202

Common Stock subject to possible redemption, December 31, 2022

 

203,420,202

Less:

 

  

Redemption

 

(152,810,179)

Plus:

 

  

Accretion of carrying value to redemption value

 

4,008,446

Common Stock subject to possible redemption, December 31, 2023

$

54,618,469

Less:

 

  

Redemption

 

(53,947,064)

Withdraw for taxes

 

(68,416)

Reclass to permanent equity

 

(1,195,566)

Plus:

 

  

Accretion of carrying value to redemption value

 

592,577

Common Stock subject to possible redemption, June 30, 2024

$

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the convertible derivative liability, subscription agreement, earnout shares nor the warrants issued and outstanding. The calculation excludes the dilutive impact of these instruments because the issuance of the securities underlying the exercise of the warrants are contingent upon the occurrence of future events and inclusion would be antidilutive. As a result, diluted net (loss) income per share of common stock is the same as basic net (loss) income per common stock for the periods presented.

The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):

    

FOR THE SIX MONTHS PERIOD ENDED

FOR THE YEAR ENDED

June 30, 2024

December 31, 2023

December 31, 2022

    

Non-

    

    

Non-

    

Non-

Redeemable

    

 redeemable

    

Redeemable

    

 redeemable

    

Redeemable

    

 Redeemable

Basic and diluted net income (loss) per share of Common Stock

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Net loss

$

(11,279,605)

$

(108,927,342)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Deemed dividend

(15,422,431)

Allocation of net income (loss)

$

(11,279,605)

$

(124,349,773)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Denominator:

 

 

 

 

Basic and diluted weighted average shares outstanding

 

10,719,043

 

1,109,975

6,898,644

5,031,250

 

20,125,000

 

5,031,250

Basic and diluted net income (loss) per share of Common Stock

$

(10.16)

$

(11.60)

$

0.07

$

0.07

$

0.44

$

0.44

Below is a summary of the dilutive instruments as of June 30, 2024, December 31, 2023 and, these were excluded as including them would be anti dilutive as of June 30, 2024 and were excluded in December 31, 2023 and June 30, 2023 as the exercise was contingent:

For the Six Months Ended

For the year ended

Description

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Shares issuable pursuant to Short Term and Long Term Notes

 

14,012,965

 

Shares issuable pursuant to Secured convertible note

 

9,801,273

 

Shares issuable pursuant to Convertible note

4,722,875

Shares issuable pursuant to Subscription agreement

938,967

Shares issuable pursuant to Promissory note

 

379,375

 

Total Shares issuable under Note obligations

 

29,855,455

 

Public Warrants

 

10,062,500

 

10,062,500

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

6,153,125

Secured convertible note warrants

 

600,000

 

Total dilutive

 

46,071,080

 

16,215,625

16,215,625

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for warrant liabilities, convertible derivatives and the earnout out liability (see Note 19).

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

v3.24.4
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS    
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS

NOTE 3. CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS

Wilson-Davis is required by Rule 15c3-3 of the SEC to maintain a cash reserve with respect to customers’ transactions and credit balances, on a settlement date basis. Such a reserve is computed weekly using a formula provided by the rule, and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of September 30, 2024, was calculated to be $18,830,537. Wilson-Davis had $19,667,586 cash which was $837,049 more than the amount required. On October 1, 2024, Wilson-Davis withdrew $337,049 from the reserve account in accordance with the rule, which resulted in an excess of $500,000.

Wilson-Davis is required by Rule 15c3-3 of the SEC to maintain a cash reserve with respect to broker-dealer transactions and credit balances. Such a reserve is computed weekly using a formula provided by the rule, and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of September 30, 2024, was calculated to be $100,000. Wilson-Davis had $200,000 cash on deposit in the reserve account, which was $100,000 more than the amount required.

NOTE 3. CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS

The Wilson-Davis is required by Rule 15c3-3 of the Securities and Exchange Commission to maintain a cash reserve with respect to customers’ transactions and credit balances, on a settlement date basis. Such a reserve is computed weekly using a formula provided by the rule and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of June 30, 2024, was calculated to be $19,326,300. Wilson-Davis had $19,677,378 cash on deposit in the reserve account, which was $351,078 more than the amount required. On July 1, 2024, Wilson-Davis deposited $150,000 to the reserve account in accordance with the rule which resulted in an excess of $501,078.

Wilson-Davis is required by Rule 15c3-3 of the Securities and Exchange Commission to maintain a cash reserve with respect to broker-dealer transactions and credit balances. Such a reserve is computed weekly using a formula provided by the rule and the reserve account must be separate from all other bank accounts of Wilson-Davis. The required reserve as of June 30, 2024, was calculated to be $100,000. Wilson-Davis had $200,738 cash on deposit in the reserve account, which was $100,738 more than the amount required.

v3.24.4
NET CAPITAL REQUIREMENTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
NET CAPITAL REQUIREMENTS    
NET CAPITAL REQUIREMENTS

NOTE 4. NET CAPITAL REQUIREMENTS

As a broker-dealer, Wilson-Davis is subject to the uniform net capital rule adopted and administered by the SEC. The rule requires maintenance of minimum net capital and prohibits a broker-dealer from engaging in securities transactions at a time when its net capital falls below minimum requirements, as those terms are defined by the rule. Under the alternative method permitted by this rule, net capital shall not be less than the greater of $250,000 or 2% of aggregate debit items arising from customer transactions, as defined. Also, Wilson-Davis has a minimum requirement based upon the number of securities markets that it maintains. On September 30, 2024, Wilson-Davis’s net capital was $10,449,178, which was $10,199,178 in excess of the minimum required.

NOTE 4. NET CAPITAL REQUIREMENTS

As a broker dealer, the Company is subject to the uniform net capital rule adopted and administered by the Securities and Exchange Commission. The rule requires maintenance of minimum net capital and prohibits a broker dealer from engaging in securities transactions at a time when its net capital falls below minimum requirements, as those terms are defined by the rule. Under the alternative method permitted by this rule, net capital shall not be less than the greater of $250,000 or 2% of aggregate debit items arising from customer transactions, as defined. Also, the Company has a minimum requirement based upon the number of securities’ markets that the Company maintains. At June 30, 2024, the Company’s net capital was $10,437,312 which was $10,187,312 in excess of the minimum required

v3.24.4
CASH AND RESTRICTED CASH
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CASH AND RESTRICTED CASH    
CASH AND RESTRICTED CASH

NOTE 5 – CASH AND RESTRICTED CASH

Reconciliation of cash and restricted cash as shown in the condensed statements of cash flows is presented in the table below:

    

For the Three Months

Ended 

September 30, 2024

Cash and cash equivalents

$

6,817,398

Cash segregated - customers

 

19,980,711

Cash segregated - PAB

 

768,767

Total cash and restricted cash shown in the statement of cash flows.

$

27,566,876

NOTE 5 – CASH AND RESTRICTED CASH

Reconciliation of cash and restricted cash as shown in the statements of cash flows is presented in the table below:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Cash and cash equivalents

$

6,558,176

$

619,554

$

129,560

Cash segregated - customers

 

20,548,972

 

 

Cash segregated - PAB

 

200,738

 

 

Total cash and restricted cash shown in the statement of cash flows.

$

27,307,886

$

619,554

$

129,560

v3.24.4
CUSTOMER RECEIVABLE AND PAYABLES
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CUSTOMER RECEIVABLE AND PAYABLES    
CUSTOMER RECEIVABLE AND PAYABLES

NOTE 6 – CUSTOMER RECEIVABLE AND PAYABLES

Accounts receivable from and payable to customers at September 30, 2024, include cash and margin accounts. Securities owned by customers are held as collateral for any unpaid amounts. Such collateral is not reflected in the financial statements. The Company provides an allowance for doubtful accounts, as needed, for accounts in which collection is uncertain. Management periodically evaluates each account on a case-by-case basis to determine impairment. Accounts that are deemed uncollectible are written off to bad debt expense. Bad debt expense net of bad debt recoveries and trading error adjustments for the three-month period ended September 30, 2024 was $639 and $15,000 for the transition period ended June 30, 2024.

NOTE 7 – CUSTOMER RECEIVABLE AND PAYABLES

Accounts receivable from and payable to customers at June 30, 2024, include cash and margin accounts. Securities owned by customers are held as collateral for any unpaid amounts. Such collateral is not reflected in the financial statements. The Company provides an allowance for doubtful accounts, as needed, for accounts in which collection is uncertain. Management periodically evaluates each account on a case-by-case basis to determine impairment. Accounts that are deemed uncollectible are written off to bad debt expense. Bad debt expense net of bad debt recoveries and trading error adjustments for the six months period ended June 30, 2024 was $15,000 and zero for the year ended December 31, 2023 and December 31, 2022.

v3.24.4
PROPERTY AND EQUIPMENT
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
PROPERTY AND EQUIPMENT    
PROPERTY AND EQUIPMENT

NOTE 7 – PROPERTY AND EQUIPMENT

Depreciation expense for the three-month period ended September 30, 2024, was $4,569. The Company acquired the below on February 9, 2024, in connection with the acquisition of Wilson-Davis, see Note 10 for further detail. Property and equipment are summarized by major classifications as follows:

    

September 30, 2024

Equipment

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(364,537)

$

11,511

NOTE 8 – PROPERTY AND EQUIPMENT

Depreciation expense for the six-month period ended June 30, 2024, was $7,565. The Company acquired the below on February 9, 2024, in connection with the closing of the business combination with Wilson-Davis, see Note 11 for further detail. Property and equipment are summarized by major classifications as follows:

June 30, 2024

Equipment

      

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(359,968)

$

16,080

v3.24.4
RELATED PARTY TRANSACTIONS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
RELATED PARTY TRANSACTIONS    
RELATED PARTY TRANSACTIONS

NOTE 8. RELATED PARTY TRANSACTIONS

Related Party Share Issuance/Transfers

Quantum Ventures LLC (“Quantum Ventures” or the “Sponsor”) and AtlasFinTech transferred 1,558,923 and 991,665 shares, respectively for total contributed shares of 2,550,588 shares recorded as contributed capital for $2,412,930. The Company recorded contributed capital for the value of the liabilities settled with their personal shareholding. The contributed capital recognized was $21,299 in interest paid in shares for Promissory Notes, $217,397 in interest paid in shares for Secured Convertible Note, $400,000 of Principal converted under the Chardan convertible note along with $212,803 in interest paid in shares for the Chardan convertible note, $351,141 in interest paid in shares for Short and long term Notes and $1,210,290 for payment in shares under the contingent obligation to sellers.

On August 9, 2024, the Company entered into a Satisfaction of Discharge of indebtedness agreement with Atlas FinTech. Pursuant to the agreement the Company issued 2,788,276 shares in satisfaction of $803,860 included in accounts payable. In addition, the Company issued 1,337,500 shares as reimbursement for 991,665 shares that were transferred by AtlasFinTech, as stated above, to satisfy the Company requirements to pay interest on various loans with unrestricted shares. As such a total of 4,125,776 shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”) were transferred to Atlas FinTech in satisfaction.

Advances from Related Parties

Atlas FinTech, a related party and shareholder, incurred expenditures of $803,860 in connection with the business combination. The amount is included in account payable and accrued liabilities as of June 30, 2024. On August 9, 2024 the Company issued 2,788,276 shares to Atlas FinTech as full settlement of this payable as described above.

On May 9, 2024, Quantum Ventures, a related party transferred 56,073 shares to pay for the $47,750 of interest in connection with the short term sellers notes. The shares are to be reissued at a 13% interest rate, as such a payable of $55,087 was accrued.

NOTE 9. RELATED PARTY TRANSACTIONS

Founder Shares

On October 23, 2020, Quantum Ventures LLC (“Quantum Ventures”), an affiliate of the Company, purchased 4,312,500 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. In January 2021, Quantum Ventures sold 813,500 Founder Shares to Chardan Quantum LLC (“Chardan Quantum” and together with Quantum Ventures, the “Co-Sponsors”) and 35,000 Founder Shares to each of the Company’s directors and director nominees, for a total of 245,000 Founder Shares, in each case at the original price per share, resulting in Quantum Ventures holding a balance of 3,254,000 Founder Shares. On February 4, 2021, the Company effected a stock dividend of 718,750 shares with respect to its common stock, resulting in the initial stockholders holding an aggregate of 5,031,250 Founder Shares. The Founder Shares included an aggregate of up to 656,250 shares that were subject to forfeiture. As a result of the underwriters’ election to fully exercise their over-allotment option on February 12, 2021, no Founder Shares are currently subject to forfeiture.

At the time of the Initial Public Offering, the initial stockholders placed the Founder Shares into an escrow account maintained by Continental Stock Transfer & Trust Company until (1) with respect to 50% of the Founder Shares, the earlier of six months after the completion of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after a Business Combination and (2) with respect to the remaining 50% of the Founder Shares, six months after the completion of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. If the Company seeks stockholder approval in connection with a Business Combination, the Co-Sponsors have (a) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination.

The sale of the Founders Shares to the Company’s directors and director nominees is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 245,000 shares granted to the Company’s directors and director nominees was $1,462,650 or $5.97 per share. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of December 31, 2023, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense had been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. Since the transaction closed on February 9, 2024 the transaction was recognized as of February 9, 2024.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, Quantum Ventures or an affiliate of Quantum Ventures, or certain of the Company’s officers and directors loaned the Company funds as required (“Working Capital Loans”). Such Working Capital Loans were to be evidenced by promissory notes. The notes were to be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may have been converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Warrants.

On March 14, 2022, the Company issued an unsecured promissory note, effective as of January 3, 2022, in the amount of up to $480,000 to Quantum Ventures to evidence the Working Capital Loans. The note bore no interest and was payable in full upon the earlier (i) February 9, 2023 and (ii) the effective date of the consummation of an initial business combination. The note was required to be repaid in cash at the Closing and was not convertible into Private Warrants. As of December 31, 2023 and 2022, a principal balance of $480,000 had been advanced. The promissory note was past due as of December 31, 2023 and on February 9, 2024, upon the Closing of the Business Combination, the unsecured promissory note was settled with the issuance of 2,000,000 shares (see below.)

Advances from Related Parties

As of December 31, 2023 and 2022, the Co-Sponsors had advanced $3,104,097 and $319,166, respectively, to the Company. Through February 9, 2024, the Co-Sponsors advanced an additional $1,052,300 for an aggregate of $4,156,397 advanced to the Company and offset the balance by $58,828 in receivable from Co-Sponsor. On February 9, 2024, upon the Closing of the Business Combination, the advances from related party, the related party loan of $480,000 as described above and the $58,828 receivable from related party was settled with the issuance of 2,000,000 shares settling a total of $4,636,397 in liabilities and $58,828 in receivables . The value of the shares granted was based on $10 per share resulting in a deemed dividend to the related party of $15,422,431.

As of February 9, 2024 and as of June 30, 2024, AtlasFintech Holdings Corp (“AFHC”), a related party and shareholder, incurred expenditures of $803,860 in connection with the business combination. The amount is included in account payable and accrued liabilities. On August 9, 2024 the Company issued 2,788,276 shares to AFHC as full settlement of this payable.

On May 9, 2024 Quantum Ventures, a shareholder and related party transferred 56,073 shares to pay for the $47,750 of interest in connection with the short term sellers notes. The shares are to be reissued at a 13% interest rate, as such a payable of $55,087 was accrued.

v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES
3 Months Ended
Sep. 30, 2024
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES  
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES

NOTE 9. NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES

Registration Rights

The Company filed a registration statement on Form S-1 to register the resale of up to 77,577,099 shares of Common Stock by the selling stockholders named in the registration statement, which became effective on August 14, 2024. The Company will not receive any of the proceeds from these sales.

Business Combination Marketing Agreement

In connection with the Closing on February 9, 2024, the Company and Chardan agreed that the fee, in the amount of $7,043,750, payable by the Company to Chardan upon the Closing pursuant to the terms of the business combination marketing agreement entered into in

connection with Quantum’s initial public offering, would be waived in exchange for the issuance by the Company to Chardan of a convertible promissory note in the aggregate principal amount of $4,150,000. Such note (the “Original Chardan Note”) was issued by the Company at the Closing. Under ASC 815 the conversion feature was bifurcated resulting in a conversion liability of $404,483 at issuance.

During the three-month period ended September 30, 2024, the Company received conversion notices for an aggregate principal amount of $725,000, and received a total of 2,263,031 shares of Common Stock, of which 366,750 were registered shares transferred from Quantum Ventures and 127,159 were registered shares transferred from Atlas FinTech, (see Note 8 above), and 1,769,122 were newly issued registered shares. During the three-month period ended September 30, 2024, the Company recognized $137,872 in interest expense on the principal and $86,209 of interest related to the amortization of the debt discount created with the derivative liability. During the three-month period ended September 30, 2024, Quantum Ventures transferred 145,606 and Atlas fintech transferred 52,590 registered shares to pay for accrued interest of $212,803. As of September 30, 2024, the principal balance on the note is $3,425,000 and $137,872 in accrued interest net of $280,355 of unamortized debt discount for total carrying balance of $3,282,518. See Note 14 for additional information on the fair value and change in fair value related to the derivative.

The Original Chardan Note had a stated maturity date of February 9, 2028. Interest accrued at a rate per annum equal to 13%, and was payable quarterly on the first day of each calendar quarter. On each interest payment date, the accrued and unpaid interest was to be, at the election of the Company, either paid in cash or, subject to the satisfaction of certain conditions, in shares of Common Stock, at a rate equal to 85% of the VWAP for the trading day immediately prior to the applicable interest payment date. The Chardan Note was convertible, in whole or in part, into shares of Common Stock at the election of the holder at any time at a conversion price equal to 85% of the VWAP of the Common Stock for the trading day immediately preceding the applicable conversion date. In addition, on each conversion date the Company was required to pay to Chardan in cash (or, at the Company’s option and subject to certain conditions, a combination of cash and Common Stock) all accrued interest on the Original Chardan Note and all interest that would have otherwise been accrued on the amount of the Original Chardan Note being converted if such converted amount would be held to three years after the applicable conversion date. Conversion of the Original Chardan Note, including the issuance of shares to pay interest thereon, was limited to the extent that such conversion would result in Chardan (together with its affiliates and any other persons acting as a group together with Chardan or its affiliates) beneficially owning in excess of 9.99% of the outstanding shares of Common Stock outstanding immediately prior to such conversion. The conversion price applicable to the Original Chardan Note was subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and was subject to price-based adjustment, on a “full ratchet” basis, in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for, Common Stock at a price below the then-applicable conversion price (subject to certain exceptions). The Original Chardan Note was subject to a demand for immediate repayment in cash upon the occurrence of certain events of default specified therein.

Also on February 9, 2024, the Company entered into a registration rights agreement with Chardan (the “Chardan Registration Rights Agreement”), pursuant to which the Company agreed, among other things, to file with the SEC within 45 days after the Closing Date a registration statement registering the resale of the shares of Common Stock issuable upon exercise of the Original Chardan Note and to use its reasonable best efforts to have such registration statement declared effective as soon as possible after filing. If the registration statement was not filed within 45 days after the Closing or was not effective within a specified period after the Closing (or if effectiveness is subsequently suspended or terminated for at least 15 days, subject to certain exceptions), then the interest rate of the Original Chardan Note increased by 2% for each week that such event continued. The Chardan Registration Rights Agreement also provided that the Company was obligated to file additional registration statements under certain circumstances, and provided Chardan with customary “piggyback” registration rights.

On May 7, 2024, Chardan Capital Markets LLC (“Chardan”) filed a complaint in the Court of Chancery of the State of Delaware in an action entitled Chardan Capital Markets LLC v. AtlasClear Holdings, Inc., C.A. No. 2024-0480-LWW, for alleged breach of contract, breach of the implied covenant of good faith and fair dealing, and specific performance, alleging that the Company breached the Chardan Registration Rights Agreement, by failing to file a registration statement with the SEC to permit the public resale of certain registerable securities in an amount sufficient to cover the Original Chardan Note. Chardan alleged that the Company’s failure to file the registration statement left Chardan without the ability to convert and sell shares of the Company’s Common Stock as allowed for under the Original Chardan Note.

On October 23, 2024, the Company, Quantum Ventures, Chardan and Chardan Quantum LLC entered into an agreement pursuant to which they settled the claim referenced above, and any and all related claims (the “Settlement Agreement”). In connection with the

Settlement Agreement, Chardan exchanged the Original Chardan Note for an amended non-interest bearing, convertible note in the aggregate principal amount of $5,209,764 (as amended the “Chardan Note”). While the Chardan Note does not bear interest, it can be converted from time to time by Chardan into shares of Common Stock, on terms substantially similar to the conversion provisions in the Original Chardan Note, and any remaining outstanding principal is to be repaid in full on the same maturity date as the Original Chardan Note. (see Note 15 Subsequent Events for additional information).

Expense Settlements

Carriage House Capital, Inc. – up to 350,000 shares of Common Stock that were issued, or may become issuable, to Carriage House Capital, Inc. (“Carriage”), pursuant to the Consulting Agreement, dated as of February 19, 2024, between Carriage and the Company (the “Carriage Agreement”), as partial consideration for consulting services rendered to the Company, at the price per share of $4.98 on the day of issuance. The total consideration due under the Consulting Agreement is 350,000 shares of Common Stock, 100,007 shares of which were due upon signing of the contract and 27,777 shares of which are due in months four through twelve from the date of signing. On February 9, 2024, 100,000 shares were issued, and were valued at $4.98 per share as agreed upon consideration. The Stock payable for the remaining 250,000 shares was valued at $1,244,965 and recorded as a stock payable. As of September 30, 2024 and June 30, 2024 the fair value of the 250,000 stock payable was $63,742 and $259,893, respectively. The shares were valued at the closing price of the ATCH trading shares on September 30, 2024 and June 30, 2024 using a level 1 measurements. As a result, the company recognized $196,150 in the change in fair value related to the Stock Payable during the three-months period ended September 30, 2024.
Interest Solutions, LLC – 144,454 shares of Common Stock that may become issuable to Interest Solutions, LLC (“Interest Solutions”), pursuant to a convertible promissory note, dated as of February 9, 2024, in the aggregate principal amount of $275,000 (the “Interest Solutions Note”) at a price per share of $2.00. Accrued interest on the Interest Solutions Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum. Until all payments have been made to the Wilson-Davis Sellers, interest on the Interest Solutions Note may be paid in cash or shares of Common Stock valued at the then-current conversion price. Thereafter, all accrued interest must be paid in cash. During the three-month period ended September 30, 2024 the company recognized $9,011 in interest expenses and the Quantum Ventures transferred 4,457 registered shares to pay for $9,011 in accrued interest. As of September 30, 2024 and June 30, 2024, there is $288,908 and $288,908 included in Promissory note payable.
JonesTrading Institutional Services LLC – up to 196,983 shares of Common Stock that may become issuable to JonesTrading Institutional Services LLC (“JonesTrading”), pursuant to a convertible promissory note, dated as of February 9, 2024, in the aggregate principal amount of $375,000 (the “JonesTrading Note”) at a price per share of $2.00. Accrued interest on the JonesTrading Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum. Until all payments have been made to the Wilson-Davis Sellers, interest on the Interest Solutions Note may be paid in cash or shares of Common Stock valued at the then-current conversion price. Thereafter, all accrued interest must be paid in cash. During the three-month period ended September 30, 2024 the Company recognized $12,288 in interest expenses and the Quantum Ventures transferred 6,077 registered shares to pay for $12,288 in accrued interest. As of September 30, 2024 and June 30, 2024, there is $393,966 and $393,966 included in Promissory note payable.
Toppan Merrill LLC – the Company issued to Toppan Merrill LLC (“Toppan”) a promissory note, dated as of February 9, 2024, in the aggregate principal amount of $160,025 (the “Toppan Note”). The maturity date of the Toppan Note is February 8, 2026 and the note accrues interest at a rate of 13% per annum. The principal and interest payments due under the note is not payable in shares of Common Stock. As of September 30, 2024 and June 30, 2024, there was $170,094 and $170,094, respectively, included in Promissory note payable.
Winston & Strawn LLP – up to $2,500,000 in shares of Common Stock that may become issuable to Winston & Strawn LLP (“Winston & Strawn”), pursuant to a subscription agreement, dated as of February 9, 2024, between Winston & Strawn and the Company (the “Winston & Strawn Agreement”). Pursuant to the Winston Agreement, the Company may issue $2,500,000 worth of shares of Common Stock as payment for legal services, in three equal installments of $833,333 beginning on August 9, 2024. As of September 30, 2024 and June 30, 2024, the amount is included in Subscription agreement as an liability of $2,460,488 and $2,425,647, respectively. Due to the nature of the settlement terms, the subreption agreement was deemed to be a derivative liability to the Company as of June 30, 2024 under ASC 480. Change in fair value of the subscription agreement
are measured at each reporting period with change reported in earnings. See valuation approach and further disclosure on Note 15.
Lead Nectar – up to 12,000 shares of Common Stock that may become issuable to Lead Nectar in lieu of payment for internet marketing services the fair value of the shares at grant date was $2,578.

Secured Convertible Note Financing

On February 9, 2024, Wilson-Davis and Quantum entered into a securities purchase agreement (the “Purchase Agreement”) with Funicular Funds, LP, a Delaware limited partnership (“Funicular”), pursuant to which the Company sold and issued to Funicular, on that date, a secured convertible promissory note in the principal amount of $6,000,000 (the “Funicular Note”) for a purchase price of $6,000,000, in a private placement (the “Secured Note Financing”). The proceeds raised in the Note Financing were used to pay a portion of the purchase price paid at Closing to the Wilson-Davis Sellers.

The Funicular Note has a stated maturity date of November 9, 2025. Interest accrues at a rate per annum equal to 12.5%, and is payable semi-annually on each June 30 and December 31. On each interest payment date, the accrued and unpaid interest shall, at the election of the Company in its sole discretion, be either paid in cash or paid in-kind by increasing the principal amount of the Funicular Note. In the event of an Event of Default (as defined in the Funicular Note), in addition to Funicular’s other rights and remedies, the interest rate would increase to 20% per annum. The Funicular Note is convertible, in whole or in part, into shares of Common Stock at the election of the holder at any time at an initial conversion price of $10.00 per share (the “Conversion Price”). The Conversion Price is subject to adjustment monthly to a price equal to the trailing five-day VWAP, subject to a floor of $2.00 per share (provided that if the Company sells stock at an effective price below $2.00 per share, such floor would be reduced to such effective price), and is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like. The Company has the right to redeem the Funicular Note upon 30 days’ notice after the earlier of August 7, 2024 and the effectiveness of the Registration Statement (as defined in the Funicular Note), and Funicular would have the right to require the Company to redeem the Note in connection with a Change of Control (as defined in the Note), in each case for a price equal to 101% of the outstanding principal amount of the Note plus accrued and unpaid interest. The Funicular Note contains covenants which, among other things, limit the ability of the Company and its subsidiaries to incur additional indebtedness, incur additional liens and sell its assets or properties.

As a result of the delay in filing the registration statement the Company incurred $1,500,000 in fees through June 30, 2024 which has been added to the principal of the note. As of June 30, 2024, the Company recognized $328,767 in interest expense on the principal and $279,032 of interest related to the amortization of the debt discount described above. As of June 30, 2024 the carrying value of the notes is $6,857,101 net of discount of $971,666.

As of September 30, 2024, the company recognized $246,660 in interest expense on the principal and $180,085 of interest related to the amortization of the debt discount described above. As of September 30, 2024, the carrying value of the notes is $7,066,449, net of discount of $791,581. During the three month period the Quantum Ventures transferred 368,004 registered shares to pay for accrued interest of $217,373.

As a result of the Company’s lack of authorized shares to satisfy its share obligations, the note now falls under ASC 815 and is required to be accounted for at fair value with change in fair value recorded in the statement of operations. See valuation approach and further disclosure on Note 14.

Sellers Note

As a result of the acquisition of Wilson-Davis the company issued (i) $5,000,000 in aggregate principal amount of notes due 90 days after the Closing Date (the “Short-Term Notes”) and (ii) $7,971,000 in aggregate principal amount of notes due 24 months after the Closing Date (the “Long-Term Notes” and, together with the Short-Term Notes, the “Seller Notes”). The Short-Term Notes accrue interest at a rate of 9% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, cash), and are convertible at the option of the holder at any time during the continuance of an event of default, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion. The Long-Term Notes accrue interest at a rate of 13% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, in cash), and are convertible at the option

of the holder at any time commencing six months after the Closing Date, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion (or 85% if an event of default occurs and is continuing).

During the three-month ended September 30, 2024, the Company received conversion notice for a total $359,896 in short term loan principal and $7,530 of short term loan interest, receiving a total of 1,862,116 shares of common stock newly issued registered shares. During the three-months ended September 30, 2024, the company recognized $158,333 in interest expense on the short-term principal, $259,063 in interest expense on the long-term principal and $99,890 of interest related to the amortization of the debt discount on long-term loan created with the derivative liability. During the three month period the Quantum Ventures transferred 368,004 registered shares to pay for accrued interest of $92,083 on short-term loan and $259,058 on long-term loan. As of September 30, 2024 the Principal balance on the short-term loan is $4,640,104 and $150,803 in accrued interest net of $0 of unamortized debt discount for total carrying balance of $4,790,907 in short-term loans. As of September 30, 2024 the Principal balance on the long-term loan is $7,971,197 and $259,064 in accrued interest net of $521,646 of unamortized debt discount for total carrying balance of $7,708,615 in long-term loans.

Contingent Guarantee

In connection with the acquisition of Wilson-Davis, Founder shares were transferred to cover a cash deficit of $6,000,000. The share have a make-whole provision that require to be accounted for under ASC 480. The Company has valued the obligation as of June 30, 2024 of $3,256,863 based on the cash value that would need to be renumerated by the Company. The value of the cash that would be paid was deemed to be the fair value of the contingent guarantee. The Company analyzed the public sales of the shares transferred to determine the amount of cash recovered less the $4,000,000 contingent guarantee resulting in a liability due of $3,256,863. As of February 9, 2024 the 885,010 shares transferred by the Founder were valued at $8,850,100 which was greater than the $4,000,000 guaranteed value as such the value of the guarantee was deemed to be zero on February 9, 2024. As a result of the decrease in stock prices through June 30, 2024 the Sellers have recovered $743,137 in cash through sales of the shares transferred resulting in the value of the liability as of June 30, 2024 to be $3,256,863.

During the three-month period ended September 30, 2024, the Atlas FinTech agreed to transfer 1,234,990 in registered shares to the sellers under the contingent guarantee, resulting in a reduction in the contingent guarantee of $1,210,290 based on the fair value of the shares transferred on the transfer date.

On August 9, 2024, the Company entered into an agreement to modify the terms of the contingent guarantee where the Company agreed to enter into a convertible note on the amount that has not yet been recovered through share issuances of $2,886,347 plus a 5% convenience fee applied resulting in the Company issuing a convertible note of $3,030,665. This Convertible Promissory Note (this “Merger Financing”) is being issued pursuant to that certain Post-Closing Agreement dated effective August 9, 2024 (the “Agreement”), by and between the Company and the former stockholders of Wilson-Davis, to address the remaining Gross Proceeds Shortfall that cannot be remedied by the transfer of Additional Shares. Capitalized terms used but not defined herein shall have the meanings given to them in the Stock Purchase Agreement, as defined in the Agreement. The note was analyzed under ASC 480 and ASC 815, as a result of the Company not having sufficient shares authorized to settled the convertible note, the Merger Financing note falls under ASC 815.

Under ASC 815 the conversion feature was bifurcated resulting in a conversion liability of $113,044 for the Merger Financing and at issuance. As of September 30, 2024, the Company recognized $56,909 in interest expense on the principal and $10,707 of interest related to the amortization of the debt discount created with the derivative liability. See Note 14 for additional information on the fair value of the derivative.

Tau Agreement - ELOC

On July 31, 2024, the Company and Tau Investment Partners LLC (“Tau”) entered into an at-the-market agreement (the “ELOC”). Pursuant to the ELOC, upon the terms of and subject to the satisfaction of certain conditions, the Company has the right from time to time at its option to direct Tau to purchase up to a specified maximum amount of shares of the Common Stock, up to a maximum aggregate purchase price of $10 million (the “Aggregate Limit”), over a 24-month term commencing on the date of the ELOC. The Company may request, on dates determined by it, individual advances up to the greater of 100,000 shares or such amount as is equal to 50% of the average daily volume traded of the Common Stock during the 30 trading days immediately prior to the date the Company requests each advance, subject to the Aggregate Limit. Any such advance will reduce amounts that the Company can request for future advances and draw downs. The purchase price payable for the shares sold pursuant to any advance will be equal to 97% of the lowest

volume weighted average price of the Common Stock during a pricing period of three consecutive trading days following Tau’s receipt of the applicable advance notice. Tau’s obligation to purchase the shares the Company requests to sell pursuant to any advance is conditioned upon, in addition to certain other customary closing conditions, the continued effectiveness of a registration statement pursuant to which Tau may freely sell the shares to be received.

The issuance and sale of the shares of Common Stock pursuant to the ELOC will be exempt from the registration requirements of the Securities Act of 1933, as amended, in accordance with Section 4(a)(2) thereof. The Company has agreed to file a registration statement with the Securities and Exchange Commission for the resale by Tau of at least 10,000,000 shares of Common Stock (the “Commitment Amount”).

The Company will sell to the Investor the Common Stock at a Purchase Price equal to 97% of the lowest VWAP of the Common Stock during a pricing period of 3 consecutive trading days commencing on the trading day the Advance Notice is received by the Investor. If the VWAP on any trading day during a pricing period under is below a minimum price set by the Company in connection with each Advance Notice (the “MAP”) then for each such trading day (i) the requested Advance amount shall automatically be reduced by an amount equal to 33% of the original requested Advance amount and (ii) such day shall not be factored into the determination of the Market Price.

The Company analyzed both the Commitment Amount and the Commitment fee under ASC 480 and ASC 815. The Commitment Amount is classified as a liability and is initially measured at fair value. The Commitment Amount is subsequently measured at fair value at each reporting period with subsequent changes in fair value recorded in earnings. ASC 815-40-35-8 through 35-9 require an issuer to reassess the classification of both freestanding equity contracts and embedded equity features at each balance sheet date. If the classification changes because of events occurring during the reporting period, the instrument is reclassified as of the date of the event that caused the reclassification.

As consideration the Company will issue to the Investor a fee equal to 1.25% of the Commitment Amount (the “Commitment Fee”) due in shares upon closing based on the closing price on the day prior to approval of the S-1. As the Commitment Fee is a variable share obligation within the scope of ASC 480, it must be initially and subsequently measured at fair value through earnings at each reporting period.

When estimating the fair value, the Company has followed the guidance in ASC 820 Fair Value Measurement.

As both the Commitment Amount and Commitment Fee were issued in a single transaction and are both remeasured to fair value through earnings in each subsequent reporting period, the proceeds received should be allocated to each freestanding financial instrument on a relative fair value basis. As such, as of September 30, 2024 the Company requested advance notices for a total of $441,524 which resulted in approximately 2,310,000 shares to be issued. The Company recorded the initial fair value of the Commitment Amount at $391,017 and the Commitment Fee at $50,506 for total receivable under the ELOC of $441,524. The receivable under the Commitment Amount for the advances is $169,084 as of September 30, 2024.

The Company then recognized a day one charge to earning to record the Commitment Amount and the Commitment Fee at fair value at issuance of $575,136 and $74,289 reflecting an initial fair value of $966,153 for the Commitment Amount and $124,796 for the Commitment Fee liability.

Tau sold and settled 1,445,527 of the shares which were issued under the ELOC resulting in realized sale of $303,001, Tau purchased the shares for $272,440 resulting in a realized gain to the Company of $30,562. As a result, the Company has a subscription receivable of $154,619 and received $148,382 in cash proceeds under the ELOC.

There are 864,473 shares which have not yet been settled which were fair valued as of September 30, 2024 resulting in a change in the fair value of the Commitment amount of $229,407 and a change in the fair value of the Commitment fee of $44,848. See Note 14 for additional information regarding the fair value method and related disclosures. See foot Note 14 for additional disclosures.

Indemnification Agreements

On the Closing Date, in connection with the Closing, the Company entered into indemnification agreements with each of its directors and executive officers, which provide for indemnification and advancements by the Company of certain expenses and costs under certain circumstances. The indemnification agreements provide that AtlasClear Holdings will indemnify each of its directors and executive officers against any and all expenses incurred by that director or executive officer because of his or her status as a director or officer of AtlasClear Holdings, to the fullest extent permitted by Delaware law, the Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws.

Wilson-Davis

On February 27, 2018, an extended hearing panel of the Department of Enforcement of the Financial Industry Regulatory Authority, Inc. (“FINRA”), Office of Hearing Officers, issued its decision ordering fines aggregating $1.47 million for violations of the applicable short sales and anti-money laundering rules. Wilson-Davis appealed the decision to the National Adjudicatory Council (“NAC”). On December 19, 2019, NAC issued its decision ordering that the fines be reduced by $205,000 to an aggregate $1.265 million. Wilson-Davis made a timely appeal to the SEC to hear the case. Pursuant to FINRA rules, Wilson-Davis’s timely appeal of the decision to the SEC deferred the effectiveness of the findings and sanctions. Due to the disparity in the range of fines of similar cases, Wilson-Davis believes that the final amount is not reasonably estimable. Wilson-Davis has booked a contingent liability totaling $100,000, which represents the estimated low end of the possible range of fines. On December 28, 2023, the SEC issued an Opinion sustaining FINRA’s findings of violations against Wilson-Davis. The Opinion set aside the fines FINRA imposed on Wilson-Davis for the Reg SHO violations and the supervisory and AML violations. The SEC remanded the case to FINRA to reconsider the appropriate sanctions.

v3.24.4
ACQUISITION OF WILSON-DAVIS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
ACQUISITION OF WILSON-DAVIS    
ACQUISITION OF WILSON-DAVIS

NOTE 10. ACQUISITION OF WILSON-DAVIS

Prior to the Closing, AtlasClear and the Company entered into two amendments to the Broker-Dealer Acquisition Agreement with Wilson-Davis and the then-owners of Wilson-Davis.

As a result of the closing of the business combination the Company allocated the purchase price with the acquisition of Wilson-Davis under the acquisition method of accounting. The final allocation of the purchase consideration for the Mergers will be determined after the completion of a thorough analysis to determine the fair value of all assets acquired and liabilities assumed, but in no event later than one year following the completion of the Mergers. During the quarter ended the Company revised the deferred tax liabilities that resulted from the business combination, thus reducing the goodwill value.

As such the allocation of the purchase price is revised as follows:

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(3,724,270)

Trading Account deposit

 

(100,000)

Net assets acquired

 

6,296,241

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

20,767,525

The fair value of property and equipment was determined using the indirect cost approach which utilizes fixed asset record information including historical costs, acquisition dates, and asset descriptions and applying asset category specific nationally recognized indices to the historical cost of each asset to derive replacement cost new less depreciation. Management has also made the initial determination that all other assets and liabilities to be acquired are primarily estimated to be stated at their fair values, which approximates their recorded cost. While a final determination of the value of the identifiable intangibles has not been completed, management has made an initial determination that approximately $20.77 million of the excess of the purchase price over the net assets acquired should be allocated to identifiable intangible assets.

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

20,767,525

 

Goodwill

$

6,142,525

 

(a)The Wilson-Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

Pro Forma Financial Information

The unaudited pro forma financial information in the table below summarizes the combined results of Wilson-Davis operations and AtlasClear Holdings’ operations, as though the acquisition of Wilson-Davis had been completed as of the beginning of fiscal 2023. The

pro forma financial information for the three months ended September 30, 2023 combines our results for these periods with that of AtlasClear Holdings’ results for the three months ended September 30, 2023.

The following table summarizes the unaudited pro forma financial information:

    

September 30, 2023

Total revenue

$

1,834,164

Net loss

$

(1,575,799)

Weighted average shares

 

  

Basic

 

11,801,759

Net loss per shares:

 

  

Basic

$

(0.13)

Weighted average shares

 

  

Diluted

 

11,801,759

Net loss per shares:

 

  

Diluted

$

(0.13)

The unaudited pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition and the cost of financing the acquisition had taken place at the beginning of fiscal 2023. The financial information for the periods presented above includes pro forma adjustments as follows:

    

September 30, 2023

Transaction cost

$

Amortization of intangibles

$

(307,192)

Interest earned on investments held in trust

$

(722,390)

NOTE 11. ACQUISITION OF WILSON-DAVIS

Prior to the Closing, AtlasClear and the Company entered into two amendments to the Broker-Dealer Acquisition Agreement with Wilson-Davis and the then-owners of Wilson-Davis (the “Wilson-Davis Sellers”), Amendment No. 8 dated January 9, 2024 (“Amendment No. 8”) and Amendment No. 9 dated February 7, 2024 (“Amendment No. 9” and, together with Amendment No. 8, the “Amendments”). Among other things, the Amendments reduced the total purchase price payable under the Broker- Dealer Acquisition Agreement by $5 million and reduced the cash payable at the Wilson-Davis Closing as part of the purchase price to $8 million, with the balance of the purchase price paid in the form of convertible promissory notes issued by AtlasClear to the Wilson-Davis Sellers, as follows: (i) $5,000,000 in aggregate principal amount of notes due 90 days after the Closing Date (the “Short-Term Notes”) and (ii) $7,971,000 in aggregate principal amount of notes due 24 months after the Closing Date (the “Long-Term Notes” and, together with the Short-Term Notes, the “Seller Notes”). The Short-Term Notes accrue interest at a rate of 9% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, cash), and are convertible at the option of the holder at any time during the continuance of an event of default, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion. The Long-Term Notes accrue interest at a rate of 13% per annum, payable quarterly in arrears, in shares of Common Stock at a rate equal to 90% of the trailing seven-trading day VWAP prior to payment (or, at the Company’s option, in cash), and are convertible at the option of the holder at any time commencing six months after the Closing Date, at a rate equal to 90% of the trailing seven-trading day VWAP prior to conversion (or 85% if an event of default occurs and is continuing). As of May 9, 2024 the short-term notes became due, as such the interest rate increase to 13% per annum, payable quarterly in arrears.

Pursuant to the terms of the Amendments, at the closing of the transactions contemplated by the Broker-Dealer Acquisition Agreement (the “Wilson-Davis Closing”) the Company entered into a parent guaranty and registration rights agreement with the Wilson-Davis Sellers (the “Wilson-Davis Guaranty and RRA”), pursuant to which the Company guaranteed the obligations of AtlasClear under the Notes.

The Sponsor also entered into Amendment No. 9, for the limited purpose of agreeing to transfer certain Founder Shares owned by the Sponsor to the Wilson-Davis Sellers. The Sponsor agreed to transfer to the Wilson-Davis Sellers, at the Wilson-Davis Closing, Founder Shares having an aggregate value of $6 million, based on the VWAP of Quantum Common Stock for the five trading days immediately prior to the Wilson-Davis Closing, which resulted in the transfer of an aggregate of 885,010 Founder Shares at the Closing to cover the cash deficit of $4,000,000 and $2,000,000 bonus paid as consideration. The share transfer from Founder was accounted for as contributed capital and recorded in additional paid in capital. From time to time prior to the six month anniversary of the Closing, the Sponsor may be required to transfer additional Founder Shares to the Wilson-Davis Sellers, as set forth in Amendment No. 9, provided that in no event will the Sponsor be required to transfer more than an aggregate of 2,500,000 Founder Shares (including the Founder Shares transferred at the Closing).

As a result of the closing of the business combination the Company allocated the purchase price with the acquisition of Wilson-Davis under the acquisition method of accounting. The final allocation of the purchase consideration for the Mergers will be determined after

the completion of a thorough analysis to determine the fair value of all assets acquired and liabilities assumed, but in no event later than one year following the completion of the Mergers.

Accordingly, the final acquisition accounting adjustments could differ. The preliminary allocation of the purchase price is as follows:

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(5,288,470)

Trading Account deposit

 

(100,000)

Net assets acquired

 

4,732,041

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

22,331,725

The fair value of property and equipment was determined using the indirect cost approach which utilizes fixed asset record information including historical costs, acquisition dates, and asset descriptions and applying asset category specific nationally recognized indices to the historical cost of each asset to derive replacement cost new less depreciation. Management has also made the initial determination that all other assets and liabilities to be acquired are primarily estimated to be stated at their fair values, which approximates their recorded cost. While a final determination of the value of the identifiable intangibles has not been completed, management has made an initial determination that approximately $20.77 million of the excess of the purchase price over the net assets acquired should be allocated to identifiable intangible assets.

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

22,331,725

 

Goodwill

$

7,706,725

 

(a)

The Wilson Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

Pro Forma Financial Information

The unaudited pro forma financial information in the table below summarizes the combined results of Wilson-Davis operations and AtlasClear Holdings’s operations, as though the acquisition of Wilson Davis had been completed as of the beginning of fiscal 2022. The pro forma financial information for the six months ended June 30, 2024, and for the years ended December 31, 2023, and 202 combines our results for these periods with that of AtlasClear Holdings’s results for the six months ended June 30, 2024 and for the years ended December 31, 2023 and 2022.

The following table summarizes the unaudited pro forma financial information:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Total revenue

$

5,247,150

$

8,258,254

$

9,527,324

Net loss

 

(23,878,060)

$

(4,695,016)

$

(90,186,458)

Weighted average shares

 

  

 

  

 

  

Basic and diluted

 

11,801,759

 

11,801,759

 

11,906,245

Net loss per shares:

 

  

 

  

 

  

Basic and diluted

$

(2.02)

$

(0.40)

$

(8.87)

The unaudited pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition and the cost of financing the acquisition had taken place at the beginning of fiscal 2022. The financial information for the periods presented above includes pro forma adjustments as follows:

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Transaction cost

$

(9,008,053)

$

$

9,008,053

Amortization of intangibles

$

$

2,437,500

$

2,437,500

Loss on AtlasClear acquisition

$

86,392,769

$

$

(86,392,769)

Interest earned on investments held in trust

$

(256,279)

$

(3,090,086)

$

(3,087,315)

v3.24.4
INTANGIBLE ASSETS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
INTANGIBLE ASSETS    
INTANGIBLE ASSETS

NOTE 11. INTANGIBLE ASSETS

Pacsquare Purchase Agreement

Pursuant to the transactions contemplated by a letter of intent, on February 16, 2024, AtlasClear and Pacsquare entered into a Source Code Purchase Agreement and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear acquired the AtlasClear Platform. Pursuant to the Pacsquare Purchase Agreement, Pacsquare will develop, implement and launch the AtlasClear Platform and provide maintenance and support services as described in the agreement. The Pacsquare Purchase Agreement provides that Pacsquare will develop and deliver to AtlasClear the Level 1 equities trading platform and that it will develop and deliver all modules of the clearing platform within 12 months of signing the Pacsquare Purchase Agreement. AtlasClear owns all the intellectual property relating to the AtlasClear Platform, including the software and source code. The Pacsquare Purchase Agreement also granted AtlasClear a right of first refusal to any products or services that relate to trading, settlement, clearance or any other business of AtlasClear that Pacsquare proposes to offer to other persons. The purchase price for the assets was $4.8 million as follows: (i) $1.9 million, consisting of (A) $100,000 payable in a cash upon delivery of the source code and execution of the Pacsquare Purchase Agreement; (B) $850,000 payable in shares of Common Stock at a price of $6.00 per share; and (C) $950,000 to be paid in four monthly installments of $237,500, payable in shares of Common Stock at the price per share on the day of issuance and (ii) $2.7 million to be paid ratably on a module-by-module basis upon delivery and acceptance of each of the AtlasClear Platform modules. AtlasClear has sole discretion to determine whether any of the foregoing payments will be made in cash or shares of Common Stock. As of June 30, 2024, the Company has issued 336,000 shares of Common Stock 141,667 of which were valued at $6 per share as per agreed upon terms and 194,333 valued at $1.50 per share based on the fair value of common stock on March 12, 2024 the date the share were issued to Pacsquare pursuant to the terms of the Pacsquare Purchase Agreement and paid $500,000 in cash and accrued $85,000 in accounts payable for total carrying value of $1,726,500. During the three months ended September 30, 2024 the Company issued 500,000 shares valued at $122,300 on issuance date to Pacsquare as additional consideration towards the AtlasClear platform and accrued and additional $15,000 in accrued invoices received bringing the balance to $1,928,800 as of September 30, 2024. The AtlasClear platform is not yet in use as such amortization has not yet commenced. The Company anticipates commencing amortization during the quarter ended December 31, 2024.

Intangible Assets of the company at September 30, 2024, are summarized as follows:

September 30, 2024

    

    

Accumulated

    

Impairment

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,928,800

 

 

 

1,928,800

Customer Lists

12 years

 

14,625,000

 

(781,335)

 

 

13,843,665

Intangible Assets

$

22,696,325

$

(781,335)

$

(17,845,813)

$

21,914,990

Below is a summary of the amortization of intangible assets for the next five years:

Fiscal Year

    

Amount

June 30, 2025

$

911,558

June 30, 2026

 

1,411,630

June 30, 2027

 

1,411,630

June 30, 2028

 

1,414,970

June 30, 2029

 

1,411,630

Thereafter

 

9,211,047

NOTE 13. INTANGIBLE ASSETS

Pacsquare Purchase Agreement

Pursuant to the transactions contemplated by a letter of intent, on February 16, 2024, AtlasClear and Pacsquare entered into a Source Code Purchase Agreement and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear acquired the AtlasClear Platform. Pursuant to the Pacsquare Purchase Agreement, Pacsquare will develop, implement and launch the AtlasClear Platform and provide maintenance and support services as described in the agreement. The Pacsquare Purchase Agreement provides that Pacsquare will develop and deliver to AtlasClear the Level 1 equities trading platform and that it will develop and deliver all modules of the clearing platform within 12 months of signing the Pacsquare Purchase Agreement. AtlasClear owns all the intellectual property relating to the AtlasClear Platform, including the software and source code. The Pacsquare Purchase Agreement also granted AtlasClear a right of first refusal to any products or services that relate to trading, settlement, clearance or any other business of AtlasClear that Pacsquare proposes to offer to other persons. The purchase price for the assets was $4.8 million as follows: (i) $1.9 million, consisting of (A) $100,000 payable in a cash upon delivery of the source code and execution of the Pacsquare Purchase Agreement; (B) $850,000 payable in shares of Common Stock at a price of $6.00 per share; and (C) $950,000 to be paid in four monthly installments of $237,500, payable in shares of Common Stock at the price per share on the day of issuance and (ii) $2.7 million to be paid ratably on a module-by-module basis upon delivery and acceptance of each of the AtlasClear Platform modules. AtlasClear has sole discretion to determine whether any of the foregoing payments will be made in cash or shares of Common Stock. As of June 30, 2024, the Company has issued 336,000 shares of Common Stock 141,667 valued at $6 per share as per agreed upon terms and 194,333 valued at $1.50 per share based on the fair value of common stock on March 12, 2024 date share were issued to Pacsquare pursuant to the terms of the Pacsquare Purchase Agreement and paid $500,000 in cash and accrued $85,000 in accounts payable for total carrying value of $1,726,500. The AtlasClear platform is not yet in use as such amortization has not yet commenced.

Intangible Assets of the company at June 30, 2024 are summarized as follows:

June 30, 2024

    

    

Accumulated

    

Impairment

    

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,726,500

 

 

 

1,726,500

Technology acquired

zero years

 

18,163,044

 

(317,231)

 

(17,845,813)

 

Customer Lists

12 years

 

14,625,000

 

(474,144)

 

 

14,150,856

Intangible Assets

$

40,657,069

$

(791,375)

$

(17,845,813)

$

22,019,881

Below is a summary of the amortization of intangible assets for the next five years:

Year

    

Amount

June 30, 2025

$

1,218,750

June 30, 2026

 

1,391,400

June 30, 2027

 

1,391,400

June 30, 2028

 

1,394,739

June 30, 2029

 

1,391,400

Thereafter

 

9,089,667

v3.24.4
STOCKHOLDERS' DEFICIT
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
STOCKHOLDERS' DEFICIT    
STOCKHOLDERS' DEFICIT

NOTE 12. STOCKHOLDERS’ DEFICIT

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2024 and June 30, 2024, there were no shares of preferred stock issued or outstanding.

Common stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At September 30, 2024 and June 30, 2024, there were 22,245,698 and 12,277,759, respectively. As of September 30, 2024 1,029,473 shares of common stock, which are considered liability under ASC 815, were issued under the Tau agreement as such they are issued but not outstanding. Refer to Note 9 Tau Agreement for further information. In additional the Company does not currently have sufficient shares authorized to issue shares under various convertible note agreements, see Note 2 Net (loss) income for common stock disclosure for additional detail.

The Common Stock commenced trading on the NYSE American LLC (“NYSE”) under the symbol “ATCH” on February 12, 2024. AtlasClear Holdings’ warrants commenced trading on the over-the-counter market (the “OTC”) under the symbol “ATCH WS” on February 12, 2024.

NOTE 16. STOCKHOLDERS’ EQUITY (DEFICIT)

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2024, December 31, 2023 and 2022, there were no shares of preferred stock issued or outstanding.

Common stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share. At June 30, 2024 and December 31, 2023 and 2022, there were 12,277,759 and 5,031,250, respectively.

In connection with the Closing, each share of Quantum’s common stock (“Quantum Common Stock” or “Public Shares”) that was outstanding and had not been redeemed was converted into one share of Common Stock. Each outstanding public warrant to purchase Quantum Common Stock became a warrant to purchase one-half of a share of Common Stock. Each outstanding warrant to purchase Quantum Common Stock initially issued in a private placement in connection with Quantum’s initial public offering became a warrant to purchase one share of Common Stock.

In connection with the stockholder vote to approve the Business Combination Agreement and the Business Combination, holders of an aggregate of 4,940,885 shares of Quantum Common Stock properly exercised their right to have their shares redeemed for a full pro rata portion of the Trust Account holding the proceeds from the IPO, which was approximately $10.92 per share, or $53,947,064 in the aggregate. The remaining balance of the Trust Account immediately prior to the Closing of approximately $1.2 million was used to partially fund the Business Combination. As a result of such redemptions, a total of 109,499 Public Shares remained outstanding at the Closing. After giving effect to the Business Combination, the redemption of the Public Shares described above, the separation of the Quantum Units and the issuance of Merger Consideration Shares and the issuance of shares of Common Stock pursuant to Expense Settlements (described below), as of the Closing Date, there were 12,277,759 shares of Common Stock issued and outstanding.

In connection with the Closing, the Company instructed Continental Stock Transfer & Trust Company (“CST”), as escrow agent under the Stock Escrow Agreement, dated as of February 4, 2021 (the “Stock Escrow Agreement”), between the Company and CST, to release from escrow 4,000,000 of the Founder Shares that were held in escrow pursuant to the terms of the Stock Escrow Agreement (consisting of 949,084 shares owned by Chardan Quantum, LLC and 3,050,916 shares owned by the Sponsor; as contemplated by the previously-disclosed amendment to the Stock Escrow Agreement entered into on October 31, 2023.)

The Common Stock commenced trading on the NYSE American LLC (“NYSE”) under the symbol “ATCH” on February 12, 2024. AtlasClear Holdings’ warrants commenced trading on the over-the-counter market (the “OTC”) under the symbol “ATCH WS” on February 12, 2024.

v3.24.4
WARRANTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
WARRANTS    
WARRANTS

NOTE 13. WARRANTS

As of September 30, 2024 and June 30, 2024, there are 20,125,000 Public Warrants outstanding, each Public Warrant entitles the holder to purchase one-half of one share of common stock at an exercise price of $11.50 per whole share, that are classified and accounted for as equity instruments. The Public Warrants are now exercisable.

As of September 30, 2024 and June 30, 2024, there are 6,153,125 Private Warrants to purchase an equal number of common shares that are outstanding that are classified and accounted for as derivative liabilities. Under this accounting treatment, the Company is required to measure the fair value of the Private Warrants at the end of each reporting period as well as re-evaluate the treatment of the Private Warrants and recognize changes in the fair value from the prior period in the Company’s operating results for the current period.

NOTE 17. WARRANTS

As of June 30, 2024 and December 31, 2023, there are 20,125,000 Public Warrants outstanding, each Public Warrant entitles the holder to purchase one-half of one share of common stock at an exercise price of $11.50 per whole share, that are classified and accounted for as equity instruments. The Public Warrants are now exercisable. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within 120 days from the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

Once the warrants become exercisable, the Company may redeem the Public Warrants:

in whole and not in part;
at a price of $0.01 per warrant;
at any time after the warrants become exercisable;
upon not less than 30 days’ prior written notice of redemption;
if, and only if, the reported last sale price of the shares of common stock equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third business day prior to the notice of redemption to warrant holders; and
if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants.

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares or Private Warrants held by the initial stockholders or their affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and income thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and Newly Issued Price, and the $16.50 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.

As of June 30, 2024 and December 31, 2023, there are 6,153,125 Private Warrants to purchase an equal number of common shares that are outstanding that are classified and accounted for as derivative liabilities. Under this accounting treatment, the Company is required to measure the fair value of the Private Warrants at the end of each reporting period as well as re-evaluate the treatment of the Private Warrants and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (i) each private warrant is exercisable for one share of common stock at an exercise price of $11.50 per share, and (ii) the Private Warrants will be non-redeemable and may be exercised on a cashless basis, in each case so long as they continue to be held by the initial purchasers or their permitted transferees. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

On the Closing Date, the Company, AtlasClear Holdings and CST entered into that certain Assignment, Assumption and Amendment Agreement (the “New Warrant Agreement”). The New Warrant Agreement amends that certain Warrant Agreement, dated as of February 4, 2021, by and between the Company and CST (the “Existing Warrant Agreement”), to provide for the assignment by the Company of all its rights, title and interest in the warrants of the Company to AtlasClear Holdings. Pursuant to the New Warrant Agreement, all Company warrants under the Existing Warrant Agreement will no longer be exercisable for shares of Quantum Common Stock, but instead will be exercisable for shares of Common Stock.

v3.24.4
FAIR VALUE MEASUREMENTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
FAIR VALUE MEASUREMENTS    
FAIR VALUE MEASUREMENTS

NOTE 14. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2024 and June 30, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

    

    

September 30,

    

June 30,

Description

Level

2024

2024

 

 

  

 

  

Liabilities:

 

Subscription agreement

3

$

2,460,488

$

2,425,647

Contingent Guarantee

3

$

$

3,256,863

Warrant liability – Private Warrants

3

$

61,531

$

307,656

Earnout liability

 

3

$

12,638,000

$

12,298,000

Convertible notes derivative

 

3

$

2,142,511

$

16,462,690

Merger financing derivative

3

$

176,239

Secured convertible derivative

3

$

89,535

Tau agreement

 

3

$

972,508

$

Subscription Agreement

On February 9, 2024, the Registrant entered into a Subscription Agreement and Discharge Agreement with Winston & Strawn LLP (“Winston”) Calculator New Pubco, Inc. and Quantum, as described in Note 9.

The Subscription Agreement is considered a variable-share obligation under ASC Topic 480 (“Distinguishing Liabilities from Equity”). The Subscription Agreement meets the requirements for classification under ASC 480 and as a result is required to be accounted for as a liability under ASC 480 and is presented as such on the Condensed Consolidated Balance Sheets. The Company will record a change in fair value on each reporting period until settlement in its Condensed Consolidated Statement of Operations. See Note 9 for further discussion.

The key inputs into the Monte Carlo model for the Subscription Agreement were as follows:

    

June 30,

    

June 30,

 

Input

 

2024

 

2024

Market price of public shares

$

0.21

$

1.04

Equity volatility

 

34.4

%  

 

26.2

%

Risk-free rate

 

4.01

%  

 

5.05

%

Contingent Guarantee

In connection with the acquisition of Wilson-Davis, Founder shares were transferred to cover a cash deficit of $6,000,000. The share have a make-whole provision that require to be accounted for under ASC 480. The Company has valued the obligation as of June 30, 2024 of $3,256,863 based on the cash value that would need to be renumerated by the Company. The value of the cash that would be paid was deemed to be the fair value of the contingent guarantee. The Company issued shares valued at $1,210,290 during the three months ended September 30, 2024 and based on the value of shares sold as of August 8, 2024 the Company was obligated to repay $2,886,347 under the contingent guarantee, resulting in a change in fair value of $839,775. On August 9, 2024 the Company issued convertible note to modify the repayment conditions, resulting in the extinguishment of the contingent liability and recognizing the fair value of the convertible note agreement referred to as Merger financing, see Note 9 for further discussion and below.

Warrant Liability

The Private Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability in the consolidated statements of operations. See Note 13 for further discussion.

The Private Placement Warrants were, initially and as of the end of each subsequent reporting period, valued using a lattice model, specifically a Black-Scholes model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the Company’s common stock. The expected volatility of the Company’s common stock was determined based on the implied volatility of the publicly traded Public Warrants.

The key inputs into the Black-Scholes model for the Private Warrants were as follows:

    

June 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Risk-free rate

 

3.52

%  

 

4.27

%

Dividend yield

 

0.00

%  

 

0.00

%

Volatility

 

87.4

%  

 

58.7

%

Exercise price

$

11.50

$

11.50

Effective expiration date

 

February 2029

 

February 2029

Earnout Liability

The Earnout liability was, initially as of February 9, 2024, valued using a Monte Carlo simulation to determine if and when the revenue hurdles would be achieved. The revenue volatility and revenue to equity correlation was based upon the same guideline public companies. The Monte Carlo simulation was performed simultaneously on both the share price and revenue to account for the correlation between revenue and equity.

The key inputs into the Monte Carlo model for the Earnout liability were as follows:

    

September 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

9.61

%  

 

9.69

%

Convertible Note Derivatives

The Conversion derivative, associated with Short-term notes, Long-Term notes, and the Original Chardan Note was accounted for as a liability in accordance with ASC 815-40. The Conversion derivative liability was measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of Conversion derivative liability in the consolidated statements of operations. The Convertible note derivative is made up of the fair value of the embedded conversion option included in the Short-term notes, Long-Term notes, and the Original Chardan Note with a fair value as of September 30, 2024 of $335,906, $983,529 and $823,076, respectively totaling, $2,142,511 and as of June 30, 2024 of $4,807,692, $7,664,613 and $3,990,385, respectively totaling, $16,462,690.

Short-Term Note

On February 9, 2024, the Company issued short-term notes to the former officers and directors of Wilson-Davis. The short-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The conversion feature is deemed to include an embedded derivative that requires bifurcation and separate account. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the note. The discount will be amortized as interest expense over the term of the short-term note(s). The derivative liability will be revalued at each reporting period with the change being charged to the income statement. The original derivative liability – for the short term note notes was valued at $487,329. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $4,320,363 to $4,807,692. The original $487,929 discount was amortized over the 90-day maturity. As of June 30, 2024, the Company did not repay the short-term notes as such has incurred penalty interest from 9% to 13% until the note is repaid. The note is due on demand but will default on the long term note date of February 2026. No notice of default has been received.

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024 valuation of the convertible note conversion feature under Black-Scholes was no longer appropriate as it does not take into account the probability of multiple components. As such as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the short term loan at $335,906. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

 

Input

 

2024

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

 

28.9

%

Volatility

 

36.7

%

Effective expiration date

 

February 2026

The key inputs into the Black-Scholes model for the Conversion derivative as of June 30, 2024 were as follows:

    

June 30,

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

5.49

%

Dividend yield

 

0.00

%

Volatility

 

14,643.0

%

Exercise price

$

0.99

Effective expiration date

May 2024

Long-Term Note

On February 9, 2024, the Company issued long-term notes to the former officers and directors of Wilson-Davis. The long-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024 and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement.

The conversion feature is deemed to include an embedded derivative that required bifurcation and separate accounting. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the notes. The discount will be amortized as interest expense over the term of the notes. The derivative liability will be revalued at each reporting period with the change being charged to Derivative liability – convertible notes. The original derivative liability – for the long term note notes was valued at $776,919. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $6,887,694 to $7,664,613. The original $776,919 discount will be amortized over the maturity.

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024 valuation of the convertible note conversion feature under Black-Scholes was no longer appropriate as it does not take into account the probability of multiple components. As such as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the long term loan at $983,529. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

28.9

%

Volatility

36.7

%

Effective expiration date

February 2026

The key inputs into the Black-Scholes model for the Conversion derivative were as follows:

    

June 30,

 

Input

 

2024

Market price of public shares

$

1.04

Risk-free rate

 

4.90

%

Dividend yield

 

0.00

%

Volatility

 

14,461

%

Exercise price

$

0.99

Effective expiration date

 

February 2026

Chardan Note

In connection with the Closing, AtlasClear Holdings and Chardan agreed that the fee, in the amount of $7,043,750, payable by Quantum to Chardan upon the Closing pursuant to the terms of the business combination marketing agreement entered into in connection with Quantum’s initial public offering, would be waived in exchange for the issuance by AtlasClear Holdings to Chardan of the Original Chardan Note in the aggregate principal amount of $4,150,000. The Original Chardan Note was issued by AtlasClear Holdings at the Closing. The Original Chardan Note had a stated maturity date of February 9, 2028. Interest accrued at a rate per annum equal to 13%, and was payable quarterly on the first day of each calendar quarter. On each interest payment date, the accrued and unpaid interest would have been, at the election of AtlasClear Holdings, either paid in cash or, subject to the satisfaction of certain conditions, in shares of Common Stock, at a rate equal to 85% of the VWAP for the trading day immediately prior to the applicable interest payment date. On October 23, 2024, the Company, Quantum Ventures, Chardan and Chardan Quantum LLC entered into the Settlement Agreement. In connection with the Settlement Agreement, Chardan exchanged the Chardan Note for an amended non-interest bearing, convertible note in the aggregate principal amount of $5,209,764 (as amended, the “Chardan Note”). While the Chardan Note does not bear interest, it can be converted from time to time by Chardan into shares of Common Stock, on terms substantially similar to the conversion provisions in the Original Chardan Note, and any remaining outstanding principal is to be repaid in full on the same maturity date as the Original Chardan Note.

The Chardan Note qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The original derivative liability – for the Chardan Note was valued at $404,483. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $3,585,901 to $3,990,385. The original $404,483 discount will be amortized over the maturity. See Note 9 for additional information.

In addition, on each conversion date AtlasClear Holdings was required to pay to Chardan in cash (or, at AtlasClear Holding’s option and subject to certain conditions, a combination of cash and Common Stock) all accrued interest on the Chardan Note and all interest that would otherwise accrue on the amount of the Note being converted if such converted amount would be held to three years after the applicable conversion date. The first quarterly interest payment due on the Chardan Note has not been paid as of the date of this filing.

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024, valuation of the convertible note conversion feature under Black-Scholes was no longer appropriate as it does not take into account the probability of multiple components. As such, as of September 30, 2024, the conversion feature was valued using Monte Carlo model resulting in the fair value of the conversion option included in the Chardan Note at $823,076. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.36

%

Discount rate

 

7.72

%

Probability of default

 

41.2

%

Recovery rate

 

47.6

%

Volatility

 

43.9

%

Effective expiration date

 

February 2028

The key inputs into the Black-Scholes model for the conversion derivative are as follows:

    

June 30,

 

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

4.52

%

Dividend yield

 

0.00

%

Volatility

 

166,681.0

%

Exercise price

$

0.84

Effective expiration date

 

February 2028

Secured Convertible Note

As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that as of September 30, 2024 valuation of the secured convertible note conversion feature now was required to be bifurcated under ASC 815 as such the Company fair valued the embedded derivative. As such as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the Secured Convertible Note at $89,535. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

3.87

%

Discount rate

 

7.84

%

Probability of default

 

19.8

%

Recovery rate

 

47.6

%

Volatility

 

36.8

%

Effective expiration date

 

November 2025

Merger Financing

As discussed above under Contingent Guarantee, on August 9, 2024 the Company issued convertible note to modify the repayment conditions, resulting in the extinguishment of the contingent liability and recognizing the fair value of the convertible note agreement. As a result of the changes in stock price, the limitation on authorized shares to comply with the conversion option, the Company determined that the merger financing notes conversion feature was required to be bifurcated under ASC 815 as such the Company fair valued the embedded derivative. As such as of August 9, 2024 the issuance date and as of September 30, 2024 the conversion feature was valued using Mote Carlo model resulting in the fair value of the conversion option included in the Merger financing notes at $113,044 and $176,239, respectively. See Note 9 for additional information.

The key inputs into the Monte-Carlo model for the Conversion derivative as of September 30, 2024 were as follows:

    

September 30,

    

August 9,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

4.84

%

 

4.78

%

Discount rate

 

11.72

%

 

16.98

%

Probability of default

 

23.5

%

 

25.4

%

Recovery rate

 

28.9

%

 

28.9

%

Volatility

 

36.7

%

 

37.2

%

Effective expiration date

 

February 2026

 

February 2026

Tau Agreement

As discussed in Note 9 the Tau Agreement has both a Commitment Amount and a Commitment fee that requires to be fair valued under ASC 815 and ASC 480, respectively. As such as of July 31, 2024 the issuance date and as of September 30, 2024 both the Commitment Amount and the Commitment Fee were valued using Mote Carlo model resulting in the fair value of the Commitment Amount at $966,153 and $892,558, respectively and the Commitment Fee at $124,796 and $79,948, respectively.

The key inputs into the Monte-Carlo model for the Commitment Amount as of issuance date of July 31, 2024, and September 30, 2024 were as follows:

    

September 30,

    

July 31

 

Input

2024

2024

 

Anticipated Monthly Advance Amounts

$

40,000

$

40,000

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

The key inputs into the Monte-Carlo model for the Commitment Fee as of issuance date of July 31, 2024, and September 30, 2024 were as follows:

    

September 30,

    

July 31,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

The following table presents the changes in the fair value of the following:

    

Private

    

Tau

Placement

 Agreement

Warrants

Liability

Fair value as of June 30, 2024

$

307,656

$

Initial measurement

1,090,949

Transferred to equity

(303,000)

Change in valuation inputs or other assumptions

(246,125)

184,559

Fair value as of September 30, 2024

$

61,531

$

972,508

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

Change in valuation inputs or other assumptions

 

(14,320,179)

 

 

340,000

Fair value as of September 30, 2024

$

2,142,511

 

$

12,638,000

    

Subscription

    

Contingent

Agreement

Guarantee

Fair value as of June 30, 2024

$

2,425,647

$

3,256,863

Shares issued as partial payment

 

 

(1,210,290)

Change in valuation inputs or other assumptions

 

34,841

 

839,774

Exchanged to Merger financing note

 

 

(2,886,347)

Fair value liability as of September 30, 2024

$

2,460,488

$

    

Merger

    

Secured

Financing

Convertible

Derivative

Derivative

Fair value as of June 30, 2024

$

$

Initial measurement

 

113,044

 

Change in valuation inputs or other assumptions

 

63,195

 

89,535

Fair value as of September 30, 2024

$

176,239

$

89,535

There were no transfers between levels during the three months ended September 30, 2024 and 2023.

NOTE 19. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2024, December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

    

    

June 30,

    

December 31,

    

December 31,

Description

Level

2024

2023

2022

Assets:

 

 

  

 

  

 

  

Marketable securities held in Trust Account

 

1

$

$

54,799,478

$

204,044,469

Liabilities:

 

 

  

 

  

 

  

Subscription agreement

3

$

2,084,691

$

$

Contingent Guarantee

3

$

3,256,863

$

$

Warrant liability – Private Warrants

 

3

$

307,656

$

307,656

$

184,594

Non-redemption agreement liability

3

$

$

1,441,653

$

Convertible notes derivative

3

$

16,462,690

$

$

Earnout liability

 

3

$

12,298,000

$

$

Subscription Agreement

On February 9, 2024, the Registrant entered into a Subscription Agreement and Discharge Agreement with Winston & Strawn LLP (“Winston”) Calculator New Pubco, Inc. and Quantum, as described in Note 1. The Company has concluded that such liabilities are no longer an obligation of the Company and therefore qualify for extinguishment.

The Subscription Agreement is considered a variable-share obligation under ASC Topic 480 (“Distinguishing Liabilities from Equity”). The Subscription Agreement meets the requirements for classification under ASC 480 and as a result is required to be accounted for as a liability under ASC 480 and is presented as such on the Consolidated Balance Sheets. The Company will record a change in fair value on each reporting period until settlement in its Consolidated Statement of Operations. See note 10 for further discussion.

The key inputs into the Monte Carlo model for the Subscription Agreement were as follows:

February 9,

 

June 30,

2024

 

Input

    

2024

    

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Equity volatility

 

26.2

%  

 

29.8

%

Risk-free rate

 

5.05

%  

 

4.67

%

Contingent Guarantee

In connection with the acquisition of Wilson-Davis, Founder shares were transferred to cover a cash deficit of $6,000,000. The share have a make-whole provision that require to be accounted for under ASC 480. The Company has valued the obligation as of June 30, 2024 of $3,256,863 based on the cash value that would need to be renumerated by the Company. The value of the cash that would be paid was deemed to be the fair value of the contingent guarantee. The company analyzed the public sales of the shares transferred to determine the amount of cash recovered less the $4,000,000 contingent guarantee resulting in a liability due of $3,256,863. As of February 9, 2024 the 885,010 shares transferred by the Founder were valued at $8,850,100 which was greater than the $4,000,000 guaranted value as such the value of the guarantee was deemed to be zero on February 9, 2024. As a result of the decrease in stock prices through June 30, 2024 the Sellers have recovered $743,137 in cash through sales of the shares transferred resulting in the value of the liability as of June 30, 2024 to be $3,256,863.

Warrant liability

The Private Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability in the consolidated statements of operations. See note 17 for further discussion.

The Private Placement Warrants were, initially and as of the end of each subsequent reporting period, valued using a lattice model, specifically a Black-Scholes model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the Company’s common stock. The expected volatility of the Company’s common stock was determined based on the implied volatility of the publicly traded Public Warrants.

The key inputs into the Black-Scholes model for the Private Warrants were as follows:

    

June 30,

    

December 31,

December 31,

 

Input

2024

2023

2022

 

Market price of public shares

$

1.04

$

6.20

$

10.05

Risk-free rate

 

4.27

%  

 

3.77

%  

 

3.91

%

Dividend yield

 

0.00

%  

 

0.00

%  

 

0.00

%

Volatility

 

58.7

%  

 

12.0

%  

 

2.6

%

Probability of a business combination

 

100

%  

 

100

%  

 

4.5

%

Exercise price

$

11.50

$

11.50

$

11.50

Effective expiration date

 

February 29

 

February 29

 

February 29

Non-Redemption Agreement

The non-redemption agreement liability was measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of non-redemption agreement liability in the consolidated statements of operations.

The non-redemption agreement liability is comprised of 235,180 shares of non-redeemable common stock and 235,180 Private Placement Warrants. The non-redeemable common stock was valued using a Monte Carlo model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the non-redeemable common stock is equity volatility, probability of acquisition, the discount for marketability and discount for expected forfeiture. As of February 9, 2024, the shares and warrants were transferred and valued based on the trading prices of the stock and warrants and reclassified as permanent equity at total value of $1,606,279.

The key inputs into the Monte Carlo model for the non-redeemable common stock were as follows:

    

December 31,

August 1,

 

Input

2023

2023

 

Market price of public shares

$

6.20

$

10.57

Probability of acquisition

 

100.0

%

 

82.0

%

Equity volatility

 

12.0

%

 

19.9

%

Discount for lack of marketability

 

8.0

%

 

3.0

%

Discount for expected forfeiture

 

5.10

%

 

5.10

%

Earnout Liability

The Earnout liability was, initially and as of February 9, 2024, valued using a Monte Carlo simulation to determine if and when the revenue hurdles would be achieved. The revenue volatility and revenue to equity correlation was based upon the same guideline public companies. The Monte Carlo simulation was performed simultaneously on both the share price and revenue to account for the correlation between revenue and equity.

The key inputs into the Monte Carlo model for the Earnout liability were as follows:

    

    

February 9,

 

June 30,

2024

 

Input

2024

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

96.9

%  

 

99.5

%

Convertible Note Derivatives

The Conversion derivative, associated with Short-term notes, Long-Term notes, and the Chardan Note was accounted for as a liability in accordance with ASC 815-40. The Conversion derivative liability was measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of Conversion derivative liability in the consolidated statements of operations. The Convertible note derivative is made up of the fair value of the embedded conversion option included in the Short-term

notes, Long-Term notes, and the Chardan Note with a fair value as of June 30, 2024 of $4,807,692, $7,664,613 and $3,990,385, respectively.

On February 9, 2024, the Company issued short-term notes to the former officers and directors of Wilson-Davis. The short-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The conversion feature is deemed to include an embedded derivative that requires bifurcation and separate account. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the note. The discount will be amortized as interest expense over the term of the short-term note(s). The derivative liability will be revalued at each reporting period with the change being charged to the income statement. The original derivative liability – for the short term note notes was valued at $487,329. On June 30, 2024, a Black-Scholes calculation was performed (see above chart) and the value of the fair value of the derivative liability – convertible notes increased $4,320,3630 to $4,807,692. The original $487,929 discount was amortized over the 90-day maturity. As of June 30, 2024, the company did not repay the short-term notes as such has incurred penalty interest from 9% to 13% until the note is repaid. No notice of default has been received. See note 10 for additional information.

The key inputs into the Black-Scholes model for the Conversion derivative were as follows:

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

5.49

 

5.44

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,643.0

 

4,120.0

%

Exercise price

$

0.99

$

7.27

Effective expiration date

May 2024

May 2024

On February 9, 2024, the Company issued long-term notes to the former officers and directors of Wilson-Davis. The long-term notes have a conversion feature that qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024 and June 30, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement.

The conversion feature is deemed to include an embedded derivative that required bifurcation and separate accounting. As such, the Company ascertained the value of the conversion option as if separate from the convertible issuance and appropriately recorded that value as a derivative liability with the offset being a discount to the notes. The discount will be amortized as interest expense over the term of the notes. The derivative liability will be revalued at each reporting period with the change being charged to Derivative liability – convertible notes. The original derivative liability – for the long term note notes was valued at $776,919. On June 30, 2024, a Black-Scholes calculation was performed (see above chart) and the value of the fair value of the derivative liability – convertible notes increased $6,887,694 to $7,664,613. The original $776,919 discount will be amortized over the maturity. See note 10 for additional information.

The key inputs into the Black-Scholes model for the Conversion derivative were as follows:

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.90

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,461

 

41,200

%

Exercise price

$

0.99

$

7.27

Effective expiration date

February 2026

February 2026

In connection with the Closing, AtlasClear Holdings and Chardan agreed that the fee, in the amount of $7,043,750, payable by Quantum to Chardan upon the Closing pursuant to the terms of the business combination marketing agreement entered into in connection with Quantum’s IPO, would be waived in exchange for the issuance by AtlasClear Holdings to Chardan of a convertible promissory note in the aggregate principal amount of $4,150,000. The Chardan Note was issued by AtlasClear Holdings at the Closing. The Chardan Note

has a stated maturity date of February 9, 2028. Interest accrues at a rate per annum equal to 13%, and is payable quarterly on the first day of each calendar quarter. On each interest payment date, the accrued and unpaid interest shall, at the election of AtlasClear Holdings, be either paid in cash or, subject to the satisfaction of certain conditions, in shares of Common Stock, at a rate equal to 85% of the VWAP for the trading day immediately prior to the applicable interest payment date.

The Chardan Note qualifies for derivative treatment in accordance with ASC 815-40. On February 9, 2024, the Company valued the derivatives using a Black-Scholes model which is considered to be a Level 3 fair value measurement. The original derivative liability – for the Chardan convertible note was valued at $404,483. On June 30, 2024, a Black-Scholes calculation was performed (see below chart) and the value of the fair value of the derivative liability – convertible notes increased $3,585,901 to $3,990,385. The original $404,483 discount will be amortized over the maturity. See note 10 for additional information.

In addition, on each conversion date AtlasClear Holdings is required to pay to Chardan in cash (or, at AtlasClear Holding’s option and subject to certain conditions, a combination of cash and Common Stock) all accrued interest on the Chardan Note and all interest that would otherwise accrue on the amount of the Note being converted if such converted amount would be held to three years after the applicable conversion date. The first quarterly interest payment due on the Chardan Note has not been paid as of the date of this filing.

The key inputs into the Black-Scholes model for the conversion derivative are as follows:

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.52

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

166,681.0

 

4,120.0

%

Exercise price

$

0.84

$

10.26

Effective expiration date

February 2028

February 2028

On February 9, 2024, the Company issued a long-term note to Interest Solutions in the amount of $275,000. The Company also issued a long-term note to JonesTrading Institutional Services for $375,000. Both of the notes accrue interest at 13% per annum. The outstanding principal, together with any then unpaid and accrued interest and other amounts payable, shall be due and payable at the earlier of (i) when requested by the note holder on or after February 9, 2026, or (ii) when, upon the occurrence and during the continuance of an event of default. The conversion feature in the notes do not qualify for derivative treatment.

The following table presents the changes in the fair value of the following:

    

Private

    

Non-Redemption

Placement

 Agreement

Warrants

Liability

Fair value as of December 31, 2021

$

7,137,930

$

Change in valuation inputs or other assumptions

(6,953,336)

1,881,440

Fair value as of December 31, 2022

$

184,594

$

Initial measurement as of August 1, 2023

1,881,440

Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability

123,062

(439,787)

Fair value as of December 31, 2023

$

307,656

$

1,441,653

Change in valuation inputs or other assumptions

164,626

Transferred to equity

(1,606,279)

Fair value as of June 30, 2024

$

307,656

$

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of December 31, 2023

$

 

$

Initial measurement as of February 9, 2024

1,668,731

10,963,000

Change in valuation inputs or other assumptions

 

14,793,959

 

 

1,335,000

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

    

Subscription

    

Merger Financing

Agreement

Liability

Fair value as of December 31, 2023

$

$

Initial measurement as of February 9, 2024

 

2,386,851

 

Change in valuation inputs or other assumptions

 

38,796

 

3,256,863

Fair value (asset) liability as of June 30, 2024

$

2,425,647

$

3,256,863

There were no transfers between levels during the year ended and period ended June 30, 2024 and December 31, 2023 and 2022.

v3.24.4
SUBSEQUENT EVENTS
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUBSEQUENT EVENTS    
SUBSEQUENT EVENTS

NOTE 15. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, other than as described below.

Prior to the maturity date of October 13, 2024, FINRA approved a one-year extension for $1,280,000 in Subordinated notes. The interest rate on the subordinated notes increased from 5% to 8% and the notes mature on October 13, 2025. One of the notes, $20,000, was not renewed and will not be included in the Net Capital calculations. The note will be treated as debt.

On October 21, 2024, the Company held a special meeting of stockholders (the “Special Meeting”) in connection with the 1-for-30 Reverse Stock Split Proposal, 1-for-40 Reverse Stock Split Proposal, 1-for-50 Reverse Stock Split Proposal, 1-for-60 Reverse Stock Split Proposal, and Authorized Share Increase Proposal as defined and described in the definitive proxy statement filed by the Company with the SEC on October 8, 2024 (the “Proxy Statement”). The Company’s board of directors subsequently approved the 1-for-60 Reverse Stock Split ratio.

The proposal to amend the Company’s amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock from 100,000,000 shares to 500,000,000 shares and the number of authorized shares of preferred stock, par value $0.0001 per share, from 1,000,000 shares to 25,000,000 shares. On December 30, 2024, the Company filed a certificate of amendment to the amended and restated certificate of incorporation to increase the number of authorized shares of common stock and preferred stock.

On October 23, 2024, AtlasClear Holdings, Quantum Ventures, Chardan and Chardan Quantum LLC entered into the Settlement Agreement discussed above. In connection with the Settlement Agreement, Chardan exchanged the convertible, interest-bearing Original Chardan Note originally issued by the Company on February 9, 2024, in the aggregate principal amount of $4,150,000 for an amended non-interest bearing, convertible note in the aggregate principal amount of $5,209,764. While the amended Chardan Note does not bear interest, it can be converted from time to time by Chardan into shares of Common Stock on terms substantially similar to the conversion provisions in the Original Chardan Note, and any remaining outstanding principal is to be repaid in full on the same maturity date as the Original Note.

In connection with the Settlement Agreement, on October 23, 2024, the Company and Chardan entered into an amendment (the “Chardan Amended RRA”) to the registration rights agreement, dated February 9, 2024, pursuant to which the Company agreed, among other things, to file, by December 31, 2024, a registration statement with the SEC, registering the resale of shares of Common Stock issuable upon conversion of the Amended Chardan Note. If the resale registration statement (i) is not filed by December 31, 2024, then the interest rate of the Amended Chardan Note will increase by 2% per annum until the date of the filing, and shall be prorated for such period until the date of such filing and (ii) is not effective by March 31, 2025, then the interest rate on the Amended Chardan Note will increase to 19.99% per annum from March 31, 2025 until the date of effectiveness.

On November 14, 2024, the Company and Commercial Bancorp agreed to amend the agreement and plan of merger, dated November 16, 2022 (as amended, the “Bank Acquisition Agreement”), to extend the termination date of the Bank Acquisition Agreement from November 16, 2024, to May 14, 2025. Pursuant to the amendment, the parties expect to enter into a new and mutually agreed agreement for the Company to acquire the shares held by such shareholders of Commercial Bancorp. No Commercial Bancorp shareholder is required to agree to such amended or new agreement. Failure to enter into a new agreement or amendment to the Bank Acquisition Agreement shall constitute termination of the Bank Acquisition Agreement without liability. The Company shall issue to the shareholders of Commercial Bancorp, without additional compensation, 500,000 shares of common stock and the previously issued 40,000 shares to the Commercial Bancorp shareholders shall be cancelled. The shares have not yet been issued as of the date of filing.

NOTE 21. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review, other than described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements, other than as described below.

On July 5, 2024 pursuant to the transactions contemplated by a letter of intent, between AtlasClear and Pacsquare for the Source Code Purchase Agreement and Master Services Agreement, the Company issued and additional 500,000 shares to Pacsquare.

In accordance with the Chardan Convertible Note agreement, the note holder converted $725,000 in principle and received 2,263,031 shares on various dates subsequent to June 30, 2024, 493,909 of the shares were transferred by Atlas Fintech, Co-Sponsor. In addition, interest for the quarter ended March 31, 2024 and June 30, 2024 was paid with shares transferred by a Atlas Fintech on behalf of the Company for a total of 198,196 shares.

Subsequent to June 30, 2024, Quantum Venture, Co-Sponsor and Atlas Fintech, Co-Sponsor transferred 1,558,923 and 1,183,629 shares respectively as payment of interest under various Note obligations such as the Promissory notes, Secured Convertible notes and the Short and long term notes due to sellers.

On July 31, 2024, the Company and Tau entered into the ELOC Agreement. Pursuant to the ELOC Agreement, upon the terms thereof and subject to the satisfaction of certain conditions, the Company has the right from time to time at the Company’s option to direct Tau to purchase up to a specified maximum amount of shares of our Common Stock, up to a maximum aggregate purchase price of $10 million (the “Aggregate Limit”), over the 24-month term of the ELOC Agreement. The Company may request, individual advances up to the greater of 100,000 shares or such amount as is equal to 50% of the average daily volume traded of the Common Stock during the 30 trading days immediately prior to the date the request of each advance, subject to the Aggregate Limit. Any such advance will reduce amounts that the Company can request for future advances and draw downs. The purchase price payable for the shares sold pursuant to any advance will be equal to 97% of the lowest VWAP of the Common Stock during a pricing period of three consecutive trading days following Tau’s receipt of the applicable advance notice. Tau’s obligation to purchase the shares the Company request to sell pursuant to any advance is conditioned upon, in addition to certain other customary closing conditions, the continued effectiveness of a registration statement pursuant to which Tau may freely sell the shares to be received. 10,000,000 of the shares of Common Stock that may be issuable to Tau pursuant to the ELOC Agreement are being registered hereby. Tau is an underwriter within the meaning of Section 2(a)(11) of the Securities Act. The registration of the shares hereunder does not mean that Tau will actually purchase or that the Company will actually issue and sell all or any of the 10,000,000 shares of our Common Stock being registered for potential issuance to Tau pursuant to this registration statement. The Company has issued 2,475,000 shares under the ELOC.

On August 9, 2024, the Company entered into a Satisfaction of Discharge of indebtedness agreement with Atlas Fintech Holdings Corporation. In the agreement the Company agreed to issue 2,788,276 shares in satisfaction of $803,860 included in accounts payable. In addition the Company issued 1,337,500 shares as reimbursement for 1,183,629 shares that were transferred by Atlas Fintech Holdings Corporation to satisfy the Company requirements to pay interest on various loans with unrestricted shares. The company agreed to compensate the Atlas Fintech Holding Corporation 13% fee. As such a total of 4,125,776 Common Stock shares were transferred.

On August 28, 2024, the Company issued an additional 1,055,448 shares to the Wilson-Davis selling shareholders as payment of interest under the short term and long term note and as consideration for the Merger Consideration paid in stock.

On August 29, 2024, the Company issued 12,000 shares of Common Stock to Lead Nectar in lieu of payment for internet marketing services in the amount of $20,000, at a price per share of $1.66.

On July 10, 2024 and August 29, 2024, the Company issued 1,602,994 and 882,668 shares, respectively as partial conversion and payments of interest on the Short- and Long term Sellers Notes, the July distribution included share transfer from counders to cover the contingent guarantee made to the sellets.

Prior to the maturity date of October 13, 2024, FINRA approved a one-year extension for $1,280,000 in Subordinated notes. The interest rate on the subordinated notes increased from 5% to 8% and the notes mature on October 13, 2025. One of the notes, $20,000, was not renewed and will not be included in the Net Capital calculations. The note will be treated as debt.

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Transition Report on Form 10-KT, as filed with the SEC on October 16, 2024. The accompanying condensed balance sheet as of June 30, 2024 has been derived from the audited financial statements included in the Form 10-KT. The interim results for the three months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending June 30, 2025 or for any future periods.

Basis of Presentation

The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.

Principles of Consolidation

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company  

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute

payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards.

The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates  

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the private warrant liabilities, the fair value of the Subscription Agreement, the fair value of the conversion liabilities, realization of deferred tax assets, and the fair value of the customer list acquired on February 9, 2024. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents  

Cash and Cash Equivalents

The Company considers all operating accounts that hold money market funds held and short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

Trading Securities  

Trading Securities

Securities held in the Company’s trading account and trading securities, consist primarily of over-the-counter securities and are valued based upon quoted market prices. The value of securities that are not readily marketable are estimated by management based upon quoted prices, the number of market makers, trading volume and number of shares held. Unrealized gains and losses are reflected in income in the financial statements.

Property and Equipment  

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation. Depreciation on property and equipment is provided using accelerated and straight-line methods over expected useful lives of three to seven years.

Leases  

Leases

In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability on the statement of financial condition for all leases with terms longer than 12 months. Pursuant to this standard, the Company has recorded an operating lease right-of use (“ROU”) asset and operating lease liability in the accompanying balance sheet as of June 30, 2024.

The Company leases office space under the terms of several operating leases. The determination of whether an arrangement is a lease is made at the lease’s inception. Under ASC 842, a contract is (or contains) a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Control is defined under the standard as having both the right to obtain substantially all of the economic benefits from use of the asset and the right to direct the use of the asset. Management only reassesses its determination if the terms and conditions of the contract are changed.

ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses the implicit rate when it is readily determinable. Since the Company’s leases do not provide implicit rates, to determine the present value of lease payments, management uses the Company’s estimated incremental borrowing rate based on the information available at lease commencement.

Goodwill

Goodwill

We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates, and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As a result of the Deferred tax the Goodwill

balance was reduced by the benefit received. As of September 30, 2024, the fair value of goodwill was $6,142,525, as described in Note 10.

Goodwill

Goodwill represents the excess of purchase price in a business combination over the fair value of the net identifiable assets acquired. We evaluate goodwill for impairment at the reporting unit level by assessing whether it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If this assessment concludes that it is more likely than not that the fair value of a reporting unit exceeds its carrying value, then goodwill is not considered impaired and no further impairment testing is required. Conversely, if the assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, a goodwill impairment test is performed to compare the fair value of the reporting unit to its carrying value. The Company determines fair value of the reporting unit using income models. Our models contain significant assumptions and accounting estimates about discount rates, future cash flows, that could materially affect our operating results or financial position if they were to change significantly in the future and could result in an impairment. We perform our goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth quarter each year. The cash flow estimates and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As of June 30, 2024, the fair value of goodwill was $7,706,725, as described in Note 11.

Intangible Assets

Intangible Assets

Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of September 30, 2024, the carrying value of developed technology and customer list was $1,928,800 and $13,843,665, respectively, as described in Note 10 and Note 11.

Intangible Assets

Intangible assets are presented at fair value, net of amortization. The fair value is determined based on the appraised value of the asset. Intangible assets comprise of developed technology and customer list (See Note 11 and 13). Developed technology and customer relationships are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of June 30, 2024, the fair value of developed technology and customer list was $1,726,500 and $14,625,000, respectively, as described in Note 11 and Note 13.

Impairment of Long-lived and Intangible Assets

Impairment of Long-lived and Intangible Assets

The Company had no impairment charges during the three-month periods ended September 30, 2024 and 2023.

Impairment of Long-lived and Intangible Assets

In accordance with ASC 360-10 Property Plant and Equipment and ASC 350-10 Intangibles, the Company, on a regular basis, reviews the carrying amount of long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. The Company determines if the carrying amount of a long-lived asset is impaired based on anticipated undiscounted cash flows, before interest, from the use of the asset. In the event of impairment, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the asset. Fair value is determined based on the appraised value of the assets or the anticipated cash flows from the use of the asset, discounted at a rate commensurate with the risk involved. The Company recorded $17,845,813 of impairment charges included in loss on AtlasClear asset acquisition during the six months ended June 30.

Warrant Liabilities

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the condensed consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 14).

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the consolidated statements of operations. The fair value of the private warrants was estimated using a Black-Scholes model approach (see Note 9).

Income Taxes  

Income Taxes

The Company utilizes the asset and liability method to account for income taxes. The objective of this method is to establish deferred tax assets and liabilities for the temporary differences between net income for financial reporting basis and the tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized.

Income tax expense or benefit is provided based upon the financial statement earnings of the Company. The allowance for doubtful accounts is deductible for financial statement purposes, but not for tax purposes. Depreciation expense is recognized in different periods for tax and financial accounting purposes due to the use of accelerated depreciation methods for income tax purposes. The tax effects of such differences are reported as deferred income taxes in the financial statements.

Revenue Recognition  

Revenue Recognition

Wilson-Davis, a subsidiary of the Company, recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, using the modified retrospective method. This revenue recognition guidance requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance requires an entity to follow a five-step model to: (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when the entity satisfies a performance obligation.

Wilson-Davis acts as an agent by selling securities to customers and collecting commissions. Wilson-Davis recognizes commissions on a trade date basis, which is the day the transaction is executed. Wilson-Davis believes that the performance obligation is satisfied on the trade date because that is when the security is selected, the price is determined, the trade is executed, and the risks and rewards of ownership have been transferred to/from the customer.

Wilson-Davis also receives commissions on mutual funds purchased by customers. Wilson-Davis believes that the performance obligation is not satisfied until the mutual funds are purchased by customers and recognizes the commission at that time.

Wilson-Davis performs vetting services to customers that wish to convert restricted stock to eligible trading stock. In addition, Wilson-Davis charges clearing fees to another broker-dealer for which it clears trades. Wilson-Davis recognizes revenue as the related performance obligations are satisfied.

Common Stock Subject to Possible Redemption  

Common Stock Subject to Possible Redemption

The Company accounts for its Common Stock subject to possible redemption in accordance with the guidance in ASC 480. Common Stock subject to mandatory redemption are classified as a liability instrument and is measured at fair value. Conditionally redeemable Common Stock (including Common Stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Common Stock is classified as stockholders’ equity. The Company’s Common Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, all Common Stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Common Stock to equal the redemption value at the end of each reporting period. The accretion of redeemable Common Stock during the year ended December 31, 2023 was an increase of $4,008,446, which represents cumulative earnings and withdrawals on the Trust Account through December 31, 2023, net of reimbursable income and franchise tax obligations as of December 31, 2023. The dissolution expense of $100,000 is not included in the redemption value of the Common Stock subject to redemption since it is only taken into account in the event of the Company’s liquidation. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Common Stock resulted in charges against additional paid-in capital, to the extent available, and accumulated deficit. On February 9, 2024, the shareholders redeemed in connection with the business combination $53,947,064, the company withdrew $68,418 from trust to cover income tax payments and recognized reclassified the unredeemed shares to permanent equity of 1,195,566. As of June 30, 2024 the Company no longer has redeemable shares.

At June 30, 2024, December 31, 2023 and 2022, the Common Stock reflected in the balance sheets is reconciled in the following table:

Common Stock subject to possible redemption, December 31, 2021

    

$

201,250,000

Plus:

  

Accretion of carrying value to redemption value

2,170,202

Common Stock subject to possible redemption, December 31, 2022

 

203,420,202

Less:

 

  

Redemption

 

(152,810,179)

Plus:

 

  

Accretion of carrying value to redemption value

 

4,008,446

Common Stock subject to possible redemption, December 31, 2023

$

54,618,469

Less:

 

  

Redemption

 

(53,947,064)

Withdraw for taxes

 

(68,416)

Reclass to permanent equity

 

(1,195,566)

Plus:

 

  

Accretion of carrying value to redemption value

 

592,577

Common Stock subject to possible redemption, June 30, 2024

$

Net (Loss) Income per Common Stock

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) Income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the warrants issued and outstanding. For the three months ended September 30, 2024, the calculation excludes the dilutive impact of warrants because none would be issued under treasury method. The convertible financial instrument and other share obligations were included in the dilutive calculation under the as converted method, as such the number of shares were included as if the shares were issued on July 1, 2024 and the interest expense and the change in fair value associated with the financial instruments was adjusted from net income to determine the numerator and denominator.

For the three months ended September 30, 2023, the calculation excludes the dilutive impact of these instruments because the exercise of the warrants were contingent upon the occurrence of future events and inclusion would be antidilutive.

The following table reflects the calculation of basic net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30, 2024

September 30, 2023

    

Non-

    

    

Non-

 redeemable

Redeemable

 redeemable

Basic net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income, as adjusted

$

10,748,033

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Basic weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

Basic net income per common stock

$

0.70

$

(0.03)

$

(0.03)

The following table reflects the calculation of diluted net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30,2024

September 30,2023

Non-

Non-

    

redeemable

    

Redeemable

    

redeemable

Diluted net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income,

$

10,748,033

$

(130,164)

$

(125,814)

Change in fair value of financial instruments

 

(12,655,000)

 

 

Interest on dilutive instruments

 

1,419,843

 

 

Allocation of net income, as adjusted

$

(487,124)

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Dilutive weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

If converted shares

 

99,180,693

 

 

 

114,565,050

 

5,205,217

 

5,031,250

Diluted net income (loss) per common stock

$

(0.00)

$

(0.03)

$

(0.03)

Below is a summary of the dilutive instruments as of September 30, 2024 and 2023:

Description

    

September 30, 2024

    

September 30, 2023

Short Term Notes

 

49,050,804

 

Convertible notes

 

19,263,975

 

Secured convertible note

 

26,202,298

 

Subscription agreement

 

2,818,665

 

Tau agreement

 

1,253,514

 

Stock payable

250,000

Promissory note

341,437

Total Shares issuable under Convertible Note obligations – if converted total dilutive

99,180,693

Public Warrants

 

10,062,500

 

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

Secured convertible note warrants

 

600,000

 

Total excluded under treasury method – out of the money

 

16,215,625

 

16,215,625

Net (Loss) Income per Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. (Loss) income is allocated between redeemable and non-redeemable shares based on relative amounts of weighted average shares outstanding. Accretion associated with the redeemable shares of common stock is excluded from (loss) income per share as the redemption value approximates fair value.

The calculation of diluted net (loss) income per share does not consider the effect of the convertible derivative liability, subscription agreement, earnout shares nor the warrants issued and outstanding. The calculation excludes the dilutive impact of these instruments because the issuance of the securities underlying the exercise of the warrants are contingent upon the occurrence of future events and inclusion would be antidilutive. As a result, diluted net (loss) income per share of common stock is the same as basic net (loss) income per common stock for the periods presented.

The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):

    

FOR THE SIX MONTHS PERIOD ENDED

FOR THE YEAR ENDED

June 30, 2024

December 31, 2023

December 31, 2022

    

Non-

    

    

Non-

    

Non-

Redeemable

    

 redeemable

    

Redeemable

    

 redeemable

    

Redeemable

    

 Redeemable

Basic and diluted net income (loss) per share of Common Stock

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Net loss

$

(11,279,605)

$

(108,927,342)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Deemed dividend

(15,422,431)

Allocation of net income (loss)

$

(11,279,605)

$

(124,349,773)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Denominator:

 

 

 

 

Basic and diluted weighted average shares outstanding

 

10,719,043

 

1,109,975

6,898,644

5,031,250

 

20,125,000

 

5,031,250

Basic and diluted net income (loss) per share of Common Stock

$

(10.16)

$

(11.60)

$

0.07

$

0.07

$

0.44

$

0.44

Below is a summary of the dilutive instruments as of June 30, 2024, December 31, 2023 and, these were excluded as including them would be anti dilutive as of June 30, 2024 and were excluded in December 31, 2023 and June 30, 2023 as the exercise was contingent:

For the Six Months Ended

For the year ended

Description

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Shares issuable pursuant to Short Term and Long Term Notes

 

14,012,965

 

Shares issuable pursuant to Secured convertible note

 

9,801,273

 

Shares issuable pursuant to Convertible note

4,722,875

Shares issuable pursuant to Subscription agreement

938,967

Shares issuable pursuant to Promissory note

 

379,375

 

Total Shares issuable under Note obligations

 

29,855,455

 

Public Warrants

 

10,062,500

 

10,062,500

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

6,153,125

Secured convertible note warrants

 

600,000

 

Total dilutive

 

46,071,080

 

16,215,625

16,215,625

Concentration of Credit Risk  

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments  

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for warrant liabilities, convertible derivatives and the earnout out liability (see Note 19).

Derivative Financial Instruments  

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Recent Accounting Standards

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
Schedule of common stock reflected in the balance sheets  

Common Stock subject to possible redemption, December 31, 2021

    

$

201,250,000

Plus:

  

Accretion of carrying value to redemption value

2,170,202

Common Stock subject to possible redemption, December 31, 2022

 

203,420,202

Less:

 

  

Redemption

 

(152,810,179)

Plus:

 

  

Accretion of carrying value to redemption value

 

4,008,446

Common Stock subject to possible redemption, December 31, 2023

$

54,618,469

Less:

 

  

Redemption

 

(53,947,064)

Withdraw for taxes

 

(68,416)

Reclass to permanent equity

 

(1,195,566)

Plus:

 

  

Accretion of carrying value to redemption value

 

592,577

Common Stock subject to possible redemption, June 30, 2024

$

Schedule of diluted net income per share of Common Stock

The following table reflects the calculation of basic net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30, 2024

September 30, 2023

    

Non-

    

    

Non-

 redeemable

Redeemable

 redeemable

Basic net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income, as adjusted

$

10,748,033

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Basic weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

Basic net income per common stock

$

0.70

$

(0.03)

$

(0.03)

The following table reflects the calculation of diluted net income (loss) per share of common stock (in dollars, except share amounts):

Three Months Ended

September 30,2024

September 30,2023

Non-

Non-

    

redeemable

    

Redeemable

    

redeemable

Diluted net income (loss) per common stock

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

Allocation of net income,

$

10,748,033

$

(130,164)

$

(125,814)

Change in fair value of financial instruments

 

(12,655,000)

 

 

Interest on dilutive instruments

 

1,419,843

 

 

Allocation of net income, as adjusted

$

(487,124)

$

(130,164)

$

(125,814)

Denominator:

 

  

 

  

 

  

Dilutive weighted average common stock outstanding

 

15,384,357

 

5,205,217

 

5,031,250

If converted shares

 

99,180,693

 

 

 

114,565,050

 

5,205,217

 

5,031,250

Diluted net income (loss) per common stock

$

(0.00)

$

(0.03)

$

(0.03)

The following table reflects the calculation of basic and diluted net (loss) income per share of common stock (in dollars, except share amounts):

    

FOR THE SIX MONTHS PERIOD ENDED

FOR THE YEAR ENDED

June 30, 2024

December 31, 2023

December 31, 2022

    

Non-

    

    

Non-

    

Non-

Redeemable

    

 redeemable

    

Redeemable

    

 redeemable

    

Redeemable

    

 Redeemable

Basic and diluted net income (loss) per share of Common Stock

 

  

 

  

 

  

 

  

Numerator:

 

  

 

  

 

  

 

  

Net loss

$

(11,279,605)

$

(108,927,342)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Deemed dividend

(15,422,431)

Allocation of net income (loss)

$

(11,279,605)

$

(124,349,773)

$

460,174

$

335,609

$

8,836,454

$

2,209,113

Denominator:

 

 

 

 

Basic and diluted weighted average shares outstanding

 

10,719,043

 

1,109,975

6,898,644

5,031,250

 

20,125,000

 

5,031,250

Basic and diluted net income (loss) per share of Common Stock

$

(10.16)

$

(11.60)

$

0.07

$

0.07

$

0.44

$

0.44

Schedule of dilutive instruments

Description

    

September 30, 2024

    

September 30, 2023

Short Term Notes

 

49,050,804

 

Convertible notes

 

19,263,975

 

Secured convertible note

 

26,202,298

 

Subscription agreement

 

2,818,665

 

Tau agreement

 

1,253,514

 

Stock payable

250,000

Promissory note

341,437

Total Shares issuable under Convertible Note obligations – if converted total dilutive

99,180,693

Public Warrants

 

10,062,500

 

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

Secured convertible note warrants

 

600,000

 

Total excluded under treasury method – out of the money

 

16,215,625

 

16,215,625

For the Six Months Ended

For the year ended

Description

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Shares issuable pursuant to Short Term and Long Term Notes

 

14,012,965

 

Shares issuable pursuant to Secured convertible note

 

9,801,273

 

Shares issuable pursuant to Convertible note

4,722,875

Shares issuable pursuant to Subscription agreement

938,967

Shares issuable pursuant to Promissory note

 

379,375

 

Total Shares issuable under Note obligations

 

29,855,455

 

Public Warrants

 

10,062,500

 

10,062,500

10,062,500

Private Warrants

 

5,553,125

 

6,153,125

6,153,125

Secured convertible note warrants

 

600,000

 

Total dilutive

 

46,071,080

 

16,215,625

16,215,625

v3.24.4
CASH AND RESTRICTED CASH (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
CASH AND RESTRICTED CASH    
Schedule of reconciliation of cash and restricted cash as shown in the statements of cash flows

    

For the Three Months

Ended 

September 30, 2024

Cash and cash equivalents

$

6,817,398

Cash segregated - customers

 

19,980,711

Cash segregated - PAB

 

768,767

Total cash and restricted cash shown in the statement of cash flows.

$

27,566,876

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Cash and cash equivalents

$

6,558,176

$

619,554

$

129,560

Cash segregated - customers

 

20,548,972

 

 

Cash segregated - PAB

 

200,738

 

 

Total cash and restricted cash shown in the statement of cash flows.

$

27,307,886

$

619,554

$

129,560

v3.24.4
PROPERTY AND EQUIPMENT (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
PROPERTY AND EQUIPMENT    
Summary of major classifications of property and equipment

    

September 30, 2024

Equipment

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(364,537)

$

11,511

June 30, 2024

Equipment

      

$

150,202

Leasehold improvements

 

89,087

Software

 

85,042

Furniture and fixtures

 

51,717

 

376,048

Less: Accumulated depreciation and Amortization

 

(359,968)

$

16,080

v3.24.4
ACQUISITION OF WILSON-DAVIS (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
ACQUISITION OF WILSON-DAVIS    
Summary of preliminary allocation of the purchase price

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(3,724,270)

Trading Account deposit

 

(100,000)

Net assets acquired

 

6,296,241

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

20,767,525

Cash paid to Wilson-Davis shareholders

    

$

8,092,569

Short-term notes

 

5,000,000

Long-term notes

 

7,971,197

Value of shares transferred from sponsor

 

6,000,000

Total consideration paid

 

27,063,766

Allocated to:

 

Cash

$

11,333,271

Cash segregated

 

22,000,605

Receivables

 

4,065,148

Trading Securities, market value

 

6,875

Prepaid Income Tax

 

201,125

Accounts payable, accrued expenses and other current liabilities

 

(28,045,034)

Current portion of lease liability

 

(161,212)

Property and equipment

 

23,645

Cash deposit BDs and Clearing Organizations

 

3,536,664

Operating Lease Right-to-Use Lease Assets

 

395,063

Other Assets

 

385,058

Stock loan

 

(1,431,068)

Long-term Lease liability

 

(239,629)

Subordinated Borrowing

 

(1,950,000)

Deferred tax liability

(5,288,470)

Trading Account deposit

 

(100,000)

Net assets acquired

 

4,732,041

Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill

$

22,331,725

Summary of identifiable intangible assets acquired

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

20,767,525

 

Goodwill

$

6,142,525

 

(a)The Wilson-Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

    

    

Estimated

Useful Life

Amount

(Years)

Customer Lists (a)

$

14,625,000

 

12

Excess of purchase price

 

22,331,725

 

Goodwill

$

7,706,725

 

(a)

The Wilson Davis customer relationships were valued using the Multi-Period Excess Earnings Method (“MPEEM”). The MPEEM reflects the present value of the operating cash flows generated by existing customer relationships after taking into account the cost to realize the revenue and an appropriate discount rate to reflect the time value and risk associated with the cash flows.

Summary the pro forma financial information

    

September 30, 2023

Total revenue

$

1,834,164

Net loss

$

(1,575,799)

Weighted average shares

 

  

Basic

 

11,801,759

Net loss per shares:

 

  

Basic

$

(0.13)

Weighted average shares

 

  

Diluted

 

11,801,759

Net loss per shares:

 

  

Diluted

$

(0.13)

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Total revenue

$

5,247,150

$

8,258,254

$

9,527,324

Net loss

 

(23,878,060)

$

(4,695,016)

$

(90,186,458)

Weighted average shares

 

  

 

  

 

  

Basic and diluted

 

11,801,759

 

11,801,759

 

11,906,245

Net loss per shares:

 

  

 

  

 

  

Basic and diluted

$

(2.02)

$

(0.40)

$

(8.87)

Summary of pro forma adjustments

    

September 30, 2023

Transaction cost

$

Amortization of intangibles

$

(307,192)

Interest earned on investments held in trust

$

(722,390)

    

June 30, 2024

    

December 31, 2023

    

December 31, 2022

Transaction cost

$

(9,008,053)

$

$

9,008,053

Amortization of intangibles

$

$

2,437,500

$

2,437,500

Loss on AtlasClear acquisition

$

86,392,769

$

$

(86,392,769)

Interest earned on investments held in trust

$

(256,279)

$

(3,090,086)

$

(3,087,315)

v3.24.4
INTANGIBLE ASSETS (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
INTANGIBLE ASSETS    
Summary of intangible assets

September 30, 2024

    

    

Accumulated

    

Impairment

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,928,800

 

 

 

1,928,800

Customer Lists

12 years

 

14,625,000

 

(781,335)

 

 

13,843,665

Intangible Assets

$

22,696,325

$

(781,335)

$

(17,845,813)

$

21,914,990

June 30, 2024

    

    

Accumulated

    

Impairment

    

    

Est useful life

    

Cost

Amortization

of Asset

Net

Goodwill

Indefinite

$

6,142,525

$

$

$

6,142,525

Pacsquare assets – Proprietary Software

10 years

 

1,726,500

 

 

 

1,726,500

Technology acquired

zero years

 

18,163,044

 

(317,231)

 

(17,845,813)

 

Customer Lists

12 years

 

14,625,000

 

(474,144)

 

 

14,150,856

Intangible Assets

$

40,657,069

$

(791,375)

$

(17,845,813)

$

22,019,881

Summary of amortization intangible assets

Fiscal Year

    

Amount

June 30, 2025

$

911,558

June 30, 2026

 

1,411,630

June 30, 2027

 

1,411,630

June 30, 2028

 

1,414,970

June 30, 2029

 

1,411,630

Thereafter

 

9,211,047

Year

    

Amount

June 30, 2025

$

1,218,750

June 30, 2026

 

1,391,400

June 30, 2027

 

1,391,400

June 30, 2028

 

1,394,739

June 30, 2029

 

1,391,400

Thereafter

 

9,089,667

v3.24.4
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
FAIR VALUE MEASUREMENTS    
Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis

    

    

September 30,

    

June 30,

Description

Level

2024

2024

 

 

  

 

  

Liabilities:

 

Subscription agreement

3

$

2,460,488

$

2,425,647

Contingent Guarantee

3

$

$

3,256,863

Warrant liability – Private Warrants

3

$

61,531

$

307,656

Earnout liability

 

3

$

12,638,000

$

12,298,000

Convertible notes derivative

 

3

$

2,142,511

$

16,462,690

Merger financing derivative

3

$

176,239

Secured convertible derivative

3

$

89,535

Tau agreement

 

3

$

972,508

$

    

    

June 30,

    

December 31,

    

December 31,

Description

Level

2024

2023

2022

Assets:

 

 

  

 

  

 

  

Marketable securities held in Trust Account

 

1

$

$

54,799,478

$

204,044,469

Liabilities:

 

 

  

 

  

 

  

Subscription agreement

3

$

2,084,691

$

$

Contingent Guarantee

3

$

3,256,863

$

$

Warrant liability – Private Warrants

 

3

$

307,656

$

307,656

$

184,594

Non-redemption agreement liability

3

$

$

1,441,653

$

Convertible notes derivative

3

$

16,462,690

$

$

Earnout liability

 

3

$

12,298,000

$

$

Schedule of key inputs into the models

    

June 30,

    

June 30,

 

Input

 

2024

 

2024

Market price of public shares

$

0.21

$

1.04

Equity volatility

 

34.4

%  

 

26.2

%

Risk-free rate

 

4.01

%  

 

5.05

%

    

June 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Risk-free rate

 

3.52

%  

 

4.27

%

Dividend yield

 

0.00

%  

 

0.00

%

Volatility

 

87.4

%  

 

58.7

%

Exercise price

$

11.50

$

11.50

Effective expiration date

 

February 2029

 

February 2029

    

September 30,

    

June 30,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

1.04

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

9.61

%  

 

9.69

%

    

September 30,

 

Input

 

2024

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

 

28.9

%

Volatility

 

36.7

%

Effective expiration date

 

February 2026

    

June 30,

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

5.49

%

Dividend yield

 

0.00

%

Volatility

 

14,643.0

%

Exercise price

$

0.99

Effective expiration date

May 2024

    

September 30,

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.84

%

Discount rate

 

11.72

%

Probability of default

 

22.9

%

Recovery rate

28.9

%

Volatility

36.7

%

Effective expiration date

February 2026

    

June 30,

 

Input

 

2024

Market price of public shares

$

1.04

Risk-free rate

 

4.90

%

Dividend yield

 

0.00

%

Volatility

 

14,461

%

Exercise price

$

0.99

Effective expiration date

 

February 2026

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

4.36

%

Discount rate

 

7.72

%

Probability of default

 

41.2

%

Recovery rate

 

47.6

%

Volatility

 

43.9

%

Effective expiration date

 

February 2028

    

June 30,

 

Input

2024

 

Market price of public shares

$

1.04

Risk-free rate

 

4.52

%

Dividend yield

 

0.00

%

Volatility

 

166,681.0

%

Exercise price

$

0.84

Effective expiration date

 

February 2028

    

September 30,

 

Input

2024

 

Market price of public shares

$

0.21

Risk-free rate

 

3.87

%

Discount rate

 

7.84

%

Probability of default

 

19.8

%

Recovery rate

 

47.6

%

Volatility

 

36.8

%

Effective expiration date

 

November 2025

    

September 30,

    

August 9,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

4.84

%

 

4.78

%

Discount rate

 

11.72

%

 

16.98

%

Probability of default

 

23.5

%

 

25.4

%

Recovery rate

 

28.9

%

 

28.9

%

Volatility

 

36.7

%

 

37.2

%

Effective expiration date

 

February 2026

 

February 2026

    

September 30,

    

July 31

 

Input

2024

2024

 

Anticipated Monthly Advance Amounts

$

40,000

$

40,000

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

    

September 30,

    

July 31,

 

Input

2024

2024

 

Market price of public shares

$

0.21

$

0.27

Risk-free rate

 

3.59

%

 

4.20

%

Volatility

 

37.4

%

 

40.3

%

Effective expiration date

 

July 2026

 

July 2026

The key inputs into the Monte Carlo model for the Subscription Agreement were as follows:

February 9,

 

June 30,

2024

 

Input

    

2024

    

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Equity volatility

 

26.2

%  

 

29.8

%

Risk-free rate

 

5.05

%  

 

4.67

%

The key inputs into the Black-Scholes model for the Private Warrants were as follows:

    

June 30,

    

December 31,

December 31,

 

Input

2024

2023

2022

 

Market price of public shares

$

1.04

$

6.20

$

10.05

Risk-free rate

 

4.27

%  

 

3.77

%  

 

3.91

%

Dividend yield

 

0.00

%  

 

0.00

%  

 

0.00

%

Volatility

 

58.7

%  

 

12.0

%  

 

2.6

%

Probability of a business combination

 

100

%  

 

100

%  

 

4.5

%

Exercise price

$

11.50

$

11.50

$

11.50

Effective expiration date

 

February 29

 

February 29

 

February 29

The key inputs into the Monte Carlo model for the non-redeemable common stock were as follows:

    

December 31,

August 1,

 

Input

2023

2023

 

Market price of public shares

$

6.20

$

10.57

Probability of acquisition

 

100.0

%

 

82.0

%

Equity volatility

 

12.0

%

 

19.9

%

Discount for lack of marketability

 

8.0

%

 

3.0

%

Discount for expected forfeiture

 

5.10

%

 

5.10

%

The key inputs into the Monte Carlo model for the Earnout liability were as follows:

    

    

February 9,

 

June 30,

2024

 

Input

2024

(initial measurement)

 

Market price of public shares

$

1.04

$

10.26

Revenue volatility

 

15.00

%  

 

15.00

%

Discount factor for revenue

 

96.9

%  

 

99.5

%

maturity. As of June 30, 2024, the company did not repay the short-term notes as such has incurred penalty interest from 9% to 13% until the note is repaid. No notice of default has been received. See note 10 for additional information.

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

5.49

 

5.44

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,643.0

 

4,120.0

%

Exercise price

$

0.99

$

7.27

Effective expiration date

May 2024

May 2024

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.90

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

14,461

 

41,200

%

Exercise price

$

0.99

$

7.27

Effective expiration date

February 2026

February 2026

February 9,

 

2024

 

    

June 30,

    

(initial

 

Input

2024

 

measurement)

Market price of public shares

$

1.04

$

10.26

Risk-free rate

 

4.52

 

4.48

%

Dividend yield

 

0.00

 

0.00

%

Volatility

 

166,681.0

 

4,120.0

%

Exercise price

$

0.84

$

10.26

Effective expiration date

February 2028

February 2028

Schedule of changes in the fair value

    

Private

    

Tau

Placement

 Agreement

Warrants

Liability

Fair value as of June 30, 2024

$

307,656

$

Initial measurement

1,090,949

Transferred to equity

(303,000)

Change in valuation inputs or other assumptions

(246,125)

184,559

Fair value as of September 30, 2024

$

61,531

$

972,508

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

Change in valuation inputs or other assumptions

 

(14,320,179)

 

 

340,000

Fair value as of September 30, 2024

$

2,142,511

 

$

12,638,000

    

Subscription

    

Contingent

Agreement

Guarantee

Fair value as of June 30, 2024

$

2,425,647

$

3,256,863

Shares issued as partial payment

 

 

(1,210,290)

Change in valuation inputs or other assumptions

 

34,841

 

839,774

Exchanged to Merger financing note

 

 

(2,886,347)

Fair value liability as of September 30, 2024

$

2,460,488

$

    

Merger

    

Secured

Financing

Convertible

Derivative

Derivative

Fair value as of June 30, 2024

$

$

Initial measurement

 

113,044

 

Change in valuation inputs or other assumptions

 

63,195

 

89,535

Fair value as of September 30, 2024

$

176,239

$

89,535

    

Private

    

Non-Redemption

Placement

 Agreement

Warrants

Liability

Fair value as of December 31, 2021

$

7,137,930

$

Change in valuation inputs or other assumptions

(6,953,336)

1,881,440

Fair value as of December 31, 2022

$

184,594

$

Initial measurement as of August 1, 2023

1,881,440

Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability

123,062

(439,787)

Fair value as of December 31, 2023

$

307,656

$

1,441,653

Change in valuation inputs or other assumptions

164,626

Transferred to equity

(1,606,279)

Fair value as of June 30, 2024

$

307,656

$

Conversion

Earnout

    

Derivative

    

Liability

Fair value as of December 31, 2023

$

 

$

Initial measurement as of February 9, 2024

1,668,731

10,963,000

Change in valuation inputs or other assumptions

 

14,793,959

 

 

1,335,000

Fair value as of June 30, 2024

$

16,462,690

 

$

12,298,000

    

Subscription

    

Merger Financing

Agreement

Liability

Fair value as of December 31, 2023

$

$

Initial measurement as of February 9, 2024

 

2,386,851

 

Change in valuation inputs or other assumptions

 

38,796

 

3,256,863

Fair value (asset) liability as of June 30, 2024

$

2,425,647

$

3,256,863

v3.24.4
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS        
Cash in bank account $ 6,817,398 $ 27,307,886    
Working capital deficit 7,068,848 21,724,075    
Excise tax payable $ 2,067,572 $ 2,067,572 $ 1,528,101 $ 1,485,236
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Accretion of redeemable common stock increase       $ 4,008,446  
Dissolution expense       $ 100,000  
Effective tax rate     0.47% 47.71% 4.64%
Statutory tax rate     21.00% 21.00% 21.00%
Fair value of goodwill $ 6,142,525   $ 7,706,725    
Impairment charges $ 0 $ 0 $ 17,845,813 $ 17,845,813 $ 17,845,813
Minimum          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives     3 years    
Maximum          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives     7 years    
Developed technology          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives 10 years   10 years    
Intangible assets fair value $ 1,928,800   $ 1,726,500    
Customer Lists          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Useful lives 12 years   12 years    
Intangible assets fair value $ 13,843,665   $ 14,625,000    
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of basic net income (loss) per share of common stock (Details) - USD ($)
3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Redeemable    
Numerator:    
Allocation of net income, as adjusted   $ (130,164)
Denominator:    
Basic weighted average common stock outstanding (in shares)   5,205,217
Basic net income per common stock (in dollars per share)   $ (0.03)
Non-redeemable    
Numerator:    
Allocation of net income, as adjusted $ 10,748,033 $ (125,814)
Denominator:    
Basic weighted average common stock outstanding (in shares) 15,384,357 5,031,250
Basic net income per common stock (in dollars per share) $ 0.7 $ (0.03)
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of basic and diluted net income (loss) per share of common stock (Details) - USD ($)
3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Redeemable    
Numerator:    
Allocation of net income,   $ (130,164)
Allocation of net income, as adjusted   $ (130,164)
Denominator:    
Basic weighted average common stock outstanding (in shares)   5,205,217
Dilutive weighted average common stock outstanding (in shares)   5,205,217
Diluted net income (loss) per common stock (in dollars per share)   $ (0.03)
Non-redeemable    
Numerator:    
Allocation of net income, $ 10,748,033 $ (125,814)
Change in fair value of financial instruments (12,655,000)  
Interest on dilutive instruments 1,419,843  
Allocation of net income, as adjusted $ (487,124) $ (125,814)
Denominator:    
Basic weighted average common stock outstanding (in shares) 15,384,357 5,031,250
If converted shares 99,180,693  
Dilutive weighted average common stock outstanding (in shares) 114,565,050 5,031,250
Diluted net income (loss) per common stock (in dollars per share) $ 0 $ (0.03)
v3.24.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of dilutive instruments (Details) - shares
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total excluded under treasury method - out of the money 16,215,625 16,215,625 46,071,080 16,215,625 16,215,625
Short Term Notes          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 49,050,804        
Convertible notes          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 19,263,975        
Secured convertible note          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 26,202,298        
Subscription agreement          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 2,818,665        
Tau agreement          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 1,253,514        
Stock payable          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 250,000        
Promissory note          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 341,437        
Total Shares issuable under Convertible Note obligations - if converted total dilutive          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total Shares issuable under Convertible Note obligations - if converted total dilutive 99,180,693        
Total excluded under treasury method - out of the money     29,855,455    
Public Warrants          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total excluded under treasury method - out of the money 10,062,500 10,062,500 10,062,500 10,062,500 10,062,500
Private Placement Warrants          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total excluded under treasury method - out of the money 5,553,125 6,153,125 5,553,125 6,153,125 6,153,125
Secured convertible note warrants          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES          
Total excluded under treasury method - out of the money 600,000   600,000    
v3.24.4
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS (Details) - USD ($)
Oct. 01, 2024
Sep. 30, 2024
Jul. 01, 2024
Jun. 30, 2024
Customers transactions and credit balances        
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS        
Calculated required reserve   $ 18,830,537   $ 19,326,300
Cash on deposit in the reserve account   19,667,586   19,677,378
Cash reserve deposit more than amount required   837,049   351,078
Amount deposited to reserve account in accordance with the rule     $ 150,000  
Amount withdrew from reserve account in accordance with the rule $ 337,049      
Cash on deposit in the reserve account in excess of the amount required $ 500,000   $ 501,078  
Broker-dealer transactions and credit balances        
CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS        
Calculated required reserve   100,000   100,000
Cash on deposit in the reserve account   200,000   200,738
Cash reserve deposit more than amount required   $ 100,000   $ 100,738
v3.24.4
NET CAPITAL REQUIREMENTS (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
NET CAPITAL REQUIREMENTS    
Net capital $ 10,449,178 $ 10,437,312
Net capital in excess of the minimum required $ 10,199,178 $ 10,187,312
v3.24.4
CASH AND RESTRICTED CASH (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH AND RESTRICTED CASH              
Cash and cash equivalents $ 6,817,398 $ 6,558,176 $ 619,554   $ 1,132,900 $ 129,560  
Cash segregated - customers 19,980,711 20,548,972          
Cash segregated - PAB 768,767 200,738          
Total cash and restricted cash shown in the statement of cash flows. $ 27,566,876 $ 27,307,886 $ 619,554 $ 712,807 $ 1,132,900 $ 129,560 $ 63,179
v3.24.4
CUSTOMER RECEIVABLE AND PAYABLES (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
CUSTOMER RECEIVABLE AND PAYABLES          
Bad Debt Expense $ 639 $ 15,000 $ 15,000 $ 0 $ 0
v3.24.4
PROPERTY AND EQUIPMENT (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2024
Jun. 30, 2024
PROPERTY AND EQUIPMENT    
Depreciation expense $ 4,569 $ 7,565
v3.24.4
PROPERTY AND EQUIPMENT - Summary of major classifications of property and equipment (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Property, Plant and Equipment    
Property and equipment, gross $ 376,048 $ 376,048
Less: Accumulated depreciation and Amortization (364,537) (359,968)
Property and equipment, net 11,511 16,080
Equipment    
Property, Plant and Equipment    
Property and equipment, gross 150,202 150,202
Leasehold improvements    
Property, Plant and Equipment    
Property and equipment, gross 89,087 89,087
Software    
Property, Plant and Equipment    
Property and equipment, gross 85,042 85,042
Furniture and fixtures    
Property, Plant and Equipment    
Property and equipment, gross $ 51,717 $ 51,717
v3.24.4
RELATED PARTY TRANSACTIONS - Related Party Share Issuance/Transfers (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 29, 2024
Aug. 09, 2024
Jul. 10, 2024
Jun. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred             2,550,588        
Conversion, capital transferred             2,412,930        
Shares issued as payment towards contingent guarantee             $ 1,210,290        
Principal amount             359,896        
Common stock, $0.0001 par value;       $ 1,246 $ 1,246   $ 2,225 $ 1,246 $ 503 $ 503 $ 503
Common stock, par value (in dollars per share)       $ 0.0001 $ 0.0001   $ 0.0001 $ 0.0001 $ 0.0001   $ 0.0001
Common stock issued to for consulting services (in shares) 882,668   1,602,994                
Promissory Notes                      
RELATED PARTY TRANSACTIONS                      
Shares issued to pay interest on convertible notes             $ 21,299        
Secured convertible notes                      
RELATED PARTY TRANSACTIONS                      
Shares issued to pay interest on convertible notes             $ 217,397        
Chardan Note                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred             145,606 198,196      
Shares issued to pay interest on convertible notes             $ 212,803        
Principal amount             $ 400,000        
Shares transferred         2,263,031 2,263,031 2,263,031        
Short and Long Term Notes                      
RELATED PARTY TRANSACTIONS                      
Shares issued to pay interest on convertible notes             $ 351,141        
Quantum Ventures LLC                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred             366,750        
Quantum Ventures LLC | Shares issuable pursuant to Short Term and Long Term Notes                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred       1,558,923              
Quantum Ventures LLC | Sponsor | Shares issuable pursuant to Short Term and Long Term Notes                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred             1,558,923        
Atlas FinTech                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred             127,159        
Shares transferred   2,788,276                  
Common stock, $0.0001 par value;   $ 803,860                  
Common stock, par value (in dollars per share)   $ 0.0001                  
Reimbursement shares transferred   1,337,500                  
Number of additional shares issued   991,665                  
Common stock issued to for consulting services (in shares)   4,125,776                  
Atlas FinTech | Shares issuable pursuant to Short Term and Long Term Notes                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred       1,183,629              
Atlas FinTech | Chardan Note                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred             52,590        
Atlas FinTech | Sponsor | Shares issuable pursuant to Short Term and Long Term Notes                      
RELATED PARTY TRANSACTIONS                      
Conversion, shares transferred             991,665        
v3.24.4
RELATED PARTY TRANSACTIONS - Advances from Related Parties (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 09, 2024
Jun. 30, 2024
May 09, 2024
Feb. 09, 2024
Sep. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
RELATED PARTY TRANSACTIONS                  
Advances from related parties             $ 1,968,116 $ 3,104,097 $ 319,166
Proceeds from related party                 480,000
Related party loan         $ 352,981 $ 1,052,300 $ 1,948,950 $ 2,855,431 $ 319,166
Number of shares issued for settlement       2,000,000          
Liabilities settled       $ 4,636,397          
Receivables settled       58,828          
Deemed dividend to the related party       15,422,431          
AtlasFintech Holdings Corp                  
RELATED PARTY TRANSACTIONS                  
Business combination expense   $ 803,860   $ 803,860          
Shares issued as settlement in related party payable 2,788,276                
Quantum Ventures LLC                  
RELATED PARTY TRANSACTIONS                  
Shares transferred     56,073            
Pay of interest on debt     $ 47,750            
Interest rate (in percent)     13.00%            
Accrued amount     $ 55,087            
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Registration Rights (Details)
May 14, 2024
shares
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES  
Number of to be resale 77,577,099
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Business Combination Marketing Agreement (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Oct. 23, 2024
Aug. 09, 2024
Jun. 30, 2024
Feb. 09, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
COMMITMENTS AND CONTINGENCIES                    
Percentage of aggregate gross proceeds       3.50%            
Marketing Fees Payable To Underwriters, Waived In Exchange For Notes Payable       $ 7,043,750            
Conversion, shares transferred             2,550,588      
Unamortized discount (Premium), Net     $ 971,666   $ 971,666   $ 791,581 $ 971,666 $ 971,666  
Convertible notes, net     3,783,437   3,783,437     3,783,437 3,783,437  
Period to file registration statement with SEC       30 days            
Carriage House Capital, Inc                    
COMMITMENTS AND CONTINGENCIES                    
Fair value of the stock payable     259,893   259,893   $ 63,742 259,893 259,893  
Atlas FinTech                    
COMMITMENTS AND CONTINGENCIES                    
Shares transferred   2,788,276                
Conversion, shares transferred             127,159      
Quantum Ventures LLC                    
COMMITMENTS AND CONTINGENCIES                    
Conversion, shares transferred             366,750      
Non-Redemption Agreement Liability                    
COMMITMENTS AND CONTINGENCIES                    
Derivative liability                   $ 1,881,440
Conversion derivative                    
COMMITMENTS AND CONTINGENCIES                    
Derivative liability               1,668,731    
Earnout Liability                    
COMMITMENTS AND CONTINGENCIES                    
Derivative liability               $ 10,963,000    
Chardan Note                    
COMMITMENTS AND CONTINGENCIES                    
Aggregate principal amount       $ 4,150,000            
Conversion amount       $ 4,150,000 $ 725,000 $ 725,000 $ 725,000      
Shares transferred         2,263,031 2,263,031 2,263,031      
Conversion, shares transferred             145,606 198,196    
Shares issued as conversion in principle and interest on convertible notes (in shares)             1,769,122      
Amortization of discount             $ 86,209      
Interest amount             212,803      
Principal balance             3,425,000      
Unamortized discount             280,355      
Accrued interest expense     212,803   $ 212,803     $ 212,803 212,803  
Interest expense related to the amortization of the debt discount     $ 37,920   37,920     37,920 37,920  
Convertible notes, net             $ 3,282,518      
Interest rate (in percent)       13.00%            
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)       85.00%            
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent)       85.00%            
Number of years up to which the converted amount is to be held for payment of interest     3 years 3 years     3 years      
Beneficial ownership (in percent)       9.99%            
Period to file registration statement with SEC       45 days            
Minimum period for which the registration statement with SEC is suspended, considered for increase in interest rate       15 days            
Incremental weekly interest rate, if the registration statement is not filed or is not effective or terminated or suspended (in percent)       2.00%            
Chardan Note | Chardan Capital Market LLC                    
COMMITMENTS AND CONTINGENCIES                    
Marketing Fees Payable To Underwriters, Waived In Exchange For Notes Payable             $ 7,043,750      
Aggregate principal amount     $ 3,990,385   $ 3,990,385   $ 4,150,000 $ 3,990,385 $ 3,990,385  
Interest rate (in percent)     13.00%   13.00%   13.00% 13.00% 13.00%  
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)             85.00%   85.00%  
Debt principal amount       $ 4,150,000            
Chardan Note | Atlas FinTech                    
COMMITMENTS AND CONTINGENCIES                    
Conversion, shares transferred             52,590      
Chardan Note | JonesTrading Institutional Services                    
COMMITMENTS AND CONTINGENCIES                    
Aggregate principal amount       375,000            
Chardan Note | Conversion derivative                    
COMMITMENTS AND CONTINGENCIES                    
Derivative liability       $ 404,483            
Unamortized discount     $ 404,483   $ 404,483     $ 404,483 $ 404,483  
Chardan Note | Subsequent event                    
COMMITMENTS AND CONTINGENCIES                    
Aggregate principal amount $ 5,209,764                  
Conversion amount $ 5,209,764                  
Interest solutions note                    
COMMITMENTS AND CONTINGENCIES                    
Shares issued as conversion in principle and interest on convertible notes (in shares)             4,457      
Interest rate (in percent)       13.00%            
Initial Public Offering                    
COMMITMENTS AND CONTINGENCIES                    
Marketing fees payable to underwriters       $ 7,043,750            
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Expense Settlements (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 29, 2024
shares
Jul. 10, 2024
shares
Feb. 19, 2024
$ / shares
shares
Feb. 09, 2024
USD ($)
installment
$ / shares
shares
Sep. 13, 2023
$ / shares
shares
Sep. 30, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares 882,668 1,602,994                
Sale price per share (in Dollars per share) | $ / shares       $ 10     $ 10 $ 10    
Stock payable for remaining shares | shares           250,000   250,000    
Change in fair value of stock payable           $ (196,151) $ (985,072)      
Interest expense on convertible notes             1,896,714      
Promissory notes           852,968 852,968 $ 852,968    
Subscription agreement           2,460,488 2,425,647 2,425,647    
Nonrelated Party                    
COMMITMENTS AND CONTINGENCIES                    
Stock payable           63,742 259,893 259,893    
Promissory notes             852,968 852,968    
Related Party                    
COMMITMENTS AND CONTINGENCIES                    
Stock payable           55,087 55,087 55,087    
Promissory notes                 $ 480,000 $ 480,000
Interest solutions note                    
COMMITMENTS AND CONTINGENCIES                    
Sale price per share (in Dollars per share) | $ / shares       $ 2            
Interest expense on convertible notes           9,011        
Promissory notes           $ 288,908 288,908 288,908    
Shares issued as conversion in principle and interest on convertible notes (in shares) | shares           4,457        
Accrued interest net           $ 9,011        
Interest rate (in percent)       13.00%            
Convertible amount       $ 275,000            
Jones Trading Note                    
COMMITMENTS AND CONTINGENCIES                    
Sale price per share (in Dollars per share) | $ / shares       $ 2            
Interest expense on convertible notes           12,288        
Promissory notes           $ 393,966 393,966 393,966    
Shares issued as conversion in principle and interest on convertible notes (in shares) | shares           6,077        
Accrued interest net           $ 12,288        
Interest rate (in percent)       13.00%            
Convertible amount       $ 375,000            
Toppan Note                    
COMMITMENTS AND CONTINGENCIES                    
Promissory notes           $ 170,094 $ 170,094 $ 170,094    
Interest rate (in percent)       13.00%            
Aggregate principal amount       $ 160,025            
Maximum | Interest solutions note                    
COMMITMENTS AND CONTINGENCIES                    
Number of shares issuable upon debt conversion | shares       144,454            
Maximum | Jones Trading Note                    
COMMITMENTS AND CONTINGENCIES                    
Number of shares issuable upon debt conversion | shares       196,983            
Grant Thornton LLP                    
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares       46,010            
Sale price per share (in Dollars per share) | $ / shares       $ 10            
IB Capital LLC                    
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares       155,000            
Sale price per share (in Dollars per share) | $ / shares       $ 1.9            
Outside The Box Capital Inc                    
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares         20,000          
Sale price per share (in Dollars per share) | $ / shares         $ 10          
Carriage House Capital, Inc                    
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares       100,000     100,000      
Sale price per share (in Dollars per share) | $ / shares     $ 4.98 $ 4.98     $ 4.41 $ 4.41    
Stock payable for remaining shares | shares           250,000 250,000      
Stock payable           $ 1,244,965 $ 1,244,965 $ 1,244,965    
Change in fair value of stock payable           196,150        
Shares issuable for consulting services | shares             250,000      
Carriage House Capital, Inc | Nonrelated Party                    
COMMITMENTS AND CONTINGENCIES                    
Stock payable             $ 259,893 259,893    
Carriage House Capital, Inc | Due upon signing of the contract                    
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares     100,007              
Carriage House Capital, Inc | Due in months four through twelve from the date of signing                    
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares     27,777              
Carriage House Capital, Inc | Maximum                    
COMMITMENTS AND CONTINGENCIES                    
Stock issued for services | shares     350,000              
Winston & Strawn LLP                    
COMMITMENTS AND CONTINGENCIES                    
Value of shares issuable for services       $ 2,500,000            
Number of installments | installment       3            
Value of shares issuable for services in each installment       $ 833,333            
Subscription payable, liability           2,460,488 $ 2,425,647 $ 2,425,647    
Aggregate principal amount       $ 2,500,000            
Winston & Strawn LLP | Maximum                    
COMMITMENTS AND CONTINGENCIES                    
Number of shares issuable for services | shares       2,500,000            
Lead Nectar                    
COMMITMENTS AND CONTINGENCIES                    
Fair value of shares at grant date           $ 2,578        
Number of shares issuable for services | shares       12,000            
Value of shares payable for internet marketing services       $ 20,000            
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Secured Convertible Note Financing (Details)
3 Months Ended 6 Months Ended
Feb. 09, 2024
USD ($)
D
$ / shares
shares
Oct. 23, 2020
USD ($)
Sep. 30, 2024
USD ($)
shares
Jun. 30, 2024
USD ($)
COMMITMENTS AND CONTINGENCIES        
Period To File Registration Statement With SEC 30 days      
Fee on Secured Convertible Note       $ 1,500,000
Secured convertible note, net       6,857,101
Unamortized discount (Premium), Net     $ 791,581 971,666
Sponsor        
COMMITMENTS AND CONTINGENCIES        
Value of shares issued   $ 25,000    
Nonrelated Party        
COMMITMENTS AND CONTINGENCIES        
Secured convertible note, net     7,066,449 6,857,101
Funicular Note        
COMMITMENTS AND CONTINGENCIES        
Aggregate principal amount $ 6,000,000      
Purchase price of notes $ 6,000,000      
Interest rate (in percent) 12.50%      
Interest rate in the event of default (in percent) 20.00%      
Conversion Price (in dollars per share) | $ / shares $ 10      
Threshold trading days over which VWAP is considered to make monthly adjustments to the Conversion price | D 5      
Floor on Conversion price (in dollars per share) | $ / shares $ 2      
Market price of public shares (in Dollars per share) | $ / shares $ 2      
Number of days notice required for redemption of notes 30 days      
Redemption price as a percentage of the outstanding principal amount (in percent) 101.00%      
Threshold maximum percentage of outstanding common stock, above which stockholder's approval is required for conversion (in percent) 19.90%      
Period To File Registration Statement With SEC 15 days      
Number Of Days Within Which The Registration Statement Should Be Declared Effective 60 days      
Stock issued for purchase price adjusted to additional paid in capital 5.00%      
Fee on Secured Convertible Note       1,500,000
Accrued interest expense     246,660 328,767
Interest expense related to the amortization of the debt discount     $ 180,085 $ 279,032
Shares transferred by related party for conversion (in shares) | shares     368,004  
Pay for accrued interest     $ 217,373  
Funicular Note | Sponsor        
COMMITMENTS AND CONTINGENCIES        
Value of warrants issued $ 28,496      
Value of shares issued 1,222,202      
Stock issued for purchase price adjusted to additional paid in capital $ 1,250,698      
Funicular Note | Sponsor | Private Placement        
COMMITMENTS AND CONTINGENCIES        
Number of private warrants transferred (in shares) | shares 600,000      
Funicular Note | Sponsor | Founder Shares        
COMMITMENTS AND CONTINGENCIES        
Number of private warrants transferred (in shares) | shares 600,000      
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Sellers Note (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 09, 2024
Feb. 07, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
COMMITMENTS AND CONTINGENCIES          
Principal amount     $ 359,896    
Interest expense on convertible notes       $ 1,896,714  
Unamortized discount (Premium), Net     791,581 971,666  
Short-term merger financing, net       5,092,083  
Non-Redemption Agreement Liability          
COMMITMENTS AND CONTINGENCIES          
Derivative liability         $ 1,881,440
Conversion derivative          
COMMITMENTS AND CONTINGENCIES          
Derivative liability       1,668,731  
Earnout Liability          
COMMITMENTS AND CONTINGENCIES          
Derivative liability       10,963,000  
Short Term Notes          
COMMITMENTS AND CONTINGENCIES          
Aggregate principal amount   $ 5,000,000      
Maturity due   90 days      
Interest rate (in percent)   9.00%      
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)   90.00%      
Conversion rate, as a percentage of trailing seven-trading day VWAP, if an event of default occurs and is continuing (in percent)   90.00%      
Accrued interest expense       610,440  
Short Term Notes | Conversion derivative          
COMMITMENTS AND CONTINGENCIES          
Derivative liability   $ 487,329      
Long-Term Notes          
COMMITMENTS AND CONTINGENCIES          
Aggregate principal amount   $ 7,971,000      
Maturity due   24 months      
Interest rate (in percent)   13.00%      
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)   90.00%      
Conversion rate, as a percentage of trailing seven-trading day VWAP, if an event of default occurs and is continuing (in percent)   85.00%      
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent)   90.00%      
Interest expense related to the amortization of the debt discount       640,555  
Long-Term Notes | Conversion derivative          
COMMITMENTS AND CONTINGENCIES          
Derivative liability   $ 776,919   776,919  
Chardan Note          
COMMITMENTS AND CONTINGENCIES          
Aggregate principal amount $ 4,150,000        
Interest rate (in percent) 13.00%        
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent) 85.00%        
Conversion rate, as a percentage of trailing specified trading day VWAP (in percent) 85.00%        
Accrued interest expense       212,803  
Principal amount     400,000    
Interest amount     212,803    
Interest expense related to the amortization of the debt discount       $ 37,920  
Principal balance     $ 3,425,000    
Shares issued as conversion in principle and interest on convertible notes (in shares)     1,769,122    
Interest expense on convertible notes     $ 137,872    
Amortization of discount     86,209    
Accrued interest net     $ 137,872    
Chardan Note | Conversion derivative          
COMMITMENTS AND CONTINGENCIES          
Derivative liability $ 404,483        
Sellers note          
COMMITMENTS AND CONTINGENCIES          
Shares issued as conversion in principle and interest on convertible notes (in shares)     1,862,116    
Shares transferred by related party for conversion (in shares)     368,004    
Short term, seller notes          
COMMITMENTS AND CONTINGENCIES          
Interest amount     $ 7,530    
Principal balance     4,640,104    
Interest expense on convertible notes     158,333    
Pay for accrued interest     92,083    
Accrued interest net     150,803    
Unamortized discount (Premium), Net     0    
Short-term merger financing, net     4,790,907    
long term, seller notes          
COMMITMENTS AND CONTINGENCIES          
Principal balance     7,971,197    
Interest expense on convertible notes     259,063    
Amortization of discount     99,890    
Pay for accrued interest     259,058    
Accrued interest net     259,064    
Unamortized discount (Premium), Net     521,646    
Long term merger financing, net     $ 7,708,615    
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Contingent Guarantee (Details) - USD ($)
3 Months Ended 5 Months Ended
Aug. 09, 2024
Feb. 09, 2024
Feb. 07, 2024
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
COMMITMENTS AND CONTINGENCIES            
Value of founder shares transferred to cover cash deficit     $ 6,000,000      
Shares of Founder Shares Transferred   885,010        
Contingent guarantee   $ 3,256,863     $ 3,256,863 $ 3,256,863
Shares issued to additional consideration for delayed payments (in shares)       1,234,990    
Reduction in the contingent guarantee       $ 1,210,290    
Stock Issued for Contingent Guarantee $ 2,886,347          
Percentage of convenience fees 5.00%          
Amount of convertible notes issued $ 3,030,665          
Contingent Guarantee Deemed Value   0        
Value of founder shares transferred   4,000,000        
Amount of cash recovered through transfer of shares         $ 743,137 $ 743,137
Initial value of derivative included in merger financing       113,044    
Interest expense on the principal       56,909    
Amortization of debt discount       $ 10,707    
Short term            
COMMITMENTS AND CONTINGENCIES            
Value of founder shares transferred   $ 8,850,100        
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Tau Agreement - ELOC (Details)
3 Months Ended
Jul. 31, 2024
USD ($)
D
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
$ / shares
Dec. 31, 2023
$ / shares
Dec. 31, 2022
$ / shares
COMMITMENTS AND CONTINGENCIES          
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Common Stock that may be issuable | shares   10,000,000      
Stock subscription receivable   $ (154,619)      
Proceeds from Tau agreement   $ 148,383      
ELOC Agreement          
COMMITMENTS AND CONTINGENCIES          
Maximum Aggregate Purchase Price $ 10,000,000        
Agreement Term 24 months        
Number of shares of individual advances requested | shares 100,000        
Advances requested, percentage of average daily volume of common stock traded 50.00%        
Threshold trading days | D 30        
Shares price payable as percentage of VWAP of the Common Stock 97.00% 97.00%      
Threshold consecutive trading days | D 3        
Common Stock that may be issuable | shares   2,310,000      
Stock issued during period shares (in Shares) | shares   1,445,527      
Pricing period of consecutive trading days   3 days      
Reduction in advance amount, percentage   33.00%      
Commitment fee, percentage   1.25%      
Amount of advance notices   $ 441,524      
Initial fair value of commitment amount   391,017      
Commitment fees payable   50,506      
Commitment fee, receivable   441,524      
Commitment amount for advances   169,084      
Fair value of commitment amount   575,136      
Fair value of commitment fee   74,289      
Initial fair value commitment fee   966,153      
Initial fair value, commitment amount   124,796      
shares sold under the share purchase agreement   303,001      
Shares purchased during the period under the agreement   272,440      
Shares purchased under the share purchase agreement   30,562      
Stock subscription receivable   (154,619)      
Proceeds from Tau agreement   $ 148,382      
Shares not settled during period | shares   864,473      
Change in fair value of commitment amount   $ 229,407      
Change in fair value of commitment fee   $ 44,848      
v3.24.4
NOTES PAYABLE AND COMMITMENTS AND CONTINGENCIES - Wilson-Davis (Details) - USD ($)
Dec. 19, 2019
Feb. 27, 2018
Feb. 29, 2024
Dec. 31, 2023
Dec. 21, 2023
Oct. 16, 2023
Apr. 30, 2020
COMMITMENTS AND CONTINGENCIES              
Term of lease     3 years 12 months     63 months
Wilson Davis Co Inc              
COMMITMENTS AND CONTINGENCIES              
Amount of damages awarded to the plaintiff in the legal matter $ 1,265,000 $ 1,470,000          
Damage reduced 205,000            
Accrued contingent liability $ 100,000            
Wilson Davis Co Inc | Lease For Salt Lake City Office              
COMMITMENTS AND CONTINGENCIES              
Term of lease           3 years  
Wilson Davis Co Inc | Office Lease For Denver Office              
COMMITMENTS AND CONTINGENCIES              
Term of lease         1 year    
v3.24.4
ACQUISITION OF WILSON-DAVIS - Allocation of the purchase price (Details) - USD ($)
6 Months Ended
Feb. 07, 2024
Jun. 30, 2024
Sep. 30, 2024
ACQUISITION OF WILSON-DAVIS      
Cash payable $ 8,000,000 $ 8,092,568  
Allocated to:      
Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill   22,019,881 $ 21,914,990
WILSON-DAVIS      
ACQUISITION OF WILSON-DAVIS      
Cash payable 8,092,569    
Value of shares transferred from sponsor 6,000,000    
Total consideration paid 27,063,766    
Allocated to:      
Cash 11,333,271    
Cash segregated 22,000,605    
Receivables 4,065,148    
Trading Securities, market value 6,875    
Prepaid Income Tax 201,125    
Accounts payable, accrued expenses and other current liabilities (28,045,034)    
Current portion of lease liability (161,212)    
Property and equipment 23,645    
Cash deposit BDs and Clearing Organizations 3,536,664    
Operating Lease Right-to-Use Lease Assets 395,063    
Other Assets 385,058    
Stock loan (1,431,068)    
Long-term Lease liability (239,629)    
Subordinated Borrowing (1,950,000)    
Deferred tax liability (3,724,270)    
Trading Account deposit (100,000)    
Net assets acquired 6,296,241    
Excess of purchase price over net liabilities assumed before allocation to identifiable intangible assets and goodwill 20,767,525 $ 22,331,725  
WILSON-DAVIS | Short term      
ACQUISITION OF WILSON-DAVIS      
Short-term and long-term notes 5,000,000    
WILSON-DAVIS | Long term      
ACQUISITION OF WILSON-DAVIS      
Short-term and long-term notes $ 7,971,197    
v3.24.4
ACQUISITION OF WILSON-DAVIS - Identified excess of the purchase price over the fair value of the net assets acquired recorded as goodwill (Details) - USD ($)
6 Months Ended
Feb. 07, 2024
Jun. 30, 2024
Sep. 30, 2024
ACQUISITION OF WILSON-DAVIS      
Excess of purchase price   $ 22,019,881 $ 21,914,990
Goodwill   7,706,725 $ 6,142,525
WILSON-DAVIS      
ACQUISITION OF WILSON-DAVIS      
Customer Lists $ 14,625,000 14,625,000  
Excess of purchase price 20,767,525 22,331,725  
Goodwill $ 6,142,525 $ 7,706,725  
Estimated Useful Life (Years) 12 years 12 years  
v3.24.4
ACQUISITION OF WILSON-DAVIS - Pro forma financial information (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
ACQUISITION OF WILSON-DAVIS        
Total revenue $ 1,834,164 $ 5,247,150 $ 8,258,254 $ 9,527,324
Net loss $ (1,575,799) $ (23,878,060) $ (4,695,016) $ (90,186,458)
Weighted average shares, Basic 11,801,759 11,801,759 11,801,759 11,906,245
Weighted average shares, Diluted 11,801,759 11,801,759 11,801,759 11,906,245
Net loss per shares: Basic $ (0.13) $ (2.02) $ (0.4) $ (8.87)
Net loss per shares: Diluted $ (0.13) $ (2.02) $ (0.4) $ (8.87)
v3.24.4
ACQUISITION OF WILSON-DAVIS - Pro forma adjustments (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
ACQUISITION OF WILSON-DAVIS        
Transaction cost   $ (9,008,053)   $ 9,008,053
Amortization of intangibles $ (307,192)   $ 2,437,500 2,437,500
Loss on AtlasClear acquisition   86,392,769   (86,392,769)
Interest earned on investments held in trust $ (722,390) $ (256,279) $ (3,090,086) $ (3,087,315)
v3.24.4
INTANGIBLE ASSETS - Pacsquare Purchase Agreement (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
installment
$ / shares
shares
Jun. 30, 2024
USD ($)
installment
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
INTANGIBLE ASSES          
Common stock, shares issued | shares 22,245,698 12,455,157 12,455,157 5,031,250 5,031,250
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Accrued in accounts payable   $ 85,000 $ 85,000    
Shares issued as purchase consideration for the assets (in shares) | shares   4,400,000      
AtlasClear Platform | Pacsquare          
INTANGIBLE ASSES          
Threshold period to receive level 1 equities trading platform from signing of agreement 12 months 12 months      
Purchase price $ 4,800,000 $ 4,800,000      
Payable in cash and in shares of common stock 1,900,000 1,900,000 1,900,000    
Payable in cash upon delivery of source code and execution of purchase agreement 100,000 100,000 $ 100,000    
Total Purchase Price $ 850,000 $ 850,000      
Market price of public shares (in Dollars per share) | $ / shares $ 6 $ 6 $ 6    
Four monthly installments payable $ 950,000 $ 950,000 $ 950,000    
Number of monthly installments 237,500 4 4    
Monthly installments payable $ 4 $ 237,500 $ 237,500    
Payable ratably on module-by-module basis upon delivery and acceptance of each of platform modules $ 2,700,000 $ 2,700,000 $ 2,700,000    
Common stock, shares issued | shares   336,000 336,000    
Cash consideration   $ 500,000 $ 500,000    
Purchase price allocated to Contribution Agreement   $ 1,726,500 $ 1,726,500    
Shares issued as purchase consideration for the assets (in shares) | shares 500,000        
Shares issued as purchase consideration for the assets $ 122,300        
Asset acquisition, additional consideration payable 15,000        
Total carrying value $ 1,928,800        
AtlasClear Platform | Pacsquare | Price per share at $6.00          
INTANGIBLE ASSES          
Common stock, shares issued | shares   141,667 141,667    
Common stock, par value (in dollars per share) | $ / shares   $ 6 $ 6    
AtlasClear Platform | Pacsquare | Price per share at $1.50          
INTANGIBLE ASSES          
Common stock, shares issued | shares   194,333 194,333    
Common stock, par value (in dollars per share) | $ / shares   $ 1.5 $ 1.5    
v3.24.4
INTANGIBLE ASSETS - Schedule of Intangible assets (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Cost    
Indefinite lived $ 6,142,525 $ 6,142,525
Intangible assets, gross including goodwill 22,696,325 40,657,069
Accumulated Amortization (781,335) (791,375)
Impairment of Asset    
Intangible assets excluding goodwill accumulated impairment loss (17,845,813) (17,845,813)
Net    
Intangible assets excluding goodwill 6,142,525 6,142,525
Excess of purchase price $ 21,914,990 $ 22,019,881
Technology acquired    
INTANGIBLE ASSES    
Est useful life   0 days
Cost    
Finite lived intangible assets, gross   $ 18,163,044
Accumulated Amortization   (317,231)
Impairment of Asset    
Intangible assets excluding goodwill accumulated impairment loss   $ (17,845,813)
Customer Lists    
INTANGIBLE ASSES    
Est useful life 12 years 12 years
Cost    
Finite lived intangible assets, gross $ 14,625,000 $ 14,625,000
Accumulated Amortization (781,335) (474,144)
Net    
Intangible assets, net $ 13,843,665 $ 14,150,856
Pacsquare assets - Proprietary Software    
INTANGIBLE ASSES    
Est useful life 10 years 10 years
Cost    
Indefinite lived $ 1,928,800 $ 1,726,500
Net    
Intangible assets excluding goodwill $ 1,928,800 $ 1,726,500
v3.24.4
INTANGIBLE ASSETS - Amortization of intangible assets (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
INTANGIBLE ASSETS    
June 30, 2025 $ 911,558 $ 1,218,750
June 30, 2026 1,411,630 1,391,400
June 30, 2027 1,411,630 1,391,400
June 30, 2028 1,414,970 1,394,739
June 30, 2029 1,411,630 1,391,400
Thereafter $ 9,211,047 $ 9,089,667
v3.24.4
STOCKHOLDERS' DEFICIT (Details)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Feb. 09, 2024
shares
Feb. 04, 2021
shares
Sep. 30, 2024
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
STOCKHOLDERS' DEFICIT            
Preferred stock, shares authorized     1,000,000 1,000,000 1,000,000 1,000,000
Preferred stock, par value (in dollars per share) | $ / shares     $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, shares issued     0 0 0 0
Preferred stock, shares outstanding     0 0 0 0
Common stock, shares authorized     100,000,000 100,000,000 100,000,000 100,000,000
Common stock, par value (in dollars per share) | $ / shares     $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Common stock, voting rights     one one    
Common stock, shares issued     22,245,698 12,455,157 5,031,250 5,031,250
Common stock, shares outstanding     22,245,698 12,455,157 5,031,250 5,031,250
Shares of common stock issued under Tau Agreement     1,029,473      
Quantum Fintech Acquisition Corp            
STOCKHOLDERS' DEFICIT            
Share exchange ratio 1          
Founder Shares            
STOCKHOLDERS' DEFICIT            
Shares owned   4,000,000        
Chardan Quantum LLC            
STOCKHOLDERS' DEFICIT            
Shares owned   949,084        
Quantum Common Stock            
STOCKHOLDERS' DEFICIT            
Common stock, shares issued 12,277,759          
Common stock, shares outstanding 12,277,759          
Aggregate shares       4,940,885    
Remaining balance of trust account | $       $ 1.2    
Common Stock subject to possible redemption       109,499    
v3.24.4
WARRANTS (Details)
6 Months Ended
Jun. 30, 2024
D
$ / shares
shares
Sep. 30, 2024
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
WARRANTS      
Issue price per share (in dollars per share) $ 9.2    
Equity proceeds 60.00%    
Exercise price per share (in dollars per share) $ 9.5    
Warrant percentage 115.00%    
Issue price 16.5    
Market value percentage 165.00%    
Public Warrants      
WARRANTS      
Public warrants outstanding (in shares) | shares 20,125,000 20,125,000 20,125,000
Number of shares called by each warrant | shares 0.5 0.5 0.5
Warrant exercise price (in dollars per share) $ 11.5 $ 11.5 $ 11.5
Number of days within which the registration statement should be declared effective 120 days    
Expire term 5 years    
Redemption price per warrant (in dollars per share) $ 0.01    
Notice period redemption 30 days    
Price of the entity's common stock (in dollars per share) $ 16.5    
Threshold number of specified trading days | D 20    
Threshold consecutive number of specified trading days | D 30    
Private Warrants      
WARRANTS      
Public warrants outstanding (in shares) | shares 6,153,125 6,153,125 6,153,125
Number of shares called by each warrant | shares 1    
Warrant exercise price (in dollars per share) $ 11.5    
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis (Details) - USD ($)
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
FAIR VALUE MEASUREMENTS        
Convertible notes derivative   $ 16,462,690    
Level 3        
FAIR VALUE MEASUREMENTS        
Subscription agreement $ 2,460,488 2,425,647    
Contingent Guarantee   3,256,863    
Warrant liability - Private Warrants 61,531 307,656 $ 307,656 $ 184,594
Earnout liability 12,638,000 12,298,000    
Convertible notes derivative 2,142,511 $ 16,462,690    
Merger financing derivative 176,239      
Secured convertible derivative 89,535      
Tau agreement $ 972,508      
Non-redemption agreement liability     $ 1,441,653  
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of key inputs into the Monte Carlo model for the Subscription Agreement (Details)
Sep. 30, 2024
$ / shares
Jun. 30, 2024
$ / shares
Feb. 09, 2024
$ / shares
Market price of public shares      
FAIR VALUE MEASUREMENTS      
Subscription agreement 0.21 1.04 10.26
Equity volatility      
FAIR VALUE MEASUREMENTS      
Subscription agreement 0.344 0.262 0.298
Risk-free rate      
FAIR VALUE MEASUREMENTS      
Subscription agreement 0.0401 0.0505 0.0467
v3.24.4
FAIR VALUE MEASUREMENTS - Contingent Guarantee (Details) - USD ($)
3 Months Ended 6 Months Ended
Feb. 07, 2024
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Feb. 09, 2024
FAIR VALUE MEASUREMENTS          
Value of founder shares transferred to cover cash deficit $ 6,000,000        
Contingent guarantee     $ 3,256,863 $ 3,256,863 $ 3,256,863
Value of shares issued as payment towards contingent guarantee   $ 1,210,290      
Repayment obligation of contingent guarantee   2,886,347      
Change in fair value, contingent guarantee   $ 839,775 $ 3,256,863 $ 3,256,863  
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of Key Inputs into the Black-Scholes model for the Private Warrants (Details)
6 Months Ended 12 Months Ended
Feb. 09, 2024
USD ($)
Jun. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
$ / shares
Dec. 31, 2022
$ / shares
Sep. 30, 2024
$ / shares
FAIR VALUE MEASUREMENTS          
Effective expiration date   Feb. 09, 2029 Feb. 09, 2029 Feb. 09, 2029  
Non-redemption agreement liability shares (in Shares) | shares   235,180      
Non-redemption of common stock shares (in Shares) | shares   235,180      
Warrants reclassified as permanent equity at total value | $ $ 1,606,279 $ 1,606,279      
Market price of public shares          
FAIR VALUE MEASUREMENTS          
Private warrants | $ / shares   1.04 6.2 10.05 0.21
Risk-free rate          
FAIR VALUE MEASUREMENTS          
Private warrants   0.0427 0.0377 0.0391 0.0352
Dividend yield          
FAIR VALUE MEASUREMENTS          
Private warrants   0 0 0 0
Volatility          
FAIR VALUE MEASUREMENTS          
Private warrants   0.587 0.12 0.026 0.874
Exercise price          
FAIR VALUE MEASUREMENTS          
Private warrants | $ / shares   11.5 11.5 11.5 11.5
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of key inputs into the Monte Carlo model for the Earnout liability (Details)
Sep. 30, 2024
$ / shares
Jun. 30, 2024
$ / shares
Feb. 09, 2024
$ / shares
Market price of public shares      
FAIR VALUE MEASUREMENTS      
Earnout liability 0.21 1.04 10.26
Revenue volatility      
FAIR VALUE MEASUREMENTS      
Earnout liability 0.15 0.15 0.15
Discount factor for revenue      
FAIR VALUE MEASUREMENTS      
Earnout liability 0.0961 0.0969 0.995
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of key inputs into the Black-Scholes model for the Conversion derivative (Details)
6 Months Ended 12 Months Ended
Feb. 09, 2024
$ / shares
Jun. 30, 2024
$ / shares
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2024
$ / shares
Aug. 09, 2024
$ / shares
FAIR VALUE MEASUREMENTS            
Effective expiration date   Feb. 09, 2029 Feb. 09, 2029 Feb. 09, 2029    
Market price of public shares            
FAIR VALUE MEASUREMENTS            
Convertible derivative   1.04        
Risk-free rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative   0.0452        
Dividend yield            
FAIR VALUE MEASUREMENTS            
Convertible derivative   0        
Volatility            
FAIR VALUE MEASUREMENTS            
Convertible derivative   1,666.81        
Exercise price            
FAIR VALUE MEASUREMENTS            
Convertible derivative   0.84        
Short Term Notes            
FAIR VALUE MEASUREMENTS            
Effective expiration date May 01, 2024 May 01, 2024        
Short Term Notes | Market price of public shares            
FAIR VALUE MEASUREMENTS            
Convertible derivative 10.26 1.04     0.21  
Short Term Notes | Risk-free rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative 0.0544 0.0549     0.0484  
Short Term Notes | Discount rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.1172  
Short Term Notes | Probability of default            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.229  
Short Term Notes | Recovery rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.289  
Short Term Notes | Dividend yield            
FAIR VALUE MEASUREMENTS            
Convertible derivative 0 0        
Short Term Notes | Volatility            
FAIR VALUE MEASUREMENTS            
Convertible derivative 41.20 146.43     0.367  
Short Term Notes | Exercise price            
FAIR VALUE MEASUREMENTS            
Convertible derivative 7.27 0.99        
Long-Term Notes | Market price of public shares            
FAIR VALUE MEASUREMENTS            
Convertible derivative 10.26 1.04     0.21  
Long-Term Notes | Risk-free rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative 0.0448 0.049     0.0484  
Long-Term Notes | Recovery rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.289  
Long-Term Notes | Dividend yield            
FAIR VALUE MEASUREMENTS            
Convertible derivative 0 0     0.1172  
Long-Term Notes | Volatility            
FAIR VALUE MEASUREMENTS            
Convertible derivative 412 144.61     0.229  
Long-Term Notes | Exercise price            
FAIR VALUE MEASUREMENTS            
Convertible derivative 7.27 0.99     0.367  
Chardan Note | Market price of public shares            
FAIR VALUE MEASUREMENTS            
Convertible derivative 10.26 1.04     0.21  
Chardan Note | Risk-free rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative 0.0448 0.0452     0.0436  
Chardan Note | Discount rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.0772  
Chardan Note | Probability of default            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.412  
Chardan Note | Recovery rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.476  
Chardan Note | Dividend yield            
FAIR VALUE MEASUREMENTS            
Convertible derivative 0 0        
Chardan Note | Volatility            
FAIR VALUE MEASUREMENTS            
Convertible derivative 41.20 1,666.81     0.439  
Chardan Note | Exercise price            
FAIR VALUE MEASUREMENTS            
Convertible derivative 10.26 0.84        
Secured Convertible Note | Market price of public shares            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.21  
Secured Convertible Note | Risk-free rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.0387  
Secured Convertible Note | Discount rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.0784  
Secured Convertible Note | Probability of default            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.198  
Secured Convertible Note | Recovery rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.476  
Secured Convertible Note | Volatility            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.368  
Merger Financing | Market price of public shares            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.21 0.27
Merger Financing | Risk-free rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.0484 0.0478
Merger Financing | Discount rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.1172 0.1698
Merger Financing | Probability of default            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.235 0.254
Merger Financing | Recovery rate            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.289 0.289
Merger Financing | Volatility            
FAIR VALUE MEASUREMENTS            
Convertible derivative         0.367 0.372
v3.24.4
FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Oct. 23, 2024
Jun. 30, 2024
Jun. 29, 2024
Feb. 09, 2024
Feb. 07, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Aug. 09, 2024
Short-Term Debt [Line Items]                      
Derivative liability - convertible notes   $ 16,462,690       $ 16,462,690     $ 16,462,690 $ 16,462,690  
Penalty interest rate   13.00% 9.00%     13.00%     13.00% 13.00%  
Marketing fees payable to underwriters       $ 7,043,750              
Conversion derivative                      
Short-Term Debt [Line Items]                      
Increase in fair value of derivative liability               $ (14,320,179) $ 14,793,959    
Derivative liability                 1,668,731    
Short Term Notes                      
Short-Term Debt [Line Items]                      
Fair value of embedded derivative   $ 4,807,692       $ 4,807,692   335,906 $ 4,807,692 $ 4,807,692  
Aggregate principal amount         $ 5,000,000            
Maturity due         90 days            
Penalty interest rate   13.00% 9.00%     13.00%     13.00% 13.00%  
Interest rate (in percent)         9.00%            
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)         90.00%            
Short Term Notes | Conversion derivative                      
Short-Term Debt [Line Items]                      
Increase in fair value of derivative liability   $ 4,807,692 $ 4,320,363                
Unamortized discount   487,929       $ 487,929     $ 487,929 $ 487,929  
Derivative liability         $ 487,329            
Short Term Notes | Wilson-Davis Sellers                      
Short-Term Debt [Line Items]                      
Aggregate principal amount       $ 487,329              
Maturity due       90 days              
Long-Term Notes                      
Short-Term Debt [Line Items]                      
Fair value of embedded derivative   7,664,613       7,664,613   983,529 7,664,613 7,664,613  
Aggregate principal amount         $ 7,971,000            
Maturity due         24 months            
Interest rate (in percent)         13.00%            
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)         90.00%            
Long-Term Notes | Conversion derivative                      
Short-Term Debt [Line Items]                      
Increase in fair value of derivative liability                 6,887,694    
Unamortized discount   776,919       776,919     776,919 776,919  
Derivative liability         $ 776,919       776,919    
Increased fair value   7,664,613       7,664,613     7,664,613 7,664,613  
Long-Term Notes | Interest Solutions                      
Short-Term Debt [Line Items]                      
Aggregate principal amount       $ 275,000              
Interest rate (in percent)       13.00%              
Long-Term Notes | JonesTrading Institutional Services                      
Short-Term Debt [Line Items]                      
Interest rate (in percent)       13.00%              
Chardan Note                      
Short-Term Debt [Line Items]                      
Fair value of embedded derivative   $ 3,990,385       3,990,385   823,076 3,990,385 3,990,385  
Aggregate principal amount       $ 4,150,000              
Unamortized discount               280,355      
Interest rate (in percent)       13.00%              
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)       85.00%              
Aggregate principal amount       $ 4,150,000   725,000 $ 725,000 $ 725,000      
Number of years up to which the converted amount is to be held for payment of interest   3 years   3 years       3 years      
Amortization of discount               $ 86,209      
Chardan Note | Conversion derivative                      
Short-Term Debt [Line Items]                      
Unamortized discount   $ 404,483       404,483     404,483 404,483  
Derivative liability       $ 404,483              
Increased fair value     $ 3,585,901                
Chardan Note | Conversion derivative | Maximum                      
Short-Term Debt [Line Items]                      
Increase in fair value of derivative liability                 404,483    
Chardan Note | Chardan Capital Market LLC                      
Short-Term Debt [Line Items]                      
Aggregate principal amount   $ 3,990,385       $ 3,990,385   4,150,000 $ 3,990,385 $ 3,990,385  
Marketing fees payable to underwriters               $ 7,043,750      
Interest rate (in percent)   13.00%       13.00%   13.00% 13.00% 13.00%  
Interest payable in shares, as a percentage of trailing specified trading day VWAP (in percent)               85.00%   85.00%  
Chardan Note | JonesTrading Institutional Services                      
Short-Term Debt [Line Items]                      
Aggregate principal amount       $ 375,000              
Chardan Note | Subsequent event                      
Short-Term Debt [Line Items]                      
Aggregate principal amount $ 5,209,764                    
Aggregate principal amount $ 5,209,764                    
Convertible notes                      
Short-Term Debt [Line Items]                      
Derivative liability - convertible notes   $ 16,462,690       $ 16,462,690   $ 2,142,511 $ 16,462,690 $ 16,462,690  
Aggregate principal amount               325,000      
Secured Convertible Note                      
Short-Term Debt [Line Items]                      
Fair value of embedded derivative               89,535      
Merger Financing                      
Short-Term Debt [Line Items]                      
Fair value of embedded derivative               $ 176,239     $ 113,044
v3.24.4
FAIR VALUE MEASUREMENTS - Tau Agreement (Details) - Tau Agreement
Sep. 30, 2024
USD ($)
$ / shares
Jul. 31, 2024
USD ($)
$ / shares
FAIR VALUE MEASUREMENTS    
Initial fair value, commitment amount $ 124,796  
Initial fair value commitment fee 966,153  
Tau Investment Partners LLC    
FAIR VALUE MEASUREMENTS    
Initial fair value, commitment amount   $ 966,153
Subsequent fair value of commitment amount 892,558  
Initial fair value commitment fee   $ 124,796
Subsequent fair value of commitment fee $ 79,948  
Tau Investment Partners LLC | Anticipated Monthly Advance Amounts    
FAIR VALUE MEASUREMENTS    
Commitment amount 40,000 40,000
Tau Investment Partners LLC | Market price of public shares    
FAIR VALUE MEASUREMENTS    
Commitment fee | $ / shares 0.21 0.27
Tau Investment Partners LLC | Risk-free rate    
FAIR VALUE MEASUREMENTS    
Commitment amount 0.0359 0.042
Commitment fee 0.0359 0.042
Tau Investment Partners LLC | Volatility    
FAIR VALUE MEASUREMENTS    
Commitment amount 0.374 0.403
Commitment fee 0.374 0.403
v3.24.4
FAIR VALUE MEASUREMENTS - Schedule of changes in the fair value (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Subscription Agreement          
Fair value asset          
Fair value $ 2,425,647 $ 0      
Initial measurement   2,386,851      
Change in valuation inputs or other assumptions 34,841 38,796      
Fair value 2,460,488 2,425,647 $ 0    
Private Placement Warrants          
Fair value liability          
Fair value 307,656 307,656 184,594 $ 7,137,930  
Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability     123,062    
Change in valuation inputs or other assumptions (246,125)       $ (6,953,336)
Fair value 61,531 307,656 307,656 184,594 $ 7,137,930
Non-Redemption Agreement Liability          
Fair value liability          
Fair value   1,441,653      
Initial measurement     1,881,440    
Fair value as of August 8, 2023, Inception of Non-Redemption Agreement Liability     (439,787)    
Transferred to equity   (1,606,279)      
Change in valuation inputs or other assumptions   164,626   $ 1,881,440  
Fair value     1,441,653    
Tau Agreement Liability          
Fair value liability          
Initial measurement 1,090,949        
Transferred to equity (303,000)        
Change in valuation inputs or other assumptions 184,559        
Fair value 972,508        
Conversion Derivative          
Fair value liability          
Fair value 16,462,690 0      
Initial measurement   1,668,731      
Change in valuation inputs or other assumptions (14,320,179) 14,793,959      
Fair value 2,142,511 16,462,690 0    
Earnout Liability          
Fair value liability          
Fair value 12,298,000 0      
Initial measurement   10,963,000      
Change in valuation inputs or other assumptions 340,000 1,335,000      
Fair value 12,638,000 12,298,000 0    
Contingent Guarantee          
Fair value liability          
Fair value 3,256,863 0      
Shares issued as partial payment (1,210,290)        
Change in valuation inputs or other assumptions 839,774 3,256,863      
Exchanged to Merger financing note (2,886,347)        
Fair value   3,256,863 $ 0    
Merger Financing Derivative          
Fair value liability          
Fair value 0        
Initial measurement 113,044        
Change in valuation inputs or other assumptions 63,195        
Fair value 176,239 0      
Secured Convertible Derivative          
Fair value liability          
Fair value 0        
Change in valuation inputs or other assumptions 89,535        
Fair value $ 89,535 $ 0      
v3.24.4
FAIR VALUE MEASUREMENTS - Fair value Assets and Liabilities Transfer Amount (Details) - USD ($)
3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
FAIR VALUE MEASUREMENTS    
Asset transfers from level 1 to level 2 $ 0 $ 0
Asset transfers from level 2 to level 1 0 0
Liability transfers from level 1 to level 2 0 0
Liability transfers from level 2 to level 1 0 0
Asset transfers into or out of level 3 0 0
Liability transfers into or out of level 3 $ 0 $ 0
v3.24.4
SUBSEQUENT EVENTS (Details)
1 Months Ended 3 Months Ended
Nov. 14, 2024
shares
Oct. 23, 2024
USD ($)
Oct. 21, 2024
$ / shares
shares
Oct. 13, 2024
USD ($)
Feb. 09, 2024
USD ($)
Jun. 30, 2024
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
SUBSEQUENT EVENTS                    
Common stock, shares authorized (in shares) | shares           100,000,000   100,000,000 100,000,000 100,000,000
Preferred stock, par value (in dollars per share) | $ / shares           $ 0.0001   $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) | shares           1,000,000   1,000,000 1,000,000 1,000,000
Common stock, par value (in dollars per share) | $ / shares           $ 0.0001   $ 0.0001 $ 0.0001 $ 0.0001
Subsequent event                    
SUBSEQUENT EVENTS                    
Common stock, shares authorized (in shares) | shares     500,000,000              
Preferred stock, par value (in dollars per share) | $ / shares     $ 0.0001              
Preferred stock, shares authorized (in shares) | shares     25,000,000              
Stock issued during period shares (in Shares) | shares 500,000                  
Number of shares | shares 40,000                  
Subordinated notes | Subsequent event                    
SUBSEQUENT EVENTS                    
Extension term       1 year            
Extension principal amount       $ 1,280,000            
Amount was not renewed and not included in capital calculations       $ 20,000            
Chardan Note                    
SUBSEQUENT EVENTS                    
Extension principal amount         $ 4,150,000          
Interest rate (in percent)         13.00%          
Aggregate principal amount         $ 4,150,000 $ 725,000 $ 725,000 $ 725,000    
Chardan Note | Subsequent event                    
SUBSEQUENT EVENTS                    
Extension principal amount   $ 5,209,764                
Aggregate principal amount   5,209,764                
Chardan Amended Note | Subsequent event                    
SUBSEQUENT EVENTS                    
Aggregate principal amount   $ 5,209,764                
Minimum | Subordinated notes | Subsequent event                    
SUBSEQUENT EVENTS                    
Interest rate (in percent)       5.00%            
Maximum | Subordinated notes | Subsequent event                    
SUBSEQUENT EVENTS                    
Interest rate (in percent)       8.00%            
Reverse stock split one | Subsequent event                    
SUBSEQUENT EVENTS                    
Stock split     0.033              
Reverse stock split two | Subsequent event                    
SUBSEQUENT EVENTS                    
Stock split     0.025              
Reverse stock split three | Subsequent event                    
SUBSEQUENT EVENTS                    
Stock split     0.02              
Reverse stock split four | Subsequent event                    
SUBSEQUENT EVENTS                    
Stock split     0.0167              
Reverse stock split approved                    
SUBSEQUENT EVENTS                    
Stock split     0.0167              
If the resale registration statement is not filed by December 31, 2024 until the date of filing | Chardan Note | Subsequent event                    
SUBSEQUENT EVENTS                    
Interest rates increase per annum (in percent)   2.00%                
If the resale registration statement is not effective by March 31, 2025, until the date of effectiveness | Chardan Note | Subsequent event                    
SUBSEQUENT EVENTS                    
Interest rates increase per annum (in percent)   19.99%